data_2k57_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k57 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 110.162 -0.31 . . . . 64.24 110.162 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.13 115.46 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.152 1.901 . . . . 73.25 112.982 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 69.6 m -125.96 122.35 35.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.46 -0.337 . . . . 73.35 111.377 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.26 115.02 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.487 0.66 . . . . 63.11 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.63 117.79 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.224 -0.444 . . . . 73.51 111.031 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.453 HG22 ' NH2' ' A' ' 48' ' ' ARG . 22.8 m -98.47 123.63 42.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.267 -0.424 . . . . 71.2 110.651 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.436 HD11 ' HD3' ' A' ' 13' ' ' ARG . 72.2 mt -83.7 174.43 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.278 0.561 . . . . 74.14 112.453 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -53.74 -43.97 69.53 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.572 -0.74 . . . . 74.43 112.866 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.77 -24.33 56.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.113 0.482 . . . . 74.42 111.455 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.98 -6.75 10.99 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.39 -0.433 . . . . 65.33 113.274 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.436 ' HD3' HD11 ' A' ' 9' ' ' LEU . 77.8 ttt180 -59.94 115.88 3.73 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.862 0.331 . . . . 75.32 111.11 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HG2' HG23 ' A' ' 8' ' ' THR . 44.8 mt-10 -105.1 130.22 53.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.745 0.307 . . . . 60.13 111.68 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -121.79 132.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.821 0.343 . . . . 75.3 110.554 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -98.73 125.86 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.132 0.492 . . . . 72.33 111.691 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.43 150.7 25.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.005 -0.543 . . . . 74.41 111.641 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.496 HG11 ' HA ' ' A' ' 35' ' ' LEU . 27.9 m -85.74 -17.18 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 120.991 0.424 . . . . 74.34 111.981 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.04 175.26 9.88 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 72.55 111.112 174.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -77.38 142.28 67.1 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 112.304 0.483 . . . . 61.3 112.304 -170.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 84.7 Cg_endo -76.47 157.47 36.6 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.855 2.37 . . . . 71.2 114.274 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -116.15 123.26 47.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.827 -0.624 . . . . 74.35 111.388 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -82.19 114.29 20.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.917 -0.401 . . . . 75.51 109.917 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.23 105.76 17.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.974 0.416 . . . . 74.5 111.591 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.43 -29.4 69.92 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.106 -0.497 . . . . 63.24 111.98 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -65.4 -55.11 19.89 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.208 0.447 . . . . 52.43 112.208 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -96.14 -17.93 20.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.014 0.375 . . . . 74.52 112.014 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.19 10.88 77.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.223 -0.513 . . . . 54.04 114.022 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.41 165.03 11.47 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.525 0.678 . . . . 71.13 112.226 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.65 122.71 44.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.413 -0.812 . . . . 74.14 110.022 167.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.591 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 26.3 mt-10 -98.96 119.66 38.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.273 -0.421 . . . . 73.45 110.527 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 23.1 p90 -140.03 144.58 36.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.192 0.52 . . . . 65.11 111.562 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 32.1 ttmt -95.08 110.58 22.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.773 -0.649 . . . . 74.42 111.564 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -60.36 169.07 1.8 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.4 0.519 . . . . 54.04 112.4 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.496 ' HA ' HG11 ' A' ' 18' ' ' VAL . 98.6 mt -53.15 -30.37 36.65 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.432 0.531 . . . . 70.25 112.432 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.626 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -73.16 -12.25 60.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.007 0.432 . . . . 72.44 111.602 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.36 60.99 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.239 -0.505 . . . . 74.23 112.55 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 30.1 mtmm -96.88 125.33 41.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.71 0.291 . . . . 73.12 111.319 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -78.44 128.36 33.49 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.841 0.353 . . . . 74.31 111.324 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.3 t -131.65 163.48 28.02 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.836 0.351 . . . . 74.44 111.002 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.591 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 87.3 mtm180 -136.43 131.55 34.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.508 -0.314 . . . . 64.23 111.635 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.15 150.92 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.524 0.202 . . . . 63.54 111.068 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.88 147.57 42.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.656 0.741 . . . . 61.41 112.881 -172.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -55.9 -24.13 35.6 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.134 1.161 . . . . 75.14 114.134 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -87.56 -17.12 32.73 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.221 0.452 . . . . 74.11 112.221 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -78.41 -17.68 56.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.342 0.497 . . . . 64.3 112.342 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.6 115.83 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.403 0.62 . . . . 73.54 112.178 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.453 ' NH2' HG22 ' A' ' 8' ' ' THR . 58.7 ttp180 -83.15 -62.29 1.63 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.141 0.496 . . . . 62.52 111.536 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.9 p -132.9 137.67 46.73 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.062 0.458 . . . . 73.24 111.963 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.2 106.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.126 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.4 149.46 49.66 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.33 0.586 . . . . 74.23 112.18 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.6 m-20 . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 70.23 111.007 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 110.671 -0.122 . . . . 51.45 110.671 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.03 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.65 1.567 . . . . 72.22 111.714 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 60.1 m -112.38 147.8 35.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.119 0.485 . . . . 72.45 111.998 -174.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.16 112.33 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.544 0.687 . . . . 63.01 110.494 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -90.41 105.68 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 70.4 111.089 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.6 m -83.72 107.7 16.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 74.23 110.987 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -78.08 153.58 32.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.653 0.263 . . . . 73.05 110.861 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -66.12 -14.32 61.6 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.918 0.39 . . . . 63.12 111.517 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.89 -8.78 57.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.762 0.315 . . . . 74.42 111.702 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 3.36 68.11 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.41 -0.424 . . . . 50.31 112.464 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -87.19 132.71 33.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.602 0.361 . . . . 74.54 111.06 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.79 130.15 55.65 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.997 0.427 . . . . 75.12 111.701 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.3 mt -109.85 128.51 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.26 -0.427 . . . . 65.42 110.894 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -97.97 126.71 43.5 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.074 0.464 . . . . 75.55 111.985 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.67 150.09 47.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.077 -0.51 . . . . 63.22 112.165 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 35' ' ' LEU . 33.1 m -94.97 5.74 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.219 -0.446 . . . . 74.21 111.559 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -144.79 160.67 40.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.339 -0.391 . . . . 70.21 110.156 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.8 p -79.46 127.32 78.88 Favored Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.044 0.387 . . . . 75.44 112.044 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.33 113.57 2.31 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.437 2.092 . . . . 61.23 112.937 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -86.47 126.39 34.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.0 -0.545 . . . . 73.23 111.241 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -82.16 127.66 33.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 74.54 110.183 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -114.4 98.35 6.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.756 0.312 . . . . 73.34 110.836 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.95 -27.29 63.27 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.291 0.478 . . . . 75.11 112.291 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.38 -47.79 66.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.228 -0.442 . . . . 70.53 111.885 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.6 p -90.29 -27.6 19.33 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.498 -0.319 . . . . 63.21 111.654 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.27 69.35 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.529 -0.367 . . . . 73.41 113.185 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -114.13 166.18 11.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.359 0.599 . . . . 70.53 112.195 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 34.1 m-85 -101.78 129.4 47.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.774 -0.648 . . . . 74.21 110.9 170.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.7 mt-10 -99.34 119.2 37.55 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.258 -0.428 . . . . 71.52 110.688 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 34.2 p90 -146.56 153.74 40.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.9 0.381 . . . . 74.23 111.786 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -110.02 109.76 20.43 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.446 -0.343 . . . . 71.01 111.245 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -62.03 168.76 3.04 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.435 0.531 . . . . 73.41 112.435 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.526 ' HA ' HG13 ' A' ' 18' ' ' VAL . 82.0 mt -54.89 -32.25 60.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.309 -0.405 . . . . 75.12 111.868 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.72 -11.77 60.75 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.856 0.36 . . . . 72.4 111.916 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.64 61.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.169 -0.538 . . . . 73.42 112.871 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.5 112.0 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.715 -0.285 . . . . 70.21 111.714 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.5 tt0 -88.67 106.21 18.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.226 0.536 . . . . 75.32 110.518 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -123.98 167.34 14.29 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.166 -0.47 . . . . 71.23 111.681 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 82.8 mtm180 -121.8 136.77 54.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.954 0.407 . . . . 75.45 112.005 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.14 150.85 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.448 -0.342 . . . . 75.32 110.757 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -65.34 140.89 58.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.318 0.58 . . . . 73.21 111.724 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.26 -14.87 54.29 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.958 1.095 . . . . 72.52 113.958 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -83.26 -23.15 32.83 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.827 -0.545 . . . . 72.53 111.903 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 12.2 mm-40 -77.09 -28.23 54.46 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.368 0.507 . . . . 70.32 112.368 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.61 118.86 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 74.34 111.93 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -81.9 -64.74 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.939 -0.573 . . . . 73.54 111.014 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -128.38 136.06 50.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.388 -0.369 . . . . 72.32 111.662 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.73 97.42 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.467 -0.333 . . . . 75.02 111.027 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -134.96 156.53 48.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.482 0.549 . . . . 63.52 112.482 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.604 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 31.9 m-20 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.828 -0.624 . . . . 75.34 111.262 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.226 0.06 . . . . 71.31 110.886 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.5 115.17 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.777 1.651 . . . . 63.04 111.478 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -107.67 132.85 52.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.867 0.365 . . . . 73.35 111.865 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.75 127.63 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.336 0.589 . . . . 64.45 111.017 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.67 115.48 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.286 -0.415 . . . . 73.12 111.548 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.2 m -88.2 123.29 32.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.558 -0.292 . . . . 51.51 110.276 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.64 159.8 15.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.334 0.588 . . . . 74.14 112.489 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -56.0 -35.34 66.67 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.558 -0.746 . . . . 74.12 110.635 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.86 -30.94 71.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.505 -0.77 . . . . 73.24 111.745 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.1 -23.24 8.24 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.149 -0.478 . . . . 65.43 112.823 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.08 143.12 58.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.849 0.357 . . . . 75.13 111.94 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.05 129.91 56.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.775 0.321 . . . . 72.14 111.407 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.646 0.26 . . . . 73.04 110.871 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -95.26 135.75 36.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.235 0.54 . . . . 74.25 112.206 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -128.44 156.94 42.4 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.859 -0.61 . . . . 75.21 111.2 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 35' ' ' LEU . 35.8 m -83.59 -16.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.046 0.387 . . . . 72.54 112.046 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -144.32 175.13 10.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.301 0.24 . . . . 71.43 111.092 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.9 p -78.33 132.29 66.58 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 111.902 0.334 . . . . 55.53 111.902 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 27.9 Cg_endo -60.32 133.24 48.22 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.202 2.601 . . . . 62.22 114.211 -174.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -87.23 116.42 25.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 71.31 110.876 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -81.31 113.62 19.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.902 -0.499 . . . . 74.43 110.654 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -97.62 95.61 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.157 0.504 . . . . 71.55 109.852 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.02 -31.62 72.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.965 -0.562 . . . . 73.5 112.199 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.01 -43.08 99.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.215 -0.448 . . . . 70.41 111.704 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.9 p -89.26 -26.98 20.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.735 0.303 . . . . 72.34 111.422 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.15 11.03 63.56 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.372 -0.442 . . . . 75.45 113.364 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.74 163.94 14.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.584 0.707 . . . . 74.24 112.385 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -100.88 122.86 44.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 73.21 109.854 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.24 119.4 37.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.496 -0.32 . . . . 73.53 110.273 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 31.3 p90 -134.95 145.28 48.01 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.953 0.406 . . . . 74.52 111.687 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -97.99 108.28 20.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.139 -0.482 . . . . 74.55 110.866 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 46.8 mt-30 -66.99 173.09 3.88 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.315 0.487 . . . . 70.53 112.315 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.458 ' HA ' HG11 ' A' ' 18' ' ' VAL . 87.0 mt -55.54 -32.73 63.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.452 0.538 . . . . 73.25 112.452 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.699 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.9 m-20 -83.95 9.46 12.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.83 0.348 . . . . 60.14 111.823 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.18 90.32 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.993 -0.623 . . . . 37.83 112.956 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.699 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.6 mtmm -71.76 97.72 1.83 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.71 -0.288 . . . . 70.02 111.688 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 27.7 tt0 -85.22 113.62 21.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.812 0.339 . . . . 75.42 110.865 176.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -136.58 168.21 19.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.961 0.41 . . . . 74.12 111.937 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -101.16 156.84 17.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.133 0.492 . . . . 74.41 111.28 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -145.53 139.59 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.25 -0.432 . . . . 42.11 110.292 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -62.72 139.52 58.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.038 0.447 . . . . 63.41 111.358 -174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -57.64 -21.3 38.92 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.001 1.111 . . . . 73.51 114.001 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -81.39 -17.73 47.98 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.049 -0.407 . . . . 54.11 112.093 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -75.94 -26.87 57.3 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.211 0.449 . . . . 72.12 112.211 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.51 117.17 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.174 0.511 . . . . 65.05 112.344 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -82.72 -60.08 2.3 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.947 0.403 . . . . 73.3 110.403 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -145.42 158.63 43.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.056 -0.52 . . . . 73.13 111.293 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.9 t -130.83 110.78 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.515 -0.312 . . . . 74.4 111.297 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -127.97 157.24 41.15 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.168 0.508 . . . . 63.3 111.646 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 . . . . . 0 CA--C 1.536 0.424 0 CA-C-N 116.257 -0.429 . . . . 72.51 110.786 175.366 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 111.264 0.098 . . . . 73.52 111.264 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.82 116.01 2.9 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.532 2.155 . . . . 74.11 112.485 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.2 m -121.84 134.59 54.89 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.179 -0.464 . . . . 70.21 111.924 -173.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.25 131.77 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.332 0.587 . . . . 74.4 111.043 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.435 HG22 HG23 ' A' ' 47' ' ' VAL . 68.7 mt -107.55 110.4 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.202 -0.454 . . . . 73.23 111.453 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.418 ' HG1' ' HG2' ' A' ' 14' ' ' GLU . 42.3 m -85.65 116.8 24.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.739 0.304 . . . . 73.42 110.585 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.8 mt -82.18 172.29 13.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.025 0.441 . . . . 63.02 111.529 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -56.79 -42.64 79.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.248 -0.433 . . . . 73.42 111.894 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.34 0.19 12.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.515 0.561 . . . . 74.44 112.515 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.38 66.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.133 -0.556 . . . . 65.42 112.997 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -67.99 131.79 46.11 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.842 -0.211 . . . . 74.33 110.829 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HG2' ' HG1' ' A' ' 8' ' ' THR . 33.4 mt-10 -116.96 138.91 51.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.893 0.377 . . . . 71.52 111.87 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.49 140.75 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.492 -0.322 . . . . 74.12 110.963 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -103.61 117.32 34.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.16 0.43 . . . . 73.0 112.16 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.68 152.68 39.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.284 0.476 . . . . 73.2 112.284 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.4 -19.02 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.106 0.41 . . . . 73.45 112.106 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.09 174.9 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.906 0.384 . . . . 74.45 111.587 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.7 p -79.45 143.02 58.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 112.603 0.594 . . . . 74.01 112.603 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.12 142.9 34.97 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.459 2.106 . . . . 73.44 113.55 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 39.1 ttmt -99.47 131.58 45.38 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.246 -0.434 . . . . 75.0 110.969 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -94.25 124.35 38.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.97 0.414 . . . . 74.31 111.708 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -99.41 119.81 38.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.12 110.168 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.54 -26.3 67.07 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.748 0.647 . . . . 73.23 112.748 -174.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -82.59 -47.39 12.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.414 0.524 . . . . 70.23 112.414 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.3 p -89.95 -27.43 19.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.725 0.297 . . . . 53.13 111.639 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 9.15 83.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.171 -0.538 . . . . 37.77 113.664 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -96.41 151.56 19.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.359 0.599 . . . . 71.2 112.22 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.9 m-85 -101.39 126.62 48.18 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.625 -0.716 . . . . 54.43 110.863 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.7 mt-10 -99.09 119.01 37.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.511 0.196 . . . . 73.42 110.688 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.16 146.33 31.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.127 0.489 . . . . 75.32 112.015 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.683 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 4.3 ttmp? -93.0 115.67 28.34 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.082 -0.508 . . . . 71.21 111.181 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.97 164.33 20.18 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.153 0.427 . . . . 65.33 112.153 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.95 -23.0 61.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.619 0.723 . . . . 72.33 110.562 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.32 -13.75 61.57 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.252 -0.885 . . . . 72.41 111.798 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.8 -38.83 2.96 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.349 -0.453 . . . . 71.02 113.284 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -68.95 127.69 34.02 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.35 -0.5 . . . . 74.43 112.225 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 63.5 tt0 -86.03 116.27 24.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.957 0.408 . . . . 73.42 110.934 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -115.5 166.49 11.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.911 0.386 . . . . 71.41 111.651 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 60.5 mtm180 -129.85 137.58 50.52 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.141 -0.481 . . . . 65.13 111.564 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.7 149.65 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.521 -0.309 . . . . 73.12 110.656 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -70.54 151.03 45.51 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.529 0.681 . . . . 73.14 112.583 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -59.6 -29.28 67.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.662 0.986 . . . . 73.45 113.662 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -76.49 -11.77 59.93 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.126 0.417 . . . . 75.32 112.126 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.85 -28.04 17.57 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.361 0.504 . . . . 72.4 112.361 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 7' ' ' ILE . 5.6 p -77.0 114.29 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.51 0.672 . . . . 74.31 112.12 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -83.1 -56.8 3.58 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.992 -0.549 . . . . 74.45 111.353 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.401 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 71.0 p -137.24 150.92 48.17 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.958 0.408 . . . . 72.52 111.665 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.47 111.23 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.358 -0.383 . . . . 61.34 110.529 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.63 168.7 13.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.002 0.429 . . . . 70.11 111.885 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 120.923 0.392 . . . . 75.4 111.17 175.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 110.707 -0.109 . . . . 64.43 110.707 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.72 114.62 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.918 1.745 . . . . 62.4 112.536 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.8 m -125.08 132.76 53.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.209 -0.45 . . . . 71.3 111.407 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.0 124.68 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.306 0.574 . . . . 71.45 111.154 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -102.87 118.8 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.219 -0.446 . . . . 73.41 111.451 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.454 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 60.7 m -90.27 122.02 32.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.317 -0.402 . . . . 74.1 110.675 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -88.93 157.03 18.55 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.977 0.418 . . . . 74.5 111.82 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -54.99 -30.77 60.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.964 -0.562 . . . . 74.21 111.022 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.66 -23.02 67.2 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.639 -0.709 . . . . 65.42 111.597 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.88 -30.89 8.5 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 112.014 -0.434 . . . . 73.43 112.014 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.578 ' NH1' HG12 ' A' ' 15' ' ' ILE . 49.5 ttt-85 -64.28 141.76 58.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.639 0.376 . . . . 75.14 111.554 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 8' ' ' THR . 44.0 mt-10 -116.26 143.54 45.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.861 0.362 . . . . 74.24 111.383 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.578 HG12 ' NH1' ' A' ' 13' ' ' ARG . 38.8 mt -124.09 132.65 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.282 -0.417 . . . . 73.31 110.787 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -95.66 133.28 39.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.51 111.479 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.31 146.26 48.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.453 0.538 . . . . 71.51 112.453 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 35' ' ' LEU . 29.7 m -87.36 -13.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.14 0.495 . . . . 75.11 111.486 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.29 154.45 36.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.007 -0.542 . . . . 71.5 110.301 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.6 p -78.86 132.38 64.43 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.882 0.372 . . . . 62.04 111.193 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.23 126.42 16.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.93 2.42 . . . . 72.54 113.755 -174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -96.48 127.78 42.79 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.053 -0.521 . . . . 63.23 110.615 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -83.48 115.04 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.822 -0.351 . . . . 72.23 110.376 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -97.31 103.28 15.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.064 0.459 . . . . 74.11 109.974 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.26 -28.55 66.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.131 -0.486 . . . . 75.45 111.571 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.33 -52.77 63.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.912 0.387 . . . . 73.41 111.071 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -88.36 -25.41 22.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.062 0.393 . . . . 71.25 112.062 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.41 61.76 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.389 -0.434 . . . . 74.02 113.673 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.98 159.65 17.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.429 0.633 . . . . 75.32 112.561 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE1' HG13 ' A' ' 47' ' ' VAL . 49.8 m-85 -100.97 122.33 43.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.636 -0.711 . . . . 71.21 109.852 169.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 47.4 mt-10 -104.69 121.64 43.99 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.821 0.343 . . . . 75.13 111.063 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -145.17 156.91 44.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 71.13 111.436 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 31.6 ttmt -106.3 111.46 24.07 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.294 -0.412 . . . . 63.21 111.197 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -60.73 166.82 3.06 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.231 0.456 . . . . 74.12 112.231 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.51 ' HA ' HG11 ' A' ' 18' ' ' VAL . 74.8 mt -61.07 -21.35 63.57 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 73.22 111.128 176.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.49 -11.44 60.22 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.963 -0.562 . . . . 54.25 111.679 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.34 -5.48 71.06 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.159 -0.544 . . . . 72.45 112.883 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -82.68 119.66 24.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.938 0.348 . . . . 70.14 111.938 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 33.8 tt0 -83.69 112.93 20.5 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.895 -0.409 . . . . 63.32 109.895 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -116.43 152.56 33.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.946 0.403 . . . . 75.21 111.802 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 44.6 mtp180 -116.28 126.32 53.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.378 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 tt -129.94 145.3 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 122.244 -0.285 . . . . 54.31 111.08 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -66.88 150.44 49.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.579 0.704 . . . . 73.21 112.687 -172.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -58.52 -19.71 39.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.936 1.087 . . . . 70.23 113.936 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -84.46 -22.92 30.15 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.879 -0.513 . . . . 73.14 112.014 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -82.24 -14.51 55.4 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.167 0.432 . . . . 73.53 112.167 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.425 HG13 ' CE1' ' A' ' 30' ' ' TYR . 7.3 p -87.49 115.37 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.453 0.644 . . . . 73.04 111.727 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -83.08 -63.49 1.35 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.136 0.493 . . . . 72.55 110.93 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.3 p -139.65 149.46 43.77 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.879 -0.601 . . . . 65.5 111.358 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.49 116.02 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.373 -0.376 . . . . 71.12 110.222 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.21 141.99 50.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.827 0.346 . . . . 74.1 111.384 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.802 0.334 . . . . 64.32 110.943 176.111 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 m . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 120.396 0.141 . . . . 75.1 111.359 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -62.67 119.93 7.23 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.651 2.234 . . . . 75.24 112.409 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.0 m -128.8 147.8 50.82 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.423 -0.353 . . . . 74.43 111.47 -174.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.4 p -121.64 125.55 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.377 0.608 . . . . 72.55 111.283 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.6 mt -98.94 116.23 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 65.45 111.391 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 113.61 22.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.31 -0.404 . . . . 65.44 110.733 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -78.46 166.07 23.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 72.34 111.538 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 64.6 t30 -63.31 -33.21 75.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.136 -0.483 . . . . 75.1 111.287 -175.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.67 7.9 6.17 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.436 -0.347 . . . . 72.33 111.865 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.04 -12.95 64.53 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.233 -0.508 . . . . 70.35 113.886 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -70.12 121.1 16.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.266 0.533 . . . . 75.31 111.426 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -103.02 130.37 50.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.867 0.365 . . . . 74.12 111.274 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.96 131.23 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.497 -0.32 . . . . 73.33 110.984 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.46 137.18 34.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.19 0.519 . . . . 72.23 112.082 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.57 150.74 50.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.81 -0.632 . . . . 70.23 111.231 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 m -74.34 -25.42 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.921 0.391 . . . . 71.35 111.788 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.3 174.43 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.223 -0.444 . . . . 74.13 111.261 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.2 p -83.02 145.75 50.21 Favored Pre-proline 0 N--CA 1.47 0.536 0 CA-C-O 120.852 0.358 . . . . 74.15 111.792 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.29 130.79 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.427 2.085 . . . . 74.14 113.364 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -98.09 122.58 41.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.3 -0.409 . . . . 71.41 110.46 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -82.17 130.51 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.012 0.434 . . . . 73.12 111.391 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.28 109.8 21.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.404 -0.362 . . . . 73.32 110.57 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -72.92 -29.99 63.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.003 0.43 . . . . 73.11 111.47 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -70.47 -33.47 71.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.805 0.669 . . . . 71.31 112.805 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -118.85 -10.49 9.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.798 0.666 . . . . 72.4 112.798 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.66 82.53 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 114.702 0.641 . . . . 55.22 114.702 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -102.6 154.15 19.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 117.887 0.843 . . . . 73.2 112.335 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.2 m-85 -102.12 128.26 48.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.15 -0.477 . . . . 73.55 110.827 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 46.2 mt-10 -99.53 119.32 37.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.6 0.238 . . . . 63.14 111.235 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -146.19 145.04 30.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.968 0.413 . . . . 74.52 111.675 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.69 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 4.4 ttmp? -97.58 111.45 23.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.435 -0.348 . . . . 64.31 111.268 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -61.01 168.11 2.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.855 0.359 . . . . 64.13 111.956 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.9 mt -52.69 -43.17 65.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.834 0.679 . . . . 75.44 112.834 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -75.79 -3.14 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.268 0.47 . . . . 71.25 112.268 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.24 -2.81 50.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.072 -0.585 . . . . 38.17 114.224 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -82.7 104.19 12.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.504 0.652 . . . . 73.31 111.68 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.637 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.1 tt0 -72.98 119.54 17.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.272 -0.422 . . . . 62.24 111.109 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 t -125.91 165.37 18.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.792 0.33 . . . . 70.03 111.83 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 47.0 mtm180 -126.71 129.42 48.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.387 -0.37 . . . . 75.22 111.252 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.5 tt -122.1 150.75 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.663 -0.244 . . . . 70.15 110.794 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -67.58 153.67 43.18 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.303 0.573 . . . . 75.3 112.367 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.474 ' O ' HG11 ' A' ' 47' ' ' VAL . 15.1 ptmm? -65.4 -21.68 66.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.797 1.036 . . . . 65.24 113.797 -172.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -79.4 -25.23 42.15 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.216 0.45 . . . . 74.31 112.216 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.83 -22.32 53.76 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.82 0.674 . . . . 41.52 112.82 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 44' ' ' LYS . 8.0 p -72.84 114.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.736 0.779 . . . . 74.13 111.981 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.441 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 10.0 tpt180 -81.83 -63.36 1.4 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.82 -0.627 . . . . 75.41 110.466 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -146.54 146.61 30.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.013 -0.539 . . . . 74.15 110.984 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.83 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.722 0.296 . . . . 73.2 110.88 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HB2' HG13 ' A' ' 6' ' ' VAL . 61.1 mttp -119.3 152.36 36.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.292 0.568 . . . . 72.32 111.919 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 . . . . . 0 CA--C 1.54 0.567 0 CA-C-N 116.102 -0.499 . . . . 73.33 111.329 178.794 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 110.252 -0.277 . . . . 75.44 110.252 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.39 116.01 4.32 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.906 1.737 . . . . 73.13 112.09 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 92.2 m -123.4 135.72 54.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.116 0.413 . . . . 74.04 112.116 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.86 118.53 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.484 0.659 . . . . 63.22 111.31 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -90.78 107.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.222 -0.445 . . . . 74.22 111.153 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 49.9 m -83.37 124.0 30.21 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.245 -0.28 . . . . 73.43 110.245 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.1 mt -96.54 162.09 13.62 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.978 0.418 . . . . 65.12 112.057 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -54.25 -45.41 72.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.027 -0.533 . . . . 74.45 111.838 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.12 5.53 5.25 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.798 0.666 . . . . 71.41 112.798 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.95 47.5 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.082 -0.58 . . . . 71.43 114.211 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -63.11 136.2 57.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.364 0.582 . . . . 71.43 111.71 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.47 129.5 55.76 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.731 0.3 . . . . 74.15 110.491 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -113.3 112.0 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.172 0.511 . . . . 65.31 111.187 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.76 117.9 30.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.324 -0.398 . . . . 71.25 111.307 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -111.93 159.9 17.94 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.159 0.504 . . . . 62.14 112.189 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 35' ' ' LEU . 35.1 m -84.59 -15.03 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.955 -0.566 . . . . 73.34 111.663 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.11 164.34 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.006 0.431 . . . . 75.43 111.327 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.401 HG21 ' OG1' ' A' ' 5' ' ' THR . 71.3 p -79.7 118.95 75.09 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.407 -0.361 . . . . 73.13 110.869 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.63 123.28 12.54 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.346 2.697 . . . . 75.32 113.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.539 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 5.5 ttpm? -87.32 123.1 31.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.357 -0.383 . . . . 71.52 110.754 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -90.3 131.59 36.02 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.005 0.431 . . . . 74.53 112.086 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -99.75 116.41 31.76 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.908 0.385 . . . . 71.41 110.157 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.26 -32.26 73.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.348 0.499 . . . . 73.43 112.348 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -72.29 -50.0 30.39 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.954 0.353 . . . . 63.34 111.954 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.1 p -89.61 -27.75 19.98 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.32 0.489 . . . . 75.25 112.32 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.93 10.69 75.0 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.06 -0.591 . . . . 72.43 113.568 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.15 149.23 23.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.416 0.627 . . . . 74.43 112.452 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -102.02 128.74 48.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.604 -0.725 . . . . 74.31 110.771 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.498 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 45.7 mt-10 -100.11 124.66 45.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.703 0.287 . . . . 72.1 111.116 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -157.19 151.77 25.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.828 0.347 . . . . 74.31 111.417 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -106.5 115.28 29.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.599 -0.273 . . . . 61.15 110.885 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 49.5 mt-30 -60.65 158.86 11.74 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.87 0.322 . . . . 74.4 111.87 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.413 ' HA ' HG11 ' A' ' 18' ' ' VAL . 89.8 mt -51.98 -30.79 26.48 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.109 0.48 . . . . 72.33 111.777 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.91 4.33 4.31 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.088 -0.506 . . . . 71.14 112.238 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 23.63 70.78 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.304 -0.474 . . . . 74.4 113.069 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -117.07 112.56 21.08 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.7 -0.294 . . . . 65.14 111.297 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.4 tt0 -87.17 138.99 31.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.815 0.341 . . . . 73.24 111.58 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -147.24 165.15 30.93 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.497 -0.319 . . . . 73.32 111.719 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 86.0 mtt180 -115.4 125.89 53.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.888 0.375 . . . . 71.11 111.03 177.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.7 tt -117.04 149.93 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.621 0.248 . . . . 73.35 111.116 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.11 148.73 32.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.538 0.685 . . . . 62.3 112.218 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 ptmt -63.17 -15.02 55.5 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.656 0.984 . . . . 72.3 113.656 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -78.08 -22.55 48.86 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.822 -0.549 . . . . 74.45 111.591 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -79.4 -28.29 41.84 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.958 0.725 . . . . 64.31 112.958 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -68.25 113.78 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.727 0.775 . . . . 74.12 112.481 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 8' ' ' THR . 75.1 ttt180 -82.08 -60.32 2.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.525 -0.762 . . . . 74.44 110.671 175.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -149.36 129.58 13.68 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.066 -0.516 . . . . 74.51 111.24 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.848 0.356 . . . . 72.4 111.314 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -125.18 152.83 43.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 74.53 111.184 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 24.0 m-20 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 120.835 0.35 . . . . 64.44 110.998 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 110.768 -0.086 . . . . 73.33 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.6 114.02 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.696 1.597 . . . . 65.04 111.633 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.0 m -126.93 149.72 49.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.296 -0.411 . . . . 52.42 111.25 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.18 129.21 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.44 0.638 . . . . 64.44 111.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.3 110.44 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.027 -0.533 . . . . 74.52 110.862 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.714 HG22 HH21 ' A' ' 48' ' ' ARG . 26.0 m -89.07 118.31 28.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.749 0.309 . . . . 72.14 111.286 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.7 170.14 13.58 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.807 0.337 . . . . 73.42 111.576 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.07 -31.29 71.7 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.871 0.367 . . . . 74.44 111.697 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.27 -20.9 66.37 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 111.992 0.367 . . . . 70.55 111.992 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.07 -7.6 62.56 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.523 -0.631 . . . . 35.23 111.523 -170.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -70.06 125.05 25.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.96 0.504 . . . . 72.23 110.913 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.8 130.67 55.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.043 0.449 . . . . 72.34 111.718 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.8 mt -110.96 125.62 68.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.241 -0.436 . . . . 70.51 110.754 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -96.73 129.57 44.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.957 0.408 . . . . 62.0 111.915 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -119.55 162.04 19.59 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.121 -0.49 . . . . 63.22 111.488 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -97.11 -3.99 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.064 0.394 . . . . 61.33 112.064 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.01 174.95 10.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.328 0.585 . . . . 74.11 112.177 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.1 p -79.01 129.89 71.64 Favored Pre-proline 0 N--CA 1.471 0.618 0 CA-C-N 115.807 -0.633 . . . . 74.14 112.083 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.2 133.79 25.58 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.618 2.212 . . . . 72.14 113.238 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 135.71 35.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.476 -0.329 . . . . 70.32 111.207 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -95.63 115.51 27.53 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.602 0.239 . . . . 72.41 111.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -109.43 118.93 37.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.85 0.357 . . . . 72.44 110.75 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.15 -42.16 63.13 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.96 0.355 . . . . 63.51 111.96 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.85 -38.72 82.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.155 0.428 . . . . 72.33 112.155 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -94.44 -27.42 16.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.224 -0.298 . . . . 74.14 111.608 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.49 12.28 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.858 -0.687 . . . . 43.04 113.839 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 72.6 m-85 -116.27 163.52 15.88 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.173 0.511 . . . . 71.31 112.156 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.3 m-85 -101.24 128.68 47.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.91 -0.586 . . . . 74.4 110.424 171.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 39.6 mt-10 -98.97 119.25 37.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.535 0.207 . . . . 75.4 111.088 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.54 155.21 42.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.991 0.424 . . . . 73.55 111.486 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.612 ' HZ2' ' HB2' ' A' ' 33' ' ' LYS . 3.8 ttmp? -108.91 109.77 20.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.414 -0.357 . . . . 73.34 111.129 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 47.3 mt-30 -61.63 164.84 5.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.224 0.453 . . . . 61.41 112.224 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.553 ' HA ' HG11 ' A' ' 18' ' ' VAL . 86.7 mt -48.8 -43.26 38.03 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.791 0.664 . . . . 73.34 112.791 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -1.97 19.7 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.327 0.492 . . . . 64.32 112.327 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.15 -2.24 63.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.446 -0.406 . . . . 41.22 112.676 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -71.75 97.87 1.85 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.809 0.3 . . . . 71.14 111.809 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.8 tt0 -80.47 120.77 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.732 -0.213 . . . . 73.41 110.463 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -145.62 165.59 28.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.925 0.393 . . . . 72.01 111.709 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 59.5 mtm180 -117.48 148.05 42.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.13 -0.487 . . . . 75.3 111.265 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.65 152.15 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.369 -0.378 . . . . 65.42 110.813 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.17 133.89 55.1 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.113 0.482 . . . . 73.23 111.425 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.09 -16.17 29.54 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.221 1.193 . . . . 73.24 114.221 -172.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -91.85 -12.13 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.694 -0.629 . . . . 74.52 112.326 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -77.05 -28.06 54.65 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.911 0.386 . . . . 62.43 111.883 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -77.77 121.82 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.296 0.569 . . . . 70.4 112.312 -175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.714 HH21 HG22 ' A' ' 8' ' ' THR . 72.0 ttp85 -82.51 -59.82 2.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.008 0.432 . . . . 74.12 110.955 174.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.478 HG23 ' HG2' ' A' ' 48' ' ' ARG . 66.5 p -141.96 136.08 30.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.156 -0.475 . . . . 75.31 111.606 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.38 108.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.645 -0.252 . . . . 61.35 110.718 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -123.96 156.34 36.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.028 0.442 . . . . 73.32 111.297 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 64.34 110.914 175.405 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 111.079 0.029 . . . . 64.12 111.079 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.83 116.12 3.49 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.159 1.906 . . . . 62.34 111.793 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.4 m -119.82 136.87 54.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.893 0.378 . . . . 72.5 111.974 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.36 0.6 . . . . 73.25 110.755 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.401 HG22 HG23 ' A' ' 47' ' ' VAL . 66.0 mt -96.59 110.53 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.153 -0.476 . . . . 72.51 111.085 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 49' ' ' THR . 41.9 m -91.02 116.45 28.8 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.823 0.344 . . . . 73.14 110.803 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.28 161.82 21.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.894 0.378 . . . . 61.02 111.917 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.69 -40.39 79.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.434 0.531 . . . . 74.0 112.434 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.41 -12.56 53.49 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.303 0.483 . . . . 75.24 112.303 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.8 10.5 40.23 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.011 -0.614 . . . . 65.12 113.643 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -95.41 132.18 40.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.152 0.476 . . . . 71.25 111.565 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -102.95 130.47 50.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.927 0.394 . . . . 74.33 111.617 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.3 119.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.689 0.28 . . . . 64.02 110.412 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -92.34 130.88 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.164 0.507 . . . . 64.24 112.03 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.38 150.65 42.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.052 -0.522 . . . . 73.53 111.46 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' A' ' 35' ' ' LEU . 26.9 m -82.52 -13.79 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.191 0.441 . . . . 71.12 112.191 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.21 173.88 11.21 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.949 0.404 . . . . 75.53 111.657 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.5 p -79.54 140.89 55.89 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 112.869 0.692 . . . . 74.44 112.869 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.33 105.01 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.572 2.181 . . . . 61.15 112.772 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.36 111.77 20.81 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.143 -0.481 . . . . 70.45 111.051 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.467 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 51.1 t80 -81.68 132.33 35.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.968 0.413 . . . . 73.13 112.102 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -123.38 119.3 29.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.9 -0.591 . . . . 71.33 110.825 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.84 -15.73 55.6 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.872 0.323 . . . . 73.41 111.872 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.46 -45.06 73.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 63.11 111.126 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.2 p -93.49 -27.53 16.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.867 0.365 . . . . 52.43 111.501 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.38 10.5 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.301 -0.476 . . . . 72.11 113.111 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 75.1 m-85 -113.44 164.69 13.29 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.507 0.67 . . . . 73.53 112.76 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 69.7 m-85 -102.34 132.41 48.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.641 -0.709 . . . . 74.04 110.457 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 43.3 mt-10 -98.57 119.5 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.882 0.372 . . . . 73.52 110.824 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -147.1 143.79 28.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.009 0.433 . . . . 72.23 111.278 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.699 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 4.7 ttmp? -97.72 110.38 22.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.454 -0.339 . . . . 70.03 111.13 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.36 164.12 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.906 0.384 . . . . 72.13 111.711 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.412 ' HA ' HG13 ' A' ' 18' ' ' VAL . 88.3 mt -53.41 -35.01 59.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.293 -0.412 . . . . 64.41 111.894 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.9 -12.26 61.18 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.036 0.384 . . . . 74.34 112.036 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.6 -7.62 50.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.496 -0.383 . . . . 51.22 112.665 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -75.16 100.42 4.27 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.086 0.469 . . . . 70.21 111.968 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.653 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.1 tt0 -84.04 104.41 14.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.024 0.44 . . . . 65.14 110.542 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 t -124.45 166.48 15.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.944 0.402 . . . . 70.21 111.532 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 64.4 mtm180 -115.66 132.14 56.72 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.33 -0.396 . . . . 74.44 111.685 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.12 151.21 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.494 -0.321 . . . . 71.32 110.693 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -71.52 145.57 49.06 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.152 0.501 . . . . 74.4 112.042 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -60.43 -16.79 39.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.776 1.028 . . . . 73.01 113.776 -173.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -83.65 -25.69 30.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.223 0.453 . . . . 64.22 112.223 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -77.12 -28.38 54.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.314 0.487 . . . . 73.44 112.314 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 7' ' ' ILE . 7.3 p -74.2 113.75 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.484 0.659 . . . . 73.3 112.163 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -83.63 -63.75 1.29 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.355 0.598 . . . . 73.41 110.856 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 77.6 p -132.99 151.17 52.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.759 -0.655 . . . . 75.52 111.733 -177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.42 117.85 46.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.255 -0.429 . . . . 72.13 111.202 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -127.64 134.02 49.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.84 0.352 . . . . 74.15 111.856 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.003 0.43 . . . . 75.41 110.929 175.043 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 110.103 -0.332 . . . . 75.52 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -60.15 130.41 34.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.271 1.98 . . . . 53.13 112.926 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -132.25 135.99 46.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.28 -0.418 . . . . 74.54 111.327 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.2 p -98.94 122.94 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.473 0.654 . . . . 61.02 111.926 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 21' ' ' PRO . 64.4 mt -98.61 110.55 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.039 -0.528 . . . . 64.31 110.677 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.0 m -90.32 124.36 34.84 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.702 0.287 . . . . 75.03 110.716 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.2 157.49 17.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.938 0.347 . . . . 74.53 111.938 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -56.14 -30.82 62.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.2 0.524 . . . . 63.13 110.853 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.632 -0.713 . . . . 74.33 111.54 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.49 -23.38 8.0 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.332 -0.394 . . . . 52.24 112.23 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -65.31 141.25 58.66 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.925 0.342 . . . . 63.34 111.925 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.63 130.62 55.7 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.587 -0.279 . . . . 73.4 111.279 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -110.02 129.32 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.757 0.313 . . . . 73.54 110.788 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -99.96 113.12 25.47 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.973 0.416 . . . . 72.34 111.575 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.72 160.55 14.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.489 -0.323 . . . . 60.21 111.81 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -91.56 -18.68 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.475 0.546 . . . . 73.42 112.475 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -133.83 176.0 8.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.921 0.391 . . . . 74.02 111.541 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.7 p -77.35 127.85 81.94 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 116.592 -0.276 . . . . 75.14 111.66 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.422 ' HB3' HD11 ' A' ' 7' ' ' ILE . 21.1 Cg_endo -60.33 125.42 17.4 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.793 2.329 . . . . 70.43 113.959 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -93.72 142.11 27.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.192 -0.913 . . . . 70.13 110.748 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.92 133.82 52.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.883 -0.511 . . . . 74.0 111.863 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.42 113.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.952 -0.567 . . . . 74.02 110.195 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -72.19 -34.66 68.59 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.863 0.363 . . . . 73.2 111.814 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -59.81 -50.58 73.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.912 0.386 . . . . 75.44 111.923 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.9 t -89.91 -23.39 21.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.341 -0.391 . . . . 65.11 111.511 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.43 10.88 79.02 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 52.12 113.705 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 97.0 m-85 -110.4 163.84 13.28 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.199 0.524 . . . . 74.11 111.877 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.0 m-85 -101.05 136.66 40.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.016 -0.538 . . . . 63.22 110.75 173.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.97 118.36 34.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.893 -0.41 . . . . 60.34 109.893 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -143.65 156.18 44.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.957 0.408 . . . . 73.43 111.256 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.677 ' HZ3' ' HB2' ' A' ' 33' ' ' LYS . 4.6 ttmp? -118.17 110.89 18.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.191 -0.458 . . . . 75.13 111.655 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -60.8 160.6 9.23 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.291 -0.413 . . . . 73.2 111.36 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.79 -27.27 11.75 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.524 0.564 . . . . 73.21 112.524 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.26 4.69 6.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.017 0.377 . . . . 74.12 112.017 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.4 20.96 78.36 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.014 -0.612 . . . . 74.33 112.507 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.73 114.9 28.31 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.64 0.376 . . . . 75.34 111.532 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -92.35 125.65 37.1 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.893 0.378 . . . . 70.51 110.769 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -145.1 166.55 25.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.514 -0.312 . . . . 74.12 110.864 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 44.2 mtm180 -114.55 140.3 48.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.412 0.523 . . . . 64.24 112.412 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -128.59 145.54 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.242 -0.436 . . . . 73.23 110.658 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.85 146.89 52.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.662 0.744 . . . . 72.44 112.518 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 47' ' ' VAL . 19.0 pttm -53.49 -27.62 26.36 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.716 -1.129 . . . . 74.31 113.999 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -77.84 -21.86 50.81 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.363 0.505 . . . . 74.01 112.363 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -77.36 -25.03 50.63 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.9 0.704 . . . . 74.41 112.9 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.2 p -75.11 113.53 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.567 0.699 . . . . 63.34 112.612 -175.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.15 -60.48 2.14 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.912 -0.585 . . . . 54.53 110.98 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 p -139.35 153.15 47.64 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.316 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.5 t -127.87 108.29 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.506 -0.315 . . . . 72.14 111.207 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -123.15 145.56 48.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.115 0.483 . . . . 64.45 111.594 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.098 0.475 . . . . 71.01 111.744 -177.938 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 120.403 0.144 . . . . 74.24 111.156 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.99 131.83 45.92 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.483 2.122 . . . . 64.42 112.391 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -127.23 133.56 50.21 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.788 0.292 . . . . 72.33 111.788 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.79 124.88 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.51 0.672 . . . . 73.23 111.053 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.57 107.99 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.027 -0.533 . . . . 75.02 111.166 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -84.27 119.56 25.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.371 -0.377 . . . . 74.32 110.648 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -86.2 155.24 20.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.627 0.251 . . . . 61.33 111.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.2 -26.24 68.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.386 0.612 . . . . 73.45 110.655 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -58.25 -29.05 65.46 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.556 -0.747 . . . . 71.53 111.659 173.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.1 -11.33 26.87 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.513 -0.375 . . . . 71.31 112.939 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -81.45 130.42 35.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.857 0.361 . . . . 72.41 111.738 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.52 129.84 53.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.009 0.433 . . . . 75.2 110.836 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.4 mt -112.74 121.92 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.485 -0.325 . . . . 73.2 111.381 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -93.91 117.76 30.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.246 0.546 . . . . 44.13 111.976 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -105.67 153.27 22.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.931 -0.577 . . . . 61.25 111.328 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -78.77 -28.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.152 0.427 . . . . 73.52 112.152 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.43 175.4 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.976 0.417 . . . . 54.13 111.764 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.5 p -78.57 131.05 69.18 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.375 -0.375 . . . . 72.43 111.572 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.526 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 58.1 Cg_endo -68.71 153.95 72.25 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.687 2.258 . . . . 71.12 113.936 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -111.51 120.2 41.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.745 -0.661 . . . . 64.11 111.134 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -82.07 125.86 31.33 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.112 -0.367 . . . . 71.05 110.307 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.11 114.98 26.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.18 0.514 . . . . 71.34 110.231 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.5 -28.08 65.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.807 -0.633 . . . . 74.44 112.102 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -83.24 -44.76 14.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.443 -0.344 . . . . 72.14 111.919 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 m -82.37 -27.81 31.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.046 0.387 . . . . 74.24 112.046 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.57 9.43 84.76 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.299 -0.477 . . . . 50.23 113.777 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.24 162.42 13.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.351 -0.5 . . . . 61.22 112.015 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 58.6 m-85 -101.77 127.07 48.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 73.13 110.282 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.5 mt-10 -99.15 119.7 38.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.498 -0.319 . . . . 74.44 110.418 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.526 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 35.9 p90 -142.21 148.37 38.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.192 0.52 . . . . 74.11 112.086 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -106.09 108.99 20.78 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.965 -0.561 . . . . 60.04 110.566 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 45.2 mt-30 -66.43 171.14 5.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.323 0.49 . . . . 70.05 112.323 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.91 -21.9 58.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.304 -0.407 . . . . 64.34 112.074 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.26 -11.91 57.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.095 0.406 . . . . 62.34 112.095 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.4 -4.73 51.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.288 -0.482 . . . . 60.43 114.095 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -75.68 117.3 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.191 -0.594 . . . . 64.41 111.765 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.07 88.56 7.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.369 0.604 . . . . 73.24 109.871 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 t -106.78 165.07 11.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.084 -0.507 . . . . 72.21 111.665 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 23.3 mtm180 -125.87 138.44 53.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.964 0.411 . . . . 73.15 112.021 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -133.17 147.65 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.245 -0.434 . . . . 62.31 110.702 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.74 148.22 50.67 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.229 0.537 . . . . 74.23 112.062 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.37 -15.49 63.33 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.736 1.013 . . . . 61.22 113.736 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -79.54 -11.01 59.9 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.797 -0.564 . . . . 55.15 111.615 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -90.57 -26.65 19.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.295 0.479 . . . . 74.14 112.295 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.81 117.63 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.455 0.645 . . . . 72.42 112.671 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HG2' HG23 ' A' ' 49' ' ' THR . 50.9 ttt180 -82.61 -60.89 2.04 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.998 -0.547 . . . . 73.05 111.524 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.517 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.2 p -141.99 143.49 33.21 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.461 -0.336 . . . . 74.22 111.858 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.23 123.65 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.5 -0.318 . . . . 62.5 111.064 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -138.41 155.52 48.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.144 0.497 . . . . 72.31 111.822 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.222 0.534 . . . . 73.05 111.512 178.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 110.842 -0.058 . . . . 72.32 110.842 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 8.1 Cg_endo -49.15 116.31 2.17 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.79 2.327 . . . . 73.32 112.951 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.6 m -121.95 132.34 54.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.3 -0.409 . . . . 73.02 111.462 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 p -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.264 0.555 . . . . 75.05 111.17 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG22 HG23 ' A' ' 47' ' ' VAL . 67.2 mt -111.69 109.3 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.031 -0.531 . . . . 74.2 111.162 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.5 m -83.77 118.62 24.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.69 0.281 . . . . 64.34 110.353 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.44 155.62 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.906 0.384 . . . . 74.44 111.603 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.29 -21.64 65.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.078 0.465 . . . . 75.52 111.194 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.82 -2.5 47.48 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.146 -0.479 . . . . 74.4 112.192 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.09 -28.06 17.42 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.624 -0.322 . . . . 65.33 113.202 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -66.68 136.23 55.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.822 0.344 . . . . 73.4 111.827 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.74 129.6 56.06 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.29 -0.256 . . . . 61.41 110.704 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.4 mt -109.68 128.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.82 0.343 . . . . 73.22 111.118 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -95.89 119.36 34.24 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.31 0.576 . . . . 73.24 112.122 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . -110.95 168.28 9.61 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.749 -0.659 . . . . 71.31 111.33 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 33.2 m -102.65 -5.26 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 111.866 0.321 . . . . 64.32 111.866 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -138.42 174.16 10.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.248 0.546 . . . . 72.14 112.059 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.2 p -80.96 121.63 81.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.946 -0.57 . . . . 71.54 111.567 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -61.34 128.53 25.24 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.92 2.413 . . . . 71.44 113.837 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 28.2 ttmt -91.65 141.97 28.12 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.925 -0.579 . . . . 73.54 110.82 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -101.67 129.83 47.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.796 -0.565 . . . . 74.25 111.366 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -132.04 116.37 16.99 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.917 0.389 . . . . 74.4 111.337 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.44 -32.2 68.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.738 0.273 . . . . 74.21 111.738 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -55.05 -37.92 67.33 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.875 0.369 . . . . 60.21 111.587 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.1 p -97.32 -27.95 14.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.887 0.375 . . . . 51.15 110.857 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.38 10.94 69.99 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.349 -0.387 . . . . 71.33 113.209 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -122.18 171.55 8.92 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.527 0.679 . . . . 71.24 112.718 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.4 m-85 -102.17 132.78 47.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 64.34 110.484 169.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -98.27 120.43 38.66 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.68 0.276 . . . . 74.44 111.028 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -148.9 146.41 27.88 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 75.44 111.331 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 37.9 ttmt -100.85 114.67 28.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.501 -0.318 . . . . 74.15 111.606 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -60.15 164.13 4.35 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.139 0.422 . . . . 64.15 112.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -53.58 -32.13 49.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.952 0.406 . . . . 71.34 111.751 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -72.88 0.22 11.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.241 0.459 . . . . 64.21 112.241 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 25.35 61.36 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.896 -0.669 . . . . 61.34 112.121 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -106.45 106.77 17.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.829 0.347 . . . . 65.33 111.04 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.628 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 57.3 tt0 -81.52 110.84 17.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.323 -0.399 . . . . 73.14 111.056 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -124.3 166.84 15.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.081 0.467 . . . . 73.14 111.966 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 62.7 mtt180 -126.06 126.59 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.153 -0.476 . . . . 72.21 111.47 -176.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.612 0.244 . . . . 73.53 111.435 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.29 148.4 51.76 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.281 0.562 . . . . 75.22 112.356 -174.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HZ2' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -62.05 -32.03 72.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.335 1.235 . . . . 74.41 114.335 -172.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -84.44 -12.69 53.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.639 -0.663 . . . . 64.32 112.209 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.77 -28.16 55.57 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.297 0.48 . . . . 65.01 112.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.524 HG23 HG22 ' A' ' 7' ' ' ILE . 7.5 p -76.82 113.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.267 0.556 . . . . 73.33 112.253 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -82.96 -60.14 2.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.031 0.444 . . . . 74.5 111.066 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.0 p -130.64 162.19 29.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.163 0.431 . . . . 71.4 112.163 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.0 t -137.36 106.95 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 116.022 -0.535 . . . . 74.3 110.743 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -132.78 154.09 50.59 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.303 0.573 . . . . 71.24 112.011 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.311 0.577 . . . . 50.1 111.133 178.8 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.238 0.066 . . . . 73.45 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 47.6 Cg_endo -68.3 114.62 3.5 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.591 1.527 . . . . 43.53 111.802 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.6 m -123.83 126.67 46.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.258 -0.428 . . . . 74.04 111.541 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.33 117.85 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.457 0.646 . . . . 72.44 110.891 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 66.6 mt -100.64 111.73 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.086 -0.507 . . . . 60.41 111.187 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 99.6 m -83.8 121.26 27.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.508 -0.315 . . . . 73.14 110.824 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 15' ' ' ILE . 75.3 mt -89.06 172.1 9.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 62.34 111.893 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -51.88 -41.24 61.75 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.87 -0.605 . . . . 64.4 112.212 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.2 -15.46 62.47 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.708 0.633 . . . . 75.4 112.708 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.79 -1.22 68.18 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.808 -0.517 . . . . 70.42 111.808 -170.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -72.11 136.36 46.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.763 0.425 . . . . 73.44 110.968 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.59 133.74 48.11 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.886 0.374 . . . . 71.32 111.592 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.549 HD13 HD12 ' A' ' 9' ' ' LEU . 63.0 mt -108.55 124.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.739 0.304 . . . . 60.41 110.555 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.6 111.34 23.28 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 72.34 111.506 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.61 150.1 33.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.82 0.343 . . . . 64.25 111.826 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.509 HG11 HD23 ' A' ' 35' ' ' LEU . 29.5 m -96.68 2.32 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.949 0.404 . . . . 74.43 111.281 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 2.7 t0 -140.19 164.69 29.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.199 -0.455 . . . . 52.42 110.077 -175.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.7 p -80.01 140.14 53.66 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 112.396 0.517 . . . . 63.35 112.396 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 32' ' ' PHE . 61.7 Cg_endo -72.6 111.15 3.16 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.545 2.163 . . . . 72.4 113.244 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -86.8 110.29 19.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.754 -0.657 . . . . 71.41 111.321 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -84.68 122.22 28.78 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.881 0.326 . . . . 72.42 111.881 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.65 122.16 41.52 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.936 0.398 . . . . 72.43 110.52 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.03 -42.14 73.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.309 -0.405 . . . . 63.43 111.987 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.41 -40.37 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.389 0.514 . . . . 71.5 112.389 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -97.54 -27.3 14.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.895 0.379 . . . . 65.11 111.825 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 10.76 79.07 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.099 -0.572 . . . . 36.89 114.252 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -101.97 154.45 18.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.286 0.543 . . . . 73.31 111.99 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CE1' HG12 ' A' ' 47' ' ' VAL . 52.8 m-85 -101.51 121.75 42.55 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.043 -0.526 . . . . 70.3 110.042 171.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.1 119.33 38.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.424 -0.353 . . . . 75.41 110.555 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.54 ' HB3' ' HA ' ' A' ' 21' ' ' PRO . 28.6 p90 -148.0 168.32 22.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.745 0.646 . . . . 74.04 112.745 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.644 ' HZ2' ' HB2' ' A' ' 33' ' ' LYS . 4.6 ttmp? -112.68 116.61 30.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.732 -0.667 . . . . 70.05 110.941 -176.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 47.9 mt-30 -76.28 173.52 11.29 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.17 0.433 . . . . 75.14 112.17 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.509 HD23 HG11 ' A' ' 18' ' ' VAL . 78.0 mt -57.11 -30.82 64.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.909 0.385 . . . . 72.24 111.902 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.92 -11.9 60.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.952 0.406 . . . . 74.11 111.58 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.33 -11.97 69.54 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.399 -0.429 . . . . 55.12 112.401 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -69.51 124.86 25.02 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.914 0.388 . . . . 74.53 111.578 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -82.67 140.07 33.35 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.375 -0.375 . . . . 75.35 110.641 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 t -145.82 156.28 43.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.93 0.395 . . . . 75.23 112.051 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 42.5 mtm180 -127.14 129.34 47.7 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.22 -0.446 . . . . 53.24 110.842 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 tt -130.44 141.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.647 0.26 . . . . 72.12 110.927 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.13 152.09 45.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.755 0.788 . . . . 75.14 112.685 -172.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -59.51 -14.96 14.82 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.309 1.226 . . . . 74.41 114.309 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -78.59 -32.07 47.46 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.984 -0.448 . . . . 61.23 112.018 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -78.72 -28.64 45.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.547 0.573 . . . . 74.15 112.547 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.468 HG12 ' CE1' ' A' ' 30' ' ' TYR . 7.4 p -73.4 114.03 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.446 0.641 . . . . 71.13 111.912 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -83.65 -58.08 2.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.363 -0.38 . . . . 74.23 111.115 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.5 p -142.58 135.26 28.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.061 0.393 . . . . 54.34 112.061 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.8 t -100.07 116.64 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 116.423 -0.353 . . . . 72.14 110.95 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -132.31 150.99 52.04 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.948 0.351 . . . . 74.44 111.948 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 120.963 0.411 . . . . 70.35 111.368 172.402 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 110.508 -0.182 . . . . 72.35 110.508 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.61 115.28 2.96 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.742 1.628 . . . . 64.24 111.479 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.9 m -125.09 128.36 48.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.761 0.315 . . . . 74.22 111.47 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.95 119.24 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.457 0.646 . . . . 73.12 111.555 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.6 mt -101.21 110.65 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.037 -0.528 . . . . 74.12 110.675 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.1 m -89.47 129.4 35.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.556 -0.293 . . . . 55.1 110.952 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.95 161.96 15.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.859 0.361 . . . . 74.31 110.8 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 11.5 t30 -62.7 -24.43 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.871 0.693 . . . . 74.13 112.871 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.52 -22.37 57.17 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.845 0.355 . . . . 71.21 111.691 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.65 -6.56 13.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.254 -0.498 . . . . 41.11 113.04 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -73.6 131.69 41.97 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.603 -0.351 . . . . 65.24 111.701 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -104.43 129.31 52.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.86 0.362 . . . . 72.22 111.178 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.93 119.37 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.781 0.324 . . . . 73.44 110.688 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -94.28 132.88 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.1 0.476 . . . . 75.03 111.584 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.3 157.34 33.43 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.183 -0.462 . . . . 72.04 111.978 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.83 2.39 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.124 -0.489 . . . . 62.44 111.296 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.61 160.47 38.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.977 -0.556 . . . . 71.11 110.529 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.8 p -79.69 142.16 56.79 Favored Pre-proline 0 N--CA 1.469 0.48 0 CA-C-O 120.694 0.283 . . . . 73.1 111.331 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HB3' HD11 ' A' ' 7' ' ' ILE . 76.2 Cg_endo -75.71 146.72 30.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.689 2.26 . . . . 75.44 113.996 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 32.2 ttmt -110.65 132.6 54.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.806 -0.634 . . . . 73.41 110.375 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -90.08 119.24 30.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.387 -0.525 . . . . 72.32 110.021 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -97.38 106.03 18.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.268 0.556 . . . . 72.33 110.641 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.31 -23.03 64.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.89 -0.595 . . . . 75.52 111.852 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -69.27 -39.24 78.52 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.584 0.587 . . . . 64.2 112.584 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -118.08 -27.19 6.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.492 0.552 . . . . 71.33 112.492 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.11 11.45 31.92 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.891 -0.671 . . . . 37.72 114.174 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.482 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 91.6 m-85 -102.05 156.65 17.41 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.776 0.658 . . . . 75.42 112.776 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 55.6 m-85 -101.43 124.46 47.14 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.808 -0.633 . . . . 72.14 110.855 173.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 22' ' ' LYS . 44.0 mt-10 -99.74 122.17 42.33 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.781 0.432 . . . . 64.14 111.955 -177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -154.85 162.3 41.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.045 0.45 . . . . 74.02 111.339 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.681 ' HZ2' ' HB2' ' A' ' 33' ' ' LYS . 4.8 ttmp? -106.14 114.66 28.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.178 -0.464 . . . . 71.25 111.337 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -65.29 169.14 6.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.131 -0.486 . . . . 64.43 112.303 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.4 mt -55.37 -26.68 42.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.292 -0.413 . . . . 61.3 112.05 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.5 -4.7 32.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 111.997 0.369 . . . . 63.23 111.997 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 28.94 57.63 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.068 -0.587 . . . . 44.14 112.368 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.2 133.67 55.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.627 0.371 . . . . 62.43 111.296 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -89.07 123.64 33.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.837 0.351 . . . . 72.31 110.822 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -133.29 165.25 25.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.879 0.371 . . . . 75.5 111.623 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 57.1 mtp180 -129.1 125.72 37.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.411 -0.359 . . . . 54.51 110.229 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.93 143.74 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.685 0.279 . . . . 75.35 111.573 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -64.5 147.5 52.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.447 0.641 . . . . 74.45 112.636 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.4 ptmt -64.0 -22.61 67.0 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.923 1.083 . . . . 63.22 113.923 -173.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -82.66 -10.85 58.75 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.61 -0.682 . . . . 73.23 111.89 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -82.67 -28.44 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.882 0.327 . . . . 73.45 111.882 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -75.7 122.17 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.777 0.798 . . . . 73.44 112.845 -173.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.416 ' HG2' HG23 ' A' ' 49' ' ' THR . 63.9 ttt180 -82.06 -62.77 1.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.608 -0.724 . . . . 75.2 110.272 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.416 HG23 ' HG2' ' A' ' 48' ' ' ARG . 46.0 p -144.38 149.03 35.46 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.832 -0.622 . . . . 71.21 111.592 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -116.01 118.94 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.289 -0.414 . . . . 75.13 110.504 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -131.25 127.8 38.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.759 0.651 . . . . 74.3 112.759 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.3 -0.63 . . . . 65.42 109.3 169.92 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 110.52 -0.178 . . . . 65.33 110.52 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.95 119.49 6.56 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.486 2.124 . . . . 71.55 112.899 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 87.2 m -116.76 128.15 55.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.779 0.323 . . . . 74.12 111.8 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 p -98.81 129.39 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.218 0.533 . . . . 73.43 110.59 173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.43 118.51 56.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.852 0.358 . . . . 73.11 111.805 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.7 m -84.01 125.94 32.56 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.788 -0.449 . . . . 65.55 109.788 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.9 176.19 6.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.944 0.878 . . . . 74.14 112.915 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -64.74 -42.45 95.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.989 -1.005 . . . . 60.21 111.166 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.55 -23.74 62.67 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.97 0.414 . . . . 73.51 111.789 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.99 -18.19 9.07 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.354 -0.451 . . . . 62.43 113.522 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -64.31 136.05 56.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.228 0.514 . . . . 73.03 111.743 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.92 135.04 52.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.616 0.246 . . . . 72.24 110.823 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.8 mt -116.83 122.98 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.597 0.237 . . . . 74.34 111.206 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -85.92 116.7 24.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.075 0.464 . . . . 72.52 111.596 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.26 142.82 41.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.32 -0.4 . . . . 73.41 111.44 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 35' ' ' LEU . 26.4 m -82.31 -11.14 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.883 0.373 . . . . 41.3 111.718 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -128.51 157.7 40.45 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.248 -0.433 . . . . 71.15 109.912 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -79.28 143.65 60.82 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-O 120.967 0.413 . . . . 75.12 111.923 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.77 131.51 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.689 2.259 . . . . 72.14 113.772 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -103.39 132.22 49.82 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.828 -0.624 . . . . 75.53 110.631 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.75 123.92 34.17 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.014 -0.429 . . . . 44.34 111.497 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.99 106.46 18.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.012 0.435 . . . . 72.3 110.19 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.84 -21.66 63.34 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.342 -0.39 . . . . 73.42 111.935 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -69.17 -46.37 67.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.86 0.362 . . . . 71.01 111.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 97.2 p -101.09 -27.03 13.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.153 0.427 . . . . 64.12 112.153 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.11 8.39 64.75 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.219 -0.515 . . . . 44.32 113.265 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -95.71 155.21 16.84 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.201 0.524 . . . . 64.41 111.767 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 39.8 m-85 -101.46 131.05 47.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.148 -0.478 . . . . 72.3 111.114 172.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -98.9 118.94 36.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.078 -0.51 . . . . 75.32 110.655 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.47 142.4 31.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.302 0.572 . . . . 75.53 111.91 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -94.11 110.72 22.41 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.764 -0.653 . . . . 51.42 111.476 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.69 173.59 2.15 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.064 0.459 . . . . 61.31 112.217 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.547 ' HA ' HG11 ' A' ' 18' ' ' VAL . 89.2 mt -49.15 -45.75 44.28 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.23 0.826 . . . . 74.11 113.23 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.3 m-20 -80.2 15.07 1.65 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.56 0.578 . . . . 45.33 112.56 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.96 86.0 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.907 -0.663 . . . . 74.25 112.454 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.7 mtpp -80.96 105.07 11.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.605 0.362 . . . . 70.51 111.79 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -73.86 123.83 24.97 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.765 0.317 . . . . 72.43 110.905 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -135.1 160.19 39.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.504 -0.316 . . . . 73.33 110.77 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 76.2 mtm180 -134.07 142.01 47.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.964 0.357 . . . . 74.22 111.964 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.28 152.91 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.253 -0.43 . . . . 64.4 110.293 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.12 153.79 36.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.76 0.652 . . . . 65.21 112.76 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.36 -14.91 62.8 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.47 0.915 . . . . 73.24 113.47 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -85.28 -11.08 55.6 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.898 -0.501 . . . . 74.41 111.595 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -90.36 -27.59 19.26 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.207 0.447 . . . . 73.45 112.207 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.3 p -70.09 111.49 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.556 0.693 . . . . 63.23 111.508 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.495 ' HG2' HG23 ' A' ' 49' ' ' THR . 21.7 ttm-85 -83.03 -62.77 1.51 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.883 -0.599 . . . . 74.14 111.254 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 48' ' ' ARG . 61.7 p -141.04 135.64 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.178 0.514 . . . . 74.5 111.95 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.54 124.57 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.022 -0.535 . . . . 73.31 111.225 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -142.64 144.22 32.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.338 0.255 . . . . 71.1 111.577 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.6 m-20 . . . . . 0 CA--C 1.541 0.615 0 CA-C-O 121.029 0.442 . . . . 64.15 111.547 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.421 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 40.5 t . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 120.068 -0.015 . . . . 65.42 111.013 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 3' ' ' SER . 10.8 Cg_endo -53.29 116.31 2.87 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.303 2.002 . . . . 64.15 111.768 177.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.8 m -132.77 141.46 48.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.342 -0.39 . . . . 71.45 111.123 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.9 117.89 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.557 0.694 . . . . 70.53 111.468 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.16 104.5 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.253 0.549 . . . . 72.1 110.513 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.0 m -85.67 119.18 25.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.964 -0.562 . . . . 74.25 110.755 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.19 157.13 24.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.779 0.323 . . . . 74.3 111.217 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.558 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 26.4 t-20 -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.993 0.368 . . . . 64.4 111.993 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.37 -8.45 55.9 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.405 0.52 . . . . 63.12 112.405 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.45 -33.2 4.58 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.803 -0.713 . . . . 72.24 114.666 175.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.2 135.1 44.49 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.673 0.736 . . . . 72.01 112.427 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.35 129.98 53.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.28 -0.418 . . . . 75.24 110.485 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.25 130.48 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.824 0.345 . . . . 71.31 111.234 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -96.56 119.2 34.61 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.06 0.457 . . . . 71.14 111.999 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.7 153.15 38.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.348 -0.387 . . . . 54.12 111.5 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.31 -10.58 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.832 0.349 . . . . 62.05 111.769 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.7 166.55 24.55 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.419 . . . . 64.32 111.579 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.7 p -80.84 138.29 50.2 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 112.178 0.436 . . . . 63.22 112.178 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.528 ' HB2' ' HB3' ' A' ' 30' ' ' TYR . 69.0 Cg_endo -71.67 126.31 11.95 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.658 2.239 . . . . 71.3 113.941 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 2.2 ttmp? -86.45 141.21 29.29 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.412 -0.358 . . . . 75.14 110.311 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -99.11 129.89 45.4 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.12 0.486 . . . . 74.12 112.095 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -109.28 111.87 23.7 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.974 -0.557 . . . . 70.11 110.109 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.73 -35.33 79.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.554 0.575 . . . . 62.2 112.554 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.11 -52.72 53.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.954 0.407 . . . . 60.02 111.829 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.5 m -85.56 -26.96 25.85 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.306 -0.406 . . . . 74.42 111.754 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.79 8.91 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.404 -0.427 . . . . 63.33 113.912 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 83.6 m-85 -102.81 156.21 17.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.222 0.534 . . . . 73.42 112.116 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.528 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 67.7 m-85 -101.93 135.59 43.21 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.627 -0.715 . . . . 63.23 110.603 172.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 36.0 mt-10 -98.89 118.78 36.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.441 0.163 . . . . 71.24 110.786 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -147.74 152.22 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.156 0.503 . . . . 73.02 111.641 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.73 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 4.1 ttmp? -106.9 112.71 25.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.128 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -64.82 164.85 11.57 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.769 0.319 . . . . 75.54 111.799 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.9 mt -53.51 -29.72 37.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.386 0.884 . . . . 61.21 113.386 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -77.28 -11.54 59.84 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.91 0.386 . . . . 70.44 111.679 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.51 -6.28 49.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.527 -0.368 . . . . 53.31 112.242 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -70.4 101.57 1.98 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.928 0.491 . . . . 75.35 111.74 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.2 tt0 -82.07 107.28 14.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.756 0.312 . . . . 74.23 110.366 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.3 t -123.68 165.2 17.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.056 0.455 . . . . 74.42 111.836 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 49.4 mtm180 -124.59 132.49 53.44 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.962 -0.563 . . . . 75.23 111.715 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 tt -130.93 146.62 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.685 0.278 . . . . 71.13 111.211 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -71.75 152.28 42.87 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.571 0.582 . . . . 73.24 112.571 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 pttp -57.97 -31.52 66.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.516 0.932 . . . . 75.33 113.516 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -69.01 -11.64 60.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.415 0.524 . . . . 54.24 112.415 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -88.14 -27.79 21.66 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.585 0.587 . . . . 74.53 112.585 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 44' ' ' LYS . 10.7 p -76.91 118.64 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.806 0.812 . . . . 74.13 112.809 -173.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.558 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 57.4 ttt180 -81.9 -58.44 2.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.211 -0.904 . . . . 74.43 111.077 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.4 p -148.08 134.53 19.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.863 -0.608 . . . . 74.4 111.189 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 111.2 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 62.31 110.983 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -133.5 141.95 48.0 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.035 0.445 . . . . 71.04 111.761 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 116.254 -0.43 . . . . 73.34 110.464 174.669 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 120.445 0.164 . . . . 62.33 110.826 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.07 120.83 6.61 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.892 2.395 . . . . 71.42 112.339 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -125.71 133.04 52.26 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.437 -0.347 . . . . 74.34 111.826 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -99.97 124.5 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.173 0.511 . . . . 75.53 110.758 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.4 120.06 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.073 0.463 . . . . 74.32 110.988 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.426 ' HG1' ' HG2' ' A' ' 14' ' ' GLU . 68.0 m -100.01 118.49 36.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.033 -0.531 . . . . 74.34 110.826 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.457 HD11 ' HD3' ' A' ' 13' ' ' ARG . 78.3 mt -83.89 168.35 16.16 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.863 0.363 . . . . 73.34 111.521 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.58 -28.73 70.13 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.493 -0.321 . . . . 63.05 111.455 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.21 -16.21 59.44 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.036 0.446 . . . . 74.22 111.61 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.35 67.81 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.677 -0.569 . . . . 54.12 111.677 -170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.457 ' HD3' HD11 ' A' ' 9' ' ' LEU . 78.0 ttt180 -77.33 136.37 38.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.308 0.643 . . . . 74.22 111.217 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' HG1' ' A' ' 8' ' ' THR . 46.7 mt-10 -117.33 130.24 56.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.989 0.423 . . . . 71.34 111.767 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.0 mt -122.42 130.49 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.093 -0.503 . . . . 52.22 110.618 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -94.85 127.99 41.27 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.101 0.477 . . . . 74.11 112.037 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.82 164.3 17.72 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.083 -0.508 . . . . 72.24 111.453 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.73 -18.36 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.211 0.448 . . . . 74.52 112.211 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -126.94 172.48 10.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.275 0.56 . . . . 65.42 111.868 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -79.81 119.39 76.57 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.812 -0.631 . . . . 71.21 110.499 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.82 134.34 41.27 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.072 2.515 . . . . 63.02 113.951 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -85.63 124.64 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.606 -0.724 . . . . 73.44 110.746 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.81 108.62 20.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 75.32 110.983 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.25 110.54 23.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.971 0.415 . . . . 74.44 110.592 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.75 -39.29 93.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 72.11 111.993 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.19 -43.03 99.36 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.157 0.429 . . . . 72.4 112.157 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 m -91.75 -28.08 17.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.934 0.346 . . . . 64.11 111.934 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 11.94 72.85 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.922 -0.656 . . . . 72.23 113.824 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.96 155.12 21.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.387 0.613 . . . . 63.12 112.462 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.69 129.9 47.95 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.58 -0.736 . . . . 72.11 110.326 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.2 mt-10 -108.28 121.91 45.86 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.592 -0.276 . . . . 72.5 111.194 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.77 143.79 29.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.82 0.343 . . . . 72.22 111.627 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.6 ttmt -98.4 114.55 26.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.767 0.318 . . . . 71.55 111.241 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -60.6 165.11 4.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.412 -0.358 . . . . 74.23 111.779 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.64 -26.68 61.97 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.87 0.366 . . . . 73.52 111.623 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.88 -6.21 43.57 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.48 0.548 . . . . 70.11 112.48 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.09 23.9 46.81 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.075 -0.584 . . . . 73.41 112.747 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -112.63 112.3 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.794 0.331 . . . . 45.43 111.457 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.9 tt0 -89.69 109.81 20.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.806 0.336 . . . . 73.15 111.319 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -111.87 163.42 14.23 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.935 0.398 . . . . 64.22 111.529 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 55.4 mtt180 -123.51 131.64 53.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.928 0.394 . . . . 74.33 111.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.84 152.37 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.441 -0.345 . . . . 62.55 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -66.87 147.29 53.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.184 0.516 . . . . 73.53 111.667 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' O ' HG11 ' A' ' 47' ' ' VAL . 21.4 ptmt -65.07 -20.2 66.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.983 0.734 . . . . 73.51 112.983 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -76.55 -10.25 59.25 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.314 0.487 . . . . 74.02 112.314 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -90.96 -17.73 25.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.875 0.694 . . . . 73.43 112.875 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 44' ' ' LYS . 8.9 p -75.0 117.79 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.481 0.658 . . . . 72.14 112.618 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -83.51 -61.72 1.77 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.303 0.573 . . . . 72.24 110.656 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.9 p -147.06 150.46 35.1 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.669 -0.696 . . . . 63.22 111.369 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.4 t -126.58 118.25 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.236 -0.438 . . . . 65.11 110.812 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.19 136.62 49.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.358 0.503 . . . . 71.22 112.358 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.332 -0.395 . . . . 74.25 110.523 172.227 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 110.689 -0.115 . . . . 71.42 110.689 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.42 116.76 3.82 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.565 2.176 . . . . 71.43 113.107 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -131.89 134.23 45.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.438 -0.346 . . . . 74.14 111.295 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.77 125.72 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.494 0.664 . . . . 63.25 111.685 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.3 mt -98.51 116.98 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.291 -0.413 . . . . 73.44 111.615 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.6 m -88.79 124.38 34.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.392 -0.367 . . . . 53.41 110.721 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.18 164.75 13.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.119 0.485 . . . . 71.04 112.282 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -54.61 -33.94 61.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.358 0.663 . . . . 73.44 111.384 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.14 -12.47 60.9 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.848 -0.615 . . . . 65.24 111.907 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.73 -24.72 30.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.436 -0.411 . . . . 61.15 112.677 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.16 135.7 57.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.846 0.355 . . . . 73.3 111.804 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.61 148.65 31.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.503 -0.317 . . . . 73.5 111.558 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.58 127.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.625 -0.261 . . . . 70.01 110.847 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -93.08 124.0 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.091 0.472 . . . . 75.34 111.995 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.06 156.8 26.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.122 -0.49 . . . . 53.34 111.55 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -88.94 -9.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.017 0.377 . . . . 63.33 112.017 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.61 166.44 24.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.102 0.477 . . . . 71.25 111.443 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.5 p -79.61 140.85 55.58 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.232 -0.44 . . . . 73.24 111.61 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 61.6 Cg_endo -71.47 148.73 54.85 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.594 2.196 . . . . 75.22 113.943 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.616 ' HZ2' ' HB2' ' A' ' 22' ' ' LYS . 3.8 ttmp? -105.62 135.1 47.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.764 -0.653 . . . . 74.51 110.324 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -87.03 122.26 30.62 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.05 0.452 . . . . 75.12 111.739 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -98.1 108.67 21.43 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.144 -0.48 . . . . 70.01 110.951 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.63 -14.24 55.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.788 0.327 . . . . 73.34 111.61 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -63.0 -52.88 61.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 74.42 111.376 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -118.72 -26.8 6.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.033 0.383 . . . . 75.1 112.033 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.69 11.88 10.98 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.406 -0.902 . . . . 71.1 114.614 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.1 162.29 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.745 0.772 . . . . 73.22 112.708 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 43.6 m-85 -110.27 132.71 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.743 -0.662 . . . . 75.42 110.798 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 55.8 mt-10 -99.28 119.57 38.13 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.364 -0.21 . . . . 61.32 111.089 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -151.32 145.04 25.04 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.009 0.433 . . . . 74.33 111.434 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HZ2' ' HB2' ' A' ' 33' ' ' LYS . 3.5 ttmp? -98.26 112.44 24.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.538 -0.301 . . . . 65.32 111.494 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.68 162.15 8.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.943 0.401 . . . . 74.43 111.853 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.51 ' HA ' HG12 ' A' ' 18' ' ' VAL . 84.1 mt -48.84 -39.91 27.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.722 0.638 . . . . 74.41 112.722 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.89 9.33 1.18 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.753 0.649 . . . . 64.35 112.753 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 46.66 25.11 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.918 -0.658 . . . . 72.44 112.322 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -125.01 104.71 8.71 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.656 -0.32 . . . . 71.42 111.289 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.9 tt0 -75.61 100.59 4.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.134 0.492 . . . . 73.14 110.371 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.3 t -114.21 165.72 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.07 0.462 . . . . 72.44 111.511 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.3 mtm180 -129.8 144.69 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.34 -0.391 . . . . 61.3 111.647 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 tt -139.51 149.71 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.301 -0.409 . . . . 73.43 110.901 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.51 153.93 30.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.797 0.665 . . . . 71.31 112.797 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HA ' ' HE1' ' A' ' 30' ' ' TYR . 25.4 pttm -58.88 -25.72 63.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.868 1.062 . . . . 74.21 113.868 -175.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -79.56 -11.22 59.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.236 0.458 . . . . 62.11 112.236 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -94.23 -18.32 21.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.426 0.528 . . . . 74.04 112.426 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.51 119.95 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.766 0.654 . . . . 71.44 112.766 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -82.68 -66.92 0.83 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.349 -0.387 . . . . 71.31 110.505 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -146.83 137.77 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.94 -0.573 . . . . 65.03 111.417 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.94 108.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.735 0.302 . . . . 71.14 110.74 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.87 142.66 39.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.084 0.469 . . . . 71.33 111.679 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.065 0.459 . . . . 71.34 111.22 177.19 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 p . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 120.389 0.137 . . . . 71.53 110.933 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.17 118.95 5.74 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.98 2.454 . . . . 71.2 112.9 -177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 m -126.24 126.95 44.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.192 -0.458 . . . . 74.11 111.378 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.5 p -105.13 125.94 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.141 0.496 . . . . 73.42 111.848 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.78 113.18 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.788 0.327 . . . . 74.3 111.324 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.598 ' HG1' ' HG2' ' A' ' 14' ' ' GLU . 13.9 m -83.44 134.58 34.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.18 -0.304 . . . . 73.01 110.18 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -100.76 170.18 8.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.053 0.454 . . . . 71.11 112.069 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -52.12 -45.11 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.864 -0.607 . . . . 75.13 112.606 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.67 -21.86 64.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.035 0.445 . . . . 73.45 111.577 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.59 -23.85 7.8 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.026 -0.607 . . . . 71.03 113.598 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -56.6 129.86 42.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.176 0.488 . . . . 65.05 111.899 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.598 ' HG2' ' HG1' ' A' ' 8' ' ' THR . 52.2 mt-10 -103.31 130.48 50.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.883 0.373 . . . . 74.33 110.909 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.87 120.52 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.543 -0.299 . . . . 74.4 110.532 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.51 127.26 41.4 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.141 0.496 . . . . 73.31 112.045 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.9 154.83 26.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.093 -0.503 . . . . 72.11 111.744 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.14 -29.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.001 0.371 . . . . 74.24 112.001 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -129.04 174.61 9.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.897 0.379 . . . . 75.23 111.348 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -78.78 141.27 59.44 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 63.52 111.648 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.51 138.66 35.93 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.616 2.211 . . . . 65.24 113.79 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -93.41 130.22 39.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.97 -0.559 . . . . 75.43 110.455 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -90.82 114.8 27.29 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.153 -0.342 . . . . 75.03 111.269 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -97.89 104.52 16.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.889 0.376 . . . . 54.44 110.672 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.89 -30.51 70.68 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.945 0.35 . . . . 74.42 111.945 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.21 -52.42 65.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.034 0.445 . . . . 54.11 111.959 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -102.41 -11.63 18.47 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.105 0.409 . . . . 72.54 112.105 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.35 80.25 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.06 -0.59 . . . . 51.21 114.005 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 67.8 m-85 -97.95 156.38 16.65 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.282 0.563 . . . . 73.41 112.477 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 68.1 m-85 -101.21 127.22 47.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.799 -0.637 . . . . 74.52 110.01 169.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.3 mt-10 -99.6 119.37 37.96 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.768 0.318 . . . . 61.01 111.088 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -144.74 144.61 31.28 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 75.33 111.942 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 2.4 ttmp? -99.33 109.81 22.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.256 -0.429 . . . . 73.03 110.698 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.8 mt-30 -60.49 160.66 8.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.002 0.371 . . . . 52.14 112.002 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.3 mt -56.29 -27.5 55.63 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.364 0.505 . . . . 74.0 112.364 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.46 -11.54 59.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.011 0.434 . . . . 65.23 111.778 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.98 -21.35 31.86 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.379 -0.439 . . . . 64.53 112.711 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -63.07 104.01 0.53 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 111.762 0.282 . . . . 75.11 111.762 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.9 tt0 -88.4 118.3 27.93 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.757 0.313 . . . . 71.32 110.606 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 t -136.07 164.59 27.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.397 0.517 . . . . 73.51 112.397 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 17.9 mtm180 -110.65 155.88 21.77 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.845 -0.616 . . . . 73.22 110.775 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -147.98 144.77 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.601 0.239 . . . . 73.44 110.935 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -70.32 150.18 46.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.258 0.551 . . . . 52.55 112.137 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -63.14 -14.86 53.68 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.759 1.022 . . . . 72.22 113.759 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -89.2 -14.95 34.85 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.767 -0.583 . . . . 71.33 111.979 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -81.67 -28.61 33.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.916 0.388 . . . . 73.42 111.406 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.14 114.34 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.682 0.753 . . . . 74.23 112.383 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -81.75 -59.4 2.61 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.475 -0.784 . . . . 70.54 110.665 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.1 p -147.32 128.41 14.63 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.556 -0.293 . . . . 74.41 111.617 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.65 117.26 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.775 0.321 . . . . 64.12 110.389 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.478 ' HB2' HG13 ' A' ' 6' ' ' VAL . 34.7 mttm -118.02 132.08 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.607 0.595 . . . . 75.11 112.607 -176.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 . . . . . 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 74.02 109.685 170.6 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 110.409 -0.219 . . . . 61.44 110.409 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.4 115.16 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.97 1.78 . . . . 74.15 112.023 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.3 m -122.25 130.74 53.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.906 0.384 . . . . 73.13 111.536 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.4 117.91 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.411 0.624 . . . . 73.13 111.316 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.7 mt -96.14 105.65 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.914 -0.585 . . . . 51.13 111.285 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.2 m -85.39 121.49 28.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.465 -0.334 . . . . 71.43 110.755 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 mt -85.56 167.34 15.49 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.665 0.269 . . . . 71.43 111.036 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -54.87 -39.24 68.46 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.587 0.588 . . . . 45.51 112.587 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.18 -24.4 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.704 0.287 . . . . 71.44 111.612 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.74 15.56 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.313 -0.403 . . . . 73.43 113.285 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -68.09 125.86 27.7 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 122.489 -0.418 . . . . 73.53 111.306 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.13 129.3 49.95 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.066 0.46 . . . . 72.24 111.287 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -121.54 113.65 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.485 -0.325 . . . . 73.13 110.654 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -95.18 129.06 42.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.176 0.512 . . . . 51.23 112.282 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -116.57 161.74 18.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.08 -0.509 . . . . 74.12 111.767 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.65 -24.59 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.853 0.358 . . . . 71.42 111.558 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -122.46 165.45 16.33 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.154 -0.475 . . . . 42.43 111.297 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.3 p -79.56 127.77 77.12 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.357 -0.383 . . . . 72.31 111.112 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -51.37 123.01 11.16 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.311 2.674 . . . . 63.24 113.734 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -86.62 129.4 34.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.688 -0.687 . . . . 74.41 110.292 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -82.2 134.05 35.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.567 0.699 . . . . 72.41 112.232 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -98.62 106.16 18.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.481 -0.781 . . . . 64.32 110.583 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.3 -20.1 59.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.944 0.402 . . . . 74.41 111.886 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -69.18 -54.79 13.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.104 0.409 . . . . 73.34 112.104 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -115.74 -6.59 12.12 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.734 0.642 . . . . 74.1 112.734 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.86 12.64 57.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.274 -0.965 . . . . 63.33 114.31 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 47.7 m-85 -90.19 171.86 9.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.397 0.599 . . . . 72.44 112.296 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 61.5 m-85 -119.54 132.18 55.69 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.027 -0.533 . . . . 73.32 110.992 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.57 119.95 38.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.775 0.322 . . . . 71.11 110.785 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -151.29 140.45 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.415 -0.357 . . . . 72.12 110.943 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 40.8 ttmt -93.14 109.28 20.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.885 0.374 . . . . 71.14 110.681 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 41.8 mt-30 -62.19 160.1 13.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.466 -0.334 . . . . 72.3 111.385 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -55.34 -29.07 57.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.473 0.545 . . . . 65.32 112.473 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.81 -12.04 60.29 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.937 0.398 . . . . 63.41 111.863 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.92 -20.67 28.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.421 -0.419 . . . . 73.23 113.567 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.48 108.2 8.13 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.243 0.46 . . . . 64.42 112.243 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 40.2 tt0 -86.02 120.77 27.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 75.51 110.494 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 165.53 25.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.343 -0.39 . . . . 70.35 111.131 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 75.1 mtm180 -111.02 139.48 46.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.978 0.418 . . . . 63.33 111.37 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.69 146.01 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.357 -0.383 . . . . 72.11 110.841 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -68.5 145.82 53.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.481 0.658 . . . . 55.44 112.291 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -63.09 -18.91 63.91 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.292 0.849 . . . . 72.41 113.292 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -81.36 -13.23 58.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.057 0.392 . . . . 61.43 112.057 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -90.86 -27.98 18.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.049 0.389 . . . . 73.22 112.049 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.7 p -76.67 116.1 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.422 0.63 . . . . 75.02 112.095 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.539 ' HG2' HG23 ' A' ' 49' ' ' THR . 78.7 ttt180 -81.96 -64.72 1.12 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.087 -0.506 . . . . 65.44 111.312 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 48' ' ' ARG . 82.8 p -133.32 133.62 42.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.853 0.358 . . . . 73.1 111.904 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.22 111.07 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.417 -0.356 . . . . 74.4 110.27 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 43.4 mtmt -121.99 145.22 48.34 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 64.22 111.663 -177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.893 0.378 . . . . 64.12 110.957 177.106 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.3 tpp . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.756 0.312 . . . . 63.25 110.936 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.56 130.45 52.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.046 0.451 . . . . 72.11 111.589 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m -156.76 137.59 9.27 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.162 -0.472 . . . . 64.24 110.162 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' HB2' HD12 ' A' ' 53' ' ' LEU . 64.1 Cg_endo -72.13 115.46 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.152 1.901 . . . . 73.25 112.982 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 69.6 m -125.96 122.35 35.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.46 -0.337 . . . . 73.35 111.377 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.26 115.02 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.487 0.66 . . . . 63.11 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.63 117.79 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.224 -0.444 . . . . 73.51 111.031 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.453 HG22 ' NH2' ' A' ' 48' ' ' ARG . 22.8 m -98.47 123.63 42.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.267 -0.424 . . . . 71.2 110.651 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.436 HD11 ' HD3' ' A' ' 13' ' ' ARG . 72.2 mt -83.7 174.43 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.278 0.561 . . . . 74.14 112.453 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -53.74 -43.97 69.53 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.572 -0.74 . . . . 74.43 112.866 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.77 -24.33 56.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.113 0.482 . . . . 74.42 111.455 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.98 -6.75 10.99 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.39 -0.433 . . . . 65.33 113.274 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.436 ' HD3' HD11 ' A' ' 9' ' ' LEU . 77.8 ttt180 -59.94 115.88 3.73 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.862 0.331 . . . . 75.32 111.11 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HG2' HG23 ' A' ' 8' ' ' THR . 44.8 mt-10 -105.1 130.22 53.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.745 0.307 . . . . 60.13 111.68 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -121.79 132.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.821 0.343 . . . . 75.3 110.554 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -98.73 125.86 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.132 0.492 . . . . 72.33 111.691 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.43 150.7 25.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.005 -0.543 . . . . 74.41 111.641 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.496 HG11 ' HA ' ' A' ' 35' ' ' LEU . 27.9 m -85.74 -17.18 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 120.991 0.424 . . . . 74.34 111.981 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.04 175.26 9.88 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 72.55 111.112 174.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -77.38 142.28 67.1 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 112.304 0.483 . . . . 61.3 112.304 -170.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 84.7 Cg_endo -76.47 157.47 36.6 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.855 2.37 . . . . 71.2 114.274 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -116.15 123.26 47.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.827 -0.624 . . . . 74.35 111.388 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -82.19 114.29 20.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.917 -0.401 . . . . 75.51 109.917 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.23 105.76 17.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.974 0.416 . . . . 74.5 111.591 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.43 -29.4 69.92 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.106 -0.497 . . . . 63.24 111.98 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -65.4 -55.11 19.89 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.208 0.447 . . . . 52.43 112.208 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -96.14 -17.93 20.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.014 0.375 . . . . 74.52 112.014 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.19 10.88 77.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.223 -0.513 . . . . 54.04 114.022 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.41 165.03 11.47 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.525 0.678 . . . . 71.13 112.226 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.65 122.71 44.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.413 -0.812 . . . . 74.14 110.022 167.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.591 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 26.3 mt-10 -98.96 119.66 38.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.273 -0.421 . . . . 73.45 110.527 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 23.1 p90 -140.03 144.58 36.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.192 0.52 . . . . 65.11 111.562 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.414 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 32.1 ttmt -95.08 110.58 22.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.773 -0.649 . . . . 74.42 111.564 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -60.36 169.07 1.8 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.4 0.519 . . . . 54.04 112.4 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.496 ' HA ' HG11 ' A' ' 18' ' ' VAL . 98.6 mt -53.15 -30.37 36.65 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.432 0.531 . . . . 70.25 112.432 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.626 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -73.16 -12.25 60.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.007 0.432 . . . . 72.44 111.602 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.36 60.99 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.239 -0.505 . . . . 74.23 112.55 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 30.1 mtmm -96.88 125.33 41.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.71 0.291 . . . . 73.12 111.319 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -78.44 128.36 33.49 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.841 0.353 . . . . 74.31 111.324 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.3 t -131.65 163.48 28.02 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.836 0.351 . . . . 74.44 111.002 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.591 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 87.3 mtm180 -136.43 131.55 34.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.508 -0.314 . . . . 64.23 111.635 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.15 150.92 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.524 0.202 . . . . 63.54 111.068 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.88 147.57 42.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.656 0.741 . . . . 61.41 112.881 -172.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -55.9 -24.13 35.6 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.134 1.161 . . . . 75.14 114.134 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -87.56 -17.12 32.73 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.221 0.452 . . . . 74.11 112.221 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -78.41 -17.68 56.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.342 0.497 . . . . 64.3 112.342 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.6 115.83 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.403 0.62 . . . . 73.54 112.178 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.453 ' NH2' HG22 ' A' ' 8' ' ' THR . 58.7 ttp180 -83.15 -62.29 1.63 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.141 0.496 . . . . 62.52 111.536 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.449 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.9 p -132.9 137.67 46.73 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.062 0.458 . . . . 73.24 111.963 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.2 106.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.126 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.4 149.46 49.66 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.33 0.586 . . . . 74.23 112.18 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 35.6 m-20 -81.78 163.04 22.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 70.23 111.007 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.509 HD12 ' HB2' ' A' ' 4' ' ' PRO . 78.1 mt -79.65 -3.78 48.76 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.324 0.583 . . . . 73.25 110.442 171.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.18 20.17 11.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.74 -0.664 . . . . 74.51 111.862 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 21.2 mm-40 . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.79 -0.624 . . . . 74.45 112.329 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.597 0.237 . . . . 53.3 111.304 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.46 -176.86 1.64 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.048 0.452 . . . . 72.22 111.567 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 t -160.62 143.31 9.66 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.289 -0.414 . . . . 51.45 110.671 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.03 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.65 1.567 . . . . 72.22 111.714 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 60.1 m -112.38 147.8 35.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.119 0.485 . . . . 72.45 111.998 -174.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.16 112.33 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.544 0.687 . . . . 63.01 110.494 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -90.41 105.68 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 70.4 111.089 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.6 m -83.72 107.7 16.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 74.23 110.987 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -78.08 153.58 32.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.653 0.263 . . . . 73.05 110.861 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -66.12 -14.32 61.6 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.918 0.39 . . . . 63.12 111.517 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.89 -8.78 57.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.762 0.315 . . . . 74.42 111.702 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 3.36 68.11 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.41 -0.424 . . . . 50.31 112.464 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -87.19 132.71 33.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.602 0.361 . . . . 74.54 111.06 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.79 130.15 55.65 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.997 0.427 . . . . 75.12 111.701 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.3 mt -109.85 128.51 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.26 -0.427 . . . . 65.42 110.894 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -97.97 126.71 43.5 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.074 0.464 . . . . 75.55 111.985 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.67 150.09 47.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.077 -0.51 . . . . 63.22 112.165 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 35' ' ' LEU . 33.1 m -94.97 5.74 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.219 -0.446 . . . . 74.21 111.559 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -144.79 160.67 40.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.339 -0.391 . . . . 70.21 110.156 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.8 p -79.46 127.32 78.88 Favored Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.044 0.387 . . . . 75.44 112.044 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.33 113.57 2.31 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.437 2.092 . . . . 61.23 112.937 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -86.47 126.39 34.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.0 -0.545 . . . . 73.23 111.241 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -82.16 127.66 33.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 74.54 110.183 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -114.4 98.35 6.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.756 0.312 . . . . 73.34 110.836 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.95 -27.29 63.27 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.291 0.478 . . . . 75.11 112.291 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.38 -47.79 66.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.228 -0.442 . . . . 70.53 111.885 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.6 p -90.29 -27.6 19.33 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.498 -0.319 . . . . 63.21 111.654 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.27 69.35 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.529 -0.367 . . . . 73.41 113.185 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -114.13 166.18 11.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.359 0.599 . . . . 70.53 112.195 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 34.1 m-85 -101.78 129.4 47.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.774 -0.648 . . . . 74.21 110.9 170.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.7 mt-10 -99.34 119.2 37.55 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.258 -0.428 . . . . 71.52 110.688 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 34.2 p90 -146.56 153.74 40.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.9 0.381 . . . . 74.23 111.786 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -110.02 109.76 20.43 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.446 -0.343 . . . . 71.01 111.245 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -62.03 168.76 3.04 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.435 0.531 . . . . 73.41 112.435 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.526 ' HA ' HG13 ' A' ' 18' ' ' VAL . 82.0 mt -54.89 -32.25 60.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.309 -0.405 . . . . 75.12 111.868 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.72 -11.77 60.75 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.856 0.36 . . . . 72.4 111.916 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.64 61.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.169 -0.538 . . . . 73.42 112.871 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.5 112.0 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.715 -0.285 . . . . 70.21 111.714 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.5 tt0 -88.67 106.21 18.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.226 0.536 . . . . 75.32 110.518 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -123.98 167.34 14.29 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.166 -0.47 . . . . 71.23 111.681 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 82.8 mtm180 -121.8 136.77 54.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.954 0.407 . . . . 75.45 112.005 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.14 150.85 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.448 -0.342 . . . . 75.32 110.757 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -65.34 140.89 58.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.318 0.58 . . . . 73.21 111.724 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.26 -14.87 54.29 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.958 1.095 . . . . 72.52 113.958 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -83.26 -23.15 32.83 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.827 -0.545 . . . . 72.53 111.903 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 12.2 mm-40 -77.09 -28.23 54.46 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.368 0.507 . . . . 70.32 112.368 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.61 118.86 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 74.34 111.93 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -81.9 -64.74 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.939 -0.573 . . . . 73.54 111.014 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -128.38 136.06 50.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.388 -0.369 . . . . 72.32 111.662 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.73 97.42 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.467 -0.333 . . . . 75.02 111.027 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -134.96 156.53 48.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.482 0.549 . . . . 63.52 112.482 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.604 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 31.9 m-20 -90.49 161.54 15.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.828 -0.624 . . . . 75.34 111.262 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.99 -27.25 64.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.324 0.583 . . . . 63.52 109.731 170.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.4 mt -124.98 93.02 3.77 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.657 -0.702 . . . . 71.41 110.777 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.699 -0.667 . . . . 62.43 111.247 177.807 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.405 0.145 . . . . 65.21 111.089 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.61 61.57 1.69 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.224 0.535 . . . . 75.15 110.267 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 m -89.88 154.04 47.55 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 115.733 -0.667 . . . . 71.31 110.886 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HB2' HD12 ' A' ' 53' ' ' LEU . 32.4 Cg_endo -63.5 115.17 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.777 1.651 . . . . 63.04 111.478 174.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.7 m -107.67 132.85 52.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.867 0.365 . . . . 73.35 111.865 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.75 127.63 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.336 0.589 . . . . 64.45 111.017 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.67 115.48 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.286 -0.415 . . . . 73.12 111.548 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.2 m -88.2 123.29 32.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.558 -0.292 . . . . 51.51 110.276 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.64 159.8 15.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.334 0.588 . . . . 74.14 112.489 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -56.0 -35.34 66.67 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.558 -0.746 . . . . 74.12 110.635 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.86 -30.94 71.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.505 -0.77 . . . . 73.24 111.745 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.1 -23.24 8.24 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.149 -0.478 . . . . 65.43 112.823 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.08 143.12 58.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.849 0.357 . . . . 75.13 111.94 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.05 129.91 56.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.775 0.321 . . . . 72.14 111.407 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.646 0.26 . . . . 73.04 110.871 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -95.26 135.75 36.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.235 0.54 . . . . 74.25 112.206 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -128.44 156.94 42.4 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.859 -0.61 . . . . 75.21 111.2 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 35' ' ' LEU . 35.8 m -83.59 -16.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.046 0.387 . . . . 72.54 112.046 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -144.32 175.13 10.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.301 0.24 . . . . 71.43 111.092 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.9 p -78.33 132.29 66.58 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 111.902 0.334 . . . . 55.53 111.902 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 27.9 Cg_endo -60.32 133.24 48.22 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.202 2.601 . . . . 62.22 114.211 -174.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -87.23 116.42 25.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 71.31 110.876 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -81.31 113.62 19.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.902 -0.499 . . . . 74.43 110.654 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -97.62 95.61 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.157 0.504 . . . . 71.55 109.852 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.02 -31.62 72.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.965 -0.562 . . . . 73.5 112.199 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.01 -43.08 99.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.215 -0.448 . . . . 70.41 111.704 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.9 p -89.26 -26.98 20.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.735 0.303 . . . . 72.34 111.422 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.15 11.03 63.56 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.372 -0.442 . . . . 75.45 113.364 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.74 163.94 14.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.584 0.707 . . . . 74.24 112.385 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -100.88 122.86 44.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 73.21 109.854 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.24 119.4 37.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.496 -0.32 . . . . 73.53 110.273 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 31.3 p90 -134.95 145.28 48.01 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.953 0.406 . . . . 74.52 111.687 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -97.99 108.28 20.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.139 -0.482 . . . . 74.55 110.866 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 46.8 mt-30 -66.99 173.09 3.88 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.315 0.487 . . . . 70.53 112.315 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.458 ' HA ' HG11 ' A' ' 18' ' ' VAL . 87.0 mt -55.54 -32.73 63.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.452 0.538 . . . . 73.25 112.452 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.699 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.9 m-20 -83.95 9.46 12.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.83 0.348 . . . . 60.14 111.823 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.18 90.32 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.993 -0.623 . . . . 37.83 112.956 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.699 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.6 mtmm -71.76 97.72 1.83 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.71 -0.288 . . . . 70.02 111.688 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 27.7 tt0 -85.22 113.62 21.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.812 0.339 . . . . 75.42 110.865 176.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -136.58 168.21 19.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.961 0.41 . . . . 74.12 111.937 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -101.16 156.84 17.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.133 0.492 . . . . 74.41 111.28 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -145.53 139.59 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.25 -0.432 . . . . 42.11 110.292 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -62.72 139.52 58.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.038 0.447 . . . . 63.41 111.358 -174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -57.64 -21.3 38.92 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.001 1.111 . . . . 73.51 114.001 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -81.39 -17.73 47.98 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.049 -0.407 . . . . 54.11 112.093 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -75.94 -26.87 57.3 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.211 0.449 . . . . 72.12 112.211 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.51 117.17 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.174 0.511 . . . . 65.05 112.344 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -82.72 -60.08 2.3 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.947 0.403 . . . . 73.3 110.403 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -145.42 158.63 43.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.056 -0.52 . . . . 73.13 111.293 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.9 t -130.83 110.78 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.515 -0.312 . . . . 74.4 111.297 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -127.97 157.24 41.15 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.168 0.508 . . . . 63.3 111.646 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -88.34 151.06 22.87 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.257 -0.429 . . . . 72.51 110.786 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.2 mt -71.28 -14.54 62.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.126 0.489 . . . . 43.42 111.052 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.82 86.82 2.63 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.289 -0.414 . . . . 62.5 111.387 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.691 -0.671 . . . . 61.11 110.976 174.058 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 111.996 0.369 . . . . 73.41 111.996 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.1 106.86 0.25 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.926 0.393 . . . . 71.31 111.713 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 m -86.3 109.64 24.93 Favored Pre-proline 0 N--CA 1.471 0.597 0 CA-C-N 116.342 -0.39 . . . . 73.52 111.264 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.492 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 19.3 Cg_endo -56.82 116.01 2.9 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.532 2.155 . . . . 74.11 112.485 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.2 m -121.84 134.59 54.89 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.179 -0.464 . . . . 70.21 111.924 -173.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.25 131.77 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.332 0.587 . . . . 74.4 111.043 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.435 HG22 HG23 ' A' ' 47' ' ' VAL . 68.7 mt -107.55 110.4 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.202 -0.454 . . . . 73.23 111.453 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.418 ' HG1' ' HG2' ' A' ' 14' ' ' GLU . 42.3 m -85.65 116.8 24.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.739 0.304 . . . . 73.42 110.585 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.8 mt -82.18 172.29 13.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.025 0.441 . . . . 63.02 111.529 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -56.79 -42.64 79.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.248 -0.433 . . . . 73.42 111.894 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.34 0.19 12.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.515 0.561 . . . . 74.44 112.515 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.38 66.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.133 -0.556 . . . . 65.42 112.997 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -67.99 131.79 46.11 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.842 -0.211 . . . . 74.33 110.829 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HG2' ' HG1' ' A' ' 8' ' ' THR . 33.4 mt-10 -116.96 138.91 51.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.893 0.377 . . . . 71.52 111.87 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.49 140.75 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.492 -0.322 . . . . 74.12 110.963 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -103.61 117.32 34.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.16 0.43 . . . . 73.0 112.16 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.68 152.68 39.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.284 0.476 . . . . 73.2 112.284 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.4 -19.02 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.106 0.41 . . . . 73.45 112.106 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.09 174.9 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.906 0.384 . . . . 74.45 111.587 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.7 p -79.45 143.02 58.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 112.603 0.594 . . . . 74.01 112.603 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.12 142.9 34.97 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.459 2.106 . . . . 73.44 113.55 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 39.1 ttmt -99.47 131.58 45.38 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.246 -0.434 . . . . 75.0 110.969 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -94.25 124.35 38.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.97 0.414 . . . . 74.31 111.708 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -99.41 119.81 38.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.12 110.168 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.54 -26.3 67.07 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.748 0.647 . . . . 73.23 112.748 -174.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -82.59 -47.39 12.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.414 0.524 . . . . 70.23 112.414 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.3 p -89.95 -27.43 19.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.725 0.297 . . . . 53.13 111.639 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 9.15 83.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.171 -0.538 . . . . 37.77 113.664 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -96.41 151.56 19.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.359 0.599 . . . . 71.2 112.22 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.9 m-85 -101.39 126.62 48.18 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.625 -0.716 . . . . 54.43 110.863 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.7 mt-10 -99.09 119.01 37.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.511 0.196 . . . . 73.42 110.688 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.16 146.33 31.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.127 0.489 . . . . 75.32 112.015 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.683 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 4.3 ttmp? -93.0 115.67 28.34 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.082 -0.508 . . . . 71.21 111.181 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.97 164.33 20.18 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.153 0.427 . . . . 65.33 112.153 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.95 -23.0 61.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.619 0.723 . . . . 72.33 110.562 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.32 -13.75 61.57 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.252 -0.885 . . . . 72.41 111.798 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.8 -38.83 2.96 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.349 -0.453 . . . . 71.02 113.284 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -68.95 127.69 34.02 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.35 -0.5 . . . . 74.43 112.225 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 63.5 tt0 -86.03 116.27 24.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.957 0.408 . . . . 73.42 110.934 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -115.5 166.49 11.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.911 0.386 . . . . 71.41 111.651 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 60.5 mtm180 -129.85 137.58 50.52 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.141 -0.481 . . . . 65.13 111.564 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.7 149.65 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.521 -0.309 . . . . 73.12 110.656 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -70.54 151.03 45.51 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.529 0.681 . . . . 73.14 112.583 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -59.6 -29.28 67.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.662 0.986 . . . . 73.45 113.662 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -76.49 -11.77 59.93 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.126 0.417 . . . . 75.32 112.126 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.85 -28.04 17.57 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.361 0.504 . . . . 72.4 112.361 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 7' ' ' ILE . 5.6 p -77.0 114.29 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.51 0.672 . . . . 74.31 112.12 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -83.1 -56.8 3.58 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.992 -0.549 . . . . 74.45 111.353 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.401 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 71.0 p -137.24 150.92 48.17 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.958 0.408 . . . . 72.52 111.665 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.47 111.23 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.358 -0.383 . . . . 61.34 110.529 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.63 168.7 13.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.002 0.429 . . . . 70.11 111.885 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -90.53 144.89 25.35 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.923 0.392 . . . . 75.4 111.17 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 71.8 mt -67.08 -18.69 65.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.043 0.449 . . . . 72.15 111.386 175.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.0 mt -105.87 36.6 2.5 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.381 -0.372 . . . . 73.41 111.66 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.694 -0.669 . . . . 73.34 111.681 177.085 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.825 0.345 . . . . 70.33 111.091 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.03 86.77 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.146 0.498 . . . . 70.5 111.034 174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m -104.38 150.35 38.35 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 115.989 -0.551 . . . . 64.43 110.707 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.511 ' HB2' HD12 ' A' ' 53' ' ' LEU . 34.0 Cg_endo -63.72 114.62 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.918 1.745 . . . . 62.4 112.536 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.8 m -125.08 132.76 53.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.209 -0.45 . . . . 71.3 111.407 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.0 124.68 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.306 0.574 . . . . 71.45 111.154 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -102.87 118.8 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.219 -0.446 . . . . 73.41 111.451 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.454 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 60.7 m -90.27 122.02 32.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.317 -0.402 . . . . 74.1 110.675 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -88.93 157.03 18.55 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.977 0.418 . . . . 74.5 111.82 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -54.99 -30.77 60.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.964 -0.562 . . . . 74.21 111.022 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.66 -23.02 67.2 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.639 -0.709 . . . . 65.42 111.597 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.88 -30.89 8.5 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 112.014 -0.434 . . . . 73.43 112.014 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.578 ' NH1' HG12 ' A' ' 15' ' ' ILE . 49.5 ttt-85 -64.28 141.76 58.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.639 0.376 . . . . 75.14 111.554 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 8' ' ' THR . 44.0 mt-10 -116.26 143.54 45.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.861 0.362 . . . . 74.24 111.383 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.578 HG12 ' NH1' ' A' ' 13' ' ' ARG . 38.8 mt -124.09 132.65 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.282 -0.417 . . . . 73.31 110.787 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -95.66 133.28 39.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.51 111.479 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.31 146.26 48.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.453 0.538 . . . . 71.51 112.453 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 35' ' ' LEU . 29.7 m -87.36 -13.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.14 0.495 . . . . 75.11 111.486 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.29 154.45 36.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.007 -0.542 . . . . 71.5 110.301 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.6 p -78.86 132.38 64.43 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.882 0.372 . . . . 62.04 111.193 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.23 126.42 16.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.93 2.42 . . . . 72.54 113.755 -174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -96.48 127.78 42.79 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.053 -0.521 . . . . 63.23 110.615 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -83.48 115.04 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.822 -0.351 . . . . 72.23 110.376 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -97.31 103.28 15.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.064 0.459 . . . . 74.11 109.974 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.26 -28.55 66.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.131 -0.486 . . . . 75.45 111.571 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.33 -52.77 63.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.912 0.387 . . . . 73.41 111.071 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -88.36 -25.41 22.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.062 0.393 . . . . 71.25 112.062 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.41 61.76 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.389 -0.434 . . . . 74.02 113.673 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.98 159.65 17.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.429 0.633 . . . . 75.32 112.561 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE1' HG13 ' A' ' 47' ' ' VAL . 49.8 m-85 -100.97 122.33 43.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.636 -0.711 . . . . 71.21 109.852 169.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 47.4 mt-10 -104.69 121.64 43.99 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.821 0.343 . . . . 75.13 111.063 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -145.17 156.91 44.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 71.13 111.436 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 31.6 ttmt -106.3 111.46 24.07 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.294 -0.412 . . . . 63.21 111.197 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -60.73 166.82 3.06 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.231 0.456 . . . . 74.12 112.231 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.51 ' HA ' HG11 ' A' ' 18' ' ' VAL . 74.8 mt -61.07 -21.35 63.57 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 73.22 111.128 176.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.49 -11.44 60.22 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.963 -0.562 . . . . 54.25 111.679 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.34 -5.48 71.06 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.159 -0.544 . . . . 72.45 112.883 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -82.68 119.66 24.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.938 0.348 . . . . 70.14 111.938 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 33.8 tt0 -83.69 112.93 20.5 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.895 -0.409 . . . . 63.32 109.895 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -116.43 152.56 33.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.946 0.403 . . . . 75.21 111.802 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 44.6 mtp180 -116.28 126.32 53.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.378 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 tt -129.94 145.3 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 122.244 -0.285 . . . . 54.31 111.08 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -66.88 150.44 49.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.579 0.704 . . . . 73.21 112.687 -172.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -58.52 -19.71 39.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.936 1.087 . . . . 70.23 113.936 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -84.46 -22.92 30.15 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.879 -0.513 . . . . 73.14 112.014 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -82.24 -14.51 55.4 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.167 0.432 . . . . 73.53 112.167 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.425 HG13 ' CE1' ' A' ' 30' ' ' TYR . 7.3 p -87.49 115.37 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.453 0.644 . . . . 73.04 111.727 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -83.08 -63.49 1.35 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.136 0.493 . . . . 72.55 110.93 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.3 p -139.65 149.46 43.77 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.879 -0.601 . . . . 65.5 111.358 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.49 116.02 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.373 -0.376 . . . . 71.12 110.222 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.21 141.99 50.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.827 0.346 . . . . 74.1 111.384 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -80.98 159.56 24.85 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.802 0.334 . . . . 64.32 110.943 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 4' ' ' PRO . 88.0 mt -82.66 -8.58 59.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.269 0.557 . . . . 62.24 110.619 173.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.5 mt -110.91 94.04 4.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.794 -0.639 . . . . 65.43 110.047 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.759 -0.639 . . . . 72.43 111.848 -177.02 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.871 0.367 . . . . 74.05 111.464 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.59 86.83 0.66 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.17 -0.468 . . . . 75.31 110.543 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 m -85.72 114.4 56.55 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.467 -0.333 . . . . 75.1 111.359 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.461 ' HB2' HD12 ' A' ' 53' ' ' LEU . 34.7 Cg_endo -62.67 119.93 7.23 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.651 2.234 . . . . 75.24 112.409 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.0 m -128.8 147.8 50.82 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.423 -0.353 . . . . 74.43 111.47 -174.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.4 p -121.64 125.55 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.377 0.608 . . . . 72.55 111.283 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.6 mt -98.94 116.23 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 65.45 111.391 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 113.61 22.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.31 -0.404 . . . . 65.44 110.733 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -78.46 166.07 23.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 72.34 111.538 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 64.6 t30 -63.31 -33.21 75.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.136 -0.483 . . . . 75.1 111.287 -175.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.67 7.9 6.17 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.436 -0.347 . . . . 72.33 111.865 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.04 -12.95 64.53 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.233 -0.508 . . . . 70.35 113.886 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -70.12 121.1 16.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.266 0.533 . . . . 75.31 111.426 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -103.02 130.37 50.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.867 0.365 . . . . 74.12 111.274 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.96 131.23 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.497 -0.32 . . . . 73.33 110.984 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.46 137.18 34.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.19 0.519 . . . . 72.23 112.082 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.57 150.74 50.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.81 -0.632 . . . . 70.23 111.231 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.3 m -74.34 -25.42 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.921 0.391 . . . . 71.35 111.788 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.3 174.43 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.223 -0.444 . . . . 74.13 111.261 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.2 p -83.02 145.75 50.21 Favored Pre-proline 0 N--CA 1.47 0.536 0 CA-C-O 120.852 0.358 . . . . 74.15 111.792 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.29 130.79 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.427 2.085 . . . . 74.14 113.364 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -98.09 122.58 41.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.3 -0.409 . . . . 71.41 110.46 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -82.17 130.51 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.012 0.434 . . . . 73.12 111.391 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.28 109.8 21.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.404 -0.362 . . . . 73.32 110.57 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -72.92 -29.99 63.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.003 0.43 . . . . 73.11 111.47 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -70.47 -33.47 71.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.805 0.669 . . . . 71.31 112.805 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -118.85 -10.49 9.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.798 0.666 . . . . 72.4 112.798 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.66 82.53 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 114.702 0.641 . . . . 55.22 114.702 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -102.6 154.15 19.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 117.887 0.843 . . . . 73.2 112.335 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.2 m-85 -102.12 128.26 48.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.15 -0.477 . . . . 73.55 110.827 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 46.2 mt-10 -99.53 119.32 37.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.6 0.238 . . . . 63.14 111.235 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -146.19 145.04 30.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.968 0.413 . . . . 74.52 111.675 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.69 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 4.4 ttmp? -97.58 111.45 23.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.435 -0.348 . . . . 64.31 111.268 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -61.01 168.11 2.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.855 0.359 . . . . 64.13 111.956 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.9 mt -52.69 -43.17 65.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.834 0.679 . . . . 75.44 112.834 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -75.79 -3.14 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.268 0.47 . . . . 71.25 112.268 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.24 -2.81 50.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.072 -0.585 . . . . 38.17 114.224 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -82.7 104.19 12.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.504 0.652 . . . . 73.31 111.68 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.637 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.1 tt0 -72.98 119.54 17.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.272 -0.422 . . . . 62.24 111.109 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 t -125.91 165.37 18.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.792 0.33 . . . . 70.03 111.83 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 47.0 mtm180 -126.71 129.42 48.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.387 -0.37 . . . . 75.22 111.252 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.5 tt -122.1 150.75 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.663 -0.244 . . . . 70.15 110.794 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -67.58 153.67 43.18 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.303 0.573 . . . . 75.3 112.367 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.474 ' O ' HG11 ' A' ' 47' ' ' VAL . 15.1 ptmm? -65.4 -21.68 66.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.797 1.036 . . . . 65.24 113.797 -172.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -79.4 -25.23 42.15 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.216 0.45 . . . . 74.31 112.216 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.83 -22.32 53.76 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.82 0.674 . . . . 41.52 112.82 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 44' ' ' LYS . 8.0 p -72.84 114.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.736 0.779 . . . . 74.13 111.981 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.441 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 10.0 tpt180 -81.83 -63.36 1.4 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.82 -0.627 . . . . 75.41 110.466 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -146.54 146.61 30.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.013 -0.539 . . . . 74.15 110.984 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.83 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.722 0.296 . . . . 73.2 110.88 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HB2' HG13 ' A' ' 6' ' ' VAL . 61.1 mttp -119.3 152.36 36.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.292 0.568 . . . . 72.32 111.919 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -92.49 139.9 30.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.102 -0.499 . . . . 73.33 111.329 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' A' ' 4' ' ' PRO . 78.6 mt -78.12 -22.45 48.85 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.818 0.342 . . . . 72.33 111.356 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.9 mt -111.42 84.54 1.96 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.905 0.383 . . . . 71.0 111.083 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.699 -0.667 . . . . 52.25 111.37 177.518 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 110.592 -0.151 . . . . 72.42 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.11 150.68 30.17 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.292 0.479 . . . . 74.05 112.292 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -123.22 136.77 27.38 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.042 -0.527 . . . . 75.44 110.252 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HB2' HD12 ' A' ' 53' ' ' LEU . 57.9 Cg_endo -69.39 116.01 4.32 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.906 1.737 . . . . 73.13 112.09 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 92.2 m -123.4 135.72 54.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.116 0.413 . . . . 74.04 112.116 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.86 118.53 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.484 0.659 . . . . 63.22 111.31 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -90.78 107.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.222 -0.445 . . . . 74.22 111.153 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 49.9 m -83.37 124.0 30.21 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.245 -0.28 . . . . 73.43 110.245 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.1 mt -96.54 162.09 13.62 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.978 0.418 . . . . 65.12 112.057 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -54.25 -45.41 72.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.027 -0.533 . . . . 74.45 111.838 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.12 5.53 5.25 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.798 0.666 . . . . 71.41 112.798 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.95 47.5 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.082 -0.58 . . . . 71.43 114.211 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -63.11 136.2 57.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.364 0.582 . . . . 71.43 111.71 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.47 129.5 55.76 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.731 0.3 . . . . 74.15 110.491 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -113.3 112.0 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.172 0.511 . . . . 65.31 111.187 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.76 117.9 30.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.324 -0.398 . . . . 71.25 111.307 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -111.93 159.9 17.94 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.159 0.504 . . . . 62.14 112.189 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 35' ' ' LEU . 35.1 m -84.59 -15.03 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.955 -0.566 . . . . 73.34 111.663 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.11 164.34 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.006 0.431 . . . . 75.43 111.327 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.401 HG21 ' OG1' ' A' ' 5' ' ' THR . 71.3 p -79.7 118.95 75.09 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.407 -0.361 . . . . 73.13 110.869 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.63 123.28 12.54 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.346 2.697 . . . . 75.32 113.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.539 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 5.5 ttpm? -87.32 123.1 31.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.357 -0.383 . . . . 71.52 110.754 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -90.3 131.59 36.02 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.005 0.431 . . . . 74.53 112.086 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -99.75 116.41 31.76 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.908 0.385 . . . . 71.41 110.157 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.26 -32.26 73.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.348 0.499 . . . . 73.43 112.348 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -72.29 -50.0 30.39 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.954 0.353 . . . . 63.34 111.954 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.1 p -89.61 -27.75 19.98 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.32 0.489 . . . . 75.25 112.32 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.93 10.69 75.0 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.06 -0.591 . . . . 72.43 113.568 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.15 149.23 23.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.416 0.627 . . . . 74.43 112.452 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -102.02 128.74 48.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.604 -0.725 . . . . 74.31 110.771 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.498 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 45.7 mt-10 -100.11 124.66 45.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.703 0.287 . . . . 72.1 111.116 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -157.19 151.77 25.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.828 0.347 . . . . 74.31 111.417 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -106.5 115.28 29.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.599 -0.273 . . . . 61.15 110.885 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 49.5 mt-30 -60.65 158.86 11.74 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.87 0.322 . . . . 74.4 111.87 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.413 ' HA ' HG11 ' A' ' 18' ' ' VAL . 89.8 mt -51.98 -30.79 26.48 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.109 0.48 . . . . 72.33 111.777 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.91 4.33 4.31 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.088 -0.506 . . . . 71.14 112.238 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 23.63 70.78 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.304 -0.474 . . . . 74.4 113.069 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -117.07 112.56 21.08 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.7 -0.294 . . . . 65.14 111.297 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.4 tt0 -87.17 138.99 31.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.815 0.341 . . . . 73.24 111.58 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -147.24 165.15 30.93 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.497 -0.319 . . . . 73.32 111.719 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 86.0 mtt180 -115.4 125.89 53.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.888 0.375 . . . . 71.11 111.03 177.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.7 tt -117.04 149.93 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.621 0.248 . . . . 73.35 111.116 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.11 148.73 32.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.538 0.685 . . . . 62.3 112.218 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 ptmt -63.17 -15.02 55.5 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.656 0.984 . . . . 72.3 113.656 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -78.08 -22.55 48.86 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.822 -0.549 . . . . 74.45 111.591 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -79.4 -28.29 41.84 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.958 0.725 . . . . 64.31 112.958 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -68.25 113.78 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.727 0.775 . . . . 74.12 112.481 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 8' ' ' THR . 75.1 ttt180 -82.08 -60.32 2.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.525 -0.762 . . . . 74.44 110.671 175.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -149.36 129.58 13.68 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.066 -0.516 . . . . 74.51 111.24 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.848 0.356 . . . . 72.4 111.314 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -125.18 152.83 43.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 74.53 111.184 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 24.0 m-20 -89.01 149.39 23.28 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.835 0.35 . . . . 64.44 110.998 176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 4' ' ' PRO . 85.1 mt -63.68 -29.22 70.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.233 0.539 . . . . 71.01 110.167 172.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.1 mt -122.1 80.02 1.66 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.697 -0.683 . . . . 74.43 110.058 172.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.599 -0.715 . . . . 70.51 112.125 -178.584 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.802 0.334 . . . . 72.22 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.68 146.93 31.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.004 0.431 . . . . 73.2 111.523 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -153.84 142.67 14.57 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 116.108 -0.496 . . . . 73.33 110.768 -176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HB2' HD13 ' A' ' 53' ' ' LEU . 38.5 Cg_endo -66.6 114.02 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.696 1.597 . . . . 65.04 111.633 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.0 m -126.93 149.72 49.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.296 -0.411 . . . . 52.42 111.25 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.18 129.21 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.44 0.638 . . . . 64.44 111.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.3 110.44 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.027 -0.533 . . . . 74.52 110.862 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.714 HG22 HH21 ' A' ' 48' ' ' ARG . 26.0 m -89.07 118.31 28.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.749 0.309 . . . . 72.14 111.286 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.7 170.14 13.58 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.807 0.337 . . . . 73.42 111.576 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.07 -31.29 71.7 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.871 0.367 . . . . 74.44 111.697 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.27 -20.9 66.37 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 111.992 0.367 . . . . 70.55 111.992 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.07 -7.6 62.56 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.523 -0.631 . . . . 35.23 111.523 -170.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -70.06 125.05 25.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.96 0.504 . . . . 72.23 110.913 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.8 130.67 55.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.043 0.449 . . . . 72.34 111.718 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.8 mt -110.96 125.62 68.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.241 -0.436 . . . . 70.51 110.754 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -96.73 129.57 44.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.957 0.408 . . . . 62.0 111.915 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -119.55 162.04 19.59 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.121 -0.49 . . . . 63.22 111.488 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -97.11 -3.99 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.064 0.394 . . . . 61.33 112.064 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.01 174.95 10.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.328 0.585 . . . . 74.11 112.177 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.1 p -79.01 129.89 71.64 Favored Pre-proline 0 N--CA 1.471 0.618 0 CA-C-N 115.807 -0.633 . . . . 74.14 112.083 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.2 133.79 25.58 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.618 2.212 . . . . 72.14 113.238 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 135.71 35.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.476 -0.329 . . . . 70.32 111.207 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -95.63 115.51 27.53 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.602 0.239 . . . . 72.41 111.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -109.43 118.93 37.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.85 0.357 . . . . 72.44 110.75 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.15 -42.16 63.13 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.96 0.355 . . . . 63.51 111.96 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.85 -38.72 82.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.155 0.428 . . . . 72.33 112.155 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -94.44 -27.42 16.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.224 -0.298 . . . . 74.14 111.608 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.49 12.28 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.858 -0.687 . . . . 43.04 113.839 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 72.6 m-85 -116.27 163.52 15.88 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.173 0.511 . . . . 71.31 112.156 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.3 m-85 -101.24 128.68 47.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.91 -0.586 . . . . 74.4 110.424 171.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 39.6 mt-10 -98.97 119.25 37.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.535 0.207 . . . . 75.4 111.088 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.54 155.21 42.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.991 0.424 . . . . 73.55 111.486 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.612 ' HZ2' ' HB2' ' A' ' 33' ' ' LYS . 3.8 ttmp? -108.91 109.77 20.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.414 -0.357 . . . . 73.34 111.129 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 47.3 mt-30 -61.63 164.84 5.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.224 0.453 . . . . 61.41 112.224 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.553 ' HA ' HG11 ' A' ' 18' ' ' VAL . 86.7 mt -48.8 -43.26 38.03 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.791 0.664 . . . . 73.34 112.791 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -1.97 19.7 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.327 0.492 . . . . 64.32 112.327 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.15 -2.24 63.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.446 -0.406 . . . . 41.22 112.676 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -71.75 97.87 1.85 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.809 0.3 . . . . 71.14 111.809 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.8 tt0 -80.47 120.77 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.732 -0.213 . . . . 73.41 110.463 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -145.62 165.59 28.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.925 0.393 . . . . 72.01 111.709 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 59.5 mtm180 -117.48 148.05 42.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.13 -0.487 . . . . 75.3 111.265 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.65 152.15 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.369 -0.378 . . . . 65.42 110.813 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.17 133.89 55.1 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.113 0.482 . . . . 73.23 111.425 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.09 -16.17 29.54 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.221 1.193 . . . . 73.24 114.221 -172.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -91.85 -12.13 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.694 -0.629 . . . . 74.52 112.326 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -77.05 -28.06 54.65 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.911 0.386 . . . . 62.43 111.883 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -77.77 121.82 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.296 0.569 . . . . 70.4 112.312 -175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.714 HH21 HG22 ' A' ' 8' ' ' THR . 72.0 ttp85 -82.51 -59.82 2.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.008 0.432 . . . . 74.12 110.955 174.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.478 HG23 ' HG2' ' A' ' 48' ' ' ARG . 66.5 p -141.96 136.08 30.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.156 -0.475 . . . . 75.31 111.606 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.38 108.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.645 -0.252 . . . . 61.35 110.718 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -123.96 156.34 36.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.028 0.442 . . . . 73.32 111.297 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -91.98 149.64 21.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 64.34 110.914 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 4' ' ' PRO . 66.6 mt -68.55 -35.1 76.97 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.266 -0.642 . . . . 65.01 109.266 172.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.6 mt -118.61 84.35 2.17 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.266 -0.879 . . . . 72.34 109.562 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.616 -0.707 . . . . 55.2 112.589 -176.026 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.73 0.3 . . . . 60.31 111.04 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 19' ' ' ASP . . . -131.37 141.32 49.87 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.88 0.371 . . . . 74.42 111.536 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 t -127.74 133.04 24.67 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 116.51 -0.314 . . . . 64.12 111.079 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HB2' HD12 ' A' ' 53' ' ' LEU . 32.6 Cg_endo -63.83 116.12 3.49 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.159 1.906 . . . . 62.34 111.793 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.4 m -119.82 136.87 54.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.893 0.378 . . . . 72.5 111.974 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.36 0.6 . . . . 73.25 110.755 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.401 HG22 HG23 ' A' ' 47' ' ' VAL . 66.0 mt -96.59 110.53 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.153 -0.476 . . . . 72.51 111.085 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 49' ' ' THR . 41.9 m -91.02 116.45 28.8 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.823 0.344 . . . . 73.14 110.803 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.28 161.82 21.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.894 0.378 . . . . 61.02 111.917 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.69 -40.39 79.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.434 0.531 . . . . 74.0 112.434 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.41 -12.56 53.49 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.303 0.483 . . . . 75.24 112.303 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.8 10.5 40.23 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.011 -0.614 . . . . 65.12 113.643 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -95.41 132.18 40.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.152 0.476 . . . . 71.25 111.565 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -102.95 130.47 50.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.927 0.394 . . . . 74.33 111.617 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.3 119.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.689 0.28 . . . . 64.02 110.412 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -92.34 130.88 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.164 0.507 . . . . 64.24 112.03 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.38 150.65 42.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.052 -0.522 . . . . 73.53 111.46 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' A' ' 35' ' ' LEU . 26.9 m -82.52 -13.79 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.191 0.441 . . . . 71.12 112.191 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.42 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -137.21 173.88 11.21 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.949 0.404 . . . . 75.53 111.657 175.099 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.5 p -79.54 140.89 55.89 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 112.869 0.692 . . . . 74.44 112.869 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.33 105.01 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.572 2.181 . . . . 61.15 112.772 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.36 111.77 20.81 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.143 -0.481 . . . . 70.45 111.051 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.467 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 51.1 t80 -81.68 132.33 35.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.968 0.413 . . . . 73.13 112.102 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -123.38 119.3 29.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.9 -0.591 . . . . 71.33 110.825 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.84 -15.73 55.6 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.872 0.323 . . . . 73.41 111.872 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.46 -45.06 73.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 63.11 111.126 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.2 p -93.49 -27.53 16.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.867 0.365 . . . . 52.43 111.501 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.38 10.5 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.301 -0.476 . . . . 72.11 113.111 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 75.1 m-85 -113.44 164.69 13.29 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.507 0.67 . . . . 73.53 112.76 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 69.7 m-85 -102.34 132.41 48.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.641 -0.709 . . . . 74.04 110.457 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 43.3 mt-10 -98.57 119.5 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.882 0.372 . . . . 73.52 110.824 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -147.1 143.79 28.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.009 0.433 . . . . 72.23 111.278 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.699 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 4.7 ttmp? -97.72 110.38 22.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.454 -0.339 . . . . 70.03 111.13 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.36 164.12 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.906 0.384 . . . . 72.13 111.711 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.412 ' HA ' HG13 ' A' ' 18' ' ' VAL . 88.3 mt -53.41 -35.01 59.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.293 -0.412 . . . . 64.41 111.894 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.9 -12.26 61.18 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.036 0.384 . . . . 74.34 112.036 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.6 -7.62 50.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.496 -0.383 . . . . 51.22 112.665 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -75.16 100.42 4.27 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.086 0.469 . . . . 70.21 111.968 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.653 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.1 tt0 -84.04 104.41 14.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.024 0.44 . . . . 65.14 110.542 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 t -124.45 166.48 15.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.944 0.402 . . . . 70.21 111.532 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 64.4 mtm180 -115.66 132.14 56.72 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.33 -0.396 . . . . 74.44 111.685 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.12 151.21 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.494 -0.321 . . . . 71.32 110.693 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -71.52 145.57 49.06 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.152 0.501 . . . . 74.4 112.042 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -60.43 -16.79 39.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.776 1.028 . . . . 73.01 113.776 -173.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -83.65 -25.69 30.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.223 0.453 . . . . 64.22 112.223 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -77.12 -28.38 54.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.314 0.487 . . . . 73.44 112.314 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 7' ' ' ILE . 7.3 p -74.2 113.75 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.484 0.659 . . . . 73.3 112.163 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -83.63 -63.75 1.29 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.355 0.598 . . . . 73.41 110.856 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 77.6 p -132.99 151.17 52.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.759 -0.655 . . . . 75.52 111.733 -177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.42 117.85 46.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.255 -0.429 . . . . 72.13 111.202 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -127.64 134.02 49.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.84 0.352 . . . . 74.15 111.856 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -84.04 127.2 33.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.003 0.43 . . . . 75.41 110.929 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 4' ' ' PRO . 87.9 mt -64.15 -21.56 66.6 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.344 0.498 . . . . 74.34 112.344 -175.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 99.2 mt -67.64 -21.42 65.38 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.5 0.556 . . . . 75.13 112.5 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.678 -0.677 . . . . 54.51 111.751 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.886 0.374 . . . . 72.13 111.081 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.19 123.42 47.81 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.036 0.446 . . . . 74.55 112.006 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m -143.77 133.55 11.78 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.103 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.52 ' HB2' HD13 ' A' ' 53' ' ' LEU . 22.9 Cg_endo -60.15 130.41 34.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.271 1.98 . . . . 53.13 112.926 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -132.25 135.99 46.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.28 -0.418 . . . . 74.54 111.327 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' HB ' HD21 ' A' ' 53' ' ' LEU . 8.2 p -98.94 122.94 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.473 0.654 . . . . 61.02 111.926 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 21' ' ' PRO . 64.4 mt -98.61 110.55 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.039 -0.528 . . . . 64.31 110.677 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.0 m -90.32 124.36 34.84 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.702 0.287 . . . . 75.03 110.716 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.2 157.49 17.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.938 0.347 . . . . 74.53 111.938 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -56.14 -30.82 62.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.2 0.524 . . . . 63.13 110.853 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.632 -0.713 . . . . 74.33 111.54 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.49 -23.38 8.0 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.332 -0.394 . . . . 52.24 112.23 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -65.31 141.25 58.66 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.925 0.342 . . . . 63.34 111.925 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.63 130.62 55.7 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.587 -0.279 . . . . 73.4 111.279 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -110.02 129.32 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.757 0.313 . . . . 73.54 110.788 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -99.96 113.12 25.47 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.973 0.416 . . . . 72.34 111.575 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.72 160.55 14.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.489 -0.323 . . . . 60.21 111.81 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -91.56 -18.68 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.475 0.546 . . . . 73.42 112.475 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -133.83 176.0 8.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.921 0.391 . . . . 74.02 111.541 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.7 p -77.35 127.85 81.94 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 116.592 -0.276 . . . . 75.14 111.66 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.422 ' HB3' HD11 ' A' ' 7' ' ' ILE . 21.1 Cg_endo -60.33 125.42 17.4 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.793 2.329 . . . . 70.43 113.959 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -93.72 142.11 27.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.192 -0.913 . . . . 70.13 110.748 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.92 133.82 52.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.883 -0.511 . . . . 74.0 111.863 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.42 113.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.952 -0.567 . . . . 74.02 110.195 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -72.19 -34.66 68.59 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.863 0.363 . . . . 73.2 111.814 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -59.81 -50.58 73.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.912 0.386 . . . . 75.44 111.923 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.9 t -89.91 -23.39 21.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.341 -0.391 . . . . 65.11 111.511 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.43 10.88 79.02 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 52.12 113.705 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 97.0 m-85 -110.4 163.84 13.28 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.199 0.524 . . . . 74.11 111.877 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.0 m-85 -101.05 136.66 40.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.016 -0.538 . . . . 63.22 110.75 173.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.97 118.36 34.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.893 -0.41 . . . . 60.34 109.893 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -143.65 156.18 44.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.957 0.408 . . . . 73.43 111.256 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.677 ' HZ3' ' HB2' ' A' ' 33' ' ' LYS . 4.6 ttmp? -118.17 110.89 18.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.191 -0.458 . . . . 75.13 111.655 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -60.8 160.6 9.23 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.291 -0.413 . . . . 73.2 111.36 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.79 -27.27 11.75 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.524 0.564 . . . . 73.21 112.524 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.26 4.69 6.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.017 0.377 . . . . 74.12 112.017 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.4 20.96 78.36 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.014 -0.612 . . . . 74.33 112.507 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.73 114.9 28.31 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.64 0.376 . . . . 75.34 111.532 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -92.35 125.65 37.1 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.893 0.378 . . . . 70.51 110.769 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -145.1 166.55 25.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.514 -0.312 . . . . 74.12 110.864 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 44.2 mtm180 -114.55 140.3 48.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.412 0.523 . . . . 64.24 112.412 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -128.59 145.54 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.242 -0.436 . . . . 73.23 110.658 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.85 146.89 52.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.662 0.744 . . . . 72.44 112.518 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' O ' HG12 ' A' ' 47' ' ' VAL . 19.0 pttm -53.49 -27.62 26.36 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.716 -1.129 . . . . 74.31 113.999 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -77.84 -21.86 50.81 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.363 0.505 . . . . 74.01 112.363 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -77.36 -25.03 50.63 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.9 0.704 . . . . 74.41 112.9 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.2 p -75.11 113.53 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.567 0.699 . . . . 63.34 112.612 -175.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.15 -60.48 2.14 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.912 -0.585 . . . . 54.53 110.98 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 p -139.35 153.15 47.64 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.316 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.5 t -127.87 108.29 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.506 -0.315 . . . . 72.14 111.207 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -123.15 145.56 48.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.115 0.483 . . . . 64.45 111.594 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -83.07 137.7 34.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.098 0.475 . . . . 71.01 111.744 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 4' ' ' PRO . 95.1 mt -75.62 -23.57 56.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.325 -0.398 . . . . 72.13 111.065 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.7 mt -119.25 87.73 2.79 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.041 0.448 . . . . 61.31 110.919 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.912 -0.566 . . . . 75.05 111.159 177.793 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 111.87 0.322 . . . . 73.45 111.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.77 85.67 1.22 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.982 0.42 . . . . 74.15 111.344 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m -81.38 113.61 43.04 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 116.204 -0.453 . . . . 74.24 111.156 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.551 ' HB2' HD12 ' A' ' 53' ' ' LEU . 18.4 Cg_endo -57.99 131.83 45.92 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.483 2.122 . . . . 64.42 112.391 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -127.23 133.56 50.21 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.788 0.292 . . . . 72.33 111.788 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.79 124.88 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.51 0.672 . . . . 73.23 111.053 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.57 107.99 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.027 -0.533 . . . . 75.02 111.166 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -84.27 119.56 25.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.371 -0.377 . . . . 74.32 110.648 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -86.2 155.24 20.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.627 0.251 . . . . 61.33 111.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.2 -26.24 68.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.386 0.612 . . . . 73.45 110.655 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -58.25 -29.05 65.46 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.556 -0.747 . . . . 71.53 111.659 173.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.1 -11.33 26.87 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.513 -0.375 . . . . 71.31 112.939 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -81.45 130.42 35.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.857 0.361 . . . . 72.41 111.738 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.52 129.84 53.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.009 0.433 . . . . 75.2 110.836 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.4 mt -112.74 121.92 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.485 -0.325 . . . . 73.2 111.381 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -93.91 117.76 30.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.246 0.546 . . . . 44.13 111.976 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -105.67 153.27 22.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.931 -0.577 . . . . 61.25 111.328 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -78.77 -28.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.152 0.427 . . . . 73.52 112.152 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.43 175.4 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.976 0.417 . . . . 54.13 111.764 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.5 p -78.57 131.05 69.18 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.375 -0.375 . . . . 72.43 111.572 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.526 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 58.1 Cg_endo -68.71 153.95 72.25 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.687 2.258 . . . . 71.12 113.936 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -111.51 120.2 41.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.745 -0.661 . . . . 64.11 111.134 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -82.07 125.86 31.33 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.112 -0.367 . . . . 71.05 110.307 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.11 114.98 26.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.18 0.514 . . . . 71.34 110.231 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.5 -28.08 65.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.807 -0.633 . . . . 74.44 112.102 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -83.24 -44.76 14.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.443 -0.344 . . . . 72.14 111.919 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 m -82.37 -27.81 31.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.046 0.387 . . . . 74.24 112.046 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.57 9.43 84.76 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.299 -0.477 . . . . 50.23 113.777 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.24 162.42 13.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.351 -0.5 . . . . 61.22 112.015 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 58.6 m-85 -101.77 127.07 48.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 73.13 110.282 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.5 mt-10 -99.15 119.7 38.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.498 -0.319 . . . . 74.44 110.418 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.526 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 35.9 p90 -142.21 148.37 38.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.192 0.52 . . . . 74.11 112.086 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -106.09 108.99 20.78 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.965 -0.561 . . . . 60.04 110.566 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 45.2 mt-30 -66.43 171.14 5.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.323 0.49 . . . . 70.05 112.323 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.91 -21.9 58.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.304 -0.407 . . . . 64.34 112.074 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.26 -11.91 57.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.095 0.406 . . . . 62.34 112.095 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.4 -4.73 51.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.288 -0.482 . . . . 60.43 114.095 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -75.68 117.3 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.191 -0.594 . . . . 64.41 111.765 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.07 88.56 7.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.369 0.604 . . . . 73.24 109.871 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 t -106.78 165.07 11.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.084 -0.507 . . . . 72.21 111.665 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 23.3 mtm180 -125.87 138.44 53.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.964 0.411 . . . . 73.15 112.021 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -133.17 147.65 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.245 -0.434 . . . . 62.31 110.702 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.74 148.22 50.67 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.229 0.537 . . . . 74.23 112.062 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.37 -15.49 63.33 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.736 1.013 . . . . 61.22 113.736 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -79.54 -11.01 59.9 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.797 -0.564 . . . . 55.15 111.615 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -90.57 -26.65 19.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.295 0.479 . . . . 74.14 112.295 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.81 117.63 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.455 0.645 . . . . 72.42 112.671 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HG2' HG23 ' A' ' 49' ' ' THR . 50.9 ttt180 -82.61 -60.89 2.04 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.998 -0.547 . . . . 73.05 111.524 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.517 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.2 p -141.99 143.49 33.21 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.461 -0.336 . . . . 74.22 111.858 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.23 123.65 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.5 -0.318 . . . . 62.5 111.064 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -138.41 155.52 48.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.144 0.497 . . . . 72.31 111.822 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.66 149.18 23.64 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.222 0.534 . . . . 73.05 111.512 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.551 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.0 mt -85.64 -3.96 59.03 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.232 -0.44 . . . . 74.12 111.111 174.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.2 71.28 0.9 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.217 -0.447 . . . . 75.23 110.843 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--O 1.256 1.435 0 CA-C-O 118.745 -0.645 . . . . 74.42 111.389 179.234 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptp . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.796 0.331 . . . . 74.42 111.225 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.16 105.8 17.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.946 0.403 . . . . 72.35 111.455 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m -115.5 129.24 25.29 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.423 -0.353 . . . . 72.32 110.842 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 8.1 Cg_endo -49.15 116.31 2.17 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.79 2.327 . . . . 73.32 112.951 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.6 m -121.95 132.34 54.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.3 -0.409 . . . . 73.02 111.462 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.509 ' HB ' HD21 ' A' ' 53' ' ' LEU . 14.4 p -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.264 0.555 . . . . 75.05 111.17 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG22 HG23 ' A' ' 47' ' ' VAL . 67.2 mt -111.69 109.3 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.031 -0.531 . . . . 74.2 111.162 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.5 m -83.77 118.62 24.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.69 0.281 . . . . 64.34 110.353 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.44 155.62 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.906 0.384 . . . . 74.44 111.603 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.29 -21.64 65.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.078 0.465 . . . . 75.52 111.194 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.82 -2.5 47.48 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.146 -0.479 . . . . 74.4 112.192 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.09 -28.06 17.42 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.624 -0.322 . . . . 65.33 113.202 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -66.68 136.23 55.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.822 0.344 . . . . 73.4 111.827 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.74 129.6 56.06 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.29 -0.256 . . . . 61.41 110.704 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.4 mt -109.68 128.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.82 0.343 . . . . 73.22 111.118 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -95.89 119.36 34.24 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.31 0.576 . . . . 73.24 112.122 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . -110.95 168.28 9.61 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.749 -0.659 . . . . 71.31 111.33 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 33.2 m -102.65 -5.26 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 111.866 0.321 . . . . 64.32 111.866 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -138.42 174.16 10.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.248 0.546 . . . . 72.14 112.059 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.2 p -80.96 121.63 81.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.946 -0.57 . . . . 71.54 111.567 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -61.34 128.53 25.24 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.92 2.413 . . . . 71.44 113.837 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 28.2 ttmt -91.65 141.97 28.12 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.925 -0.579 . . . . 73.54 110.82 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -101.67 129.83 47.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.796 -0.565 . . . . 74.25 111.366 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -132.04 116.37 16.99 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.917 0.389 . . . . 74.4 111.337 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.44 -32.2 68.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.738 0.273 . . . . 74.21 111.738 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -55.05 -37.92 67.33 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.875 0.369 . . . . 60.21 111.587 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.1 p -97.32 -27.95 14.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.887 0.375 . . . . 51.15 110.857 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.38 10.94 69.99 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.349 -0.387 . . . . 71.33 113.209 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -122.18 171.55 8.92 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.527 0.679 . . . . 71.24 112.718 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.4 m-85 -102.17 132.78 47.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 64.34 110.484 169.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -98.27 120.43 38.66 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.68 0.276 . . . . 74.44 111.028 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -148.9 146.41 27.88 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 75.44 111.331 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 37.9 ttmt -100.85 114.67 28.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.501 -0.318 . . . . 74.15 111.606 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -60.15 164.13 4.35 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.139 0.422 . . . . 64.15 112.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -53.58 -32.13 49.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.952 0.406 . . . . 71.34 111.751 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -72.88 0.22 11.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.241 0.459 . . . . 64.21 112.241 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 25.35 61.36 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.896 -0.669 . . . . 61.34 112.121 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -106.45 106.77 17.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.829 0.347 . . . . 65.33 111.04 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.628 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 57.3 tt0 -81.52 110.84 17.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.323 -0.399 . . . . 73.14 111.056 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -124.3 166.84 15.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.081 0.467 . . . . 73.14 111.966 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 62.7 mtt180 -126.06 126.59 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.153 -0.476 . . . . 72.21 111.47 -176.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.612 0.244 . . . . 73.53 111.435 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.29 148.4 51.76 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.281 0.562 . . . . 75.22 112.356 -174.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.579 ' HZ2' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -62.05 -32.03 72.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.335 1.235 . . . . 74.41 114.335 -172.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -84.44 -12.69 53.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.639 -0.663 . . . . 64.32 112.209 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.77 -28.16 55.57 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.297 0.48 . . . . 65.01 112.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.524 HG23 HG22 ' A' ' 7' ' ' ILE . 7.5 p -76.82 113.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.267 0.556 . . . . 73.33 112.253 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -82.96 -60.14 2.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.031 0.444 . . . . 74.5 111.066 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.0 p -130.64 162.19 29.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.163 0.431 . . . . 71.4 112.163 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.0 t -137.36 106.95 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 116.022 -0.535 . . . . 74.3 110.743 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -132.78 154.09 50.59 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.303 0.573 . . . . 71.24 112.011 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -78.29 160.17 28.03 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.311 0.577 . . . . 50.1 111.133 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.509 HD21 ' HB ' ' A' ' 6' ' ' VAL . 93.1 mt -93.86 -4.21 50.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.185 -0.461 . . . . 71.45 110.753 173.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -105.23 8.4 33.94 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.15 0.426 . . . . 72.01 112.15 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 119.356 -0.354 . . . . 71.23 111.881 178.24 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 mtm . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.706 0.289 . . . . 52.54 111.266 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 150.16 21.26 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.017 0.437 . . . . 70.21 111.084 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 t -145.86 133.63 10.45 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 116.331 -0.395 . . . . 73.45 110.86 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.439 ' HB2' HD12 ' A' ' 53' ' ' LEU . 47.6 Cg_endo -68.3 114.62 3.5 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.591 1.527 . . . . 43.53 111.802 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.6 m -123.83 126.67 46.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.258 -0.428 . . . . 74.04 111.541 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.33 117.85 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.457 0.646 . . . . 72.44 110.891 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 66.6 mt -100.64 111.73 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.086 -0.507 . . . . 60.41 111.187 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 99.6 m -83.8 121.26 27.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.508 -0.315 . . . . 73.14 110.824 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.549 HD12 HD13 ' A' ' 15' ' ' ILE . 75.3 mt -89.06 172.1 9.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 62.34 111.893 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -51.88 -41.24 61.75 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.87 -0.605 . . . . 64.4 112.212 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.2 -15.46 62.47 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.708 0.633 . . . . 75.4 112.708 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.79 -1.22 68.18 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.808 -0.517 . . . . 70.42 111.808 -170.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -72.11 136.36 46.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.763 0.425 . . . . 73.44 110.968 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.59 133.74 48.11 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.886 0.374 . . . . 71.32 111.592 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.549 HD13 HD12 ' A' ' 9' ' ' LEU . 63.0 mt -108.55 124.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.739 0.304 . . . . 60.41 110.555 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.6 111.34 23.28 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 72.34 111.506 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.61 150.1 33.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.82 0.343 . . . . 64.25 111.826 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.509 HG11 HD23 ' A' ' 35' ' ' LEU . 29.5 m -96.68 2.32 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.949 0.404 . . . . 74.43 111.281 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 2.7 t0 -140.19 164.69 29.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.199 -0.455 . . . . 52.42 110.077 -175.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.7 p -80.01 140.14 53.66 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 112.396 0.517 . . . . 63.35 112.396 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 32' ' ' PHE . 61.7 Cg_endo -72.6 111.15 3.16 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.545 2.163 . . . . 72.4 113.244 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -86.8 110.29 19.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.754 -0.657 . . . . 71.41 111.321 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -84.68 122.22 28.78 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.881 0.326 . . . . 72.42 111.881 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.65 122.16 41.52 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.936 0.398 . . . . 72.43 110.52 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.03 -42.14 73.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.309 -0.405 . . . . 63.43 111.987 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.41 -40.37 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.389 0.514 . . . . 71.5 112.389 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.7 t -97.54 -27.3 14.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.895 0.379 . . . . 65.11 111.825 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 10.76 79.07 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.099 -0.572 . . . . 36.89 114.252 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -101.97 154.45 18.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.286 0.543 . . . . 73.31 111.99 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CE1' HG12 ' A' ' 47' ' ' VAL . 52.8 m-85 -101.51 121.75 42.55 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.043 -0.526 . . . . 70.3 110.042 171.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.1 119.33 38.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.424 -0.353 . . . . 75.41 110.555 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.54 ' HB3' ' HA ' ' A' ' 21' ' ' PRO . 28.6 p90 -148.0 168.32 22.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.745 0.646 . . . . 74.04 112.745 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.644 ' HZ2' ' HB2' ' A' ' 33' ' ' LYS . 4.6 ttmp? -112.68 116.61 30.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.732 -0.667 . . . . 70.05 110.941 -176.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 47.9 mt-30 -76.28 173.52 11.29 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.17 0.433 . . . . 75.14 112.17 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.509 HD23 HG11 ' A' ' 18' ' ' VAL . 78.0 mt -57.11 -30.82 64.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.909 0.385 . . . . 72.24 111.902 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.92 -11.9 60.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.952 0.406 . . . . 74.11 111.58 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.33 -11.97 69.54 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.399 -0.429 . . . . 55.12 112.401 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -69.51 124.86 25.02 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.914 0.388 . . . . 74.53 111.578 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -82.67 140.07 33.35 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.375 -0.375 . . . . 75.35 110.641 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 t -145.82 156.28 43.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.93 0.395 . . . . 75.23 112.051 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 42.5 mtm180 -127.14 129.34 47.7 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.22 -0.446 . . . . 53.24 110.842 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 tt -130.44 141.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.647 0.26 . . . . 72.12 110.927 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.13 152.09 45.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.755 0.788 . . . . 75.14 112.685 -172.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -59.51 -14.96 14.82 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.309 1.226 . . . . 74.41 114.309 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -78.59 -32.07 47.46 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.984 -0.448 . . . . 61.23 112.018 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -78.72 -28.64 45.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.547 0.573 . . . . 74.15 112.547 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG12 ' CE1' ' A' ' 30' ' ' TYR . 7.4 p -73.4 114.03 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.446 0.641 . . . . 71.13 111.912 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -83.65 -58.08 2.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.363 -0.38 . . . . 74.23 111.115 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.5 p -142.58 135.26 28.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.061 0.393 . . . . 54.34 112.061 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.8 t -100.07 116.64 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 116.423 -0.353 . . . . 72.14 110.95 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -132.31 150.99 52.04 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.948 0.351 . . . . 74.44 111.948 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -88.67 150.32 23.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.963 0.411 . . . . 70.35 111.368 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' A' ' 4' ' ' PRO . 93.1 mt -78.16 -18.15 55.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.214 -0.448 . . . . 75.13 111.42 176.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.8 mt -96.27 86.99 4.36 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.056 0.455 . . . . 74.41 111.101 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.648 -0.692 . . . . 73.53 111.409 178.05 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.572 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.71 0.291 . . . . 71.24 111.249 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.9 135.11 52.56 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.144 0.497 . . . . 75.03 111.523 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -125.22 149.88 65.34 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 116.161 -0.472 . . . . 72.35 110.508 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.536 ' HB2' HD12 ' A' ' 53' ' ' LEU . 30.7 Cg_endo -63.61 115.28 2.96 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.742 1.628 . . . . 64.24 111.479 173.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.9 m -125.09 128.36 48.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.761 0.315 . . . . 74.22 111.47 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.95 119.24 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.457 0.646 . . . . 73.12 111.555 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.6 mt -101.21 110.65 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.037 -0.528 . . . . 74.12 110.675 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.1 m -89.47 129.4 35.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.556 -0.293 . . . . 55.1 110.952 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.95 161.96 15.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.859 0.361 . . . . 74.31 110.8 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 11.5 t30 -62.7 -24.43 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.871 0.693 . . . . 74.13 112.871 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.52 -22.37 57.17 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.845 0.355 . . . . 71.21 111.691 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.65 -6.56 13.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.254 -0.498 . . . . 41.11 113.04 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -73.6 131.69 41.97 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.603 -0.351 . . . . 65.24 111.701 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -104.43 129.31 52.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.86 0.362 . . . . 72.22 111.178 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.93 119.37 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.781 0.324 . . . . 73.44 110.688 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -94.28 132.88 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.1 0.476 . . . . 75.03 111.584 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.3 157.34 33.43 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.183 -0.462 . . . . 72.04 111.978 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.83 2.39 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.124 -0.489 . . . . 62.44 111.296 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.61 160.47 38.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.977 -0.556 . . . . 71.11 110.529 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.8 p -79.69 142.16 56.79 Favored Pre-proline 0 N--CA 1.469 0.48 0 CA-C-O 120.694 0.283 . . . . 73.1 111.331 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HB3' HD11 ' A' ' 7' ' ' ILE . 76.2 Cg_endo -75.71 146.72 30.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.689 2.26 . . . . 75.44 113.996 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 32.2 ttmt -110.65 132.6 54.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.806 -0.634 . . . . 73.41 110.375 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -90.08 119.24 30.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.387 -0.525 . . . . 72.32 110.021 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -97.38 106.03 18.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.268 0.556 . . . . 72.33 110.641 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.31 -23.03 64.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.89 -0.595 . . . . 75.52 111.852 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -69.27 -39.24 78.52 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.584 0.587 . . . . 64.2 112.584 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -118.08 -27.19 6.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.492 0.552 . . . . 71.33 112.492 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.11 11.45 31.92 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.891 -0.671 . . . . 37.72 114.174 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.482 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 91.6 m-85 -102.05 156.65 17.41 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.776 0.658 . . . . 75.42 112.776 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 55.6 m-85 -101.43 124.46 47.14 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.808 -0.633 . . . . 72.14 110.855 173.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 22' ' ' LYS . 44.0 mt-10 -99.74 122.17 42.33 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.781 0.432 . . . . 64.14 111.955 -177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -154.85 162.3 41.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.045 0.45 . . . . 74.02 111.339 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.681 ' HZ2' ' HB2' ' A' ' 33' ' ' LYS . 4.8 ttmp? -106.14 114.66 28.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.178 -0.464 . . . . 71.25 111.337 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -65.29 169.14 6.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.131 -0.486 . . . . 64.43 112.303 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.4 mt -55.37 -26.68 42.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.292 -0.413 . . . . 61.3 112.05 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.5 -4.7 32.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 111.997 0.369 . . . . 63.23 111.997 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 28.94 57.63 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.068 -0.587 . . . . 44.14 112.368 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.2 133.67 55.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.627 0.371 . . . . 62.43 111.296 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -89.07 123.64 33.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.837 0.351 . . . . 72.31 110.822 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -133.29 165.25 25.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.879 0.371 . . . . 75.5 111.623 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 57.1 mtp180 -129.1 125.72 37.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.411 -0.359 . . . . 54.51 110.229 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.93 143.74 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.685 0.279 . . . . 75.35 111.573 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -64.5 147.5 52.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.447 0.641 . . . . 74.45 112.636 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.4 ptmt -64.0 -22.61 67.0 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.923 1.083 . . . . 63.22 113.923 -173.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -82.66 -10.85 58.75 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.61 -0.682 . . . . 73.23 111.89 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -82.67 -28.44 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.882 0.327 . . . . 73.45 111.882 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -75.7 122.17 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.777 0.798 . . . . 73.44 112.845 -173.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.416 ' HG2' HG23 ' A' ' 49' ' ' THR . 63.9 ttt180 -82.06 -62.77 1.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.608 -0.724 . . . . 75.2 110.272 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.416 HG23 ' HG2' ' A' ' 48' ' ' ARG . 46.0 p -144.38 149.03 35.46 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.832 -0.622 . . . . 71.21 111.592 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -116.01 118.94 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.289 -0.414 . . . . 75.13 110.504 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -131.25 127.8 38.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.759 0.651 . . . . 74.3 112.759 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.33 131.09 38.98 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.3 -0.63 . . . . 65.42 109.3 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 4' ' ' PRO . 89.3 mt -66.74 -24.94 66.28 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.953 0.406 . . . . 75.04 110.861 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.8 mt -93.84 83.56 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.126 -0.488 . . . . 61.32 110.029 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.497 -0.763 . . . . 74.34 112.644 -175.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.389 0.138 . . . . 73.54 111.001 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.93 121.39 12.26 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.782 0.325 . . . . 74.33 111.53 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -88.15 120.45 70.61 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.691 -0.231 . . . . 65.33 110.52 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HB2' HD12 ' A' ' 53' ' ' LEU . 36.2 Cg_endo -63.95 119.49 6.56 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.486 2.124 . . . . 71.55 112.899 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 87.2 m -116.76 128.15 55.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.779 0.323 . . . . 74.12 111.8 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 53' ' ' LEU . 14.0 p -98.81 129.39 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.218 0.533 . . . . 73.43 110.59 173.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.43 118.51 56.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.852 0.358 . . . . 73.11 111.805 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.7 m -84.01 125.94 32.56 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.788 -0.449 . . . . 65.55 109.788 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.9 176.19 6.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.944 0.878 . . . . 74.14 112.915 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -64.74 -42.45 95.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.989 -1.005 . . . . 60.21 111.166 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.55 -23.74 62.67 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.97 0.414 . . . . 73.51 111.789 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.99 -18.19 9.07 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.354 -0.451 . . . . 62.43 113.522 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -64.31 136.05 56.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.228 0.514 . . . . 73.03 111.743 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.92 135.04 52.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.616 0.246 . . . . 72.24 110.823 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.8 mt -116.83 122.98 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.597 0.237 . . . . 74.34 111.206 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -85.92 116.7 24.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.075 0.464 . . . . 72.52 111.596 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.26 142.82 41.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.32 -0.4 . . . . 73.41 111.44 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 35' ' ' LEU . 26.4 m -82.31 -11.14 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.883 0.373 . . . . 41.3 111.718 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -128.51 157.7 40.45 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.248 -0.433 . . . . 71.15 109.912 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -79.28 143.65 60.82 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-O 120.967 0.413 . . . . 75.12 111.923 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.77 131.51 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.689 2.259 . . . . 72.14 113.772 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -103.39 132.22 49.82 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.828 -0.624 . . . . 75.53 110.631 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.75 123.92 34.17 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.014 -0.429 . . . . 44.34 111.497 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.99 106.46 18.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.012 0.435 . . . . 72.3 110.19 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.84 -21.66 63.34 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.342 -0.39 . . . . 73.42 111.935 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -69.17 -46.37 67.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.86 0.362 . . . . 71.01 111.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 97.2 p -101.09 -27.03 13.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.153 0.427 . . . . 64.12 112.153 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.11 8.39 64.75 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.219 -0.515 . . . . 44.32 113.265 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -95.71 155.21 16.84 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.201 0.524 . . . . 64.41 111.767 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 39.8 m-85 -101.46 131.05 47.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.148 -0.478 . . . . 72.3 111.114 172.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -98.9 118.94 36.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.078 -0.51 . . . . 75.32 110.655 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.47 142.4 31.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.302 0.572 . . . . 75.53 111.91 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -94.11 110.72 22.41 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.764 -0.653 . . . . 51.42 111.476 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.69 173.59 2.15 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.064 0.459 . . . . 61.31 112.217 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.547 ' HA ' HG11 ' A' ' 18' ' ' VAL . 89.2 mt -49.15 -45.75 44.28 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.23 0.826 . . . . 74.11 113.23 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.3 m-20 -80.2 15.07 1.65 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.56 0.578 . . . . 45.33 112.56 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.96 86.0 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.907 -0.663 . . . . 74.25 112.454 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.7 mtpp -80.96 105.07 11.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.605 0.362 . . . . 70.51 111.79 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -73.86 123.83 24.97 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.765 0.317 . . . . 72.43 110.905 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -135.1 160.19 39.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.504 -0.316 . . . . 73.33 110.77 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 76.2 mtm180 -134.07 142.01 47.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.964 0.357 . . . . 74.22 111.964 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.28 152.91 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.253 -0.43 . . . . 64.4 110.293 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.12 153.79 36.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.76 0.652 . . . . 65.21 112.76 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.36 -14.91 62.8 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.47 0.915 . . . . 73.24 113.47 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -85.28 -11.08 55.6 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.898 -0.501 . . . . 74.41 111.595 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -90.36 -27.59 19.26 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.207 0.447 . . . . 73.45 112.207 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.3 p -70.09 111.49 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.556 0.693 . . . . 63.23 111.508 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.495 ' HG2' HG23 ' A' ' 49' ' ' THR . 21.7 ttm-85 -83.03 -62.77 1.51 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.883 -0.599 . . . . 74.14 111.254 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 48' ' ' ARG . 61.7 p -141.04 135.64 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.178 0.514 . . . . 74.5 111.95 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.54 124.57 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.022 -0.535 . . . . 73.31 111.225 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -142.64 144.22 32.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.338 0.255 . . . . 71.1 111.577 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.548 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 35.6 m-20 -86.28 142.9 28.2 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.029 0.442 . . . . 64.15 111.547 175.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.4 mt -67.62 -19.83 65.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.082 0.468 . . . . 74.33 111.568 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.63 -2.79 47.98 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.347 -0.388 . . . . 61.52 111.815 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 13.3 mm-40 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.818 -0.61 . . . . 75.54 111.643 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.733 0.302 . . . . 64.15 111.207 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.64 160.29 25.1 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.017 0.437 . . . . 75.11 111.4 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.421 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 40.5 t -161.79 118.27 1.33 Allowed Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.424 -0.353 . . . . 65.42 111.013 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 3' ' ' SER . 10.8 Cg_endo -53.29 116.31 2.87 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.303 2.002 . . . . 64.15 111.768 177.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.8 m -132.77 141.46 48.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.342 -0.39 . . . . 71.45 111.123 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HB ' HD21 ' A' ' 53' ' ' LEU . 7.2 p -105.9 117.89 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.557 0.694 . . . . 70.53 111.468 178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.16 104.5 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.253 0.549 . . . . 72.1 110.513 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.0 m -85.67 119.18 25.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.964 -0.562 . . . . 74.25 110.755 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.19 157.13 24.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.779 0.323 . . . . 74.3 111.217 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.558 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 26.4 t-20 -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.993 0.368 . . . . 64.4 111.993 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.37 -8.45 55.9 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.405 0.52 . . . . 63.12 112.405 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.45 -33.2 4.58 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.803 -0.713 . . . . 72.24 114.666 175.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.2 135.1 44.49 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.673 0.736 . . . . 72.01 112.427 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.35 129.98 53.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.28 -0.418 . . . . 75.24 110.485 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.25 130.48 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.824 0.345 . . . . 71.31 111.234 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -96.56 119.2 34.61 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.06 0.457 . . . . 71.14 111.999 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.7 153.15 38.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.348 -0.387 . . . . 54.12 111.5 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.31 -10.58 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.832 0.349 . . . . 62.05 111.769 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.7 166.55 24.55 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.419 . . . . 64.32 111.579 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.7 p -80.84 138.29 50.2 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 112.178 0.436 . . . . 63.22 112.178 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.528 ' HB2' ' HB3' ' A' ' 30' ' ' TYR . 69.0 Cg_endo -71.67 126.31 11.95 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.658 2.239 . . . . 71.3 113.941 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 2.2 ttmp? -86.45 141.21 29.29 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.412 -0.358 . . . . 75.14 110.311 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -99.11 129.89 45.4 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.12 0.486 . . . . 74.12 112.095 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -109.28 111.87 23.7 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.974 -0.557 . . . . 70.11 110.109 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.73 -35.33 79.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.554 0.575 . . . . 62.2 112.554 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.11 -52.72 53.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.954 0.407 . . . . 60.02 111.829 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.5 m -85.56 -26.96 25.85 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.306 -0.406 . . . . 74.42 111.754 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.79 8.91 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.404 -0.427 . . . . 63.33 113.912 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 83.6 m-85 -102.81 156.21 17.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.222 0.534 . . . . 73.42 112.116 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.528 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 67.7 m-85 -101.93 135.59 43.21 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.627 -0.715 . . . . 63.23 110.603 172.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 36.0 mt-10 -98.89 118.78 36.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.441 0.163 . . . . 71.24 110.786 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -147.74 152.22 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.156 0.503 . . . . 73.02 111.641 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.73 ' HZ1' ' HB2' ' A' ' 33' ' ' LYS . 4.1 ttmp? -106.9 112.71 25.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.128 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -64.82 164.85 11.57 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.769 0.319 . . . . 75.54 111.799 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.9 mt -53.51 -29.72 37.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.386 0.884 . . . . 61.21 113.386 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -77.28 -11.54 59.84 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.91 0.386 . . . . 70.44 111.679 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.51 -6.28 49.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.527 -0.368 . . . . 53.31 112.242 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -70.4 101.57 1.98 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.928 0.491 . . . . 75.35 111.74 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.2 tt0 -82.07 107.28 14.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.756 0.312 . . . . 74.23 110.366 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.3 t -123.68 165.2 17.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.056 0.455 . . . . 74.42 111.836 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 49.4 mtm180 -124.59 132.49 53.44 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.962 -0.563 . . . . 75.23 111.715 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 tt -130.93 146.62 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.685 0.278 . . . . 71.13 111.211 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -71.75 152.28 42.87 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.571 0.582 . . . . 73.24 112.571 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 pttp -57.97 -31.52 66.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.516 0.932 . . . . 75.33 113.516 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -69.01 -11.64 60.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.415 0.524 . . . . 54.24 112.415 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -88.14 -27.79 21.66 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.585 0.587 . . . . 74.53 112.585 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 44' ' ' LYS . 10.7 p -76.91 118.64 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.806 0.812 . . . . 74.13 112.809 -173.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.558 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 57.4 ttt180 -81.9 -58.44 2.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.211 -0.904 . . . . 74.43 111.077 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.4 p -148.08 134.53 19.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.863 -0.608 . . . . 74.4 111.189 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 111.2 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 62.31 110.983 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -133.5 141.95 48.0 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.035 0.445 . . . . 71.04 111.761 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 24.2 m-20 -72.13 156.98 38.59 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.254 -0.43 . . . . 73.34 110.464 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.492 HD21 ' HB ' ' A' ' 6' ' ' VAL . 95.1 mt -85.74 -6.4 59.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.253 0.549 . . . . 61.22 110.73 173.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.5 mt -106.5 42.06 1.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.937 -0.574 . . . . 73.13 111.415 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 49.4 mt-10 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.457 -0.782 . . . . 64.41 111.5 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.431 0.158 . . . . 75.12 110.799 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.93 102.07 1.21 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.97 0.414 . . . . 63.14 111.392 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 p -105.95 119.69 51.46 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.178 -0.465 . . . . 62.33 110.826 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.52 ' HB2' HD13 ' A' ' 53' ' ' LEU . 9.6 Cg_endo -50.07 120.83 6.61 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.892 2.395 . . . . 71.42 112.339 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -125.71 133.04 52.26 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.437 -0.347 . . . . 74.34 111.826 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.5 ' HB ' HD21 ' A' ' 53' ' ' LEU . 14.2 p -99.97 124.5 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.173 0.511 . . . . 75.53 110.758 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.4 120.06 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.073 0.463 . . . . 74.32 110.988 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.426 ' HG1' ' HG2' ' A' ' 14' ' ' GLU . 68.0 m -100.01 118.49 36.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.033 -0.531 . . . . 74.34 110.826 177.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.457 HD11 ' HD3' ' A' ' 13' ' ' ARG . 78.3 mt -83.89 168.35 16.16 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.863 0.363 . . . . 73.34 111.521 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.58 -28.73 70.13 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.493 -0.321 . . . . 63.05 111.455 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.21 -16.21 59.44 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.036 0.446 . . . . 74.22 111.61 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.35 67.81 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.677 -0.569 . . . . 54.12 111.677 -170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.457 ' HD3' HD11 ' A' ' 9' ' ' LEU . 78.0 ttt180 -77.33 136.37 38.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.308 0.643 . . . . 74.22 111.217 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' HG1' ' A' ' 8' ' ' THR . 46.7 mt-10 -117.33 130.24 56.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.989 0.423 . . . . 71.34 111.767 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.0 mt -122.42 130.49 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.093 -0.503 . . . . 52.22 110.618 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -94.85 127.99 41.27 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.101 0.477 . . . . 74.11 112.037 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.82 164.3 17.72 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.083 -0.508 . . . . 72.24 111.453 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.73 -18.36 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.211 0.448 . . . . 74.52 112.211 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -126.94 172.48 10.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.275 0.56 . . . . 65.42 111.868 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -79.81 119.39 76.57 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.812 -0.631 . . . . 71.21 110.499 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.82 134.34 41.27 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.072 2.515 . . . . 63.02 113.951 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -85.63 124.64 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.606 -0.724 . . . . 73.44 110.746 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.81 108.62 20.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 75.32 110.983 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.25 110.54 23.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.971 0.415 . . . . 74.44 110.592 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.75 -39.29 93.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 72.11 111.993 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.19 -43.03 99.36 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.157 0.429 . . . . 72.4 112.157 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 m -91.75 -28.08 17.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.934 0.346 . . . . 64.11 111.934 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 11.94 72.85 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.922 -0.656 . . . . 72.23 113.824 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.96 155.12 21.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.387 0.613 . . . . 63.12 112.462 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.69 129.9 47.95 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.58 -0.736 . . . . 72.11 110.326 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.2 mt-10 -108.28 121.91 45.86 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.592 -0.276 . . . . 72.5 111.194 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.77 143.79 29.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.82 0.343 . . . . 72.22 111.627 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.6 ttmt -98.4 114.55 26.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.767 0.318 . . . . 71.55 111.241 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -60.6 165.11 4.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.412 -0.358 . . . . 74.23 111.779 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.64 -26.68 61.97 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.87 0.366 . . . . 73.52 111.623 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.88 -6.21 43.57 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.48 0.548 . . . . 70.11 112.48 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.09 23.9 46.81 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.075 -0.584 . . . . 73.41 112.747 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -112.63 112.3 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.794 0.331 . . . . 45.43 111.457 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.9 tt0 -89.69 109.81 20.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.806 0.336 . . . . 73.15 111.319 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -111.87 163.42 14.23 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.935 0.398 . . . . 64.22 111.529 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 55.4 mtt180 -123.51 131.64 53.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.928 0.394 . . . . 74.33 111.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.84 152.37 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.441 -0.345 . . . . 62.55 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -66.87 147.29 53.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.184 0.516 . . . . 73.53 111.667 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' O ' HG11 ' A' ' 47' ' ' VAL . 21.4 ptmt -65.07 -20.2 66.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.983 0.734 . . . . 73.51 112.983 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -76.55 -10.25 59.25 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.314 0.487 . . . . 74.02 112.314 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -90.96 -17.73 25.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.875 0.694 . . . . 73.43 112.875 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 44' ' ' LYS . 8.9 p -75.0 117.79 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.481 0.658 . . . . 72.14 112.618 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -83.51 -61.72 1.77 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.303 0.573 . . . . 72.24 110.656 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.9 p -147.06 150.46 35.1 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.669 -0.696 . . . . 63.22 111.369 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.4 t -126.58 118.25 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.236 -0.438 . . . . 65.11 110.812 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.19 136.62 49.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.358 0.503 . . . . 71.22 112.358 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -68.03 128.18 35.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.332 -0.395 . . . . 74.25 110.523 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 4' ' ' PRO . 84.8 mt -59.16 -17.52 27.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.906 0.384 . . . . 75.34 111.779 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.77 85.09 7.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.16 0.505 . . . . 54.43 110.336 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 118.571 -0.728 . . . . 71.12 111.975 -178.279 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.182 0.515 . . . . 73.44 110.999 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.81 146.06 17.54 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.804 -0.635 . . . . 71.41 110.981 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -156.51 142.08 12.66 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 116.536 -0.302 . . . . 71.42 110.689 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HB2' HD12 ' A' ' 53' ' ' LEU . 35.7 Cg_endo -63.42 116.76 3.82 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.565 2.176 . . . . 71.43 113.107 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -131.89 134.23 45.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.438 -0.346 . . . . 74.14 111.295 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.77 125.72 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.494 0.664 . . . . 63.25 111.685 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.3 mt -98.51 116.98 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.291 -0.413 . . . . 73.44 111.615 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.6 m -88.79 124.38 34.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.392 -0.367 . . . . 53.41 110.721 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.18 164.75 13.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.119 0.485 . . . . 71.04 112.282 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -54.61 -33.94 61.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.358 0.663 . . . . 73.44 111.384 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.14 -12.47 60.9 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.848 -0.615 . . . . 65.24 111.907 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.73 -24.72 30.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.436 -0.411 . . . . 61.15 112.677 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.16 135.7 57.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.846 0.355 . . . . 73.3 111.804 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.61 148.65 31.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.503 -0.317 . . . . 73.5 111.558 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.58 127.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.625 -0.261 . . . . 70.01 110.847 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -93.08 124.0 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.091 0.472 . . . . 75.34 111.995 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.06 156.8 26.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.122 -0.49 . . . . 53.34 111.55 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -88.94 -9.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.017 0.377 . . . . 63.33 112.017 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.61 166.44 24.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.102 0.477 . . . . 71.25 111.443 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.5 p -79.61 140.85 55.58 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.232 -0.44 . . . . 73.24 111.61 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 61.6 Cg_endo -71.47 148.73 54.85 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.594 2.196 . . . . 75.22 113.943 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.616 ' HZ2' ' HB2' ' A' ' 22' ' ' LYS . 3.8 ttmp? -105.62 135.1 47.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.764 -0.653 . . . . 74.51 110.324 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -87.03 122.26 30.62 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.05 0.452 . . . . 75.12 111.739 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -98.1 108.67 21.43 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.144 -0.48 . . . . 70.01 110.951 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.63 -14.24 55.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.788 0.327 . . . . 73.34 111.61 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -63.0 -52.88 61.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 74.42 111.376 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -118.72 -26.8 6.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.033 0.383 . . . . 75.1 112.033 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.69 11.88 10.98 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.406 -0.902 . . . . 71.1 114.614 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.1 162.29 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.745 0.772 . . . . 73.22 112.708 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 43.6 m-85 -110.27 132.71 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.743 -0.662 . . . . 75.42 110.798 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 55.8 mt-10 -99.28 119.57 38.13 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.364 -0.21 . . . . 61.32 111.089 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -151.32 145.04 25.04 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.009 0.433 . . . . 74.33 111.434 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HZ2' ' HB2' ' A' ' 33' ' ' LYS . 3.5 ttmp? -98.26 112.44 24.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.538 -0.301 . . . . 65.32 111.494 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.68 162.15 8.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.943 0.401 . . . . 74.43 111.853 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.51 ' HA ' HG12 ' A' ' 18' ' ' VAL . 84.1 mt -48.84 -39.91 27.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.722 0.638 . . . . 74.41 112.722 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.89 9.33 1.18 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.753 0.649 . . . . 64.35 112.753 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 46.66 25.11 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.918 -0.658 . . . . 72.44 112.322 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -125.01 104.71 8.71 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.656 -0.32 . . . . 71.42 111.289 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.9 tt0 -75.61 100.59 4.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.134 0.492 . . . . 73.14 110.371 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.3 t -114.21 165.72 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.07 0.462 . . . . 72.44 111.511 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.3 mtm180 -129.8 144.69 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.34 -0.391 . . . . 61.3 111.647 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 tt -139.51 149.71 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.301 -0.409 . . . . 73.43 110.901 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.51 153.93 30.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.797 0.665 . . . . 71.31 112.797 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HA ' ' HE1' ' A' ' 30' ' ' TYR . 25.4 pttm -58.88 -25.72 63.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.868 1.062 . . . . 74.21 113.868 -175.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -79.56 -11.22 59.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.236 0.458 . . . . 62.11 112.236 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -94.23 -18.32 21.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.426 0.528 . . . . 74.04 112.426 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.51 119.95 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.766 0.654 . . . . 71.44 112.766 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -82.68 -66.92 0.83 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.349 -0.387 . . . . 71.31 110.505 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -146.83 137.77 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.94 -0.573 . . . . 65.03 111.417 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.94 108.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.735 0.302 . . . . 71.14 110.74 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.87 142.66 39.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.084 0.469 . . . . 71.33 111.679 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -94.53 155.39 16.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.065 0.459 . . . . 71.34 111.22 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 4' ' ' PRO . 82.3 mt -95.99 -3.36 45.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.374 -0.375 . . . . 73.12 111.699 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.1 mt -112.86 85.11 2.1 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.846 0.355 . . . . 74.33 111.949 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 118.421 -0.799 . . . . 52.25 112.358 177.583 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.716 0.293 . . . . 73.22 111.205 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.07 95.35 2.06 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.092 0.473 . . . . 74.03 111.433 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 p -127.0 131.39 23.84 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-N 116.241 -0.436 . . . . 71.53 110.933 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.573 ' HB2' HD13 ' A' ' 53' ' ' LEU . 14.1 Cg_endo -55.17 118.95 5.74 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.98 2.454 . . . . 71.2 112.9 -177.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 m -126.24 126.95 44.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.192 -0.458 . . . . 74.11 111.378 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.478 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.5 p -105.13 125.94 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.141 0.496 . . . . 73.42 111.848 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.78 113.18 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.788 0.327 . . . . 74.3 111.324 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.598 ' HG1' ' HG2' ' A' ' 14' ' ' GLU . 13.9 m -83.44 134.58 34.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.18 -0.304 . . . . 73.01 110.18 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -100.76 170.18 8.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.053 0.454 . . . . 71.11 112.069 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -52.12 -45.11 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.864 -0.607 . . . . 75.13 112.606 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.67 -21.86 64.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.035 0.445 . . . . 73.45 111.577 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.59 -23.85 7.8 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.026 -0.607 . . . . 71.03 113.598 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -56.6 129.86 42.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.176 0.488 . . . . 65.05 111.899 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.598 ' HG2' ' HG1' ' A' ' 8' ' ' THR . 52.2 mt-10 -103.31 130.48 50.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.883 0.373 . . . . 74.33 110.909 177.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.87 120.52 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.543 -0.299 . . . . 74.4 110.532 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.51 127.26 41.4 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.141 0.496 . . . . 73.31 112.045 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.9 154.83 26.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.093 -0.503 . . . . 72.11 111.744 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.14 -29.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.001 0.371 . . . . 74.24 112.001 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -129.04 174.61 9.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.897 0.379 . . . . 75.23 111.348 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -78.78 141.27 59.44 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 63.52 111.648 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.51 138.66 35.93 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.616 2.211 . . . . 65.24 113.79 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -93.41 130.22 39.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.97 -0.559 . . . . 75.43 110.455 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -90.82 114.8 27.29 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.153 -0.342 . . . . 75.03 111.269 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -97.89 104.52 16.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.889 0.376 . . . . 54.44 110.672 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.89 -30.51 70.68 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.945 0.35 . . . . 74.42 111.945 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.21 -52.42 65.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.034 0.445 . . . . 54.11 111.959 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -102.41 -11.63 18.47 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.105 0.409 . . . . 72.54 112.105 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.35 80.25 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.06 -0.59 . . . . 51.21 114.005 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 67.8 m-85 -97.95 156.38 16.65 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.282 0.563 . . . . 73.41 112.477 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 68.1 m-85 -101.21 127.22 47.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.799 -0.637 . . . . 74.52 110.01 169.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.3 mt-10 -99.6 119.37 37.96 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.768 0.318 . . . . 61.01 111.088 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -144.74 144.61 31.28 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 75.33 111.942 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 2.4 ttmp? -99.33 109.81 22.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.256 -0.429 . . . . 73.03 110.698 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.8 mt-30 -60.49 160.66 8.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.002 0.371 . . . . 52.14 112.002 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.3 mt -56.29 -27.5 55.63 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.364 0.505 . . . . 74.0 112.364 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.46 -11.54 59.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.011 0.434 . . . . 65.23 111.778 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.98 -21.35 31.86 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.379 -0.439 . . . . 64.53 112.711 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -63.07 104.01 0.53 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 111.762 0.282 . . . . 75.11 111.762 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.9 tt0 -88.4 118.3 27.93 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.757 0.313 . . . . 71.32 110.606 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 t -136.07 164.59 27.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.397 0.517 . . . . 73.51 112.397 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 17.9 mtm180 -110.65 155.88 21.77 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.845 -0.616 . . . . 73.22 110.775 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -147.98 144.77 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.601 0.239 . . . . 73.44 110.935 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -70.32 150.18 46.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.258 0.551 . . . . 52.55 112.137 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -63.14 -14.86 53.68 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.759 1.022 . . . . 72.22 113.759 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -89.2 -14.95 34.85 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.767 -0.583 . . . . 71.33 111.979 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -81.67 -28.61 33.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.916 0.388 . . . . 73.42 111.406 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.14 114.34 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.682 0.753 . . . . 74.23 112.383 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -81.75 -59.4 2.61 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.475 -0.784 . . . . 70.54 110.665 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.1 p -147.32 128.41 14.63 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.556 -0.293 . . . . 74.41 111.617 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.65 117.26 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.775 0.321 . . . . 64.12 110.389 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.478 ' HB2' HG13 ' A' ' 6' ' ' VAL . 34.7 mttm -118.02 132.08 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.607 0.595 . . . . 75.11 112.607 -176.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 34.4 m-20 -83.14 133.24 35.05 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 74.02 109.685 170.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 4' ' ' PRO . 60.3 mt -79.62 -3.29 46.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.703 -0.623 . . . . 63.33 111.268 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.6 mt -120.76 25.75 9.52 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.447 -0.342 . . . . 43.22 111.668 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 2.9 pp20? . . . . . 0 C--O 1.249 1.063 0 N-CA-C 112.43 0.53 . . . . 74.02 112.43 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.754 0.311 . . . . 62.14 110.966 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.99 126.45 39.57 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.843 0.354 . . . . 51.43 111.404 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -121.7 143.21 37.66 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.442 -0.345 . . . . 61.44 110.409 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HB2' HD12 ' A' ' 53' ' ' LEU . 29.1 Cg_endo -62.4 115.16 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.97 1.78 . . . . 74.15 112.023 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.3 m -122.25 130.74 53.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.906 0.384 . . . . 73.13 111.536 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.4 117.91 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.411 0.624 . . . . 73.13 111.316 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.7 mt -96.14 105.65 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.914 -0.585 . . . . 51.13 111.285 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.2 m -85.39 121.49 28.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.465 -0.334 . . . . 71.43 110.755 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 mt -85.56 167.34 15.49 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.665 0.269 . . . . 71.43 111.036 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -54.87 -39.24 68.46 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.587 0.588 . . . . 45.51 112.587 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.18 -24.4 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.704 0.287 . . . . 71.44 111.612 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.74 15.56 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.313 -0.403 . . . . 73.43 113.285 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -68.09 125.86 27.7 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 122.489 -0.418 . . . . 73.53 111.306 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.13 129.3 49.95 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.066 0.46 . . . . 72.24 111.287 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -121.54 113.65 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.485 -0.325 . . . . 73.13 110.654 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -95.18 129.06 42.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.176 0.512 . . . . 51.23 112.282 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -116.57 161.74 18.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.08 -0.509 . . . . 74.12 111.767 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.65 -24.59 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.853 0.358 . . . . 71.42 111.558 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -122.46 165.45 16.33 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.154 -0.475 . . . . 42.43 111.297 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.3 p -79.56 127.77 77.12 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.357 -0.383 . . . . 72.31 111.112 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -51.37 123.01 11.16 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.311 2.674 . . . . 63.24 113.734 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -86.62 129.4 34.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.688 -0.687 . . . . 74.41 110.292 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -82.2 134.05 35.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.567 0.699 . . . . 72.41 112.232 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -98.62 106.16 18.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.481 -0.781 . . . . 64.32 110.583 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.3 -20.1 59.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.944 0.402 . . . . 74.41 111.886 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -69.18 -54.79 13.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.104 0.409 . . . . 73.34 112.104 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -115.74 -6.59 12.12 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.734 0.642 . . . . 74.1 112.734 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.86 12.64 57.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.274 -0.965 . . . . 63.33 114.31 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 47.7 m-85 -90.19 171.86 9.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.397 0.599 . . . . 72.44 112.296 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 61.5 m-85 -119.54 132.18 55.69 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.027 -0.533 . . . . 73.32 110.992 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.57 119.95 38.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.775 0.322 . . . . 71.11 110.785 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -151.29 140.45 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.415 -0.357 . . . . 72.12 110.943 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 40.8 ttmt -93.14 109.28 20.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.885 0.374 . . . . 71.14 110.681 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 41.8 mt-30 -62.19 160.1 13.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.466 -0.334 . . . . 72.3 111.385 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -55.34 -29.07 57.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.473 0.545 . . . . 65.32 112.473 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.81 -12.04 60.29 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.937 0.398 . . . . 63.41 111.863 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.92 -20.67 28.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.421 -0.419 . . . . 73.23 113.567 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.48 108.2 8.13 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.243 0.46 . . . . 64.42 112.243 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 40.2 tt0 -86.02 120.77 27.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 75.51 110.494 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 165.53 25.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.343 -0.39 . . . . 70.35 111.131 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 75.1 mtm180 -111.02 139.48 46.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.978 0.418 . . . . 63.33 111.37 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.69 146.01 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.357 -0.383 . . . . 72.11 110.841 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -68.5 145.82 53.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.481 0.658 . . . . 55.44 112.291 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -63.09 -18.91 63.91 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.292 0.849 . . . . 72.41 113.292 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -81.36 -13.23 58.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.057 0.392 . . . . 61.43 112.057 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -90.86 -27.98 18.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.049 0.389 . . . . 73.22 112.049 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.7 p -76.67 116.1 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.422 0.63 . . . . 75.02 112.095 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.539 ' HG2' HG23 ' A' ' 49' ' ' THR . 78.7 ttt180 -81.96 -64.72 1.12 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.087 -0.506 . . . . 65.44 111.312 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 48' ' ' ARG . 82.8 p -133.32 133.62 42.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.853 0.358 . . . . 73.1 111.904 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.22 111.07 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.417 -0.356 . . . . 74.4 110.27 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 43.4 mtmt -121.99 145.22 48.34 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 64.22 111.663 -177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -94.4 133.38 38.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.893 0.378 . . . . 64.12 110.957 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 4' ' ' PRO . 87.8 mt -66.01 -19.65 65.93 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.876 0.324 . . . . 75.24 111.876 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.93 35.49 1.4 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.993 0.425 . . . . 63.21 111.253 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? . . . . . 0 C--O 1.252 1.231 0 N-CA-C 113.523 0.935 . . . . 71.45 113.523 -179.792 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 110.162 -0.31 . . . . 64.239999999999995 110.162 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.13 115.46 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.152 1.901 . . . . 73.25 112.982 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 69.6 m -125.96 122.35 35.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.46 -0.337 . . . . 70.140000000000001 111.377 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.26 115.02 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.487 0.66 . . . . 63.109999999999999 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.63 117.79 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.224 -0.444 . . . . 73.510000000000005 111.031 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 14' ' ' GLU . 22.8 m -98.47 123.63 42.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.267 -0.424 . . . . 71.200000000000003 110.651 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.432 HD12 ' HD3' ' A' ' 13' ' ' ARG . 72.2 mt -83.7 174.43 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.278 0.561 . . . . 74.140000000000001 112.453 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -53.74 -43.97 69.53 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.572 -0.74 . . . . 74.430000000000007 112.866 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.77 -24.33 56.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.113 0.482 . . . . 74.420000000000002 111.455 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.98 -6.75 10.99 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.39 -0.433 . . . . 65.329999999999998 113.274 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.432 ' HD3' HD12 ' A' ' 9' ' ' LEU . 77.8 ttt180 -59.94 115.88 3.73 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.862 0.331 . . . . 75.319999999999993 111.11 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HG2' HG23 ' A' ' 8' ' ' THR . 44.8 mt-10 -105.1 130.22 53.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.745 0.307 . . . . 60.130000000000003 111.68 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -121.79 132.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.821 0.343 . . . . 75.299999999999997 110.554 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -98.73 125.86 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.132 0.492 . . . . 72.329999999999998 111.691 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.43 150.7 25.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.005 -0.543 . . . . 74.409999999999997 111.641 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.9 m -85.74 -17.18 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 120.991 0.424 . . . . 73.120000000000005 111.981 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.04 175.26 9.88 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 71.420000000000002 111.112 174.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -77.38 142.28 67.1 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 112.304 0.483 . . . . 61.299999999999997 112.304 -170.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 84.7 Cg_endo -76.47 157.47 36.6 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.855 2.37 . . . . 71.200000000000003 114.274 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -116.15 123.26 47.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.827 -0.624 . . . . 74.349999999999994 111.388 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -82.19 114.29 20.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.917 -0.401 . . . . 71.349999999999994 109.917 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.23 105.76 17.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.974 0.416 . . . . 74.5 111.591 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.43 -29.4 69.92 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.106 -0.497 . . . . 63.240000000000002 111.98 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -65.4 -55.11 19.89 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.208 0.447 . . . . 52.240000000000002 112.208 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -96.14 -17.93 20.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.014 0.375 . . . . 74.519999999999996 112.014 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.19 10.88 77.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.223 -0.513 . . . . 54.039999999999999 114.022 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.41 165.03 11.47 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.525 0.678 . . . . 71.129999999999995 112.226 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.65 122.71 44.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.413 -0.812 . . . . 72.25 110.022 167.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.592 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 26.3 mt-10 -98.96 119.66 38.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.273 -0.421 . . . . 73.450000000000003 110.527 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 23.1 p90 -140.03 144.58 36.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.192 0.52 . . . . 65.109999999999999 111.562 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 32.1 ttmt -95.08 110.58 22.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.773 -0.649 . . . . 72.25 111.564 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -60.36 169.07 1.8 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.4 0.519 . . . . 54.039999999999999 112.4 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.52 ' HA ' HG13 ' A' ' 18' ' ' VAL . 98.6 mt -53.15 -30.37 36.65 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.432 0.531 . . . . 70.25 112.432 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.642 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -73.16 -12.25 60.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.007 0.432 . . . . 72.439999999999998 111.602 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.36 60.99 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.239 -0.505 . . . . 74.230000000000004 112.55 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.642 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 30.1 mtmm -96.88 125.33 41.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.71 0.291 . . . . 73.120000000000005 111.319 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -78.44 128.36 33.49 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.841 0.353 . . . . 74.310000000000002 111.324 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.3 t -131.65 163.48 28.02 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.836 0.351 . . . . 64.420000000000002 111.002 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.592 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 87.3 mtm180 -136.43 131.55 34.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.508 -0.314 . . . . 64.230000000000004 111.635 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.15 150.92 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.524 0.202 . . . . 63.539999999999999 111.068 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.88 147.57 42.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.656 0.741 . . . . 61.409999999999997 112.881 -172.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -55.9 -24.13 35.6 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.134 1.161 . . . . 75.140000000000001 114.134 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -87.56 -17.12 32.73 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.221 0.452 . . . . 74.109999999999999 112.221 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -78.41 -17.68 56.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.342 0.497 . . . . 64.299999999999997 112.342 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.6 115.83 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.403 0.62 . . . . 73.540000000000006 112.178 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.461 ' NH2' HG21 ' A' ' 8' ' ' THR . 58.7 ttp180 -83.15 -62.29 1.63 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.141 0.496 . . . . 62.520000000000003 111.536 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.9 p -132.9 137.67 46.73 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.062 0.458 . . . . 73.239999999999995 111.963 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.2 106.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.126 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.4 149.46 49.66 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.33 0.586 . . . . 74.230000000000004 112.18 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.6 m-20 . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 70.230000000000004 111.007 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 110.671 -0.122 . . . . 44.329999999999998 110.671 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.03 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.65 1.567 . . . . 72.219999999999999 111.714 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 60.1 m -112.38 147.8 35.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.119 0.485 . . . . 72.450000000000003 111.998 -174.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.16 112.33 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.544 0.687 . . . . 63.009999999999998 110.494 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -90.41 105.68 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 70.400000000000006 111.089 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.6 m -83.72 107.7 16.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 74.230000000000004 110.987 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -78.08 153.58 32.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.653 0.263 . . . . 73.049999999999997 110.861 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -66.12 -14.32 61.6 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.918 0.39 . . . . 63.119999999999997 111.517 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.89 -8.78 57.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.762 0.315 . . . . 74.420000000000002 111.702 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 3.36 68.11 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.41 -0.424 . . . . 50.310000000000002 112.464 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -87.19 132.71 33.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.602 0.361 . . . . 74.540000000000006 111.06 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.79 130.15 55.65 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.997 0.427 . . . . 75.120000000000005 111.701 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.3 mt -109.85 128.51 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.26 -0.427 . . . . 65.420000000000002 110.894 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -97.97 126.71 43.5 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.074 0.464 . . . . 75.549999999999997 111.985 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -125.67 150.09 47.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.077 -0.51 . . . . 63.219999999999999 112.165 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.542 HG13 ' HA ' ' A' ' 35' ' ' LEU . 33.1 m -94.97 5.74 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 111.559 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -144.79 160.67 40.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.339 -0.391 . . . . 70.209999999999994 110.156 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.8 p -79.46 127.32 78.88 Favored Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.044 0.387 . . . . 74.129999999999995 112.044 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.33 113.57 2.31 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.437 2.092 . . . . 61.229999999999997 112.937 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -86.47 126.39 34.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.0 -0.545 . . . . 73.230000000000004 111.241 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -82.16 127.66 33.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 74.540000000000006 110.183 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -114.4 98.35 6.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.756 0.312 . . . . 73.340000000000003 110.836 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.95 -27.29 63.27 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.291 0.478 . . . . 75.109999999999999 112.291 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.38 -47.79 66.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.228 -0.442 . . . . 70.530000000000001 111.885 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.6 p -90.29 -27.6 19.33 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.498 -0.319 . . . . 63.210000000000001 111.654 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.27 69.35 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.529 -0.367 . . . . 73.409999999999997 113.185 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -114.13 166.18 11.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.359 0.599 . . . . 63.5 112.195 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 34.1 m-85 -101.78 129.4 47.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.774 -0.648 . . . . 74.129999999999995 110.9 170.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.476 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.7 mt-10 -99.34 119.2 37.55 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.258 -0.428 . . . . 65.230000000000004 110.688 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 34.2 p90 -146.56 153.74 40.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.9 0.381 . . . . 74.230000000000004 111.786 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -110.02 109.76 20.43 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.446 -0.343 . . . . 71.010000000000005 111.245 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.0 mt-30 -62.03 168.76 3.04 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.435 0.531 . . . . 73.409999999999997 112.435 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.542 ' HA ' HG13 ' A' ' 18' ' ' VAL . 82.0 mt -54.89 -32.25 60.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.309 -0.405 . . . . 75.120000000000005 111.868 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.72 -11.77 60.75 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.856 0.36 . . . . 72.400000000000006 111.916 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.64 61.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.169 -0.538 . . . . 73.420000000000002 112.871 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.5 112.0 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.715 -0.285 . . . . 70.209999999999994 111.714 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.5 tt0 -88.67 106.21 18.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.226 0.536 . . . . 74.129999999999995 110.518 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -123.98 167.34 14.29 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.166 -0.47 . . . . 64.230000000000004 111.681 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 82.8 mtm180 -121.8 136.77 54.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.954 0.407 . . . . 75.450000000000003 112.005 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.14 150.85 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.448 -0.342 . . . . 71.439999999999998 110.757 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -65.34 140.89 58.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.318 0.58 . . . . 73.209999999999994 111.724 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.26 -14.87 54.29 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.958 1.095 . . . . 72.519999999999996 113.958 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -83.26 -23.15 32.83 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.827 -0.545 . . . . 72.530000000000001 111.903 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 12.2 mm-40 -77.09 -28.23 54.46 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.368 0.507 . . . . 61.009999999999998 112.368 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.61 118.86 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 74.340000000000003 111.93 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -81.9 -64.74 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.939 -0.573 . . . . 73.540000000000006 111.014 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -128.38 136.06 50.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.388 -0.369 . . . . 52.210000000000001 111.662 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.73 97.42 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.467 -0.333 . . . . 75.019999999999996 111.027 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -134.96 156.53 48.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.482 0.549 . . . . 63.520000000000003 112.482 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 31.9 m-20 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.828 -0.624 . . . . 73.129999999999995 111.262 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.226 0.06 . . . . 71.310000000000002 110.886 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.5 115.17 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.777 1.651 . . . . 63.039999999999999 111.478 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 57.7 m -107.67 132.85 52.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.867 0.365 . . . . 63.119999999999997 111.865 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.75 127.63 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.336 0.589 . . . . 64.450000000000003 111.017 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.67 115.48 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.286 -0.415 . . . . 73.120000000000005 111.548 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.2 m -88.2 123.29 32.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.558 -0.292 . . . . 51.509999999999998 110.276 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.64 159.8 15.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.334 0.588 . . . . 74.140000000000001 112.489 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -56.0 -35.34 66.67 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.558 -0.746 . . . . 74.120000000000005 110.635 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.86 -30.94 71.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.505 -0.77 . . . . 73.239999999999995 111.745 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.1 -23.24 8.24 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.149 -0.478 . . . . 65.430000000000007 112.823 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.08 143.12 58.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.849 0.357 . . . . 75.129999999999995 111.94 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.05 129.91 56.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.775 0.321 . . . . 72.140000000000001 111.407 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.646 0.26 . . . . 52.509999999999998 110.871 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -95.26 135.75 36.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.235 0.54 . . . . 74.25 112.206 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -128.44 156.94 42.4 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.859 -0.61 . . . . 75.209999999999994 111.2 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.8 m -83.59 -16.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.046 0.387 . . . . 72.540000000000006 112.046 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -144.32 175.13 10.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.301 0.24 . . . . 71.430000000000007 111.092 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.9 p -78.33 132.29 66.58 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 111.902 0.334 . . . . 55.530000000000001 111.902 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 27.9 Cg_endo -60.32 133.24 48.22 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.202 2.601 . . . . 62.219999999999999 114.211 -174.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -87.23 116.42 25.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 71.310000000000002 110.876 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -81.31 113.62 19.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.902 -0.499 . . . . 72.549999999999997 110.654 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -97.62 95.61 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.157 0.504 . . . . 71.549999999999997 109.852 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.02 -31.62 72.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.965 -0.562 . . . . 73.5 112.199 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.01 -43.08 99.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.215 -0.448 . . . . 64.25 111.704 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.9 p -89.26 -26.98 20.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.735 0.303 . . . . 72.340000000000003 111.422 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.15 11.03 63.56 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.372 -0.442 . . . . 75.450000000000003 113.364 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.74 163.94 14.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.584 0.707 . . . . 74.239999999999995 112.385 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -100.88 122.86 44.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 73.209999999999994 109.854 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.24 119.4 37.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.496 -0.32 . . . . 73.530000000000001 110.273 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 31.3 p90 -134.95 145.28 48.01 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.953 0.406 . . . . 74.519999999999996 111.687 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -97.99 108.28 20.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.139 -0.482 . . . . 74.549999999999997 110.866 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.8 mt-30 -66.99 173.09 3.88 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.315 0.487 . . . . 70.530000000000001 112.315 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.475 ' HA ' HG13 ' A' ' 18' ' ' VAL . 87.0 mt -55.54 -32.73 63.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.452 0.538 . . . . 73.25 112.452 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.721 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.9 m-20 -83.95 9.46 12.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.83 0.348 . . . . 60.140000000000001 111.823 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.18 90.32 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.993 -0.623 . . . . 34.530000000000001 112.956 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.721 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.6 mtmm -71.76 97.72 1.83 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.71 -0.288 . . . . 70.019999999999996 111.688 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 27.7 tt0 -85.22 113.62 21.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.812 0.339 . . . . 75.420000000000002 110.865 176.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -136.58 168.21 19.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.961 0.41 . . . . 54.009999999999998 111.937 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -101.16 156.84 17.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.133 0.492 . . . . 74.400000000000006 111.28 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -145.53 139.59 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.25 -0.432 . . . . 42.109999999999999 110.292 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -62.72 139.52 58.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.038 0.447 . . . . 63.409999999999997 111.358 -174.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -57.64 -21.3 38.92 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.001 1.111 . . . . 73.510000000000005 114.001 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -81.39 -17.73 47.98 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.049 -0.407 . . . . 54.109999999999999 112.093 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -75.94 -26.87 57.3 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.211 0.449 . . . . 72.120000000000005 112.211 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.51 117.17 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.174 0.511 . . . . 65.049999999999997 112.344 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -82.72 -60.08 2.3 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.947 0.403 . . . . 73.299999999999997 110.403 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -145.42 158.63 43.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.056 -0.52 . . . . 62.32 111.293 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.9 t -130.83 110.78 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.515 -0.312 . . . . 74.400000000000006 111.297 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -127.97 157.24 41.15 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.168 0.508 . . . . 63.299999999999997 111.646 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 33.4 m-20 . . . . . 0 CA--C 1.536 0.424 0 CA-C-N 116.257 -0.429 . . . . 72.510000000000005 110.786 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 111.264 0.098 . . . . 61.520000000000003 111.264 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.82 116.01 2.9 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.532 2.155 . . . . 74.109999999999999 112.485 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.2 m -121.84 134.59 54.89 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.179 -0.464 . . . . 70.209999999999994 111.924 -173.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.25 131.77 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.332 0.587 . . . . 74.400000000000006 111.043 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.455 HG23 HG23 ' A' ' 47' ' ' VAL . 68.7 mt -107.55 110.4 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 111.453 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.4 ' HB ' ' OG1' ' A' ' 49' ' ' THR . 42.3 m -85.65 116.8 24.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.739 0.304 . . . . 73.420000000000002 110.585 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.8 mt -82.18 172.29 13.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.025 0.441 . . . . 63.020000000000003 111.529 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -56.79 -42.64 79.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.894 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.34 0.19 12.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.515 0.561 . . . . 74.439999999999998 112.515 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.38 66.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.133 -0.556 . . . . 65.420000000000002 112.997 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -67.99 131.79 46.11 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.842 -0.211 . . . . 74.329999999999998 110.829 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.96 138.91 51.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.893 0.377 . . . . 71.519999999999996 111.87 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.49 140.75 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.492 -0.322 . . . . 74.120000000000005 110.963 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -103.61 117.32 34.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.16 0.43 . . . . 73.0 112.16 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -121.68 152.68 39.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.284 0.476 . . . . 73.200000000000003 112.284 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.4 -19.02 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.106 0.41 . . . . 73.25 112.106 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.09 174.9 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.906 0.384 . . . . 74.450000000000003 111.587 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.7 p -79.45 143.02 58.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 112.603 0.594 . . . . 74.010000000000005 112.603 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 68.5 Cg_endo -73.12 142.9 34.97 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.459 2.106 . . . . 65.5 113.55 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 39.1 ttmt -99.47 131.58 45.38 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.246 -0.434 . . . . 45.219999999999999 110.969 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -94.25 124.35 38.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.97 0.414 . . . . 74.310000000000002 111.708 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -99.41 119.81 38.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.120000000000005 110.168 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.54 -26.3 67.07 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.748 0.647 . . . . 73.230000000000004 112.748 -174.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -82.59 -47.39 12.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.414 0.524 . . . . 70.230000000000004 112.414 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.3 p -89.95 -27.43 19.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.725 0.297 . . . . 23.32 111.639 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 9.15 83.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.171 -0.538 . . . . 33.140000000000001 113.664 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -96.41 151.56 19.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.359 0.599 . . . . 71.200000000000003 112.22 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.9 m-85 -101.39 126.62 48.18 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.625 -0.716 . . . . 54.43 110.863 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.7 mt-10 -99.09 119.01 37.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.511 0.196 . . . . 73.420000000000002 110.688 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.16 146.33 31.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.127 0.489 . . . . 75.319999999999993 112.015 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.3 ttmp? -93.0 115.67 28.34 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.082 -0.508 . . . . 71.209999999999994 111.181 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 45.6 mt-30 -67.97 164.33 20.18 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.153 0.427 . . . . 65.329999999999998 112.153 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.95 -23.0 61.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.619 0.723 . . . . 72.329999999999998 110.562 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.32 -13.75 61.57 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.252 -0.885 . . . . 72.409999999999997 111.798 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.8 -38.83 2.96 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.349 -0.453 . . . . 71.019999999999996 113.284 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -68.95 127.69 34.02 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.35 -0.5 . . . . 74.430000000000007 112.225 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 63.5 tt0 -86.03 116.27 24.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.957 0.408 . . . . 73.420000000000002 110.934 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -115.5 166.49 11.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.911 0.386 . . . . 64.430000000000007 111.651 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 60.5 mtm180 -129.85 137.58 50.52 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.141 -0.481 . . . . 65.129999999999995 111.564 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.7 149.65 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.521 -0.309 . . . . 73.120000000000005 110.656 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -70.54 151.03 45.51 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.529 0.681 . . . . 73.140000000000001 112.583 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -59.6 -29.28 67.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.662 0.986 . . . . 73.450000000000003 113.662 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -76.49 -11.77 59.93 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.126 0.417 . . . . 75.319999999999993 112.126 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.85 -28.04 17.57 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.361 0.504 . . . . 62.030000000000001 112.361 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 7' ' ' ILE . 5.6 p -77.0 114.29 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.51 0.672 . . . . 74.310000000000002 112.12 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -83.1 -56.8 3.58 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.992 -0.549 . . . . 62.039999999999999 111.353 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.4 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 71.0 p -137.24 150.92 48.17 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.958 0.408 . . . . 72.519999999999996 111.665 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.47 111.23 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.358 -0.383 . . . . 61.340000000000003 110.529 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.63 168.7 13.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.002 0.429 . . . . 70.109999999999999 111.885 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 120.923 0.392 . . . . 75.400000000000006 111.17 175.991 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 110.707 -0.109 . . . . 33.100000000000001 110.707 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.72 114.62 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.918 1.745 . . . . 62.399999999999999 112.536 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.8 m -125.08 132.76 53.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.209 -0.45 . . . . 71.299999999999997 111.407 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.0 124.68 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.306 0.574 . . . . 71.450000000000003 111.154 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.3 mt -102.87 118.8 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 111.451 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.473 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 60.7 m -90.27 122.02 32.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.317 -0.402 . . . . 53.140000000000001 110.675 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -88.93 157.03 18.55 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.977 0.418 . . . . 74.5 111.82 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -54.99 -30.77 60.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.964 -0.562 . . . . 74.209999999999994 111.022 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.66 -23.02 67.2 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.639 -0.709 . . . . 65.420000000000002 111.597 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.88 -30.89 8.5 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 112.014 -0.434 . . . . 73.430000000000007 112.014 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.589 ' NH1' HG12 ' A' ' 15' ' ' ILE . 49.5 ttt-85 -64.28 141.76 58.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.639 0.376 . . . . 75.140000000000001 111.554 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 8' ' ' THR . 44.0 mt-10 -116.26 143.54 45.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.861 0.362 . . . . 74.239999999999995 111.383 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.589 HG12 ' NH1' ' A' ' 13' ' ' ARG . 38.8 mt -124.09 132.65 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.282 -0.417 . . . . 73.310000000000002 110.787 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -95.66 133.28 39.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.510000000000005 111.479 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.31 146.26 48.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.453 0.538 . . . . 71.510000000000005 112.453 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.528 HG13 ' HA ' ' A' ' 35' ' ' LEU . 29.7 m -87.36 -13.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.14 0.495 . . . . 75.109999999999999 111.486 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.29 154.45 36.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.007 -0.542 . . . . 71.5 110.301 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.6 p -78.86 132.38 64.43 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.882 0.372 . . . . 61.009999999999998 111.193 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.422 ' HB3' HD11 ' A' ' 7' ' ' ILE . 41.5 Cg_endo -65.23 126.42 16.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.93 2.42 . . . . 72.540000000000006 113.755 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -96.48 127.78 42.79 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.053 -0.521 . . . . 63.229999999999997 110.615 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -83.48 115.04 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.822 -0.351 . . . . 71.129999999999995 110.376 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -97.31 103.28 15.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.064 0.459 . . . . 74.109999999999999 109.974 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.26 -28.55 66.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.571 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.33 -52.77 63.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.912 0.387 . . . . 73.409999999999997 111.071 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -88.36 -25.41 22.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.062 0.393 . . . . 71.25 112.062 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.41 61.76 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.389 -0.434 . . . . 74.019999999999996 113.673 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.98 159.65 17.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.429 0.633 . . . . 75.319999999999993 112.561 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.439 ' CE1' HG11 ' A' ' 47' ' ' VAL . 49.8 m-85 -100.97 122.33 43.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.636 -0.711 . . . . 64.329999999999998 109.852 169.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 47.4 mt-10 -104.69 121.64 43.99 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.821 0.343 . . . . 64.549999999999997 111.063 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -145.17 156.91 44.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 64.439999999999998 111.436 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 31.6 ttmt -106.3 111.46 24.07 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.294 -0.412 . . . . 63.210000000000001 111.197 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -60.73 166.82 3.06 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.231 0.456 . . . . 74.120000000000005 112.231 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.528 ' HA ' HG13 ' A' ' 18' ' ' VAL . 74.8 mt -61.07 -21.35 63.57 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 73.219999999999999 111.128 176.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.49 -11.44 60.22 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.963 -0.562 . . . . 52.420000000000002 111.679 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.34 -5.48 71.06 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.159 -0.544 . . . . 72.450000000000003 112.883 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -82.68 119.66 24.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.938 0.348 . . . . 70.140000000000001 111.938 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 33.8 tt0 -83.69 112.93 20.5 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.895 -0.409 . . . . 63.32 109.895 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -116.43 152.56 33.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.946 0.403 . . . . 75.209999999999994 111.802 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 44.6 mtp180 -116.28 126.32 53.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.12 -0.491 . . . . 74.230000000000004 110.378 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 tt -129.94 145.3 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 122.244 -0.285 . . . . 51.409999999999997 111.08 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -66.88 150.44 49.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.579 0.704 . . . . 73.209999999999994 112.687 -172.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -58.52 -19.71 39.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.936 1.087 . . . . 70.230000000000004 113.936 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -84.46 -22.92 30.15 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.879 -0.513 . . . . 73.140000000000001 112.014 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -82.24 -14.51 55.4 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.167 0.432 . . . . 73.530000000000001 112.167 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.439 HG11 ' CE1' ' A' ' 30' ' ' TYR . 7.3 p -87.49 115.37 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.453 0.644 . . . . 73.040000000000006 111.727 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -83.08 -63.49 1.35 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.136 0.493 . . . . 72.549999999999997 110.93 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.3 p -139.65 149.46 43.77 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.879 -0.601 . . . . 65.5 111.358 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.49 116.02 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.373 -0.376 . . . . 71.120000000000005 110.222 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.21 141.99 50.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.827 0.346 . . . . 74.099999999999994 111.384 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.802 0.334 . . . . 64.319999999999993 110.943 176.111 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 m . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 120.396 0.141 . . . . 75.099999999999994 111.359 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -62.67 119.93 7.23 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.651 2.234 . . . . 75.239999999999995 112.409 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.0 m -128.8 147.8 50.82 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.423 -0.353 . . . . 74.430000000000007 111.47 -174.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.4 p -121.64 125.55 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.377 0.608 . . . . 72.549999999999997 111.283 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.6 mt -98.94 116.23 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 63.509999999999998 111.391 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 113.61 22.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.31 -0.404 . . . . 65.439999999999998 110.733 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -78.46 166.07 23.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 72.340000000000003 111.538 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 64.6 t30 -63.31 -33.21 75.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.136 -0.483 . . . . 75.099999999999994 111.287 -175.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.67 7.9 6.17 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.436 -0.347 . . . . 72.329999999999998 111.865 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.04 -12.95 64.53 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.233 -0.508 . . . . 70.349999999999994 113.886 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -70.12 121.1 16.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.266 0.533 . . . . 75.310000000000002 111.426 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -103.02 130.37 50.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.867 0.365 . . . . 74.120000000000005 111.274 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.96 131.23 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.497 -0.32 . . . . 73.329999999999998 110.984 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.46 137.18 34.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.19 0.519 . . . . 72.230000000000004 112.082 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.57 150.74 50.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.81 -0.632 . . . . 70.230000000000004 111.231 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.3 m -74.34 -25.42 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.921 0.391 . . . . 71.349999999999994 111.788 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.3 174.43 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 111.261 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.2 p -83.02 145.75 50.21 Favored Pre-proline 0 N--CA 1.47 0.536 0 CA-C-O 120.852 0.358 . . . . 50.229999999999997 111.792 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HB3' HD11 ' A' ' 7' ' ' ILE . 60.4 Cg_endo -71.29 130.79 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.427 2.085 . . . . 72.349999999999994 113.364 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -98.09 122.58 41.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.3 -0.409 . . . . 71.409999999999997 110.46 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -82.17 130.51 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.012 0.434 . . . . 71.239999999999995 111.391 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.28 109.8 21.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.404 -0.362 . . . . 73.319999999999993 110.57 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -72.92 -29.99 63.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.003 0.43 . . . . 73.109999999999999 111.47 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -70.47 -33.47 71.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.805 0.669 . . . . 71.310000000000002 112.805 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -118.85 -10.49 9.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.798 0.666 . . . . 72.400000000000006 112.798 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.66 82.53 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 114.702 0.641 . . . . 55.219999999999999 114.702 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -102.6 154.15 19.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 117.887 0.843 . . . . 73.200000000000003 112.335 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.2 m-85 -102.12 128.26 48.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.15 -0.477 . . . . 73.549999999999997 110.827 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 46.2 mt-10 -99.53 119.32 37.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.6 0.238 . . . . 63.140000000000001 111.235 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -146.19 145.04 30.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.968 0.413 . . . . 74.519999999999996 111.675 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.4 ttmp? -97.58 111.45 23.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.435 -0.348 . . . . 64.310000000000002 111.268 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -61.01 168.11 2.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.855 0.359 . . . . 64.129999999999995 111.956 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.424 ' HA ' HG13 ' A' ' 18' ' ' VAL . 92.9 mt -52.69 -43.17 65.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.834 0.679 . . . . 75.439999999999998 112.834 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -75.79 -3.14 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.268 0.47 . . . . 71.25 112.268 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.24 -2.81 50.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.072 -0.585 . . . . 33.119999999999997 114.224 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -82.7 104.19 12.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.504 0.652 . . . . 73.310000000000002 111.68 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.1 tt0 -72.98 119.54 17.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.272 -0.422 . . . . 62.240000000000002 111.109 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 t -125.91 165.37 18.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.792 0.33 . . . . 70.030000000000001 111.83 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 47.0 mtm180 -126.71 129.42 48.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.387 -0.37 . . . . 73.200000000000003 111.252 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.5 tt -122.1 150.75 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.663 -0.244 . . . . 70.150000000000006 110.794 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -67.58 153.67 43.18 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.303 0.573 . . . . 75.299999999999997 112.367 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 47' ' ' VAL . 15.1 ptmm? -65.4 -21.68 66.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.797 1.036 . . . . 65.239999999999995 113.797 -172.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -79.4 -25.23 42.15 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.216 0.45 . . . . 74.310000000000002 112.216 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.83 -22.32 53.76 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.82 0.674 . . . . 41.520000000000003 112.82 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 44' ' ' LYS . 8.0 p -72.84 114.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.736 0.779 . . . . 74.129999999999995 111.981 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 10.0 tpt180 -81.83 -63.36 1.4 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.82 -0.627 . . . . 75.409999999999997 110.466 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -146.54 146.61 30.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.013 -0.539 . . . . 74.150000000000006 110.984 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.83 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.722 0.296 . . . . 73.200000000000003 110.88 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB2' HG13 ' A' ' 6' ' ' VAL . 61.1 mttp -119.3 152.36 36.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.292 0.568 . . . . 72.319999999999993 111.919 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 . . . . . 0 CA--C 1.54 0.567 0 CA-C-N 116.102 -0.499 . . . . 73.329999999999998 111.329 178.794 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 110.252 -0.277 . . . . 75.439999999999998 110.252 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.39 116.01 4.32 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.906 1.737 . . . . 73.129999999999995 112.09 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 92.2 m -123.4 135.72 54.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.116 0.413 . . . . 62.409999999999997 112.116 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.86 118.53 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.484 0.659 . . . . 63.219999999999999 111.31 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -90.78 107.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.222 -0.445 . . . . 74.219999999999999 111.153 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.455 HG22 ' HD3' ' A' ' 48' ' ' ARG . 49.9 m -83.37 124.0 30.21 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.245 -0.28 . . . . 73.430000000000007 110.245 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.1 mt -96.54 162.09 13.62 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.978 0.418 . . . . 65.120000000000005 112.057 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -54.25 -45.41 72.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.027 -0.533 . . . . 74.450000000000003 111.838 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.12 5.53 5.25 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.798 0.666 . . . . 71.409999999999997 112.798 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.95 47.5 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.082 -0.58 . . . . 71.430000000000007 114.211 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -63.11 136.2 57.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.364 0.582 . . . . 63.039999999999999 111.71 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.47 129.5 55.76 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.731 0.3 . . . . 74.150000000000006 110.491 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -113.3 112.0 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.172 0.511 . . . . 65.310000000000002 111.187 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.76 117.9 30.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.324 -0.398 . . . . 71.25 111.307 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -111.93 159.9 17.94 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.159 0.504 . . . . 62.140000000000001 112.189 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.1 m -84.59 -15.03 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.955 -0.566 . . . . 73.340000000000003 111.663 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.11 164.34 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.006 0.431 . . . . 75.430000000000007 111.327 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.406 HG22 ' OG1' ' A' ' 5' ' ' THR . 71.3 p -79.7 118.95 75.09 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.407 -0.361 . . . . 73.129999999999995 110.869 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.63 123.28 12.54 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.346 2.697 . . . . 75.319999999999993 113.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 5.5 ttpm? -87.32 123.1 31.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.357 -0.383 . . . . 71.519999999999996 110.754 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -90.3 131.59 36.02 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.005 0.431 . . . . 74.530000000000001 112.086 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -99.75 116.41 31.76 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.908 0.385 . . . . 71.409999999999997 110.157 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.26 -32.26 73.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.348 0.499 . . . . 73.430000000000007 112.348 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -72.29 -50.0 30.39 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.954 0.353 . . . . 63.340000000000003 111.954 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.1 p -89.61 -27.75 19.98 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.32 0.489 . . . . 75.25 112.32 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.93 10.69 75.0 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.06 -0.591 . . . . 72.430000000000007 113.568 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.15 149.23 23.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.416 0.627 . . . . 73.400000000000006 112.452 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -102.02 128.74 48.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.604 -0.725 . . . . 74.310000000000002 110.771 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 45.7 mt-10 -100.11 124.66 45.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.703 0.287 . . . . 72.099999999999994 111.116 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.405 ' HE1' HG22 ' A' ' 42' ' ' ILE . 34.4 p90 -157.19 151.77 25.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.828 0.347 . . . . 72.540000000000006 111.417 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -106.5 115.28 29.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.599 -0.273 . . . . 54.409999999999997 110.885 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 49.5 mt-30 -60.65 158.86 11.74 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.87 0.322 . . . . 74.400000000000006 111.87 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.433 ' HA ' HG13 ' A' ' 18' ' ' VAL . 89.8 mt -51.98 -30.79 26.48 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.109 0.48 . . . . 72.329999999999998 111.777 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.91 4.33 4.31 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.088 -0.506 . . . . 71.140000000000001 112.238 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 23.63 70.78 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.304 -0.474 . . . . 74.400000000000006 113.069 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -117.07 112.56 21.08 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.7 -0.294 . . . . 65.140000000000001 111.297 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.4 tt0 -87.17 138.99 31.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.815 0.341 . . . . 73.239999999999995 111.58 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -147.24 165.15 30.93 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.497 -0.319 . . . . 73.319999999999993 111.719 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 86.0 mtt180 -115.4 125.89 53.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.888 0.375 . . . . 71.109999999999999 111.03 177.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.405 HG22 ' HE1' ' A' ' 32' ' ' PHE . 15.7 tt -117.04 149.93 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.621 0.248 . . . . 73.349999999999994 111.116 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.11 148.73 32.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.538 0.685 . . . . 62.299999999999997 112.218 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 ptmt -63.17 -15.02 55.5 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.656 0.984 . . . . 71.319999999999993 113.656 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -78.08 -22.55 48.86 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.822 -0.549 . . . . 74.450000000000003 111.591 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -79.4 -28.29 41.84 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.958 0.725 . . . . 64.310000000000002 112.958 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -68.25 113.78 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.727 0.775 . . . . 74.120000000000005 112.481 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HD3' HG22 ' A' ' 8' ' ' THR . 75.1 ttt180 -82.08 -60.32 2.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.525 -0.762 . . . . 74.439999999999998 110.671 175.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -149.36 129.58 13.68 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.066 -0.516 . . . . 74.510000000000005 111.24 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.848 0.356 . . . . 72.400000000000006 111.314 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -125.18 152.83 43.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 74.530000000000001 111.184 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 24.0 m-20 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 120.835 0.35 . . . . 64.439999999999998 110.998 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 110.768 -0.086 . . . . 73.329999999999998 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.6 114.02 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.696 1.597 . . . . 65.040000000000006 111.633 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.0 m -126.93 149.72 49.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.296 -0.411 . . . . 52.420000000000002 111.25 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.18 129.21 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.44 0.638 . . . . 64.439999999999998 111.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.3 110.44 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.027 -0.533 . . . . 74.519999999999996 110.862 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.752 HG21 HH21 ' A' ' 48' ' ' ARG . 26.0 m -89.07 118.31 28.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.749 0.309 . . . . 61.409999999999997 111.286 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.7 170.14 13.58 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.807 0.337 . . . . 61.310000000000002 111.576 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.07 -31.29 71.7 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.871 0.367 . . . . 74.439999999999998 111.697 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.27 -20.9 66.37 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 111.992 0.367 . . . . 70.549999999999997 111.992 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.07 -7.6 62.56 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.523 -0.631 . . . . 35.229999999999997 111.523 -170.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -70.06 125.05 25.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.96 0.504 . . . . 72.230000000000004 110.913 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.8 130.67 55.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.043 0.449 . . . . 72.209999999999994 111.718 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.8 mt -110.96 125.62 68.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.241 -0.436 . . . . 70.510000000000005 110.754 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -96.73 129.57 44.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.957 0.408 . . . . 62.0 111.915 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -119.55 162.04 19.59 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.121 -0.49 . . . . 63.219999999999999 111.488 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -97.11 -3.99 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.064 0.394 . . . . 61.329999999999998 112.064 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.01 174.95 10.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.328 0.585 . . . . 74.109999999999999 112.177 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.1 p -79.01 129.89 71.64 Favored Pre-proline 0 N--CA 1.471 0.618 0 CA-C-N 115.807 -0.633 . . . . 74.140000000000001 112.083 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.2 133.79 25.58 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.618 2.212 . . . . 72.140000000000001 113.238 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 135.71 35.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.476 -0.329 . . . . 70.319999999999993 111.207 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -95.63 115.51 27.53 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.602 0.239 . . . . 72.409999999999997 111.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -109.43 118.93 37.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.85 0.357 . . . . 72.439999999999998 110.75 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.15 -42.16 63.13 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.96 0.355 . . . . 63.509999999999998 111.96 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.85 -38.72 82.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.155 0.428 . . . . 72.329999999999998 112.155 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -94.44 -27.42 16.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.224 -0.298 . . . . 74.140000000000001 111.608 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.49 12.28 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.858 -0.687 . . . . 43.039999999999999 113.839 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.485 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 72.6 m-85 -116.27 163.52 15.88 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.173 0.511 . . . . 71.310000000000002 112.156 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.3 m-85 -101.24 128.68 47.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.91 -0.586 . . . . 74.400000000000006 110.424 171.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 39.6 mt-10 -98.97 119.25 37.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.535 0.207 . . . . 75.400000000000006 111.088 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.54 155.21 42.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.991 0.424 . . . . 63.409999999999997 111.486 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 3.8 ttmp? -108.91 109.77 20.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.414 -0.357 . . . . 63.219999999999999 111.129 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 50.8 mt-30 -61.63 164.84 5.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.224 0.453 . . . . 61.409999999999997 112.224 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.584 ' HA ' HG13 ' A' ' 18' ' ' VAL . 86.7 mt -48.8 -43.26 38.03 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.791 0.664 . . . . 73.340000000000003 112.791 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -73.15 -1.97 19.7 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.327 0.492 . . . . 64.319999999999993 112.327 -176.494 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.15 -2.24 63.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.446 -0.406 . . . . 41.219999999999999 112.676 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 31.4 mtmm -71.75 97.87 1.85 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.809 0.3 . . . . 71.140000000000001 111.809 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.8 tt0 -80.47 120.77 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.732 -0.213 . . . . 73.409999999999997 110.463 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -145.62 165.59 28.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.925 0.393 . . . . 64.329999999999998 111.709 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 59.5 mtm180 -117.48 148.05 42.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.13 -0.487 . . . . 75.299999999999997 111.265 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.65 152.15 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.369 -0.378 . . . . 65.420000000000002 110.813 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.17 133.89 55.1 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.113 0.482 . . . . 73.230000000000004 111.425 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.09 -16.17 29.54 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.221 1.193 . . . . 73.239999999999995 114.221 -172.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -91.85 -12.13 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.694 -0.629 . . . . 74.519999999999996 112.326 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -77.05 -28.06 54.65 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.911 0.386 . . . . 62.43 111.883 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -77.77 121.82 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.296 0.569 . . . . 70.400000000000006 112.312 -175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.752 HH21 HG21 ' A' ' 8' ' ' THR . 72.0 ttp85 -82.51 -59.82 2.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.008 0.432 . . . . 74.120000000000005 110.955 174.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 48' ' ' ARG . 66.5 p -141.96 136.08 30.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.156 -0.475 . . . . 61.520000000000003 111.606 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.38 108.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.645 -0.252 . . . . 44.439999999999998 110.718 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -123.96 156.34 36.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.028 0.442 . . . . 73.319999999999993 111.297 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 64.340000000000003 110.914 175.405 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 111.079 0.029 . . . . 64.120000000000005 111.079 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.83 116.12 3.49 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.159 1.906 . . . . 62.340000000000003 111.793 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.4 m -119.82 136.87 54.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.893 0.378 . . . . 63.329999999999998 111.974 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.36 0.6 . . . . 73.25 110.755 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.437 HG23 HG23 ' A' ' 47' ' ' VAL . 66.0 mt -96.59 110.53 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.153 -0.476 . . . . 72.510000000000005 111.085 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.426 ' HB ' ' OG1' ' A' ' 49' ' ' THR . 41.9 m -91.02 116.45 28.8 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.823 0.344 . . . . 73.140000000000001 110.803 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.28 161.82 21.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.894 0.378 . . . . 61.020000000000003 111.917 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.69 -40.39 79.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.434 0.531 . . . . 74.0 112.434 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.41 -12.56 53.49 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.303 0.483 . . . . 74.340000000000003 112.303 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.8 10.5 40.23 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.011 -0.614 . . . . 65.120000000000005 113.643 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -95.41 132.18 40.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.152 0.476 . . . . 71.25 111.565 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -102.95 130.47 50.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.927 0.394 . . . . 74.329999999999998 111.617 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.3 119.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.689 0.28 . . . . 63.140000000000001 110.412 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -92.34 130.88 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.164 0.507 . . . . 64.239999999999995 112.03 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.38 150.65 42.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.052 -0.522 . . . . 73.530000000000001 111.46 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 35' ' ' LEU . 26.9 m -82.52 -13.79 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.191 0.441 . . . . 71.120000000000005 112.191 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.21 173.88 11.21 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.949 0.404 . . . . 75.530000000000001 111.657 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.5 p -79.54 140.89 55.89 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 112.869 0.692 . . . . 74.439999999999998 112.869 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.33 105.01 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.572 2.181 . . . . 61.149999999999999 112.772 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.36 111.77 20.81 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.143 -0.481 . . . . 70.450000000000003 111.051 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.472 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 51.1 t80 -81.68 132.33 35.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.968 0.413 . . . . 73.129999999999995 112.102 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -123.38 119.3 29.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.9 -0.591 . . . . 71.329999999999998 110.825 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.84 -15.73 55.6 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.872 0.323 . . . . 73.409999999999997 111.872 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.46 -45.06 73.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 63.109999999999999 111.126 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.2 p -93.49 -27.53 16.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.867 0.365 . . . . 52.43 111.501 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.38 10.5 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.301 -0.476 . . . . 72.109999999999999 113.111 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 75.1 m-85 -113.44 164.69 13.29 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.507 0.67 . . . . 73.530000000000001 112.76 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 69.7 m-85 -102.34 132.41 48.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.641 -0.709 . . . . 64.239999999999995 110.457 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 43.3 mt-10 -98.57 119.5 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.882 0.372 . . . . 73.519999999999996 110.824 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -147.1 143.79 28.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.009 0.433 . . . . 72.230000000000004 111.278 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.7 ttmp? -97.72 110.38 22.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.454 -0.339 . . . . 70.030000000000001 111.13 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.36 164.12 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.906 0.384 . . . . 72.129999999999995 111.711 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.426 ' HA ' HG13 ' A' ' 18' ' ' VAL . 88.3 mt -53.41 -35.01 59.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.293 -0.412 . . . . 64.409999999999997 111.894 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.9 -12.26 61.18 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.036 0.384 . . . . 74.340000000000003 112.036 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.6 -7.62 50.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.496 -0.383 . . . . 51.219999999999999 112.665 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -75.16 100.42 4.27 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.086 0.469 . . . . 62.439999999999998 111.968 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.1 tt0 -84.04 104.41 14.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.024 0.44 . . . . 65.140000000000001 110.542 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 t -124.45 166.48 15.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.944 0.402 . . . . 63.130000000000003 111.532 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 64.4 mtm180 -115.66 132.14 56.72 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.33 -0.396 . . . . 74.439999999999998 111.685 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.12 151.21 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.494 -0.321 . . . . 53.25 110.693 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -71.52 145.57 49.06 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.152 0.501 . . . . 74.400000000000006 112.042 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -60.43 -16.79 39.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.776 1.028 . . . . 73.010000000000005 113.776 -173.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -83.65 -25.69 30.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.223 0.453 . . . . 64.219999999999999 112.223 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -77.12 -28.38 54.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.314 0.487 . . . . 73.439999999999998 112.314 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG23 HG23 ' A' ' 7' ' ' ILE . 7.3 p -74.2 113.75 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.484 0.659 . . . . 73.299999999999997 112.163 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 48' ' ' ARG . 22.0 ttt180 -83.63 -63.75 1.29 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.355 0.598 . . . . 73.409999999999997 110.856 177.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.426 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 77.6 p -132.99 151.17 52.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.759 -0.655 . . . . 75.519999999999996 111.733 -177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.42 117.85 46.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.255 -0.429 . . . . 72.129999999999995 111.202 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -127.64 134.02 49.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.84 0.352 . . . . 74.150000000000006 111.856 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.003 0.43 . . . . 75.409999999999997 110.929 175.043 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 110.103 -0.332 . . . . 75.519999999999996 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -60.15 130.41 34.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.271 1.98 . . . . 53.130000000000003 112.926 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -132.25 135.99 46.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.28 -0.418 . . . . 74.540000000000006 111.327 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.2 p -98.94 122.94 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.473 0.654 . . . . 61.020000000000003 111.926 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 21' ' ' PRO . 64.4 mt -98.61 110.55 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.039 -0.528 . . . . 64.310000000000002 110.677 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.0 m -90.32 124.36 34.84 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.702 0.287 . . . . 75.030000000000001 110.716 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.2 157.49 17.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.938 0.347 . . . . 74.530000000000001 111.938 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -56.14 -30.82 62.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.2 0.524 . . . . 63.130000000000003 110.853 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.632 -0.713 . . . . 74.329999999999998 111.54 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.49 -23.38 8.0 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.332 -0.394 . . . . 52.240000000000002 112.23 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -65.31 141.25 58.66 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.925 0.342 . . . . 63.340000000000003 111.925 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.63 130.62 55.7 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.587 -0.279 . . . . 73.400000000000006 111.279 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -110.02 129.32 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.757 0.313 . . . . 73.540000000000006 110.788 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -99.96 113.12 25.47 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.973 0.416 . . . . 72.340000000000003 111.575 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.72 160.55 14.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.489 -0.323 . . . . 60.210000000000001 111.81 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -91.56 -18.68 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.475 0.546 . . . . 73.420000000000002 112.475 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -133.83 176.0 8.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.921 0.391 . . . . 74.019999999999996 111.541 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.7 p -77.35 127.85 81.94 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 116.592 -0.276 . . . . 75.140000000000001 111.66 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HB3' HD11 ' A' ' 7' ' ' ILE . 21.1 Cg_endo -60.33 125.42 17.4 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.793 2.329 . . . . 70.430000000000007 113.959 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -93.72 142.11 27.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.192 -0.913 . . . . 70.129999999999995 110.748 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.92 133.82 52.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.883 -0.511 . . . . 74.0 111.863 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.42 113.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.952 -0.567 . . . . 74.019999999999996 110.195 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -72.19 -34.66 68.59 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.863 0.363 . . . . 73.200000000000003 111.814 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -59.81 -50.58 73.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.912 0.386 . . . . 75.439999999999998 111.923 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.438 ' HG ' ' HD2' ' A' ' 29' ' ' PHE . 14.9 t -89.91 -23.39 21.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.341 -0.391 . . . . 65.109999999999999 111.511 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.43 10.88 79.02 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 52.119999999999997 113.705 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 97.0 m-85 -110.4 163.84 13.28 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.199 0.524 . . . . 62.310000000000002 111.877 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.0 m-85 -101.05 136.66 40.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.016 -0.538 . . . . 63.219999999999999 110.75 173.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.97 118.36 34.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.893 -0.41 . . . . 60.340000000000003 109.893 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -143.65 156.18 44.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.957 0.408 . . . . 73.430000000000007 111.256 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 4.6 ttmp? -118.17 110.89 18.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.191 -0.458 . . . . 75.129999999999995 111.655 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -60.8 160.6 9.23 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.291 -0.413 . . . . 73.200000000000003 111.36 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.79 -27.27 11.75 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.524 0.564 . . . . 73.209999999999994 112.524 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.26 4.69 6.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.017 0.377 . . . . 73.209999999999994 112.017 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.4 20.96 78.36 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.014 -0.612 . . . . 74.329999999999998 112.507 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.73 114.9 28.31 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.64 0.376 . . . . 75.340000000000003 111.532 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -92.35 125.65 37.1 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.893 0.378 . . . . 70.510000000000005 110.769 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -145.1 166.55 25.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.514 -0.312 . . . . 74.120000000000005 110.864 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 44.2 mtm180 -114.55 140.3 48.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.412 0.523 . . . . 64.239999999999995 112.412 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -128.59 145.54 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.242 -0.436 . . . . 73.230000000000004 110.658 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.85 146.89 52.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.662 0.744 . . . . 72.439999999999998 112.518 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 47' ' ' VAL . 19.0 pttm -53.49 -27.62 26.36 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.716 -1.129 . . . . 74.310000000000002 113.999 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -77.84 -21.86 50.81 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.363 0.505 . . . . 74.010000000000005 112.363 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -77.36 -25.03 50.63 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.9 0.704 . . . . 74.409999999999997 112.9 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.2 p -75.11 113.53 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.567 0.699 . . . . 63.340000000000003 112.612 -175.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.15 -60.48 2.14 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.912 -0.585 . . . . 54.530000000000001 110.98 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 p -139.35 153.15 47.64 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.316 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.5 t -127.87 108.29 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.506 -0.315 . . . . 72.140000000000001 111.207 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -123.15 145.56 48.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.115 0.483 . . . . 64.450000000000003 111.594 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.098 0.475 . . . . 65.439999999999998 111.744 -177.938 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 120.403 0.144 . . . . 74.239999999999995 111.156 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.99 131.83 45.92 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.483 2.122 . . . . 64.420000000000002 112.391 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -127.23 133.56 50.21 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.788 0.292 . . . . 72.329999999999998 111.788 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.79 124.88 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.51 0.672 . . . . 62.039999999999999 111.053 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.57 107.99 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.027 -0.533 . . . . 75.019999999999996 111.166 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -84.27 119.56 25.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.371 -0.377 . . . . 74.319999999999993 110.648 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -86.2 155.24 20.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.627 0.251 . . . . 61.329999999999998 111.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.2 -26.24 68.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.386 0.612 . . . . 73.450000000000003 110.655 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -58.25 -29.05 65.46 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.556 -0.747 . . . . 71.530000000000001 111.659 173.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.1 -11.33 26.87 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.513 -0.375 . . . . 71.310000000000002 112.939 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -81.45 130.42 35.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.857 0.361 . . . . 71.540000000000006 111.738 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.52 129.84 53.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.009 0.433 . . . . 75.200000000000003 110.836 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.421 HG21 ' HE2' ' A' ' 32' ' ' PHE . 46.4 mt -112.74 121.92 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.485 -0.325 . . . . 73.099999999999994 111.381 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -93.91 117.76 30.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.246 0.546 . . . . 44.130000000000003 111.976 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -105.67 153.27 22.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.931 -0.577 . . . . 54.039999999999999 111.328 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.402 HG13 ' HA ' ' A' ' 35' ' ' LEU . 32.9 m -78.77 -28.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.152 0.427 . . . . 72.109999999999999 112.152 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.43 175.4 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.976 0.417 . . . . 54.130000000000003 111.764 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.5 p -78.57 131.05 69.18 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.375 -0.375 . . . . 72.430000000000007 111.572 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 58.1 Cg_endo -68.71 153.95 72.25 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.687 2.258 . . . . 51.32 113.936 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -111.51 120.2 41.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.745 -0.661 . . . . 64.109999999999999 111.134 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -82.07 125.86 31.33 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.112 -0.367 . . . . 64.430000000000007 110.307 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.11 114.98 26.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.18 0.514 . . . . 71.340000000000003 110.231 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.5 -28.08 65.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.807 -0.633 . . . . 74.439999999999998 112.102 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -83.24 -44.76 14.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.443 -0.344 . . . . 55.340000000000003 111.919 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 m -82.37 -27.81 31.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.046 0.387 . . . . 54.210000000000001 112.046 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.57 9.43 84.76 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.299 -0.477 . . . . 50.229999999999997 113.777 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.24 162.42 13.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.351 -0.5 . . . . 61.219999999999999 112.015 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 58.6 m-85 -101.77 127.07 48.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 73.129999999999995 110.282 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.5 mt-10 -99.15 119.7 38.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.498 -0.319 . . . . 71.230000000000004 110.418 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 35.9 p90 -142.21 148.37 38.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.192 0.52 . . . . 74.109999999999999 112.086 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -106.09 108.99 20.78 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.965 -0.561 . . . . 60.039999999999999 110.566 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 45.2 mt-30 -66.43 171.14 5.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.323 0.49 . . . . 70.049999999999997 112.323 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.402 ' HA ' HG13 ' A' ' 18' ' ' VAL . 84.7 mt -58.91 -21.9 58.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.304 -0.407 . . . . 64.340000000000003 112.074 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.26 -11.91 57.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.095 0.406 . . . . 62.340000000000003 112.095 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.4 -4.73 51.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.288 -0.482 . . . . 60.43 114.095 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -75.68 117.3 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.191 -0.594 . . . . 64.409999999999997 111.765 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.07 88.56 7.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.369 0.604 . . . . 73.239999999999995 109.871 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 t -106.78 165.07 11.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.084 -0.507 . . . . 72.209999999999994 111.665 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 23.3 mtm180 -125.87 138.44 53.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.964 0.411 . . . . 73.150000000000006 112.021 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -133.17 147.65 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.245 -0.434 . . . . 62.310000000000002 110.702 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.74 148.22 50.67 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.229 0.537 . . . . 74.230000000000004 112.062 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.37 -15.49 63.33 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.736 1.013 . . . . 61.219999999999999 113.736 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -79.54 -11.01 59.9 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.797 -0.564 . . . . 55.130000000000003 111.615 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -90.57 -26.65 19.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.295 0.479 . . . . 65.400000000000006 112.295 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.81 117.63 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.455 0.645 . . . . 72.420000000000002 112.671 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.537 ' HG2' HG23 ' A' ' 49' ' ' THR . 50.9 ttt180 -82.61 -60.89 2.04 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.998 -0.547 . . . . 73.049999999999997 111.524 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.2 p -141.99 143.49 33.21 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.461 -0.336 . . . . 74.219999999999999 111.858 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.23 123.65 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.5 -0.318 . . . . 62.5 111.064 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -138.41 155.52 48.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.144 0.497 . . . . 72.310000000000002 111.822 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.222 0.534 . . . . 73.049999999999997 111.512 178.874 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 110.842 -0.058 . . . . 72.319999999999993 110.842 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 8.1 Cg_endo -49.15 116.31 2.17 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.79 2.327 . . . . 73.319999999999993 112.951 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.6 m -121.95 132.34 54.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.3 -0.409 . . . . 73.019999999999996 111.462 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 p -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.264 0.555 . . . . 75.049999999999997 111.17 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG23 HG23 ' A' ' 47' ' ' VAL . 67.2 mt -111.69 109.3 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.031 -0.531 . . . . 74.200000000000003 111.162 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.5 m -83.77 118.62 24.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.69 0.281 . . . . 64.340000000000003 110.353 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.44 155.62 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.906 0.384 . . . . 74.439999999999998 111.603 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.29 -21.64 65.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.078 0.465 . . . . 75.519999999999996 111.194 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.82 -2.5 47.48 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.146 -0.479 . . . . 74.400000000000006 112.192 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.09 -28.06 17.42 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.624 -0.322 . . . . 65.329999999999998 113.202 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -66.68 136.23 55.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.822 0.344 . . . . 73.400000000000006 111.827 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.74 129.6 56.06 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.29 -0.256 . . . . 61.409999999999997 110.704 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.4 mt -109.68 128.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.82 0.343 . . . . 73.219999999999999 111.118 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -95.89 119.36 34.24 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.31 0.576 . . . . 73.239999999999995 112.122 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . -110.95 168.28 9.61 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.749 -0.659 . . . . 65.040000000000006 111.33 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 33.2 m -102.65 -5.26 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 111.866 0.321 . . . . 64.319999999999993 111.866 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -138.42 174.16 10.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.248 0.546 . . . . 72.140000000000001 112.059 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.2 p -80.96 121.63 81.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.946 -0.57 . . . . 71.540000000000006 111.567 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -61.34 128.53 25.24 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.92 2.413 . . . . 71.439999999999998 113.837 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 28.2 ttmt -91.65 141.97 28.12 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.925 -0.579 . . . . 73.540000000000006 110.82 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -101.67 129.83 47.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.796 -0.565 . . . . 74.25 111.366 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -132.04 116.37 16.99 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.917 0.389 . . . . 74.400000000000006 111.337 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.44 -32.2 68.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.738 0.273 . . . . 74.209999999999994 111.738 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -55.05 -37.92 67.33 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.875 0.369 . . . . 60.210000000000001 111.587 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.1 p -97.32 -27.95 14.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.887 0.375 . . . . 51.149999999999999 110.857 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.38 10.94 69.99 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.349 -0.387 . . . . 71.329999999999998 113.209 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -122.18 171.55 8.92 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.527 0.679 . . . . 64.349999999999994 112.718 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.4 m-85 -102.17 132.78 47.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 64.340000000000003 110.484 169.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -98.27 120.43 38.66 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.68 0.276 . . . . 74.439999999999998 111.028 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -148.9 146.41 27.88 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 75.439999999999998 111.331 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 37.9 ttmt -100.85 114.67 28.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.501 -0.318 . . . . 74.150000000000006 111.606 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -60.15 164.13 4.35 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.139 0.422 . . . . 64.150000000000006 112.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -53.58 -32.13 49.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.952 0.406 . . . . 71.340000000000003 111.751 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -72.88 0.22 11.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.241 0.459 . . . . 64.209999999999994 112.241 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 25.35 61.36 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.896 -0.669 . . . . 61.340000000000003 112.121 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -106.45 106.77 17.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.829 0.347 . . . . 65.329999999999998 111.04 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 57.3 tt0 -81.52 110.84 17.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.323 -0.399 . . . . 73.140000000000001 111.056 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -124.3 166.84 15.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.081 0.467 . . . . 64.140000000000001 111.966 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 62.7 mtt180 -126.06 126.59 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 111.47 -176.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.612 0.244 . . . . 73.530000000000001 111.435 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.29 148.4 51.76 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.281 0.562 . . . . 75.219999999999999 112.356 -174.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HZ2' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -62.05 -32.03 72.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.335 1.235 . . . . 74.409999999999997 114.335 -172.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -84.44 -12.69 53.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.639 -0.663 . . . . 54.340000000000003 112.209 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.77 -28.16 55.57 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.297 0.48 . . . . 61.439999999999998 112.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 7' ' ' ILE . 7.5 p -76.82 113.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.267 0.556 . . . . 73.329999999999998 112.253 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -82.96 -60.14 2.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.031 0.444 . . . . 74.5 111.066 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.0 p -130.64 162.19 29.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.163 0.431 . . . . 64.329999999999998 112.163 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.0 t -137.36 106.95 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 116.022 -0.535 . . . . 63.420000000000002 110.743 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -132.78 154.09 50.59 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.303 0.573 . . . . 71.239999999999995 112.011 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.311 0.577 . . . . 50.100000000000001 111.133 178.8 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.238 0.066 . . . . 73.450000000000003 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 47.6 Cg_endo -68.3 114.62 3.5 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.591 1.527 . . . . 43.530000000000001 111.802 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.6 m -123.83 126.67 46.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.258 -0.428 . . . . 71.519999999999996 111.541 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.33 117.85 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.457 0.646 . . . . 60.009999999999998 110.891 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.412 HD11 ' HB3' ' A' ' 21' ' ' PRO . 66.6 mt -100.64 111.73 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.086 -0.507 . . . . 60.409999999999997 111.187 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 99.6 m -83.8 121.26 27.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.508 -0.315 . . . . 73.120000000000005 110.824 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 15' ' ' ILE . 75.3 mt -89.06 172.1 9.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 62.340000000000003 111.893 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -51.88 -41.24 61.75 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.87 -0.605 . . . . 61.299999999999997 112.212 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.2 -15.46 62.47 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.708 0.633 . . . . 75.400000000000006 112.708 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.79 -1.22 68.18 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.808 -0.517 . . . . 70.420000000000002 111.808 -170.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -72.11 136.36 46.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.763 0.425 . . . . 73.439999999999998 110.968 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.59 133.74 48.11 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.886 0.374 . . . . 71.319999999999993 111.592 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 9' ' ' LEU . 63.0 mt -108.55 124.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.739 0.304 . . . . 60.409999999999997 110.555 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.6 111.34 23.28 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 72.340000000000003 111.506 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.61 150.1 33.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.82 0.343 . . . . 64.25 111.826 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.557 HG13 HD23 ' A' ' 35' ' ' LEU . 29.5 m -96.68 2.32 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.949 0.404 . . . . 74.430000000000007 111.281 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 2.7 t0 -140.19 164.69 29.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.199 -0.455 . . . . 52.420000000000002 110.077 -175.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.7 p -80.01 140.14 53.66 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 112.396 0.517 . . . . 63.350000000000001 112.396 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 32' ' ' PHE . 61.7 Cg_endo -72.6 111.15 3.16 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.545 2.163 . . . . 72.400000000000006 113.244 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -86.8 110.29 19.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.754 -0.657 . . . . 71.409999999999997 111.321 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -84.68 122.22 28.78 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.881 0.326 . . . . 72.420000000000002 111.881 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.65 122.16 41.52 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.936 0.398 . . . . 72.430000000000007 110.52 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.03 -42.14 73.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.309 -0.405 . . . . 63.43 111.987 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.41 -40.37 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.389 0.514 . . . . 71.5 112.389 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.579 ' HG ' ' HD2' ' A' ' 29' ' ' PHE . 8.7 t -97.54 -27.3 14.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.895 0.379 . . . . 65.109999999999999 111.825 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 10.76 79.07 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.099 -0.572 . . . . 33.329999999999998 114.252 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' HD2' ' HG ' ' A' ' 27' ' ' SER . 95.9 m-85 -101.97 154.45 18.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.286 0.543 . . . . 71.030000000000001 111.99 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CE1' HG11 ' A' ' 47' ' ' VAL . 52.8 m-85 -101.51 121.75 42.55 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.043 -0.526 . . . . 64.430000000000007 110.042 171.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.1 119.33 38.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.424 -0.353 . . . . 75.409999999999997 110.555 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.486 ' HB3' ' HA ' ' A' ' 21' ' ' PRO . 28.6 p90 -148.0 168.32 22.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.745 0.646 . . . . 72.209999999999994 112.745 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 4.6 ttmp? -112.68 116.61 30.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.732 -0.667 . . . . 70.049999999999997 110.941 -176.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 47.9 mt-30 -76.28 173.52 11.29 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.17 0.433 . . . . 75.140000000000001 112.17 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 18' ' ' VAL . 78.0 mt -57.11 -30.82 64.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.909 0.385 . . . . 65.409999999999997 111.902 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.92 -11.9 60.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.952 0.406 . . . . 74.109999999999999 111.58 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.33 -11.97 69.54 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.399 -0.429 . . . . 55.119999999999997 112.401 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -69.51 124.86 25.02 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.914 0.388 . . . . 74.530000000000001 111.578 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -82.67 140.07 33.35 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.375 -0.375 . . . . 75.349999999999994 110.641 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 t -145.82 156.28 43.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.93 0.395 . . . . 62.539999999999999 112.051 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 42.5 mtm180 -127.14 129.34 47.7 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.22 -0.446 . . . . 53.240000000000002 110.842 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 tt -130.44 141.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.647 0.26 . . . . 72.120000000000005 110.927 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.13 152.09 45.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.755 0.788 . . . . 75.140000000000001 112.685 -172.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -59.51 -14.96 14.82 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.309 1.226 . . . . 74.409999999999997 114.309 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -78.59 -32.07 47.46 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.984 -0.448 . . . . 61.229999999999997 112.018 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -78.72 -28.64 45.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.547 0.573 . . . . 74.150000000000006 112.547 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.482 HG11 ' CE1' ' A' ' 30' ' ' TYR . 7.4 p -73.4 114.03 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.446 0.641 . . . . 71.129999999999995 111.912 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -83.65 -58.08 2.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.363 -0.38 . . . . 74.230000000000004 111.115 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.5 p -142.58 135.26 28.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.061 0.393 . . . . 54.310000000000002 112.061 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.8 t -100.07 116.64 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 116.423 -0.353 . . . . 72.140000000000001 110.95 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -132.31 150.99 52.04 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.948 0.351 . . . . 74.439999999999998 111.948 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 120.963 0.411 . . . . 70.349999999999994 111.368 172.402 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 110.508 -0.182 . . . . 72.349999999999994 110.508 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.61 115.28 2.96 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.742 1.628 . . . . 64.239999999999995 111.479 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.9 m -125.09 128.36 48.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.761 0.315 . . . . 74.219999999999999 111.47 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.95 119.24 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.457 0.646 . . . . 73.120000000000005 111.555 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.6 mt -101.21 110.65 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.037 -0.528 . . . . 72.329999999999998 110.675 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.1 m -89.47 129.4 35.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.556 -0.293 . . . . 54.32 110.952 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.95 161.96 15.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.859 0.361 . . . . 74.310000000000002 110.8 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 11.5 t30 -62.7 -24.43 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.871 0.693 . . . . 74.129999999999995 112.871 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.52 -22.37 57.17 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.845 0.355 . . . . 71.209999999999994 111.691 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.65 -6.56 13.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.254 -0.498 . . . . 41.109999999999999 113.04 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -73.6 131.69 41.97 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.603 -0.351 . . . . 65.239999999999995 111.701 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -104.43 129.31 52.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.86 0.362 . . . . 72.219999999999999 111.178 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.93 119.37 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.781 0.324 . . . . 73.439999999999998 110.688 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -94.28 132.88 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.1 0.476 . . . . 75.030000000000001 111.584 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.3 157.34 33.43 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.183 -0.462 . . . . 72.040000000000006 111.978 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.83 2.39 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.124 -0.489 . . . . 54.140000000000001 111.296 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.61 160.47 38.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.977 -0.556 . . . . 71.109999999999999 110.529 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.8 p -79.69 142.16 56.79 Favored Pre-proline 0 N--CA 1.469 0.48 0 CA-C-O 120.694 0.283 . . . . 73.099999999999994 111.331 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HB3' HD11 ' A' ' 7' ' ' ILE . 76.2 Cg_endo -75.71 146.72 30.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.689 2.26 . . . . 75.439999999999998 113.996 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 32.2 ttmt -110.65 132.6 54.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.806 -0.634 . . . . 73.409999999999997 110.375 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -90.08 119.24 30.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.387 -0.525 . . . . 72.319999999999993 110.021 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -97.38 106.03 18.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.268 0.556 . . . . 72.329999999999998 110.641 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.31 -23.03 64.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.89 -0.595 . . . . 75.519999999999996 111.852 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -69.27 -39.24 78.52 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.584 0.587 . . . . 64.200000000000003 112.584 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -118.08 -27.19 6.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.492 0.552 . . . . 71.329999999999998 112.492 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.11 11.45 31.92 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.891 -0.671 . . . . 33.25 114.174 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.511 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 91.6 m-85 -102.05 156.65 17.41 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.776 0.658 . . . . 75.420000000000002 112.776 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 55.6 m-85 -101.43 124.46 47.14 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.808 -0.633 . . . . 72.140000000000001 110.855 173.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 22' ' ' LYS . 44.0 mt-10 -99.74 122.17 42.33 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.781 0.432 . . . . 64.140000000000001 111.955 -177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -154.85 162.3 41.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.045 0.45 . . . . 72.430000000000007 111.339 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -106.14 114.66 28.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.178 -0.464 . . . . 71.25 111.337 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -65.29 169.14 6.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.131 -0.486 . . . . 64.430000000000007 112.303 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.4 mt -55.37 -26.68 42.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.292 -0.413 . . . . 61.299999999999997 112.05 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.5 -4.7 32.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 111.997 0.369 . . . . 63.229999999999997 111.997 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 28.94 57.63 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.068 -0.587 . . . . 44.140000000000001 112.368 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.2 133.67 55.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.627 0.371 . . . . 62.43 111.296 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -89.07 123.64 33.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.837 0.351 . . . . 72.310000000000002 110.822 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -133.29 165.25 25.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.879 0.371 . . . . 73.010000000000005 111.623 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 29' ' ' PHE . 57.1 mtp180 -129.1 125.72 37.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.411 -0.359 . . . . 54.340000000000003 110.229 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.93 143.74 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.685 0.279 . . . . 75.349999999999994 111.573 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -64.5 147.5 52.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.447 0.641 . . . . 74.450000000000003 112.636 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.4 ptmt -64.0 -22.61 67.0 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.923 1.083 . . . . 63.219999999999999 113.923 -173.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -82.66 -10.85 58.75 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.61 -0.682 . . . . 73.230000000000004 111.89 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -82.67 -28.44 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.882 0.327 . . . . 73.450000000000003 111.882 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -75.7 122.17 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.777 0.798 . . . . 73.439999999999998 112.845 -173.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HG2' HG23 ' A' ' 49' ' ' THR . 63.9 ttt180 -82.06 -62.77 1.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.608 -0.724 . . . . 75.200000000000003 110.272 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 48' ' ' ARG . 46.0 p -144.38 149.03 35.46 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.832 -0.622 . . . . 71.209999999999994 111.592 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -116.01 118.94 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.289 -0.414 . . . . 75.129999999999995 110.504 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -131.25 127.8 38.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.759 0.651 . . . . 74.299999999999997 112.759 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.3 -0.63 . . . . 65.420000000000002 109.3 169.92 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 110.52 -0.178 . . . . 65.329999999999998 110.52 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.95 119.49 6.56 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.486 2.124 . . . . 71.549999999999997 112.899 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 87.2 m -116.76 128.15 55.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.779 0.323 . . . . 74.120000000000005 111.8 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 p -98.81 129.39 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.218 0.533 . . . . 63.049999999999997 110.59 173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.43 118.51 56.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.852 0.358 . . . . 73.109999999999999 111.805 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.7 m -84.01 125.94 32.56 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.788 -0.449 . . . . 65.549999999999997 109.788 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.9 176.19 6.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.944 0.878 . . . . 74.140000000000001 112.915 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -64.74 -42.45 95.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.989 -1.005 . . . . 60.210000000000001 111.166 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.55 -23.74 62.67 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.97 0.414 . . . . 73.510000000000005 111.789 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.99 -18.19 9.07 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.354 -0.451 . . . . 62.43 113.522 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -64.31 136.05 56.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.228 0.514 . . . . 73.030000000000001 111.743 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.92 135.04 52.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.616 0.246 . . . . 72.239999999999995 110.823 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.8 mt -116.83 122.98 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.597 0.237 . . . . 71.310000000000002 111.206 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -85.92 116.7 24.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.075 0.464 . . . . 72.519999999999996 111.596 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.26 142.82 41.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.32 -0.4 . . . . 73.409999999999997 111.44 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 35' ' ' LEU . 26.4 m -82.31 -11.14 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.883 0.373 . . . . 41.299999999999997 111.718 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -128.51 157.7 40.45 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.248 -0.433 . . . . 71.150000000000006 109.912 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -79.28 143.65 60.82 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-O 120.967 0.413 . . . . 74.439999999999998 111.923 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.77 131.51 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.689 2.259 . . . . 72.140000000000001 113.772 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -103.39 132.22 49.82 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.828 -0.624 . . . . 75.530000000000001 110.631 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.75 123.92 34.17 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.014 -0.429 . . . . 44.340000000000003 111.497 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.99 106.46 18.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.012 0.435 . . . . 72.299999999999997 110.19 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.84 -21.66 63.34 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.342 -0.39 . . . . 73.420000000000002 111.935 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -69.17 -46.37 67.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.86 0.362 . . . . 71.010000000000005 111.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 97.2 p -101.09 -27.03 13.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.153 0.427 . . . . 64.120000000000005 112.153 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.11 8.39 64.75 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.219 -0.515 . . . . 44.32 113.265 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.409 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 59.2 m-85 -95.71 155.21 16.84 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.201 0.524 . . . . 63.509999999999998 111.767 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 39.8 m-85 -101.46 131.05 47.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.148 -0.478 . . . . 72.299999999999997 111.114 172.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -98.9 118.94 36.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.078 -0.51 . . . . 75.319999999999993 110.655 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.47 142.4 31.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.302 0.572 . . . . 75.530000000000001 111.91 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -94.11 110.72 22.41 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.764 -0.653 . . . . 51.420000000000002 111.476 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.69 173.59 2.15 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.064 0.459 . . . . 61.310000000000002 112.217 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.605 ' HA ' HG13 ' A' ' 18' ' ' VAL . 89.2 mt -49.15 -45.75 44.28 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.23 0.826 . . . . 74.109999999999999 113.23 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.3 m-20 -80.2 15.07 1.65 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.56 0.578 . . . . 45.329999999999998 112.56 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.96 86.0 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.907 -0.663 . . . . 74.25 112.454 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.7 mtpp -80.96 105.07 11.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.605 0.362 . . . . 64.040000000000006 111.79 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -73.86 123.83 24.97 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.765 0.317 . . . . 72.430000000000007 110.905 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -135.1 160.19 39.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.504 -0.316 . . . . 63.009999999999998 110.77 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 76.2 mtm180 -134.07 142.01 47.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.964 0.357 . . . . 74.219999999999999 111.964 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.28 152.91 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.253 -0.43 . . . . 64.400000000000006 110.293 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.12 153.79 36.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.76 0.652 . . . . 65.209999999999994 112.76 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.36 -14.91 62.8 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.47 0.915 . . . . 73.239999999999995 113.47 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -85.28 -11.08 55.6 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.898 -0.501 . . . . 74.409999999999997 111.595 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -90.36 -27.59 19.26 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.207 0.447 . . . . 73.450000000000003 112.207 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.3 p -70.09 111.49 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.556 0.693 . . . . 63.229999999999997 111.508 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HG2' HG23 ' A' ' 49' ' ' THR . 21.7 ttm-85 -83.03 -62.77 1.51 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.883 -0.599 . . . . 74.140000000000001 111.254 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.513 HG23 ' HG2' ' A' ' 48' ' ' ARG . 61.7 p -141.04 135.64 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.178 0.514 . . . . 74.5 111.95 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.54 124.57 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.022 -0.535 . . . . 73.310000000000002 111.225 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -142.64 144.22 32.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.338 0.255 . . . . 71.099999999999994 111.577 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.6 m-20 . . . . . 0 CA--C 1.541 0.615 0 CA-C-O 121.029 0.442 . . . . 60.439999999999998 111.547 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 40.5 t . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 120.068 -0.015 . . . . 65.420000000000002 111.013 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 3' ' ' SER . 10.8 Cg_endo -53.29 116.31 2.87 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.303 2.002 . . . . 64.150000000000006 111.768 177.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.8 m -132.77 141.46 48.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.342 -0.39 . . . . 71.450000000000003 111.123 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.9 117.89 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.557 0.694 . . . . 70.530000000000001 111.468 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.16 104.5 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.253 0.549 . . . . 72.099999999999994 110.513 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.0 m -85.67 119.18 25.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.964 -0.562 . . . . 52.420000000000002 110.755 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.19 157.13 24.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.779 0.323 . . . . 74.299999999999997 111.217 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.545 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 26.4 t-20 -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.993 0.368 . . . . 64.400000000000006 111.993 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.37 -8.45 55.9 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.405 0.52 . . . . 63.119999999999997 112.405 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.45 -33.2 4.58 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.803 -0.713 . . . . 72.239999999999995 114.666 175.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.2 135.1 44.49 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.673 0.736 . . . . 72.010000000000005 112.427 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.35 129.98 53.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.28 -0.418 . . . . 75.239999999999995 110.485 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.25 130.48 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.824 0.345 . . . . 71.310000000000002 111.234 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -96.56 119.2 34.61 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.06 0.457 . . . . 71.140000000000001 111.999 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.7 153.15 38.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.348 -0.387 . . . . 54.119999999999997 111.5 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.31 -10.58 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.832 0.349 . . . . 62.049999999999997 111.769 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.7 166.55 24.55 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.419 . . . . 64.319999999999993 111.579 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.7 p -80.84 138.29 50.2 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 112.178 0.436 . . . . 61.240000000000002 112.178 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 69.0 Cg_endo -71.67 126.31 11.95 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.658 2.239 . . . . 65.209999999999994 113.941 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 2.2 ttmp? -86.45 141.21 29.29 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.412 -0.358 . . . . 75.140000000000001 110.311 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -99.11 129.89 45.4 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.12 0.486 . . . . 74.120000000000005 112.095 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -109.28 111.87 23.7 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.974 -0.557 . . . . 70.109999999999999 110.109 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.73 -35.33 79.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.554 0.575 . . . . 62.200000000000003 112.554 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.11 -52.72 53.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.954 0.407 . . . . 51.219999999999999 111.829 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.5 m -85.56 -26.96 25.85 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.306 -0.406 . . . . 34.539999999999999 111.754 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.79 8.91 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.404 -0.427 . . . . 63.329999999999998 113.912 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 83.6 m-85 -102.81 156.21 17.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.222 0.534 . . . . 73.420000000000002 112.116 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 67.7 m-85 -101.93 135.59 43.21 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.627 -0.715 . . . . 63.229999999999997 110.603 172.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 36.0 mt-10 -98.89 118.78 36.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.441 0.163 . . . . 71.239999999999995 110.786 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -147.74 152.22 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.156 0.503 . . . . 73.019999999999996 111.641 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 4.1 ttmp? -106.9 112.71 25.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 111.128 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -64.82 164.85 11.57 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.769 0.319 . . . . 75.540000000000006 111.799 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.9 mt -53.51 -29.72 37.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.386 0.884 . . . . 61.210000000000001 113.386 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -77.28 -11.54 59.84 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.91 0.386 . . . . 70.439999999999998 111.679 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.51 -6.28 49.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.527 -0.368 . . . . 53.310000000000002 112.242 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -70.4 101.57 1.98 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.928 0.491 . . . . 75.349999999999994 111.74 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.2 tt0 -82.07 107.28 14.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.756 0.312 . . . . 74.230000000000004 110.366 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.3 t -123.68 165.2 17.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.056 0.455 . . . . 74.420000000000002 111.836 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 49.4 mtm180 -124.59 132.49 53.44 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.962 -0.563 . . . . 75.230000000000004 111.715 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 tt -130.93 146.62 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.685 0.278 . . . . 71.129999999999995 111.211 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -71.75 152.28 42.87 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.571 0.582 . . . . 73.239999999999995 112.571 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 pttp -57.97 -31.52 66.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.516 0.932 . . . . 53.539999999999999 113.516 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -69.01 -11.64 60.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.415 0.524 . . . . 54.240000000000002 112.415 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -88.14 -27.79 21.66 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.585 0.587 . . . . 74.530000000000001 112.585 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 44' ' ' LYS . 10.7 p -76.91 118.64 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.806 0.812 . . . . 64.030000000000001 112.809 -173.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 57.4 ttt180 -81.9 -58.44 2.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.211 -0.904 . . . . 74.430000000000007 111.077 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.4 p -148.08 134.53 19.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.863 -0.608 . . . . 73.549999999999997 111.189 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 111.2 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 62.310000000000002 110.983 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -133.5 141.95 48.0 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.035 0.445 . . . . 71.040000000000006 111.761 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 116.254 -0.43 . . . . 72.310000000000002 110.464 174.669 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 120.445 0.164 . . . . 62.329999999999998 110.826 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.07 120.83 6.61 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.892 2.395 . . . . 61.130000000000003 112.339 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -125.71 133.04 52.26 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.437 -0.347 . . . . 71.519999999999996 111.826 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -99.97 124.5 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.173 0.511 . . . . 75.530000000000001 110.758 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.4 120.06 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.073 0.463 . . . . 71.340000000000003 110.988 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.0 m -100.01 118.49 36.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.033 -0.531 . . . . 71.150000000000006 110.826 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.467 HD12 ' HD3' ' A' ' 13' ' ' ARG . 78.3 mt -83.89 168.35 16.16 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.863 0.363 . . . . 73.340000000000003 111.521 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.58 -28.73 70.13 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.493 -0.321 . . . . 63.049999999999997 111.455 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.21 -16.21 59.44 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.036 0.446 . . . . 74.219999999999999 111.61 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.35 67.81 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.677 -0.569 . . . . 54.119999999999997 111.677 -170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HD3' HD12 ' A' ' 9' ' ' LEU . 78.0 ttt180 -77.33 136.37 38.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.308 0.643 . . . . 74.219999999999999 111.217 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.33 130.24 56.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.989 0.423 . . . . 71.340000000000003 111.767 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.0 mt -122.42 130.49 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.093 -0.503 . . . . 52.219999999999999 110.618 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -94.85 127.99 41.27 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.101 0.477 . . . . 74.109999999999999 112.037 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.82 164.3 17.72 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.083 -0.508 . . . . 72.239999999999995 111.453 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.73 -18.36 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.211 0.448 . . . . 72.239999999999995 112.211 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -126.94 172.48 10.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.275 0.56 . . . . 65.420000000000002 111.868 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -79.81 119.39 76.57 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.812 -0.631 . . . . 64.019999999999996 110.499 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.82 134.34 41.27 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.072 2.515 . . . . 63.020000000000003 113.951 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -85.63 124.64 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.606 -0.724 . . . . 73.439999999999998 110.746 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.81 108.62 20.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 75.319999999999993 110.983 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.25 110.54 23.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.971 0.415 . . . . 74.439999999999998 110.592 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.75 -39.29 93.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 71.510000000000005 111.993 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.19 -43.03 99.36 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.157 0.429 . . . . 72.400000000000006 112.157 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 m -91.75 -28.08 17.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.934 0.346 . . . . 54.399999999999999 111.934 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 11.94 72.85 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.922 -0.656 . . . . 72.230000000000004 113.824 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.96 155.12 21.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.387 0.613 . . . . 63.119999999999997 112.462 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.69 129.9 47.95 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.58 -0.736 . . . . 72.109999999999999 110.326 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.579 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.2 mt-10 -108.28 121.91 45.86 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.592 -0.276 . . . . 72.5 111.194 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.77 143.79 29.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.82 0.343 . . . . 72.219999999999999 111.627 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.6 ttmt -98.4 114.55 26.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.767 0.318 . . . . 71.549999999999997 111.241 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -60.6 165.11 4.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.412 -0.358 . . . . 74.230000000000004 111.779 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.64 -26.68 61.97 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.87 0.366 . . . . 73.519999999999996 111.623 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.88 -6.21 43.57 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.48 0.548 . . . . 70.109999999999999 112.48 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.09 23.9 46.81 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.075 -0.584 . . . . 73.409999999999997 112.747 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -112.63 112.3 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.794 0.331 . . . . 45.43 111.457 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.9 tt0 -89.69 109.81 20.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.806 0.336 . . . . 73.150000000000006 111.319 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -111.87 163.42 14.23 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.935 0.398 . . . . 61.109999999999999 111.529 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 55.4 mtt180 -123.51 131.64 53.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.928 0.394 . . . . 74.329999999999998 111.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.84 152.37 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.441 -0.345 . . . . 62.549999999999997 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -66.87 147.29 53.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.184 0.516 . . . . 73.530000000000001 111.667 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.4 ptmt -65.07 -20.2 66.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.983 0.734 . . . . 73.510000000000005 112.983 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -76.55 -10.25 59.25 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.314 0.487 . . . . 74.019999999999996 112.314 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -90.96 -17.73 25.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.875 0.694 . . . . 73.430000000000007 112.875 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 44' ' ' LYS . 8.9 p -75.0 117.79 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.481 0.658 . . . . 60.039999999999999 112.618 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -83.51 -61.72 1.77 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.303 0.573 . . . . 51.240000000000002 110.656 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.9 p -147.06 150.46 35.1 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.669 -0.696 . . . . 63.219999999999999 111.369 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.4 t -126.58 118.25 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.236 -0.438 . . . . 65.109999999999999 110.812 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.19 136.62 49.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.358 0.503 . . . . 71.219999999999999 112.358 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.332 -0.395 . . . . 74.25 110.523 172.227 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 110.689 -0.115 . . . . 71.420000000000002 110.689 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.42 116.76 3.82 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.565 2.176 . . . . 71.430000000000007 113.107 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -131.89 134.23 45.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.438 -0.346 . . . . 74.140000000000001 111.295 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.77 125.72 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.494 0.664 . . . . 63.25 111.685 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.3 mt -98.51 116.98 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.291 -0.413 . . . . 73.409999999999997 111.615 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.6 m -88.79 124.38 34.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.392 -0.367 . . . . 53.409999999999997 110.721 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.18 164.75 13.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.119 0.485 . . . . 71.040000000000006 112.282 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -54.61 -33.94 61.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.358 0.663 . . . . 73.439999999999998 111.384 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.14 -12.47 60.9 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.848 -0.615 . . . . 65.239999999999995 111.907 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.73 -24.72 30.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.436 -0.411 . . . . 61.149999999999999 112.677 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.16 135.7 57.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.846 0.355 . . . . 73.299999999999997 111.804 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.61 148.65 31.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.503 -0.317 . . . . 73.5 111.558 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.58 127.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.625 -0.261 . . . . 61.229999999999997 110.847 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -93.08 124.0 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.091 0.472 . . . . 71.299999999999997 111.995 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.06 156.8 26.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.122 -0.49 . . . . 53.130000000000003 111.55 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -88.94 -9.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.017 0.377 . . . . 63.329999999999998 112.017 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.61 166.44 24.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.102 0.477 . . . . 71.25 111.443 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.5 p -79.61 140.85 55.58 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 111.61 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 61.6 Cg_endo -71.47 148.73 54.85 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.594 2.196 . . . . 75.219999999999999 113.943 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -105.62 135.1 47.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.764 -0.653 . . . . 74.510000000000005 110.324 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -87.03 122.26 30.62 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.05 0.452 . . . . 75.120000000000005 111.739 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -98.1 108.67 21.43 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.144 -0.48 . . . . 70.010000000000005 110.951 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.63 -14.24 55.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.788 0.327 . . . . 71.430000000000007 111.61 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -63.0 -52.88 61.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 74.420000000000002 111.376 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -118.72 -26.8 6.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.033 0.383 . . . . 75.099999999999994 112.033 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.69 11.88 10.98 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.406 -0.902 . . . . 71.099999999999994 114.614 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.1 162.29 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.745 0.772 . . . . 70.230000000000004 112.708 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 43.6 m-85 -110.27 132.71 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.743 -0.662 . . . . 72.430000000000007 110.798 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 55.8 mt-10 -99.28 119.57 38.13 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.364 -0.21 . . . . 61.32 111.089 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -151.32 145.04 25.04 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.009 0.433 . . . . 72.329999999999998 111.434 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 3.5 ttmp? -98.26 112.44 24.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.538 -0.301 . . . . 65.319999999999993 111.494 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.68 162.15 8.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.943 0.401 . . . . 74.430000000000007 111.853 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 18' ' ' VAL . 84.1 mt -48.84 -39.91 27.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.722 0.638 . . . . 74.409999999999997 112.722 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.89 9.33 1.18 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.753 0.649 . . . . 64.349999999999994 112.753 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 46.66 25.11 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.918 -0.658 . . . . 72.439999999999998 112.322 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -125.01 104.71 8.71 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.656 -0.32 . . . . 71.420000000000002 111.289 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.9 tt0 -75.61 100.59 4.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.134 0.492 . . . . 73.140000000000001 110.371 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.3 t -114.21 165.72 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.07 0.462 . . . . 72.439999999999998 111.511 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.3 mtm180 -129.8 144.69 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.34 -0.391 . . . . 61.299999999999997 111.647 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 tt -139.51 149.71 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.301 -0.409 . . . . 73.430000000000007 110.901 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.51 153.93 30.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.797 0.665 . . . . 71.310000000000002 112.797 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 30' ' ' TYR . 25.4 pttm -58.88 -25.72 63.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.868 1.062 . . . . 74.209999999999994 113.868 -175.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -79.56 -11.22 59.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.236 0.458 . . . . 62.109999999999999 112.236 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -94.23 -18.32 21.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.426 0.528 . . . . 74.040000000000006 112.426 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.51 119.95 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.766 0.654 . . . . 71.439999999999998 112.766 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -82.68 -66.92 0.83 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.349 -0.387 . . . . 71.310000000000002 110.505 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -146.83 137.77 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.94 -0.573 . . . . 54.240000000000002 111.417 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.94 108.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.735 0.302 . . . . 54.210000000000001 110.74 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.87 142.66 39.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.084 0.469 . . . . 71.329999999999998 111.679 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.065 0.459 . . . . 71.340000000000003 111.22 177.19 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 p . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 120.389 0.137 . . . . 71.530000000000001 110.933 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.17 118.95 5.74 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.98 2.454 . . . . 71.200000000000003 112.9 -177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 m -126.24 126.95 44.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.192 -0.458 . . . . 74.109999999999999 111.378 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.511 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.5 p -105.13 125.94 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.141 0.496 . . . . 73.420000000000002 111.848 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.78 113.18 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.788 0.327 . . . . 74.299999999999997 111.324 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.9 m -83.44 134.58 34.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.18 -0.304 . . . . 53.439999999999998 110.18 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -100.76 170.18 8.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.053 0.454 . . . . 71.109999999999999 112.069 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -52.12 -45.11 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.864 -0.607 . . . . 75.129999999999995 112.606 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.67 -21.86 64.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.035 0.445 . . . . 73.450000000000003 111.577 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.59 -23.85 7.8 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.026 -0.607 . . . . 71.030000000000001 113.598 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -56.6 129.86 42.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.176 0.488 . . . . 64.019999999999996 111.899 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -103.31 130.48 50.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.883 0.373 . . . . 74.329999999999998 110.909 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.87 120.52 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.543 -0.299 . . . . 71.329999999999998 110.532 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.51 127.26 41.4 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.141 0.496 . . . . 73.310000000000002 112.045 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.9 154.83 26.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.093 -0.503 . . . . 72.109999999999999 111.744 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.0 m -75.14 -29.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.001 0.371 . . . . 64.409999999999997 112.001 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -129.04 174.61 9.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.897 0.379 . . . . 75.230000000000004 111.348 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -78.78 141.27 59.44 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 63.520000000000003 111.648 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.51 138.66 35.93 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.616 2.211 . . . . 65.239999999999995 113.79 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -93.41 130.22 39.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.97 -0.559 . . . . 75.099999999999994 110.455 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -90.82 114.8 27.29 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.153 -0.342 . . . . 75.030000000000001 111.269 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -97.89 104.52 16.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.889 0.376 . . . . 54.439999999999998 110.672 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.89 -30.51 70.68 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.945 0.35 . . . . 74.420000000000002 111.945 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.21 -52.42 65.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.034 0.445 . . . . 54.109999999999999 111.959 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -102.41 -11.63 18.47 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.105 0.409 . . . . 72.540000000000006 112.105 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.35 80.25 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.06 -0.59 . . . . 51.210000000000001 114.005 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.516 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 67.8 m-85 -97.95 156.38 16.65 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.282 0.563 . . . . 73.409999999999997 112.477 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 68.1 m-85 -101.21 127.22 47.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.799 -0.637 . . . . 74.519999999999996 110.01 169.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.3 mt-10 -99.6 119.37 37.96 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.768 0.318 . . . . 61.009999999999998 111.088 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -144.74 144.61 31.28 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 75.329999999999998 111.942 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 2.4 ttmp? -99.33 109.81 22.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.256 -0.429 . . . . 73.030000000000001 110.698 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.8 mt-30 -60.49 160.66 8.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.002 0.371 . . . . 52.140000000000001 112.002 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HA ' HG13 ' A' ' 18' ' ' VAL . 83.3 mt -56.29 -27.5 55.63 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.364 0.505 . . . . 74.0 112.364 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.46 -11.54 59.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.011 0.434 . . . . 65.230000000000004 111.778 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.98 -21.35 31.86 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.379 -0.439 . . . . 64.530000000000001 112.711 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -63.07 104.01 0.53 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 111.762 0.282 . . . . 75.109999999999999 111.762 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.9 tt0 -88.4 118.3 27.93 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.757 0.313 . . . . 71.319999999999993 110.606 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 t -136.07 164.59 27.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.397 0.517 . . . . 73.510000000000005 112.397 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 17.9 mtm180 -110.65 155.88 21.77 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.845 -0.616 . . . . 73.219999999999999 110.775 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -147.98 144.77 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.601 0.239 . . . . 73.439999999999998 110.935 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -70.32 150.18 46.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.258 0.551 . . . . 52.549999999999997 112.137 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -63.14 -14.86 53.68 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.759 1.022 . . . . 72.219999999999999 113.759 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -89.2 -14.95 34.85 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.767 -0.583 . . . . 71.200000000000003 111.979 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -81.67 -28.61 33.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.916 0.388 . . . . 73.420000000000002 111.406 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.14 114.34 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.682 0.753 . . . . 74.230000000000004 112.383 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -81.75 -59.4 2.61 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.475 -0.784 . . . . 65.099999999999994 110.665 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.1 p -147.32 128.41 14.63 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.556 -0.293 . . . . 74.409999999999997 111.617 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.65 117.26 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.775 0.321 . . . . 63.32 110.389 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' HG13 ' A' ' 6' ' ' VAL . 34.7 mttm -118.02 132.08 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.607 0.595 . . . . 75.109999999999999 112.607 -176.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 . . . . . 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 74.019999999999996 109.685 170.6 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 110.409 -0.219 . . . . 61.439999999999998 110.409 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.4 115.16 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.97 1.78 . . . . 74.150000000000006 112.023 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.3 m -122.25 130.74 53.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.906 0.384 . . . . 73.129999999999995 111.536 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.4 117.91 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.411 0.624 . . . . 73.129999999999995 111.316 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.406 HG23 HG23 ' A' ' 47' ' ' VAL . 61.7 mt -96.14 105.65 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.914 -0.585 . . . . 51.130000000000003 111.285 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.2 m -85.39 121.49 28.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.465 -0.334 . . . . 71.430000000000007 110.755 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 mt -85.56 167.34 15.49 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.665 0.269 . . . . 71.430000000000007 111.036 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -54.87 -39.24 68.46 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.587 0.588 . . . . 45.509999999999998 112.587 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.18 -24.4 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.704 0.287 . . . . 71.439999999999998 111.612 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.74 15.56 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.313 -0.403 . . . . 73.430000000000007 113.285 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -68.09 125.86 27.7 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 122.489 -0.418 . . . . 64.409999999999997 111.306 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.13 129.3 49.95 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.066 0.46 . . . . 72.239999999999995 111.287 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -121.54 113.65 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.485 -0.325 . . . . 73.129999999999995 110.654 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -95.18 129.06 42.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.176 0.512 . . . . 44.039999999999999 112.282 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -116.57 161.74 18.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.08 -0.509 . . . . 74.120000000000005 111.767 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.65 -24.59 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.853 0.358 . . . . 60.549999999999997 111.558 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -122.46 165.45 16.33 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.154 -0.475 . . . . 42.43 111.297 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.3 p -79.56 127.77 77.12 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.357 -0.383 . . . . 71.0 111.112 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -51.37 123.01 11.16 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.311 2.674 . . . . 63.240000000000002 113.734 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -86.62 129.4 34.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.688 -0.687 . . . . 74.409999999999997 110.292 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -82.2 134.05 35.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.567 0.699 . . . . 72.409999999999997 112.232 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -98.62 106.16 18.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.481 -0.781 . . . . 64.319999999999993 110.583 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.3 -20.1 59.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.944 0.402 . . . . 74.409999999999997 111.886 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -69.18 -54.79 13.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.104 0.409 . . . . 73.340000000000003 112.104 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -115.74 -6.59 12.12 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.734 0.642 . . . . 71.200000000000003 112.734 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.86 12.64 57.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.274 -0.965 . . . . 63.329999999999998 114.31 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 47.7 m-85 -90.19 171.86 9.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.397 0.599 . . . . 72.439999999999998 112.296 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 61.5 m-85 -119.54 132.18 55.69 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.027 -0.533 . . . . 73.319999999999993 110.992 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.57 119.95 38.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.775 0.322 . . . . 71.109999999999999 110.785 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -151.29 140.45 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.415 -0.357 . . . . 72.120000000000005 110.943 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 40.8 ttmt -93.14 109.28 20.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.885 0.374 . . . . 71.140000000000001 110.681 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 41.8 mt-30 -62.19 160.1 13.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.466 -0.334 . . . . 72.299999999999997 111.385 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -55.34 -29.07 57.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.473 0.545 . . . . 65.319999999999993 112.473 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.81 -12.04 60.29 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.937 0.398 . . . . 63.409999999999997 111.863 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.92 -20.67 28.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.421 -0.419 . . . . 73.230000000000004 113.567 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.48 108.2 8.13 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.243 0.46 . . . . 64.420000000000002 112.243 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 40.2 tt0 -86.02 120.77 27.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 75.510000000000005 110.494 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 165.53 25.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.343 -0.39 . . . . 70.349999999999994 111.131 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 75.1 mtm180 -111.02 139.48 46.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.978 0.418 . . . . 63.329999999999998 111.37 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.69 146.01 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.357 -0.383 . . . . 45.039999999999999 110.841 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -68.5 145.82 53.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.481 0.658 . . . . 55.439999999999998 112.291 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -63.09 -18.91 63.91 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.292 0.849 . . . . 72.409999999999997 113.292 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -81.36 -13.23 58.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.057 0.392 . . . . 61.43 112.057 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -90.86 -27.98 18.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.049 0.389 . . . . 73.219999999999999 112.049 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 7' ' ' ILE . 6.7 p -76.67 116.1 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.422 0.63 . . . . 75.019999999999996 112.095 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HG2' HG23 ' A' ' 49' ' ' THR . 78.7 ttt180 -81.96 -64.72 1.12 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.087 -0.506 . . . . 65.439999999999998 111.312 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.554 HG23 ' HG2' ' A' ' 48' ' ' ARG . 82.8 p -133.32 133.62 42.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.853 0.358 . . . . 71.340000000000003 111.904 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.22 111.07 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.417 -0.356 . . . . 74.400000000000006 110.27 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 43.4 mtmt -121.99 145.22 48.34 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 64.219999999999999 111.663 -177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.893 0.378 . . . . 64.120000000000005 110.957 177.106 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.3 tpp . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.756 0.312 . . . . 63.25 110.936 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.56 130.45 52.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.046 0.451 . . . . 72.109999999999999 111.589 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m -156.76 137.59 9.27 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.162 -0.472 . . . . 64.239999999999995 110.162 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.566 ' HB2' HD12 ' A' ' 53' ' ' LEU . 64.1 Cg_endo -72.13 115.46 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.152 1.901 . . . . 73.25 112.982 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 69.6 m -125.96 122.35 35.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.46 -0.337 . . . . 70.140000000000001 111.377 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.26 115.02 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.487 0.66 . . . . 63.109999999999999 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.63 117.79 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.224 -0.444 . . . . 73.510000000000005 111.031 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 14' ' ' GLU . 22.8 m -98.47 123.63 42.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.267 -0.424 . . . . 71.200000000000003 110.651 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.432 HD12 ' HD3' ' A' ' 13' ' ' ARG . 72.2 mt -83.7 174.43 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.278 0.561 . . . . 74.140000000000001 112.453 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -53.74 -43.97 69.53 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.572 -0.74 . . . . 74.430000000000007 112.866 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.77 -24.33 56.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.113 0.482 . . . . 74.420000000000002 111.455 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.98 -6.75 10.99 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.39 -0.433 . . . . 65.329999999999998 113.274 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.432 ' HD3' HD12 ' A' ' 9' ' ' LEU . 77.8 ttt180 -59.94 115.88 3.73 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.862 0.331 . . . . 75.319999999999993 111.11 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HG2' HG23 ' A' ' 8' ' ' THR . 44.8 mt-10 -105.1 130.22 53.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.745 0.307 . . . . 60.130000000000003 111.68 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -121.79 132.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.821 0.343 . . . . 75.299999999999997 110.554 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -98.73 125.86 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.132 0.492 . . . . 72.329999999999998 111.691 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.43 150.7 25.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.005 -0.543 . . . . 74.409999999999997 111.641 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.9 m -85.74 -17.18 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 120.991 0.424 . . . . 73.120000000000005 111.981 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.04 175.26 9.88 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 71.420000000000002 111.112 174.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -77.38 142.28 67.1 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 112.304 0.483 . . . . 61.299999999999997 112.304 -170.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 84.7 Cg_endo -76.47 157.47 36.6 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.855 2.37 . . . . 71.200000000000003 114.274 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -116.15 123.26 47.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.827 -0.624 . . . . 74.349999999999994 111.388 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -82.19 114.29 20.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.917 -0.401 . . . . 71.349999999999994 109.917 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.23 105.76 17.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.974 0.416 . . . . 74.5 111.591 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.43 -29.4 69.92 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.106 -0.497 . . . . 63.240000000000002 111.98 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -65.4 -55.11 19.89 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.208 0.447 . . . . 52.240000000000002 112.208 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -96.14 -17.93 20.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.014 0.375 . . . . 74.519999999999996 112.014 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.19 10.88 77.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.223 -0.513 . . . . 54.039999999999999 114.022 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.41 165.03 11.47 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.525 0.678 . . . . 71.129999999999995 112.226 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.65 122.71 44.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.413 -0.812 . . . . 72.25 110.022 167.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.592 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 26.3 mt-10 -98.96 119.66 38.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.273 -0.421 . . . . 73.450000000000003 110.527 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 23.1 p90 -140.03 144.58 36.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.192 0.52 . . . . 65.109999999999999 111.562 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 32.1 ttmt -95.08 110.58 22.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.773 -0.649 . . . . 72.25 111.564 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -60.36 169.07 1.8 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.4 0.519 . . . . 54.039999999999999 112.4 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.52 ' HA ' HG13 ' A' ' 18' ' ' VAL . 98.6 mt -53.15 -30.37 36.65 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.432 0.531 . . . . 70.25 112.432 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.642 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -73.16 -12.25 60.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.007 0.432 . . . . 72.439999999999998 111.602 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.36 60.99 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.239 -0.505 . . . . 74.230000000000004 112.55 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.642 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 30.1 mtmm -96.88 125.33 41.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.71 0.291 . . . . 73.120000000000005 111.319 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -78.44 128.36 33.49 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.841 0.353 . . . . 74.310000000000002 111.324 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.3 t -131.65 163.48 28.02 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.836 0.351 . . . . 64.420000000000002 111.002 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 87.3 mtm180 -136.43 131.55 34.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.508 -0.314 . . . . 64.230000000000004 111.635 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.15 150.92 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.524 0.202 . . . . 63.539999999999999 111.068 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.88 147.57 42.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.656 0.741 . . . . 61.409999999999997 112.881 -172.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -55.9 -24.13 35.6 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.134 1.161 . . . . 75.140000000000001 114.134 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -87.56 -17.12 32.73 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.221 0.452 . . . . 74.109999999999999 112.221 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -78.41 -17.68 56.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.342 0.497 . . . . 64.299999999999997 112.342 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.6 115.83 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.403 0.62 . . . . 73.540000000000006 112.178 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.461 ' NH2' HG21 ' A' ' 8' ' ' THR . 58.7 ttp180 -83.15 -62.29 1.63 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.141 0.496 . . . . 62.520000000000003 111.536 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.9 p -132.9 137.67 46.73 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.062 0.458 . . . . 73.239999999999995 111.963 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.2 106.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.126 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.4 149.46 49.66 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.33 0.586 . . . . 74.230000000000004 112.18 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.545 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 35.6 m-20 -81.78 163.04 22.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 70.230000000000004 111.007 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.566 HD12 ' HB2' ' A' ' 4' ' ' PRO . 78.1 mt -79.65 -3.78 48.76 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.324 0.583 . . . . 62.200000000000003 110.442 171.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.18 20.17 11.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.74 -0.664 . . . . 74.510000000000005 111.862 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 21.2 mm-40 . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.79 -0.624 . . . . 74.450000000000003 112.329 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.597 0.237 . . . . 53.299999999999997 111.304 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.46 -176.86 1.64 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.048 0.452 . . . . 72.219999999999999 111.567 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 t -160.62 143.31 9.66 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.289 -0.414 . . . . 44.329999999999998 110.671 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.03 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.65 1.567 . . . . 72.219999999999999 111.714 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 60.1 m -112.38 147.8 35.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.119 0.485 . . . . 72.450000000000003 111.998 -174.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.16 112.33 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.544 0.687 . . . . 63.009999999999998 110.494 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -90.41 105.68 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 70.400000000000006 111.089 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.6 m -83.72 107.7 16.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 74.230000000000004 110.987 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -78.08 153.58 32.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.653 0.263 . . . . 73.049999999999997 110.861 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -66.12 -14.32 61.6 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.918 0.39 . . . . 63.119999999999997 111.517 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.89 -8.78 57.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.762 0.315 . . . . 74.420000000000002 111.702 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 3.36 68.11 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.41 -0.424 . . . . 50.310000000000002 112.464 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -87.19 132.71 33.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.602 0.361 . . . . 74.540000000000006 111.06 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.79 130.15 55.65 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.997 0.427 . . . . 75.120000000000005 111.701 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.3 mt -109.85 128.51 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.26 -0.427 . . . . 65.420000000000002 110.894 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -97.97 126.71 43.5 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.074 0.464 . . . . 75.549999999999997 111.985 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -125.67 150.09 47.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.077 -0.51 . . . . 63.219999999999999 112.165 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.542 HG13 ' HA ' ' A' ' 35' ' ' LEU . 33.1 m -94.97 5.74 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 111.559 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -144.79 160.67 40.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.339 -0.391 . . . . 70.209999999999994 110.156 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.8 p -79.46 127.32 78.88 Favored Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.044 0.387 . . . . 74.129999999999995 112.044 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.33 113.57 2.31 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.437 2.092 . . . . 61.229999999999997 112.937 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -86.47 126.39 34.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.0 -0.545 . . . . 73.230000000000004 111.241 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -82.16 127.66 33.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 74.540000000000006 110.183 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -114.4 98.35 6.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.756 0.312 . . . . 73.340000000000003 110.836 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.95 -27.29 63.27 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.291 0.478 . . . . 75.109999999999999 112.291 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.38 -47.79 66.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.228 -0.442 . . . . 70.530000000000001 111.885 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.6 p -90.29 -27.6 19.33 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.498 -0.319 . . . . 63.210000000000001 111.654 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.27 69.35 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.529 -0.367 . . . . 73.409999999999997 113.185 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -114.13 166.18 11.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.359 0.599 . . . . 63.5 112.195 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 34.1 m-85 -101.78 129.4 47.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.774 -0.648 . . . . 74.129999999999995 110.9 170.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.7 mt-10 -99.34 119.2 37.55 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.258 -0.428 . . . . 65.230000000000004 110.688 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 34.2 p90 -146.56 153.74 40.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.9 0.381 . . . . 74.230000000000004 111.786 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -110.02 109.76 20.43 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.446 -0.343 . . . . 71.010000000000005 111.245 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.0 mt-30 -62.03 168.76 3.04 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.435 0.531 . . . . 73.409999999999997 112.435 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.542 ' HA ' HG13 ' A' ' 18' ' ' VAL . 82.0 mt -54.89 -32.25 60.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.309 -0.405 . . . . 75.120000000000005 111.868 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.72 -11.77 60.75 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.856 0.36 . . . . 72.400000000000006 111.916 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.64 61.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.169 -0.538 . . . . 73.420000000000002 112.871 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.5 112.0 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.715 -0.285 . . . . 70.209999999999994 111.714 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.5 tt0 -88.67 106.21 18.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.226 0.536 . . . . 74.129999999999995 110.518 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -123.98 167.34 14.29 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.166 -0.47 . . . . 64.230000000000004 111.681 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 82.8 mtm180 -121.8 136.77 54.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.954 0.407 . . . . 75.450000000000003 112.005 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.14 150.85 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.448 -0.342 . . . . 71.439999999999998 110.757 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -65.34 140.89 58.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.318 0.58 . . . . 73.209999999999994 111.724 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.26 -14.87 54.29 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.958 1.095 . . . . 72.519999999999996 113.958 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -83.26 -23.15 32.83 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.827 -0.545 . . . . 72.530000000000001 111.903 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 12.2 mm-40 -77.09 -28.23 54.46 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.368 0.507 . . . . 61.009999999999998 112.368 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.61 118.86 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 74.340000000000003 111.93 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -81.9 -64.74 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.939 -0.573 . . . . 73.540000000000006 111.014 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -128.38 136.06 50.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.388 -0.369 . . . . 52.210000000000001 111.662 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.73 97.42 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.467 -0.333 . . . . 75.019999999999996 111.027 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -134.96 156.53 48.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.482 0.549 . . . . 63.520000000000003 112.482 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 31.9 m-20 -90.49 161.54 15.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.828 -0.624 . . . . 73.129999999999995 111.262 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.99 -27.25 64.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.324 0.583 . . . . 63.240000000000002 109.731 170.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.4 mt -124.98 93.02 3.77 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.657 -0.702 . . . . 63.340000000000003 110.777 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.699 -0.667 . . . . 54.200000000000003 111.247 177.807 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.405 0.145 . . . . 65.209999999999994 111.089 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.61 61.57 1.69 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.224 0.535 . . . . 75.150000000000006 110.267 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 m -89.88 154.04 47.55 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 115.733 -0.667 . . . . 71.310000000000002 110.886 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HB2' HD12 ' A' ' 53' ' ' LEU . 32.4 Cg_endo -63.5 115.17 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.777 1.651 . . . . 63.039999999999999 111.478 174.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 57.7 m -107.67 132.85 52.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.867 0.365 . . . . 63.119999999999997 111.865 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.75 127.63 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.336 0.589 . . . . 64.450000000000003 111.017 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.67 115.48 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.286 -0.415 . . . . 73.120000000000005 111.548 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.2 m -88.2 123.29 32.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.558 -0.292 . . . . 51.509999999999998 110.276 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.64 159.8 15.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.334 0.588 . . . . 74.140000000000001 112.489 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -56.0 -35.34 66.67 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.558 -0.746 . . . . 74.120000000000005 110.635 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.86 -30.94 71.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.505 -0.77 . . . . 73.239999999999995 111.745 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.1 -23.24 8.24 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.149 -0.478 . . . . 65.430000000000007 112.823 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.08 143.12 58.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.849 0.357 . . . . 75.129999999999995 111.94 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.05 129.91 56.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.775 0.321 . . . . 72.140000000000001 111.407 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.646 0.26 . . . . 52.509999999999998 110.871 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -95.26 135.75 36.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.235 0.54 . . . . 74.25 112.206 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -128.44 156.94 42.4 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.859 -0.61 . . . . 75.209999999999994 111.2 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.8 m -83.59 -16.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.046 0.387 . . . . 72.540000000000006 112.046 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -144.32 175.13 10.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.301 0.24 . . . . 71.430000000000007 111.092 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.9 p -78.33 132.29 66.58 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 111.902 0.334 . . . . 55.530000000000001 111.902 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 27.9 Cg_endo -60.32 133.24 48.22 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.202 2.601 . . . . 62.219999999999999 114.211 -174.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -87.23 116.42 25.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 71.310000000000002 110.876 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -81.31 113.62 19.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.902 -0.499 . . . . 72.549999999999997 110.654 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -97.62 95.61 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.157 0.504 . . . . 71.549999999999997 109.852 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.02 -31.62 72.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.965 -0.562 . . . . 73.5 112.199 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.01 -43.08 99.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.215 -0.448 . . . . 64.25 111.704 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.9 p -89.26 -26.98 20.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.735 0.303 . . . . 72.340000000000003 111.422 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.15 11.03 63.56 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.372 -0.442 . . . . 75.450000000000003 113.364 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.74 163.94 14.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.584 0.707 . . . . 74.239999999999995 112.385 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -100.88 122.86 44.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 73.209999999999994 109.854 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.24 119.4 37.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.496 -0.32 . . . . 73.530000000000001 110.273 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 31.3 p90 -134.95 145.28 48.01 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.953 0.406 . . . . 74.519999999999996 111.687 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -97.99 108.28 20.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.139 -0.482 . . . . 74.549999999999997 110.866 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.8 mt-30 -66.99 173.09 3.88 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.315 0.487 . . . . 70.530000000000001 112.315 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.475 ' HA ' HG13 ' A' ' 18' ' ' VAL . 87.0 mt -55.54 -32.73 63.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.452 0.538 . . . . 73.25 112.452 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.721 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.9 m-20 -83.95 9.46 12.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.83 0.348 . . . . 60.140000000000001 111.823 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.18 90.32 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.993 -0.623 . . . . 34.530000000000001 112.956 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.721 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.6 mtmm -71.76 97.72 1.83 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.71 -0.288 . . . . 70.019999999999996 111.688 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 27.7 tt0 -85.22 113.62 21.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.812 0.339 . . . . 75.420000000000002 110.865 176.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -136.58 168.21 19.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.961 0.41 . . . . 54.009999999999998 111.937 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -101.16 156.84 17.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.133 0.492 . . . . 74.400000000000006 111.28 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -145.53 139.59 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.25 -0.432 . . . . 42.109999999999999 110.292 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -62.72 139.52 58.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.038 0.447 . . . . 63.409999999999997 111.358 -174.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -57.64 -21.3 38.92 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.001 1.111 . . . . 73.510000000000005 114.001 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -81.39 -17.73 47.98 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.049 -0.407 . . . . 54.109999999999999 112.093 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -75.94 -26.87 57.3 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.211 0.449 . . . . 72.120000000000005 112.211 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.51 117.17 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.174 0.511 . . . . 65.049999999999997 112.344 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -82.72 -60.08 2.3 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.947 0.403 . . . . 73.299999999999997 110.403 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -145.42 158.63 43.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.056 -0.52 . . . . 62.32 111.293 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.9 t -130.83 110.78 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.515 -0.312 . . . . 74.400000000000006 111.297 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -127.97 157.24 41.15 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.168 0.508 . . . . 63.299999999999997 111.646 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 33.4 m-20 -88.34 151.06 22.87 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.257 -0.429 . . . . 72.510000000000005 110.786 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.2 mt -71.28 -14.54 62.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.126 0.489 . . . . 43.420000000000002 111.052 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.82 86.82 2.63 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.289 -0.414 . . . . 61.299999999999997 111.387 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.691 -0.671 . . . . 61.109999999999999 110.976 174.058 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 111.996 0.369 . . . . 73.409999999999997 111.996 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.1 106.86 0.25 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.926 0.393 . . . . 71.310000000000002 111.713 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 m -86.3 109.64 24.93 Favored Pre-proline 0 N--CA 1.471 0.597 0 CA-C-N 116.342 -0.39 . . . . 61.520000000000003 111.264 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 19.3 Cg_endo -56.82 116.01 2.9 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.532 2.155 . . . . 74.109999999999999 112.485 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.2 m -121.84 134.59 54.89 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.179 -0.464 . . . . 70.209999999999994 111.924 -173.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.25 131.77 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.332 0.587 . . . . 74.400000000000006 111.043 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.455 HG23 HG23 ' A' ' 47' ' ' VAL . 68.7 mt -107.55 110.4 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.202 -0.454 . . . . 73.230000000000004 111.453 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.4 ' HB ' ' OG1' ' A' ' 49' ' ' THR . 42.3 m -85.65 116.8 24.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.739 0.304 . . . . 73.420000000000002 110.585 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.8 mt -82.18 172.29 13.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.025 0.441 . . . . 63.020000000000003 111.529 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -56.79 -42.64 79.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.894 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.34 0.19 12.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.515 0.561 . . . . 74.439999999999998 112.515 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.38 66.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.133 -0.556 . . . . 65.420000000000002 112.997 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -67.99 131.79 46.11 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.842 -0.211 . . . . 74.329999999999998 110.829 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.96 138.91 51.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.893 0.377 . . . . 71.519999999999996 111.87 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.49 140.75 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.492 -0.322 . . . . 74.120000000000005 110.963 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -103.61 117.32 34.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.16 0.43 . . . . 73.0 112.16 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -121.68 152.68 39.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.284 0.476 . . . . 73.200000000000003 112.284 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.4 -19.02 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.106 0.41 . . . . 73.25 112.106 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.09 174.9 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.906 0.384 . . . . 74.450000000000003 111.587 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.7 p -79.45 143.02 58.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 112.603 0.594 . . . . 74.010000000000005 112.603 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 68.5 Cg_endo -73.12 142.9 34.97 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.459 2.106 . . . . 65.5 113.55 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 39.1 ttmt -99.47 131.58 45.38 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.246 -0.434 . . . . 45.219999999999999 110.969 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -94.25 124.35 38.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.97 0.414 . . . . 74.310000000000002 111.708 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -99.41 119.81 38.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.120000000000005 110.168 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.54 -26.3 67.07 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.748 0.647 . . . . 73.230000000000004 112.748 -174.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -82.59 -47.39 12.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.414 0.524 . . . . 70.230000000000004 112.414 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.3 p -89.95 -27.43 19.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.725 0.297 . . . . 23.32 111.639 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 9.15 83.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.171 -0.538 . . . . 33.140000000000001 113.664 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -96.41 151.56 19.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.359 0.599 . . . . 71.200000000000003 112.22 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.9 m-85 -101.39 126.62 48.18 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.625 -0.716 . . . . 54.43 110.863 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.7 mt-10 -99.09 119.01 37.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.511 0.196 . . . . 73.420000000000002 110.688 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.16 146.33 31.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.127 0.489 . . . . 75.319999999999993 112.015 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.3 ttmp? -93.0 115.67 28.34 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.082 -0.508 . . . . 71.209999999999994 111.181 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 45.6 mt-30 -67.97 164.33 20.18 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.153 0.427 . . . . 65.329999999999998 112.153 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.95 -23.0 61.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.619 0.723 . . . . 72.329999999999998 110.562 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.32 -13.75 61.57 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.252 -0.885 . . . . 72.409999999999997 111.798 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.8 -38.83 2.96 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.349 -0.453 . . . . 71.019999999999996 113.284 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -68.95 127.69 34.02 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.35 -0.5 . . . . 74.430000000000007 112.225 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 63.5 tt0 -86.03 116.27 24.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.957 0.408 . . . . 73.420000000000002 110.934 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -115.5 166.49 11.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.911 0.386 . . . . 64.430000000000007 111.651 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 60.5 mtm180 -129.85 137.58 50.52 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.141 -0.481 . . . . 65.129999999999995 111.564 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.7 149.65 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.521 -0.309 . . . . 73.120000000000005 110.656 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -70.54 151.03 45.51 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.529 0.681 . . . . 73.140000000000001 112.583 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -59.6 -29.28 67.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.662 0.986 . . . . 73.450000000000003 113.662 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -76.49 -11.77 59.93 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.126 0.417 . . . . 75.319999999999993 112.126 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.85 -28.04 17.57 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.361 0.504 . . . . 62.030000000000001 112.361 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 7' ' ' ILE . 5.6 p -77.0 114.29 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.51 0.672 . . . . 74.310000000000002 112.12 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -83.1 -56.8 3.58 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.992 -0.549 . . . . 62.039999999999999 111.353 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.4 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 71.0 p -137.24 150.92 48.17 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.958 0.408 . . . . 72.519999999999996 111.665 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.47 111.23 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.358 -0.383 . . . . 61.340000000000003 110.529 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.63 168.7 13.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.002 0.429 . . . . 70.109999999999999 111.885 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -90.53 144.89 25.35 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.923 0.392 . . . . 75.400000000000006 111.17 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 71.8 mt -67.08 -18.69 65.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.043 0.449 . . . . 72.150000000000006 111.386 175.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.0 mt -105.87 36.6 2.5 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.381 -0.372 . . . . 73.409999999999997 111.66 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.694 -0.669 . . . . 73.340000000000003 111.681 177.085 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.825 0.345 . . . . 70.329999999999998 111.091 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.03 86.77 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.146 0.498 . . . . 70.5 111.034 174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m -104.38 150.35 38.35 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 115.989 -0.551 . . . . 33.100000000000001 110.707 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.544 ' HB2' HD12 ' A' ' 53' ' ' LEU . 34.0 Cg_endo -63.72 114.62 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.918 1.745 . . . . 62.399999999999999 112.536 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.8 m -125.08 132.76 53.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.209 -0.45 . . . . 71.299999999999997 111.407 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.0 124.68 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.306 0.574 . . . . 71.450000000000003 111.154 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.3 mt -102.87 118.8 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 111.451 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.473 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 60.7 m -90.27 122.02 32.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.317 -0.402 . . . . 53.140000000000001 110.675 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -88.93 157.03 18.55 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.977 0.418 . . . . 74.5 111.82 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -54.99 -30.77 60.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.964 -0.562 . . . . 74.209999999999994 111.022 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.66 -23.02 67.2 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.639 -0.709 . . . . 65.420000000000002 111.597 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.88 -30.89 8.5 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 112.014 -0.434 . . . . 73.430000000000007 112.014 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.589 ' NH1' HG12 ' A' ' 15' ' ' ILE . 49.5 ttt-85 -64.28 141.76 58.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.639 0.376 . . . . 75.140000000000001 111.554 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 8' ' ' THR . 44.0 mt-10 -116.26 143.54 45.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.861 0.362 . . . . 74.239999999999995 111.383 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.589 HG12 ' NH1' ' A' ' 13' ' ' ARG . 38.8 mt -124.09 132.65 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.282 -0.417 . . . . 73.310000000000002 110.787 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -95.66 133.28 39.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.510000000000005 111.479 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.31 146.26 48.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.453 0.538 . . . . 71.510000000000005 112.453 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.528 HG13 ' HA ' ' A' ' 35' ' ' LEU . 29.7 m -87.36 -13.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.14 0.495 . . . . 75.109999999999999 111.486 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.29 154.45 36.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.007 -0.542 . . . . 71.5 110.301 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.6 p -78.86 132.38 64.43 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.882 0.372 . . . . 61.009999999999998 111.193 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.422 ' HB3' HD11 ' A' ' 7' ' ' ILE . 41.5 Cg_endo -65.23 126.42 16.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.93 2.42 . . . . 72.540000000000006 113.755 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -96.48 127.78 42.79 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.053 -0.521 . . . . 63.229999999999997 110.615 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -83.48 115.04 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.822 -0.351 . . . . 71.129999999999995 110.376 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -97.31 103.28 15.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.064 0.459 . . . . 74.109999999999999 109.974 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.26 -28.55 66.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.571 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.33 -52.77 63.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.912 0.387 . . . . 73.409999999999997 111.071 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -88.36 -25.41 22.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.062 0.393 . . . . 71.25 112.062 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.41 61.76 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.389 -0.434 . . . . 74.019999999999996 113.673 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.98 159.65 17.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.429 0.633 . . . . 75.319999999999993 112.561 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.439 ' CE1' HG11 ' A' ' 47' ' ' VAL . 49.8 m-85 -100.97 122.33 43.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.636 -0.711 . . . . 64.329999999999998 109.852 169.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 47.4 mt-10 -104.69 121.64 43.99 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.821 0.343 . . . . 64.549999999999997 111.063 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -145.17 156.91 44.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 64.439999999999998 111.436 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 31.6 ttmt -106.3 111.46 24.07 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.294 -0.412 . . . . 63.210000000000001 111.197 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -60.73 166.82 3.06 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.231 0.456 . . . . 74.120000000000005 112.231 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.528 ' HA ' HG13 ' A' ' 18' ' ' VAL . 74.8 mt -61.07 -21.35 63.57 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 73.219999999999999 111.128 176.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.49 -11.44 60.22 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.963 -0.562 . . . . 52.420000000000002 111.679 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.34 -5.48 71.06 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.159 -0.544 . . . . 72.450000000000003 112.883 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -82.68 119.66 24.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.938 0.348 . . . . 70.140000000000001 111.938 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 33.8 tt0 -83.69 112.93 20.5 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.895 -0.409 . . . . 63.32 109.895 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -116.43 152.56 33.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.946 0.403 . . . . 75.209999999999994 111.802 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 44.6 mtp180 -116.28 126.32 53.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.12 -0.491 . . . . 74.230000000000004 110.378 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 tt -129.94 145.3 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 122.244 -0.285 . . . . 51.409999999999997 111.08 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -66.88 150.44 49.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.579 0.704 . . . . 73.209999999999994 112.687 -172.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -58.52 -19.71 39.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.936 1.087 . . . . 70.230000000000004 113.936 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -84.46 -22.92 30.15 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.879 -0.513 . . . . 73.140000000000001 112.014 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -82.24 -14.51 55.4 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.167 0.432 . . . . 73.530000000000001 112.167 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.439 HG11 ' CE1' ' A' ' 30' ' ' TYR . 7.3 p -87.49 115.37 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.453 0.644 . . . . 73.040000000000006 111.727 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -83.08 -63.49 1.35 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.136 0.493 . . . . 72.549999999999997 110.93 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.3 p -139.65 149.46 43.77 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.879 -0.601 . . . . 65.5 111.358 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.49 116.02 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.373 -0.376 . . . . 71.120000000000005 110.222 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.21 141.99 50.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.827 0.346 . . . . 74.099999999999994 111.384 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -80.98 159.56 24.85 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.802 0.334 . . . . 64.319999999999993 110.943 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 4' ' ' PRO . 88.0 mt -82.66 -8.58 59.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.269 0.557 . . . . 62.240000000000002 110.619 173.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.5 mt -110.91 94.04 4.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.794 -0.639 . . . . 53.32 110.047 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.759 -0.639 . . . . 72.430000000000007 111.848 -177.02 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.871 0.367 . . . . 74.049999999999997 111.464 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.59 86.83 0.66 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.17 -0.468 . . . . 75.310000000000002 110.543 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 m -85.72 114.4 56.55 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.467 -0.333 . . . . 75.099999999999994 111.359 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HB2' HD12 ' A' ' 53' ' ' LEU . 34.7 Cg_endo -62.67 119.93 7.23 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.651 2.234 . . . . 75.239999999999995 112.409 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.0 m -128.8 147.8 50.82 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.423 -0.353 . . . . 74.430000000000007 111.47 -174.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.4 p -121.64 125.55 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.377 0.608 . . . . 72.549999999999997 111.283 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.6 mt -98.94 116.23 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 63.509999999999998 111.391 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 113.61 22.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.31 -0.404 . . . . 65.439999999999998 110.733 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -78.46 166.07 23.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 72.340000000000003 111.538 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 64.6 t30 -63.31 -33.21 75.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.136 -0.483 . . . . 75.099999999999994 111.287 -175.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.67 7.9 6.17 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.436 -0.347 . . . . 72.329999999999998 111.865 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.04 -12.95 64.53 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.233 -0.508 . . . . 70.349999999999994 113.886 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -70.12 121.1 16.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.266 0.533 . . . . 75.310000000000002 111.426 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -103.02 130.37 50.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.867 0.365 . . . . 74.120000000000005 111.274 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.96 131.23 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.497 -0.32 . . . . 73.329999999999998 110.984 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.46 137.18 34.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.19 0.519 . . . . 72.230000000000004 112.082 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.57 150.74 50.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.81 -0.632 . . . . 70.230000000000004 111.231 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.3 m -74.34 -25.42 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.921 0.391 . . . . 71.349999999999994 111.788 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.3 174.43 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 111.261 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.2 p -83.02 145.75 50.21 Favored Pre-proline 0 N--CA 1.47 0.536 0 CA-C-O 120.852 0.358 . . . . 50.229999999999997 111.792 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HB3' HD11 ' A' ' 7' ' ' ILE . 60.4 Cg_endo -71.29 130.79 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.427 2.085 . . . . 72.349999999999994 113.364 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -98.09 122.58 41.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.3 -0.409 . . . . 71.409999999999997 110.46 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -82.17 130.51 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.012 0.434 . . . . 71.239999999999995 111.391 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.28 109.8 21.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.404 -0.362 . . . . 73.319999999999993 110.57 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -72.92 -29.99 63.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.003 0.43 . . . . 73.109999999999999 111.47 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -70.47 -33.47 71.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.805 0.669 . . . . 71.310000000000002 112.805 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -118.85 -10.49 9.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.798 0.666 . . . . 72.400000000000006 112.798 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.66 82.53 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 114.702 0.641 . . . . 55.219999999999999 114.702 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -102.6 154.15 19.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 117.887 0.843 . . . . 73.200000000000003 112.335 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.2 m-85 -102.12 128.26 48.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.15 -0.477 . . . . 73.549999999999997 110.827 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 46.2 mt-10 -99.53 119.32 37.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.6 0.238 . . . . 63.140000000000001 111.235 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -146.19 145.04 30.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.968 0.413 . . . . 74.519999999999996 111.675 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.4 ttmp? -97.58 111.45 23.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.435 -0.348 . . . . 64.310000000000002 111.268 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -61.01 168.11 2.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.855 0.359 . . . . 64.129999999999995 111.956 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.424 ' HA ' HG13 ' A' ' 18' ' ' VAL . 92.9 mt -52.69 -43.17 65.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.834 0.679 . . . . 75.439999999999998 112.834 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -75.79 -3.14 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.268 0.47 . . . . 71.25 112.268 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.24 -2.81 50.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.072 -0.585 . . . . 33.119999999999997 114.224 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -82.7 104.19 12.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.504 0.652 . . . . 73.310000000000002 111.68 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.1 tt0 -72.98 119.54 17.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.272 -0.422 . . . . 62.240000000000002 111.109 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 t -125.91 165.37 18.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.792 0.33 . . . . 70.030000000000001 111.83 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 47.0 mtm180 -126.71 129.42 48.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.387 -0.37 . . . . 73.200000000000003 111.252 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.5 tt -122.1 150.75 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.663 -0.244 . . . . 70.150000000000006 110.794 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -67.58 153.67 43.18 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.303 0.573 . . . . 75.299999999999997 112.367 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 47' ' ' VAL . 15.1 ptmm? -65.4 -21.68 66.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.797 1.036 . . . . 65.239999999999995 113.797 -172.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -79.4 -25.23 42.15 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.216 0.45 . . . . 74.310000000000002 112.216 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.83 -22.32 53.76 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.82 0.674 . . . . 41.520000000000003 112.82 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 44' ' ' LYS . 8.0 p -72.84 114.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.736 0.779 . . . . 74.129999999999995 111.981 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 10.0 tpt180 -81.83 -63.36 1.4 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.82 -0.627 . . . . 75.409999999999997 110.466 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -146.54 146.61 30.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.013 -0.539 . . . . 74.150000000000006 110.984 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.83 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.722 0.296 . . . . 73.200000000000003 110.88 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB2' HG13 ' A' ' 6' ' ' VAL . 61.1 mttp -119.3 152.36 36.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.292 0.568 . . . . 72.319999999999993 111.919 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -92.49 139.9 30.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.102 -0.499 . . . . 73.329999999999998 111.329 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.46 HD12 ' HB2' ' A' ' 4' ' ' PRO . 78.6 mt -78.12 -22.45 48.85 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.818 0.342 . . . . 72.329999999999998 111.356 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.9 mt -111.42 84.54 1.96 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.905 0.383 . . . . 71.0 111.083 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.699 -0.667 . . . . 52.25 111.37 177.518 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 110.592 -0.151 . . . . 72.420000000000002 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.11 150.68 30.17 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.292 0.479 . . . . 74.049999999999997 112.292 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -123.22 136.77 27.38 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.042 -0.527 . . . . 75.439999999999998 110.252 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HB2' HD12 ' A' ' 53' ' ' LEU . 57.9 Cg_endo -69.39 116.01 4.32 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.906 1.737 . . . . 73.129999999999995 112.09 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 92.2 m -123.4 135.72 54.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.116 0.413 . . . . 62.409999999999997 112.116 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.86 118.53 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.484 0.659 . . . . 63.219999999999999 111.31 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -90.78 107.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.222 -0.445 . . . . 74.219999999999999 111.153 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.455 HG22 ' HD3' ' A' ' 48' ' ' ARG . 49.9 m -83.37 124.0 30.21 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.245 -0.28 . . . . 73.430000000000007 110.245 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.1 mt -96.54 162.09 13.62 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.978 0.418 . . . . 65.120000000000005 112.057 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -54.25 -45.41 72.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.027 -0.533 . . . . 74.450000000000003 111.838 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.12 5.53 5.25 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.798 0.666 . . . . 71.409999999999997 112.798 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.95 47.5 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.082 -0.58 . . . . 71.430000000000007 114.211 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -63.11 136.2 57.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.364 0.582 . . . . 63.039999999999999 111.71 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.47 129.5 55.76 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.731 0.3 . . . . 74.150000000000006 110.491 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -113.3 112.0 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.172 0.511 . . . . 65.310000000000002 111.187 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -92.76 117.9 30.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.324 -0.398 . . . . 71.25 111.307 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -111.93 159.9 17.94 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.159 0.504 . . . . 62.140000000000001 112.189 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.1 m -84.59 -15.03 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.955 -0.566 . . . . 73.340000000000003 111.663 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.11 164.34 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.006 0.431 . . . . 75.430000000000007 111.327 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.406 HG22 ' OG1' ' A' ' 5' ' ' THR . 71.3 p -79.7 118.95 75.09 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.407 -0.361 . . . . 73.129999999999995 110.869 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.63 123.28 12.54 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.346 2.697 . . . . 75.319999999999993 113.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 5.5 ttpm? -87.32 123.1 31.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.357 -0.383 . . . . 71.519999999999996 110.754 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -90.3 131.59 36.02 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.005 0.431 . . . . 74.530000000000001 112.086 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -99.75 116.41 31.76 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.908 0.385 . . . . 71.409999999999997 110.157 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.26 -32.26 73.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.348 0.499 . . . . 73.430000000000007 112.348 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -72.29 -50.0 30.39 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.954 0.353 . . . . 63.340000000000003 111.954 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.1 p -89.61 -27.75 19.98 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.32 0.489 . . . . 75.25 112.32 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.93 10.69 75.0 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.06 -0.591 . . . . 72.430000000000007 113.568 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.15 149.23 23.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.416 0.627 . . . . 73.400000000000006 112.452 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -102.02 128.74 48.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.604 -0.725 . . . . 74.310000000000002 110.771 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 45.7 mt-10 -100.11 124.66 45.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.703 0.287 . . . . 72.099999999999994 111.116 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.405 ' HE1' HG22 ' A' ' 42' ' ' ILE . 34.4 p90 -157.19 151.77 25.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.828 0.347 . . . . 72.540000000000006 111.417 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -106.5 115.28 29.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.599 -0.273 . . . . 54.409999999999997 110.885 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 49.5 mt-30 -60.65 158.86 11.74 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.87 0.322 . . . . 74.400000000000006 111.87 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.433 ' HA ' HG13 ' A' ' 18' ' ' VAL . 89.8 mt -51.98 -30.79 26.48 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.109 0.48 . . . . 72.329999999999998 111.777 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.91 4.33 4.31 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.088 -0.506 . . . . 71.140000000000001 112.238 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 23.63 70.78 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.304 -0.474 . . . . 74.400000000000006 113.069 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -117.07 112.56 21.08 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.7 -0.294 . . . . 65.140000000000001 111.297 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.4 tt0 -87.17 138.99 31.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.815 0.341 . . . . 73.239999999999995 111.58 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -147.24 165.15 30.93 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.497 -0.319 . . . . 73.319999999999993 111.719 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 86.0 mtt180 -115.4 125.89 53.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.888 0.375 . . . . 71.109999999999999 111.03 177.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.405 HG22 ' HE1' ' A' ' 32' ' ' PHE . 15.7 tt -117.04 149.93 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.621 0.248 . . . . 73.349999999999994 111.116 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.11 148.73 32.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.538 0.685 . . . . 62.299999999999997 112.218 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 ptmt -63.17 -15.02 55.5 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.656 0.984 . . . . 71.319999999999993 113.656 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -78.08 -22.55 48.86 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.822 -0.549 . . . . 74.450000000000003 111.591 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -79.4 -28.29 41.84 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.958 0.725 . . . . 64.310000000000002 112.958 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -68.25 113.78 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.727 0.775 . . . . 74.120000000000005 112.481 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HD3' HG22 ' A' ' 8' ' ' THR . 75.1 ttt180 -82.08 -60.32 2.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.525 -0.762 . . . . 74.439999999999998 110.671 175.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -149.36 129.58 13.68 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.066 -0.516 . . . . 74.510000000000005 111.24 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.848 0.356 . . . . 72.400000000000006 111.314 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -125.18 152.83 43.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 74.530000000000001 111.184 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 24.0 m-20 -89.01 149.39 23.28 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.835 0.35 . . . . 64.439999999999998 110.998 176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 4' ' ' PRO . 85.1 mt -63.68 -29.22 70.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.233 0.539 . . . . 53.310000000000002 110.167 172.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.1 mt -122.1 80.02 1.66 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.697 -0.683 . . . . 54.130000000000003 110.058 172.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.599 -0.715 . . . . 70.510000000000005 112.125 -178.584 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.802 0.334 . . . . 71.519999999999996 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.68 146.93 31.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.004 0.431 . . . . 73.200000000000003 111.523 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -153.84 142.67 14.57 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 116.108 -0.496 . . . . 73.329999999999998 110.768 -176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.571 ' HB2' HD12 ' A' ' 53' ' ' LEU . 38.5 Cg_endo -66.6 114.02 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.696 1.597 . . . . 65.040000000000006 111.633 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.0 m -126.93 149.72 49.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.296 -0.411 . . . . 52.420000000000002 111.25 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.18 129.21 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.44 0.638 . . . . 64.439999999999998 111.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.3 110.44 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.027 -0.533 . . . . 74.519999999999996 110.862 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.752 HG21 HH21 ' A' ' 48' ' ' ARG . 26.0 m -89.07 118.31 28.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.749 0.309 . . . . 61.409999999999997 111.286 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.7 170.14 13.58 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.807 0.337 . . . . 61.310000000000002 111.576 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.07 -31.29 71.7 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.871 0.367 . . . . 74.439999999999998 111.697 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.27 -20.9 66.37 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 111.992 0.367 . . . . 70.549999999999997 111.992 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.07 -7.6 62.56 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.523 -0.631 . . . . 35.229999999999997 111.523 -170.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -70.06 125.05 25.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.96 0.504 . . . . 72.230000000000004 110.913 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.8 130.67 55.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.043 0.449 . . . . 72.209999999999994 111.718 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.8 mt -110.96 125.62 68.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.241 -0.436 . . . . 70.510000000000005 110.754 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -96.73 129.57 44.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.957 0.408 . . . . 62.0 111.915 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -119.55 162.04 19.59 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.121 -0.49 . . . . 63.219999999999999 111.488 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -97.11 -3.99 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.064 0.394 . . . . 61.329999999999998 112.064 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.01 174.95 10.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.328 0.585 . . . . 74.109999999999999 112.177 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.1 p -79.01 129.89 71.64 Favored Pre-proline 0 N--CA 1.471 0.618 0 CA-C-N 115.807 -0.633 . . . . 74.140000000000001 112.083 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.2 133.79 25.58 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.618 2.212 . . . . 72.140000000000001 113.238 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 135.71 35.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.476 -0.329 . . . . 70.319999999999993 111.207 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -95.63 115.51 27.53 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.602 0.239 . . . . 72.409999999999997 111.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -109.43 118.93 37.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.85 0.357 . . . . 72.439999999999998 110.75 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.15 -42.16 63.13 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.96 0.355 . . . . 63.509999999999998 111.96 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.85 -38.72 82.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.155 0.428 . . . . 72.329999999999998 112.155 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -94.44 -27.42 16.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.224 -0.298 . . . . 74.140000000000001 111.608 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.49 12.28 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.858 -0.687 . . . . 43.039999999999999 113.839 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.485 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 72.6 m-85 -116.27 163.52 15.88 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.173 0.511 . . . . 71.310000000000002 112.156 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.3 m-85 -101.24 128.68 47.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.91 -0.586 . . . . 74.400000000000006 110.424 171.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 39.6 mt-10 -98.97 119.25 37.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.535 0.207 . . . . 75.400000000000006 111.088 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.54 155.21 42.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.991 0.424 . . . . 63.409999999999997 111.486 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 3.8 ttmp? -108.91 109.77 20.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.414 -0.357 . . . . 63.219999999999999 111.129 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 50.8 mt-30 -61.63 164.84 5.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.224 0.453 . . . . 61.409999999999997 112.224 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.584 ' HA ' HG13 ' A' ' 18' ' ' VAL . 86.7 mt -48.8 -43.26 38.03 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.791 0.664 . . . . 73.340000000000003 112.791 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -73.15 -1.97 19.7 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.327 0.492 . . . . 64.319999999999993 112.327 -176.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.15 -2.24 63.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.446 -0.406 . . . . 41.219999999999999 112.676 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 31.4 mtmm -71.75 97.87 1.85 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.809 0.3 . . . . 71.140000000000001 111.809 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.8 tt0 -80.47 120.77 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.732 -0.213 . . . . 73.409999999999997 110.463 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -145.62 165.59 28.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.925 0.393 . . . . 64.329999999999998 111.709 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 59.5 mtm180 -117.48 148.05 42.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.13 -0.487 . . . . 75.299999999999997 111.265 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.65 152.15 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.369 -0.378 . . . . 65.420000000000002 110.813 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.17 133.89 55.1 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.113 0.482 . . . . 73.230000000000004 111.425 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.09 -16.17 29.54 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.221 1.193 . . . . 73.239999999999995 114.221 -172.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -91.85 -12.13 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.694 -0.629 . . . . 74.519999999999996 112.326 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -77.05 -28.06 54.65 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.911 0.386 . . . . 62.43 111.883 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -77.77 121.82 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.296 0.569 . . . . 70.400000000000006 112.312 -175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.752 HH21 HG21 ' A' ' 8' ' ' THR . 72.0 ttp85 -82.51 -59.82 2.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.008 0.432 . . . . 74.120000000000005 110.955 174.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 48' ' ' ARG . 66.5 p -141.96 136.08 30.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.156 -0.475 . . . . 61.520000000000003 111.606 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.38 108.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.645 -0.252 . . . . 44.439999999999998 110.718 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -123.96 156.34 36.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.028 0.442 . . . . 73.319999999999993 111.297 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 55' ' ' GLU . 35.9 m-20 -91.98 149.64 21.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 64.340000000000003 110.914 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 4' ' ' PRO . 66.6 mt -68.55 -35.1 76.97 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.266 -0.642 . . . . 64.129999999999995 109.266 172.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.6 mt -118.61 84.35 2.17 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.266 -0.879 . . . . 72.340000000000003 109.562 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 47.8 mt-10 . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.616 -0.707 . . . . 55.200000000000003 112.589 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.73 0.3 . . . . 60.310000000000002 111.04 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 19' ' ' ASP . . . -131.37 141.32 49.87 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.88 0.371 . . . . 74.420000000000002 111.536 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 t -127.74 133.04 24.67 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 116.51 -0.314 . . . . 64.120000000000005 111.079 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HB2' HD12 ' A' ' 53' ' ' LEU . 32.6 Cg_endo -63.83 116.12 3.49 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.159 1.906 . . . . 62.340000000000003 111.793 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.4 m -119.82 136.87 54.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.893 0.378 . . . . 63.329999999999998 111.974 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.36 0.6 . . . . 73.25 110.755 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.437 HG23 HG23 ' A' ' 47' ' ' VAL . 66.0 mt -96.59 110.53 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.153 -0.476 . . . . 72.510000000000005 111.085 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.426 ' HB ' ' OG1' ' A' ' 49' ' ' THR . 41.9 m -91.02 116.45 28.8 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.823 0.344 . . . . 73.140000000000001 110.803 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.28 161.82 21.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.894 0.378 . . . . 61.020000000000003 111.917 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.69 -40.39 79.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.434 0.531 . . . . 74.0 112.434 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.41 -12.56 53.49 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.303 0.483 . . . . 74.340000000000003 112.303 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.8 10.5 40.23 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.011 -0.614 . . . . 65.120000000000005 113.643 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -95.41 132.18 40.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.152 0.476 . . . . 71.25 111.565 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -102.95 130.47 50.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.927 0.394 . . . . 74.329999999999998 111.617 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.3 119.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.689 0.28 . . . . 63.140000000000001 110.412 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -92.34 130.88 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.164 0.507 . . . . 64.239999999999995 112.03 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.38 150.65 42.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.052 -0.522 . . . . 73.530000000000001 111.46 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 35' ' ' LEU . 26.9 m -82.52 -13.79 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.191 0.441 . . . . 71.120000000000005 112.191 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -137.21 173.88 11.21 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.949 0.404 . . . . 75.530000000000001 111.657 175.099 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.5 p -79.54 140.89 55.89 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 112.869 0.692 . . . . 74.439999999999998 112.869 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.33 105.01 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.572 2.181 . . . . 61.149999999999999 112.772 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.36 111.77 20.81 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.143 -0.481 . . . . 70.450000000000003 111.051 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.472 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 51.1 t80 -81.68 132.33 35.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.968 0.413 . . . . 73.129999999999995 112.102 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -123.38 119.3 29.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.9 -0.591 . . . . 71.329999999999998 110.825 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.84 -15.73 55.6 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.872 0.323 . . . . 73.409999999999997 111.872 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.46 -45.06 73.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 63.109999999999999 111.126 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.2 p -93.49 -27.53 16.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.867 0.365 . . . . 52.43 111.501 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.38 10.5 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.301 -0.476 . . . . 72.109999999999999 113.111 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 75.1 m-85 -113.44 164.69 13.29 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.507 0.67 . . . . 73.530000000000001 112.76 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 69.7 m-85 -102.34 132.41 48.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.641 -0.709 . . . . 64.239999999999995 110.457 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 43.3 mt-10 -98.57 119.5 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.882 0.372 . . . . 73.519999999999996 110.824 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -147.1 143.79 28.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.009 0.433 . . . . 72.230000000000004 111.278 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.7 ttmp? -97.72 110.38 22.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.454 -0.339 . . . . 70.030000000000001 111.13 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.36 164.12 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.906 0.384 . . . . 72.129999999999995 111.711 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.426 ' HA ' HG13 ' A' ' 18' ' ' VAL . 88.3 mt -53.41 -35.01 59.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.293 -0.412 . . . . 64.409999999999997 111.894 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.9 -12.26 61.18 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.036 0.384 . . . . 74.340000000000003 112.036 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.6 -7.62 50.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.496 -0.383 . . . . 51.219999999999999 112.665 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -75.16 100.42 4.27 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.086 0.469 . . . . 62.439999999999998 111.968 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.1 tt0 -84.04 104.41 14.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.024 0.44 . . . . 65.140000000000001 110.542 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 t -124.45 166.48 15.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.944 0.402 . . . . 63.130000000000003 111.532 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 64.4 mtm180 -115.66 132.14 56.72 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.33 -0.396 . . . . 74.439999999999998 111.685 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.12 151.21 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.494 -0.321 . . . . 53.25 110.693 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -71.52 145.57 49.06 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.152 0.501 . . . . 74.400000000000006 112.042 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -60.43 -16.79 39.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.776 1.028 . . . . 73.010000000000005 113.776 -173.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -83.65 -25.69 30.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.223 0.453 . . . . 64.219999999999999 112.223 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -77.12 -28.38 54.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.314 0.487 . . . . 73.439999999999998 112.314 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG23 HG23 ' A' ' 7' ' ' ILE . 7.3 p -74.2 113.75 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.484 0.659 . . . . 73.299999999999997 112.163 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 48' ' ' ARG . 22.0 ttt180 -83.63 -63.75 1.29 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.355 0.598 . . . . 73.409999999999997 110.856 177.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.426 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 77.6 p -132.99 151.17 52.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.759 -0.655 . . . . 75.519999999999996 111.733 -177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.42 117.85 46.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.255 -0.429 . . . . 72.129999999999995 111.202 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -127.64 134.02 49.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.84 0.352 . . . . 74.150000000000006 111.856 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -84.04 127.2 33.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.003 0.43 . . . . 75.409999999999997 110.929 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 4' ' ' PRO . 87.9 mt -64.15 -21.56 66.6 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.344 0.498 . . . . 72.530000000000001 112.344 -175.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 99.2 mt -67.64 -21.42 65.38 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.5 0.556 . . . . 75.129999999999995 112.5 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.678 -0.677 . . . . 54.509999999999998 111.751 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.886 0.374 . . . . 72.129999999999995 111.081 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.19 123.42 47.81 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.036 0.446 . . . . 74.549999999999997 112.006 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m -143.77 133.55 11.78 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.175 -0.466 . . . . 75.519999999999996 110.103 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.55 ' HB2' HD12 ' A' ' 53' ' ' LEU . 22.9 Cg_endo -60.15 130.41 34.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.271 1.98 . . . . 53.130000000000003 112.926 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -132.25 135.99 46.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.28 -0.418 . . . . 74.540000000000006 111.327 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HB ' HD21 ' A' ' 53' ' ' LEU . 8.2 p -98.94 122.94 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.473 0.654 . . . . 61.020000000000003 111.926 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 21' ' ' PRO . 64.4 mt -98.61 110.55 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.039 -0.528 . . . . 64.310000000000002 110.677 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.0 m -90.32 124.36 34.84 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.702 0.287 . . . . 75.030000000000001 110.716 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.2 157.49 17.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.938 0.347 . . . . 74.530000000000001 111.938 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -56.14 -30.82 62.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.2 0.524 . . . . 63.130000000000003 110.853 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.632 -0.713 . . . . 74.329999999999998 111.54 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.49 -23.38 8.0 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.332 -0.394 . . . . 52.240000000000002 112.23 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -65.31 141.25 58.66 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.925 0.342 . . . . 63.340000000000003 111.925 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.63 130.62 55.7 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.587 -0.279 . . . . 73.400000000000006 111.279 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -110.02 129.32 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.757 0.313 . . . . 73.540000000000006 110.788 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -99.96 113.12 25.47 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.973 0.416 . . . . 72.340000000000003 111.575 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.72 160.55 14.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.489 -0.323 . . . . 60.210000000000001 111.81 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -91.56 -18.68 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.475 0.546 . . . . 73.420000000000002 112.475 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -133.83 176.0 8.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.921 0.391 . . . . 74.019999999999996 111.541 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.7 p -77.35 127.85 81.94 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 116.592 -0.276 . . . . 75.140000000000001 111.66 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HB3' HD11 ' A' ' 7' ' ' ILE . 21.1 Cg_endo -60.33 125.42 17.4 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.793 2.329 . . . . 70.430000000000007 113.959 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -93.72 142.11 27.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.192 -0.913 . . . . 70.129999999999995 110.748 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.92 133.82 52.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.883 -0.511 . . . . 74.0 111.863 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.42 113.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.952 -0.567 . . . . 74.019999999999996 110.195 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -72.19 -34.66 68.59 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.863 0.363 . . . . 73.200000000000003 111.814 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -59.81 -50.58 73.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.912 0.386 . . . . 75.439999999999998 111.923 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.438 ' HG ' ' HD2' ' A' ' 29' ' ' PHE . 14.9 t -89.91 -23.39 21.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.341 -0.391 . . . . 65.109999999999999 111.511 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.43 10.88 79.02 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 52.119999999999997 113.705 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 97.0 m-85 -110.4 163.84 13.28 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.199 0.524 . . . . 62.310000000000002 111.877 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.0 m-85 -101.05 136.66 40.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.016 -0.538 . . . . 63.219999999999999 110.75 173.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.97 118.36 34.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.893 -0.41 . . . . 60.340000000000003 109.893 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -143.65 156.18 44.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.957 0.408 . . . . 73.430000000000007 111.256 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 4.6 ttmp? -118.17 110.89 18.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.191 -0.458 . . . . 75.129999999999995 111.655 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -60.8 160.6 9.23 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.291 -0.413 . . . . 73.200000000000003 111.36 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.79 -27.27 11.75 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.524 0.564 . . . . 73.209999999999994 112.524 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.26 4.69 6.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.017 0.377 . . . . 73.209999999999994 112.017 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.4 20.96 78.36 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.014 -0.612 . . . . 74.329999999999998 112.507 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.73 114.9 28.31 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.64 0.376 . . . . 75.340000000000003 111.532 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -92.35 125.65 37.1 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.893 0.378 . . . . 70.510000000000005 110.769 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -145.1 166.55 25.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.514 -0.312 . . . . 74.120000000000005 110.864 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 44.2 mtm180 -114.55 140.3 48.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.412 0.523 . . . . 64.239999999999995 112.412 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -128.59 145.54 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.242 -0.436 . . . . 73.230000000000004 110.658 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.85 146.89 52.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.662 0.744 . . . . 72.439999999999998 112.518 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 47' ' ' VAL . 19.0 pttm -53.49 -27.62 26.36 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.716 -1.129 . . . . 74.310000000000002 113.999 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -77.84 -21.86 50.81 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.363 0.505 . . . . 74.010000000000005 112.363 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -77.36 -25.03 50.63 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.9 0.704 . . . . 74.409999999999997 112.9 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.2 p -75.11 113.53 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.567 0.699 . . . . 63.340000000000003 112.612 -175.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.15 -60.48 2.14 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.912 -0.585 . . . . 54.530000000000001 110.98 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 p -139.35 153.15 47.64 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.146 -0.479 . . . . 72.439999999999998 111.316 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.5 t -127.87 108.29 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.506 -0.315 . . . . 72.140000000000001 111.207 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -123.15 145.56 48.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.115 0.483 . . . . 64.450000000000003 111.594 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -83.07 137.7 34.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.098 0.475 . . . . 65.439999999999998 111.744 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.1 mt -75.62 -23.57 56.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.325 -0.398 . . . . 64.349999999999994 111.065 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.7 mt -119.25 87.73 2.79 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.041 0.448 . . . . 61.310000000000002 110.919 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.912 -0.566 . . . . 75.049999999999997 111.159 177.793 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 111.87 0.322 . . . . 73.450000000000003 111.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.77 85.67 1.22 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.982 0.42 . . . . 74.150000000000006 111.344 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m -81.38 113.61 43.04 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 111.156 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.586 ' HB2' HD12 ' A' ' 53' ' ' LEU . 18.4 Cg_endo -57.99 131.83 45.92 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.483 2.122 . . . . 64.420000000000002 112.391 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -127.23 133.56 50.21 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.788 0.292 . . . . 72.329999999999998 111.788 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.79 124.88 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.51 0.672 . . . . 62.039999999999999 111.053 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.57 107.99 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.027 -0.533 . . . . 75.019999999999996 111.166 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -84.27 119.56 25.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.371 -0.377 . . . . 74.319999999999993 110.648 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -86.2 155.24 20.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.627 0.251 . . . . 61.329999999999998 111.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.2 -26.24 68.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.386 0.612 . . . . 73.450000000000003 110.655 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -58.25 -29.05 65.46 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.556 -0.747 . . . . 71.530000000000001 111.659 173.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.1 -11.33 26.87 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.513 -0.375 . . . . 71.310000000000002 112.939 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -81.45 130.42 35.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.857 0.361 . . . . 71.540000000000006 111.738 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.52 129.84 53.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.009 0.433 . . . . 75.200000000000003 110.836 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.421 HG21 ' HE2' ' A' ' 32' ' ' PHE . 46.4 mt -112.74 121.92 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.485 -0.325 . . . . 73.099999999999994 111.381 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -93.91 117.76 30.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.246 0.546 . . . . 44.130000000000003 111.976 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -105.67 153.27 22.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.931 -0.577 . . . . 54.039999999999999 111.328 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.402 HG13 ' HA ' ' A' ' 35' ' ' LEU . 32.9 m -78.77 -28.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.152 0.427 . . . . 72.109999999999999 112.152 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.43 175.4 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.976 0.417 . . . . 54.130000000000003 111.764 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.5 p -78.57 131.05 69.18 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.375 -0.375 . . . . 72.430000000000007 111.572 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 58.1 Cg_endo -68.71 153.95 72.25 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.687 2.258 . . . . 51.32 113.936 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -111.51 120.2 41.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.745 -0.661 . . . . 64.109999999999999 111.134 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -82.07 125.86 31.33 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.112 -0.367 . . . . 64.430000000000007 110.307 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.11 114.98 26.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.18 0.514 . . . . 71.340000000000003 110.231 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.5 -28.08 65.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.807 -0.633 . . . . 74.439999999999998 112.102 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -83.24 -44.76 14.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.443 -0.344 . . . . 55.340000000000003 111.919 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 m -82.37 -27.81 31.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.046 0.387 . . . . 54.210000000000001 112.046 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.57 9.43 84.76 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.299 -0.477 . . . . 50.229999999999997 113.777 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.24 162.42 13.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.351 -0.5 . . . . 61.219999999999999 112.015 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 58.6 m-85 -101.77 127.07 48.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 73.129999999999995 110.282 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.5 mt-10 -99.15 119.7 38.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.498 -0.319 . . . . 71.230000000000004 110.418 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 35.9 p90 -142.21 148.37 38.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.192 0.52 . . . . 74.109999999999999 112.086 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -106.09 108.99 20.78 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.965 -0.561 . . . . 60.039999999999999 110.566 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 45.2 mt-30 -66.43 171.14 5.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.323 0.49 . . . . 70.049999999999997 112.323 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.402 ' HA ' HG13 ' A' ' 18' ' ' VAL . 84.7 mt -58.91 -21.9 58.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.304 -0.407 . . . . 64.340000000000003 112.074 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.26 -11.91 57.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.095 0.406 . . . . 62.340000000000003 112.095 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.4 -4.73 51.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.288 -0.482 . . . . 60.43 114.095 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -75.68 117.3 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.191 -0.594 . . . . 64.409999999999997 111.765 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.07 88.56 7.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.369 0.604 . . . . 73.239999999999995 109.871 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 t -106.78 165.07 11.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.084 -0.507 . . . . 72.209999999999994 111.665 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 23.3 mtm180 -125.87 138.44 53.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.964 0.411 . . . . 73.150000000000006 112.021 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -133.17 147.65 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.245 -0.434 . . . . 62.310000000000002 110.702 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.74 148.22 50.67 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.229 0.537 . . . . 74.230000000000004 112.062 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.37 -15.49 63.33 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.736 1.013 . . . . 61.219999999999999 113.736 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -79.54 -11.01 59.9 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.797 -0.564 . . . . 55.130000000000003 111.615 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -90.57 -26.65 19.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.295 0.479 . . . . 65.400000000000006 112.295 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.81 117.63 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.455 0.645 . . . . 72.420000000000002 112.671 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.537 ' HG2' HG23 ' A' ' 49' ' ' THR . 50.9 ttt180 -82.61 -60.89 2.04 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.998 -0.547 . . . . 73.049999999999997 111.524 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.2 p -141.99 143.49 33.21 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.461 -0.336 . . . . 74.219999999999999 111.858 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.23 123.65 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.5 -0.318 . . . . 62.5 111.064 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -138.41 155.52 48.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.144 0.497 . . . . 72.310000000000002 111.822 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.66 149.18 23.64 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.222 0.534 . . . . 73.049999999999997 111.512 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.0 mt -85.64 -3.96 59.03 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.232 -0.44 . . . . 74.120000000000005 111.111 174.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.2 71.28 0.9 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 110.843 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--O 1.256 1.435 0 CA-C-O 118.745 -0.645 . . . . 74.420000000000002 111.389 179.234 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptp . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.796 0.331 . . . . 74.420000000000002 111.225 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.16 105.8 17.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.946 0.403 . . . . 72.349999999999994 111.455 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m -115.5 129.24 25.29 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.423 -0.353 . . . . 72.319999999999993 110.842 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 8.1 Cg_endo -49.15 116.31 2.17 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.79 2.327 . . . . 73.319999999999993 112.951 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.6 m -121.95 132.34 54.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.3 -0.409 . . . . 73.019999999999996 111.462 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HB ' HD21 ' A' ' 53' ' ' LEU . 14.4 p -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.264 0.555 . . . . 75.049999999999997 111.17 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG23 HG23 ' A' ' 47' ' ' VAL . 67.2 mt -111.69 109.3 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.031 -0.531 . . . . 74.200000000000003 111.162 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.5 m -83.77 118.62 24.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.69 0.281 . . . . 64.340000000000003 110.353 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.44 155.62 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.906 0.384 . . . . 74.439999999999998 111.603 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.29 -21.64 65.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.078 0.465 . . . . 75.519999999999996 111.194 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.82 -2.5 47.48 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.146 -0.479 . . . . 74.400000000000006 112.192 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.09 -28.06 17.42 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.624 -0.322 . . . . 65.329999999999998 113.202 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -66.68 136.23 55.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.822 0.344 . . . . 73.400000000000006 111.827 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.74 129.6 56.06 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.29 -0.256 . . . . 61.409999999999997 110.704 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.4 mt -109.68 128.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.82 0.343 . . . . 73.219999999999999 111.118 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -95.89 119.36 34.24 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.31 0.576 . . . . 73.239999999999995 112.122 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . -110.95 168.28 9.61 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.749 -0.659 . . . . 65.040000000000006 111.33 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 33.2 m -102.65 -5.26 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 111.866 0.321 . . . . 64.319999999999993 111.866 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -138.42 174.16 10.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.248 0.546 . . . . 72.140000000000001 112.059 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.2 p -80.96 121.63 81.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.946 -0.57 . . . . 71.540000000000006 111.567 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -61.34 128.53 25.24 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.92 2.413 . . . . 71.439999999999998 113.837 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 28.2 ttmt -91.65 141.97 28.12 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.925 -0.579 . . . . 73.540000000000006 110.82 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -101.67 129.83 47.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.796 -0.565 . . . . 74.25 111.366 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -132.04 116.37 16.99 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.917 0.389 . . . . 74.400000000000006 111.337 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.44 -32.2 68.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.738 0.273 . . . . 74.209999999999994 111.738 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -55.05 -37.92 67.33 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.875 0.369 . . . . 60.210000000000001 111.587 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.1 p -97.32 -27.95 14.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.887 0.375 . . . . 51.149999999999999 110.857 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.38 10.94 69.99 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.349 -0.387 . . . . 71.329999999999998 113.209 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -122.18 171.55 8.92 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.527 0.679 . . . . 64.349999999999994 112.718 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.4 m-85 -102.17 132.78 47.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 64.340000000000003 110.484 169.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -98.27 120.43 38.66 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.68 0.276 . . . . 74.439999999999998 111.028 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -148.9 146.41 27.88 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 75.439999999999998 111.331 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 37.9 ttmt -100.85 114.67 28.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.501 -0.318 . . . . 74.150000000000006 111.606 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -60.15 164.13 4.35 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.139 0.422 . . . . 64.150000000000006 112.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -53.58 -32.13 49.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.952 0.406 . . . . 71.340000000000003 111.751 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -72.88 0.22 11.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.241 0.459 . . . . 64.209999999999994 112.241 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 25.35 61.36 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.896 -0.669 . . . . 61.340000000000003 112.121 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -106.45 106.77 17.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.829 0.347 . . . . 65.329999999999998 111.04 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 57.3 tt0 -81.52 110.84 17.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.323 -0.399 . . . . 73.140000000000001 111.056 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -124.3 166.84 15.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.081 0.467 . . . . 64.140000000000001 111.966 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 62.7 mtt180 -126.06 126.59 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 111.47 -176.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.612 0.244 . . . . 73.530000000000001 111.435 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.29 148.4 51.76 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.281 0.562 . . . . 75.219999999999999 112.356 -174.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HZ2' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -62.05 -32.03 72.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.335 1.235 . . . . 74.409999999999997 114.335 -172.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -84.44 -12.69 53.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.639 -0.663 . . . . 54.340000000000003 112.209 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.77 -28.16 55.57 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.297 0.48 . . . . 61.439999999999998 112.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 7' ' ' ILE . 7.5 p -76.82 113.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.267 0.556 . . . . 73.329999999999998 112.253 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -82.96 -60.14 2.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.031 0.444 . . . . 74.5 111.066 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.0 p -130.64 162.19 29.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.163 0.431 . . . . 64.329999999999998 112.163 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.0 t -137.36 106.95 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 116.022 -0.535 . . . . 63.420000000000002 110.743 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -132.78 154.09 50.59 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.303 0.573 . . . . 71.239999999999995 112.011 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -78.29 160.17 28.03 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.311 0.577 . . . . 50.100000000000001 111.133 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 6' ' ' VAL . 93.1 mt -93.86 -4.21 50.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.185 -0.461 . . . . 71.450000000000003 110.753 173.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -105.23 8.4 33.94 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.15 0.426 . . . . 72.010000000000005 112.15 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 119.356 -0.354 . . . . 71.230000000000004 111.881 178.24 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 mtm . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.706 0.289 . . . . 52.539999999999999 111.266 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 150.16 21.26 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.017 0.437 . . . . 70.209999999999994 111.084 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 t -145.86 133.63 10.45 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 116.331 -0.395 . . . . 73.450000000000003 110.86 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HB2' HD12 ' A' ' 53' ' ' LEU . 47.6 Cg_endo -68.3 114.62 3.5 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.591 1.527 . . . . 43.530000000000001 111.802 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.6 m -123.83 126.67 46.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.258 -0.428 . . . . 71.519999999999996 111.541 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.33 117.85 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.457 0.646 . . . . 60.009999999999998 110.891 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.412 HD11 ' HB3' ' A' ' 21' ' ' PRO . 66.6 mt -100.64 111.73 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.086 -0.507 . . . . 60.409999999999997 111.187 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 99.6 m -83.8 121.26 27.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.508 -0.315 . . . . 73.120000000000005 110.824 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 15' ' ' ILE . 75.3 mt -89.06 172.1 9.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 62.340000000000003 111.893 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -51.88 -41.24 61.75 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.87 -0.605 . . . . 61.299999999999997 112.212 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.2 -15.46 62.47 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.708 0.633 . . . . 75.400000000000006 112.708 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.79 -1.22 68.18 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.808 -0.517 . . . . 70.420000000000002 111.808 -170.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -72.11 136.36 46.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.763 0.425 . . . . 73.439999999999998 110.968 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.59 133.74 48.11 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.886 0.374 . . . . 71.319999999999993 111.592 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 9' ' ' LEU . 63.0 mt -108.55 124.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.739 0.304 . . . . 60.409999999999997 110.555 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.6 111.34 23.28 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 72.340000000000003 111.506 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.61 150.1 33.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.82 0.343 . . . . 64.25 111.826 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.557 HG13 HD23 ' A' ' 35' ' ' LEU . 29.5 m -96.68 2.32 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.949 0.404 . . . . 74.430000000000007 111.281 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 2.7 t0 -140.19 164.69 29.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.199 -0.455 . . . . 52.420000000000002 110.077 -175.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.7 p -80.01 140.14 53.66 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 112.396 0.517 . . . . 63.350000000000001 112.396 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 32' ' ' PHE . 61.7 Cg_endo -72.6 111.15 3.16 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.545 2.163 . . . . 72.400000000000006 113.244 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -86.8 110.29 19.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.754 -0.657 . . . . 71.409999999999997 111.321 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -84.68 122.22 28.78 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.881 0.326 . . . . 72.420000000000002 111.881 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.65 122.16 41.52 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.936 0.398 . . . . 72.430000000000007 110.52 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.03 -42.14 73.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.309 -0.405 . . . . 63.43 111.987 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.41 -40.37 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.389 0.514 . . . . 71.5 112.389 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.579 ' HG ' ' HD2' ' A' ' 29' ' ' PHE . 8.7 t -97.54 -27.3 14.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.895 0.379 . . . . 65.109999999999999 111.825 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 10.76 79.07 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.099 -0.572 . . . . 33.329999999999998 114.252 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' HD2' ' HG ' ' A' ' 27' ' ' SER . 95.9 m-85 -101.97 154.45 18.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.286 0.543 . . . . 71.030000000000001 111.99 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CE1' HG11 ' A' ' 47' ' ' VAL . 52.8 m-85 -101.51 121.75 42.55 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.043 -0.526 . . . . 64.430000000000007 110.042 171.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.1 119.33 38.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.424 -0.353 . . . . 75.409999999999997 110.555 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.486 ' HB3' ' HA ' ' A' ' 21' ' ' PRO . 28.6 p90 -148.0 168.32 22.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.745 0.646 . . . . 72.209999999999994 112.745 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 4.6 ttmp? -112.68 116.61 30.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.732 -0.667 . . . . 70.049999999999997 110.941 -176.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 47.9 mt-30 -76.28 173.52 11.29 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.17 0.433 . . . . 75.140000000000001 112.17 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 18' ' ' VAL . 78.0 mt -57.11 -30.82 64.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.909 0.385 . . . . 65.409999999999997 111.902 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.92 -11.9 60.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.952 0.406 . . . . 74.109999999999999 111.58 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.33 -11.97 69.54 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.399 -0.429 . . . . 55.119999999999997 112.401 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -69.51 124.86 25.02 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.914 0.388 . . . . 74.530000000000001 111.578 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -82.67 140.07 33.35 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.375 -0.375 . . . . 75.349999999999994 110.641 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 t -145.82 156.28 43.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.93 0.395 . . . . 62.539999999999999 112.051 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 42.5 mtm180 -127.14 129.34 47.7 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.22 -0.446 . . . . 53.240000000000002 110.842 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 tt -130.44 141.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.647 0.26 . . . . 72.120000000000005 110.927 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.13 152.09 45.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.755 0.788 . . . . 75.140000000000001 112.685 -172.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -59.51 -14.96 14.82 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.309 1.226 . . . . 74.409999999999997 114.309 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -78.59 -32.07 47.46 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.984 -0.448 . . . . 61.229999999999997 112.018 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -78.72 -28.64 45.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.547 0.573 . . . . 74.150000000000006 112.547 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.482 HG11 ' CE1' ' A' ' 30' ' ' TYR . 7.4 p -73.4 114.03 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.446 0.641 . . . . 71.129999999999995 111.912 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -83.65 -58.08 2.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.363 -0.38 . . . . 74.230000000000004 111.115 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.5 p -142.58 135.26 28.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.061 0.393 . . . . 54.310000000000002 112.061 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.8 t -100.07 116.64 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 116.423 -0.353 . . . . 72.140000000000001 110.95 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -132.31 150.99 52.04 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.948 0.351 . . . . 74.439999999999998 111.948 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -88.67 150.32 23.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.963 0.411 . . . . 70.349999999999994 111.368 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' A' ' 4' ' ' PRO . 93.1 mt -78.16 -18.15 55.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.214 -0.448 . . . . 75.129999999999995 111.42 176.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.416 ' HG ' ' HG2' ' A' ' 4' ' ' PRO . 76.8 mt -96.27 86.99 4.36 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.056 0.455 . . . . 74.409999999999997 111.101 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.648 -0.692 . . . . 70.239999999999995 111.409 178.05 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.71 0.291 . . . . 71.239999999999995 111.249 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.9 135.11 52.56 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.144 0.497 . . . . 75.030000000000001 111.523 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -125.22 149.88 65.34 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 116.161 -0.472 . . . . 72.349999999999994 110.508 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.56 ' HB2' HD12 ' A' ' 53' ' ' LEU . 30.7 Cg_endo -63.61 115.28 2.96 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.742 1.628 . . . . 64.239999999999995 111.479 173.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.9 m -125.09 128.36 48.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.761 0.315 . . . . 74.219999999999999 111.47 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.95 119.24 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.457 0.646 . . . . 73.120000000000005 111.555 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.6 mt -101.21 110.65 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.037 -0.528 . . . . 72.329999999999998 110.675 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.1 m -89.47 129.4 35.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.556 -0.293 . . . . 54.32 110.952 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.95 161.96 15.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.859 0.361 . . . . 74.310000000000002 110.8 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 11.5 t30 -62.7 -24.43 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.871 0.693 . . . . 74.129999999999995 112.871 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.52 -22.37 57.17 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.845 0.355 . . . . 71.209999999999994 111.691 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.65 -6.56 13.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.254 -0.498 . . . . 41.109999999999999 113.04 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -73.6 131.69 41.97 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.603 -0.351 . . . . 65.239999999999995 111.701 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -104.43 129.31 52.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.86 0.362 . . . . 72.219999999999999 111.178 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.93 119.37 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.781 0.324 . . . . 73.439999999999998 110.688 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -94.28 132.88 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.1 0.476 . . . . 75.030000000000001 111.584 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.3 157.34 33.43 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.183 -0.462 . . . . 72.040000000000006 111.978 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.83 2.39 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.124 -0.489 . . . . 54.140000000000001 111.296 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.61 160.47 38.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.977 -0.556 . . . . 71.109999999999999 110.529 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.8 p -79.69 142.16 56.79 Favored Pre-proline 0 N--CA 1.469 0.48 0 CA-C-O 120.694 0.283 . . . . 73.099999999999994 111.331 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HB3' HD11 ' A' ' 7' ' ' ILE . 76.2 Cg_endo -75.71 146.72 30.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.689 2.26 . . . . 75.439999999999998 113.996 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 32.2 ttmt -110.65 132.6 54.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.806 -0.634 . . . . 73.409999999999997 110.375 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -90.08 119.24 30.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.387 -0.525 . . . . 72.319999999999993 110.021 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -97.38 106.03 18.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.268 0.556 . . . . 72.329999999999998 110.641 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.31 -23.03 64.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.89 -0.595 . . . . 75.519999999999996 111.852 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -69.27 -39.24 78.52 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.584 0.587 . . . . 64.200000000000003 112.584 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -118.08 -27.19 6.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.492 0.552 . . . . 71.329999999999998 112.492 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.11 11.45 31.92 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.891 -0.671 . . . . 33.25 114.174 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.511 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 91.6 m-85 -102.05 156.65 17.41 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.776 0.658 . . . . 75.420000000000002 112.776 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 55.6 m-85 -101.43 124.46 47.14 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.808 -0.633 . . . . 72.140000000000001 110.855 173.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 22' ' ' LYS . 44.0 mt-10 -99.74 122.17 42.33 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.781 0.432 . . . . 64.140000000000001 111.955 -177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -154.85 162.3 41.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.045 0.45 . . . . 72.430000000000007 111.339 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -106.14 114.66 28.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.178 -0.464 . . . . 71.25 111.337 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -65.29 169.14 6.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.131 -0.486 . . . . 64.430000000000007 112.303 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.4 mt -55.37 -26.68 42.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.292 -0.413 . . . . 61.299999999999997 112.05 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.5 -4.7 32.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 111.997 0.369 . . . . 63.229999999999997 111.997 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 28.94 57.63 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.068 -0.587 . . . . 44.140000000000001 112.368 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.2 133.67 55.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.627 0.371 . . . . 62.43 111.296 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -89.07 123.64 33.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.837 0.351 . . . . 72.310000000000002 110.822 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -133.29 165.25 25.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.879 0.371 . . . . 73.010000000000005 111.623 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 29' ' ' PHE . 57.1 mtp180 -129.1 125.72 37.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.411 -0.359 . . . . 54.340000000000003 110.229 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.93 143.74 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.685 0.279 . . . . 75.349999999999994 111.573 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -64.5 147.5 52.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.447 0.641 . . . . 74.450000000000003 112.636 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.4 ptmt -64.0 -22.61 67.0 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.923 1.083 . . . . 63.219999999999999 113.923 -173.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -82.66 -10.85 58.75 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.61 -0.682 . . . . 73.230000000000004 111.89 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -82.67 -28.44 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.882 0.327 . . . . 73.450000000000003 111.882 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -75.7 122.17 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.777 0.798 . . . . 73.439999999999998 112.845 -173.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HG2' HG23 ' A' ' 49' ' ' THR . 63.9 ttt180 -82.06 -62.77 1.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.608 -0.724 . . . . 75.200000000000003 110.272 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 48' ' ' ARG . 46.0 p -144.38 149.03 35.46 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.832 -0.622 . . . . 71.209999999999994 111.592 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -116.01 118.94 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.289 -0.414 . . . . 75.129999999999995 110.504 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -131.25 127.8 38.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.759 0.651 . . . . 74.299999999999997 112.759 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.33 131.09 38.98 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.3 -0.63 . . . . 65.420000000000002 109.3 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 4' ' ' PRO . 89.3 mt -66.74 -24.94 66.28 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.953 0.406 . . . . 74.420000000000002 110.861 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.8 mt -93.84 83.56 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.126 -0.488 . . . . 61.32 110.029 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.497 -0.763 . . . . 62.25 112.644 -175.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.389 0.138 . . . . 73.540000000000006 111.001 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.93 121.39 12.26 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.782 0.325 . . . . 74.329999999999998 111.53 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -88.15 120.45 70.61 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.691 -0.231 . . . . 65.329999999999998 110.52 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.501 ' HB2' HD12 ' A' ' 53' ' ' LEU . 36.2 Cg_endo -63.95 119.49 6.56 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.486 2.124 . . . . 71.549999999999997 112.899 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 87.2 m -116.76 128.15 55.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.779 0.323 . . . . 74.120000000000005 111.8 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.409 ' HB ' HD21 ' A' ' 53' ' ' LEU . 14.0 p -98.81 129.39 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.218 0.533 . . . . 63.049999999999997 110.59 173.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.43 118.51 56.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.852 0.358 . . . . 73.109999999999999 111.805 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.7 m -84.01 125.94 32.56 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.788 -0.449 . . . . 65.549999999999997 109.788 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.9 176.19 6.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.944 0.878 . . . . 74.140000000000001 112.915 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -64.74 -42.45 95.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.989 -1.005 . . . . 60.210000000000001 111.166 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.55 -23.74 62.67 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.97 0.414 . . . . 73.510000000000005 111.789 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.99 -18.19 9.07 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.354 -0.451 . . . . 62.43 113.522 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -64.31 136.05 56.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.228 0.514 . . . . 73.030000000000001 111.743 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.92 135.04 52.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.616 0.246 . . . . 72.239999999999995 110.823 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.8 mt -116.83 122.98 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.597 0.237 . . . . 71.310000000000002 111.206 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -85.92 116.7 24.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.075 0.464 . . . . 72.519999999999996 111.596 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.26 142.82 41.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.32 -0.4 . . . . 73.409999999999997 111.44 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 35' ' ' LEU . 26.4 m -82.31 -11.14 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.883 0.373 . . . . 41.299999999999997 111.718 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -128.51 157.7 40.45 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.248 -0.433 . . . . 71.150000000000006 109.912 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -79.28 143.65 60.82 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-O 120.967 0.413 . . . . 74.439999999999998 111.923 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.77 131.51 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.689 2.259 . . . . 72.140000000000001 113.772 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -103.39 132.22 49.82 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.828 -0.624 . . . . 75.530000000000001 110.631 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.75 123.92 34.17 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.014 -0.429 . . . . 44.340000000000003 111.497 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.99 106.46 18.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.012 0.435 . . . . 72.299999999999997 110.19 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.84 -21.66 63.34 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.342 -0.39 . . . . 73.420000000000002 111.935 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -69.17 -46.37 67.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.86 0.362 . . . . 71.010000000000005 111.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 97.2 p -101.09 -27.03 13.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.153 0.427 . . . . 64.120000000000005 112.153 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.11 8.39 64.75 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.219 -0.515 . . . . 44.32 113.265 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.409 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 59.2 m-85 -95.71 155.21 16.84 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.201 0.524 . . . . 63.509999999999998 111.767 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 39.8 m-85 -101.46 131.05 47.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.148 -0.478 . . . . 72.299999999999997 111.114 172.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -98.9 118.94 36.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.078 -0.51 . . . . 75.319999999999993 110.655 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.47 142.4 31.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.302 0.572 . . . . 75.530000000000001 111.91 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -94.11 110.72 22.41 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.764 -0.653 . . . . 51.420000000000002 111.476 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.69 173.59 2.15 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.064 0.459 . . . . 61.310000000000002 112.217 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.605 ' HA ' HG13 ' A' ' 18' ' ' VAL . 89.2 mt -49.15 -45.75 44.28 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.23 0.826 . . . . 74.109999999999999 113.23 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.3 m-20 -80.2 15.07 1.65 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.56 0.578 . . . . 45.329999999999998 112.56 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.96 86.0 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.907 -0.663 . . . . 74.25 112.454 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.7 mtpp -80.96 105.07 11.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.605 0.362 . . . . 64.040000000000006 111.79 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -73.86 123.83 24.97 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.765 0.317 . . . . 72.430000000000007 110.905 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -135.1 160.19 39.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.504 -0.316 . . . . 63.009999999999998 110.77 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 76.2 mtm180 -134.07 142.01 47.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.964 0.357 . . . . 74.219999999999999 111.964 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.28 152.91 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.253 -0.43 . . . . 64.400000000000006 110.293 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.12 153.79 36.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.76 0.652 . . . . 65.209999999999994 112.76 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.36 -14.91 62.8 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.47 0.915 . . . . 73.239999999999995 113.47 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -85.28 -11.08 55.6 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.898 -0.501 . . . . 74.409999999999997 111.595 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -90.36 -27.59 19.26 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.207 0.447 . . . . 73.450000000000003 112.207 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.3 p -70.09 111.49 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.556 0.693 . . . . 63.229999999999997 111.508 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HG2' HG23 ' A' ' 49' ' ' THR . 21.7 ttm-85 -83.03 -62.77 1.51 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.883 -0.599 . . . . 74.140000000000001 111.254 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.513 HG23 ' HG2' ' A' ' 48' ' ' ARG . 61.7 p -141.04 135.64 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.178 0.514 . . . . 74.5 111.95 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.54 124.57 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.022 -0.535 . . . . 73.310000000000002 111.225 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -142.64 144.22 32.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.338 0.255 . . . . 71.099999999999994 111.577 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.578 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 35.6 m-20 -86.28 142.9 28.2 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.029 0.442 . . . . 60.439999999999998 111.547 175.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.4 mt -67.62 -19.83 65.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.082 0.468 . . . . 74.329999999999998 111.568 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.63 -2.79 47.98 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.347 -0.388 . . . . 52.0 111.815 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.578 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 13.3 mm-40 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.818 -0.61 . . . . 75.540000000000006 111.643 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.733 0.302 . . . . 64.150000000000006 111.207 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.64 160.29 25.1 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.017 0.437 . . . . 75.109999999999999 111.4 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 40.5 t -161.79 118.27 1.33 Allowed Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.424 -0.353 . . . . 65.420000000000002 111.013 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 3' ' ' SER . 10.8 Cg_endo -53.29 116.31 2.87 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.303 2.002 . . . . 64.150000000000006 111.768 177.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.8 m -132.77 141.46 48.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.342 -0.39 . . . . 71.450000000000003 111.123 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HB ' HD21 ' A' ' 53' ' ' LEU . 7.2 p -105.9 117.89 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.557 0.694 . . . . 70.530000000000001 111.468 178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.16 104.5 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.253 0.549 . . . . 72.099999999999994 110.513 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.0 m -85.67 119.18 25.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.964 -0.562 . . . . 52.420000000000002 110.755 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.19 157.13 24.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.779 0.323 . . . . 74.299999999999997 111.217 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.545 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 26.4 t-20 -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.993 0.368 . . . . 64.400000000000006 111.993 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.37 -8.45 55.9 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.405 0.52 . . . . 63.119999999999997 112.405 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.45 -33.2 4.58 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.803 -0.713 . . . . 72.239999999999995 114.666 175.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.2 135.1 44.49 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.673 0.736 . . . . 72.010000000000005 112.427 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.35 129.98 53.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.28 -0.418 . . . . 75.239999999999995 110.485 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.25 130.48 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.824 0.345 . . . . 71.310000000000002 111.234 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -96.56 119.2 34.61 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.06 0.457 . . . . 71.140000000000001 111.999 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.7 153.15 38.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.348 -0.387 . . . . 54.119999999999997 111.5 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.31 -10.58 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.832 0.349 . . . . 62.049999999999997 111.769 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.7 166.55 24.55 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.419 . . . . 64.319999999999993 111.579 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.7 p -80.84 138.29 50.2 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 112.178 0.436 . . . . 61.240000000000002 112.178 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 69.0 Cg_endo -71.67 126.31 11.95 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.658 2.239 . . . . 65.209999999999994 113.941 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 2.2 ttmp? -86.45 141.21 29.29 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.412 -0.358 . . . . 75.140000000000001 110.311 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -99.11 129.89 45.4 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.12 0.486 . . . . 74.120000000000005 112.095 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -109.28 111.87 23.7 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.974 -0.557 . . . . 70.109999999999999 110.109 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.73 -35.33 79.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.554 0.575 . . . . 62.200000000000003 112.554 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.11 -52.72 53.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.954 0.407 . . . . 51.219999999999999 111.829 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.5 m -85.56 -26.96 25.85 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.306 -0.406 . . . . 34.539999999999999 111.754 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.79 8.91 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.404 -0.427 . . . . 63.329999999999998 113.912 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 83.6 m-85 -102.81 156.21 17.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.222 0.534 . . . . 73.420000000000002 112.116 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 67.7 m-85 -101.93 135.59 43.21 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.627 -0.715 . . . . 63.229999999999997 110.603 172.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 36.0 mt-10 -98.89 118.78 36.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.441 0.163 . . . . 71.239999999999995 110.786 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -147.74 152.22 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.156 0.503 . . . . 73.019999999999996 111.641 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 4.1 ttmp? -106.9 112.71 25.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 111.128 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -64.82 164.85 11.57 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.769 0.319 . . . . 75.540000000000006 111.799 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.9 mt -53.51 -29.72 37.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.386 0.884 . . . . 61.210000000000001 113.386 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -77.28 -11.54 59.84 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.91 0.386 . . . . 70.439999999999998 111.679 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.51 -6.28 49.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.527 -0.368 . . . . 53.310000000000002 112.242 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -70.4 101.57 1.98 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.928 0.491 . . . . 75.349999999999994 111.74 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.2 tt0 -82.07 107.28 14.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.756 0.312 . . . . 74.230000000000004 110.366 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.3 t -123.68 165.2 17.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.056 0.455 . . . . 74.420000000000002 111.836 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 49.4 mtm180 -124.59 132.49 53.44 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.962 -0.563 . . . . 75.230000000000004 111.715 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 tt -130.93 146.62 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.685 0.278 . . . . 71.129999999999995 111.211 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -71.75 152.28 42.87 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.571 0.582 . . . . 73.239999999999995 112.571 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 pttp -57.97 -31.52 66.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.516 0.932 . . . . 53.539999999999999 113.516 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -69.01 -11.64 60.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.415 0.524 . . . . 54.240000000000002 112.415 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -88.14 -27.79 21.66 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.585 0.587 . . . . 74.530000000000001 112.585 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 44' ' ' LYS . 10.7 p -76.91 118.64 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.806 0.812 . . . . 64.030000000000001 112.809 -173.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 57.4 ttt180 -81.9 -58.44 2.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.211 -0.904 . . . . 74.430000000000007 111.077 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.4 p -148.08 134.53 19.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.863 -0.608 . . . . 73.549999999999997 111.189 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 111.2 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 62.310000000000002 110.983 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -133.5 141.95 48.0 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.035 0.445 . . . . 71.040000000000006 111.761 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 24.2 m-20 -72.13 156.98 38.59 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.254 -0.43 . . . . 72.310000000000002 110.464 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 6' ' ' VAL . 95.1 mt -85.74 -6.4 59.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.253 0.549 . . . . 61.219999999999999 110.73 173.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.5 mt -106.5 42.06 1.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.937 -0.574 . . . . 65.25 111.415 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 49.4 mt-10 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.457 -0.782 . . . . 64.409999999999997 111.5 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.431 0.158 . . . . 75.120000000000005 110.799 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.93 102.07 1.21 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.97 0.414 . . . . 45.299999999999997 111.392 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 p -105.95 119.69 51.46 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.178 -0.465 . . . . 62.329999999999998 110.826 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HB2' HD12 ' A' ' 53' ' ' LEU . 9.6 Cg_endo -50.07 120.83 6.61 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.892 2.395 . . . . 61.130000000000003 112.339 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -125.71 133.04 52.26 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.437 -0.347 . . . . 71.519999999999996 111.826 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' HD21 ' A' ' 53' ' ' LEU . 14.2 p -99.97 124.5 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.173 0.511 . . . . 75.530000000000001 110.758 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.4 120.06 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.073 0.463 . . . . 71.340000000000003 110.988 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.0 m -100.01 118.49 36.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.033 -0.531 . . . . 71.150000000000006 110.826 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.467 HD12 ' HD3' ' A' ' 13' ' ' ARG . 78.3 mt -83.89 168.35 16.16 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.863 0.363 . . . . 73.340000000000003 111.521 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.58 -28.73 70.13 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.493 -0.321 . . . . 63.049999999999997 111.455 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.21 -16.21 59.44 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.036 0.446 . . . . 74.219999999999999 111.61 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.35 67.81 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.677 -0.569 . . . . 54.119999999999997 111.677 -170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HD3' HD12 ' A' ' 9' ' ' LEU . 78.0 ttt180 -77.33 136.37 38.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.308 0.643 . . . . 74.219999999999999 111.217 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.33 130.24 56.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.989 0.423 . . . . 71.340000000000003 111.767 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.0 mt -122.42 130.49 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.093 -0.503 . . . . 52.219999999999999 110.618 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -94.85 127.99 41.27 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.101 0.477 . . . . 74.109999999999999 112.037 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.82 164.3 17.72 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.083 -0.508 . . . . 72.239999999999995 111.453 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.73 -18.36 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.211 0.448 . . . . 72.239999999999995 112.211 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -126.94 172.48 10.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.275 0.56 . . . . 65.420000000000002 111.868 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -79.81 119.39 76.57 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.812 -0.631 . . . . 64.019999999999996 110.499 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.82 134.34 41.27 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.072 2.515 . . . . 63.020000000000003 113.951 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -85.63 124.64 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.606 -0.724 . . . . 73.439999999999998 110.746 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.81 108.62 20.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 75.319999999999993 110.983 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.25 110.54 23.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.971 0.415 . . . . 74.439999999999998 110.592 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.75 -39.29 93.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 71.510000000000005 111.993 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.19 -43.03 99.36 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.157 0.429 . . . . 72.400000000000006 112.157 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 m -91.75 -28.08 17.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.934 0.346 . . . . 54.399999999999999 111.934 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 11.94 72.85 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.922 -0.656 . . . . 72.230000000000004 113.824 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.96 155.12 21.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.387 0.613 . . . . 63.119999999999997 112.462 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.69 129.9 47.95 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.58 -0.736 . . . . 72.109999999999999 110.326 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.2 mt-10 -108.28 121.91 45.86 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.592 -0.276 . . . . 72.5 111.194 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.77 143.79 29.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.82 0.343 . . . . 72.219999999999999 111.627 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.6 ttmt -98.4 114.55 26.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.767 0.318 . . . . 71.549999999999997 111.241 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -60.6 165.11 4.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.412 -0.358 . . . . 74.230000000000004 111.779 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.64 -26.68 61.97 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.87 0.366 . . . . 73.519999999999996 111.623 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.88 -6.21 43.57 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.48 0.548 . . . . 70.109999999999999 112.48 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.09 23.9 46.81 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.075 -0.584 . . . . 73.409999999999997 112.747 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -112.63 112.3 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.794 0.331 . . . . 45.43 111.457 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.9 tt0 -89.69 109.81 20.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.806 0.336 . . . . 73.150000000000006 111.319 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -111.87 163.42 14.23 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.935 0.398 . . . . 61.109999999999999 111.529 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 55.4 mtt180 -123.51 131.64 53.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.928 0.394 . . . . 74.329999999999998 111.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.84 152.37 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.441 -0.345 . . . . 62.549999999999997 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -66.87 147.29 53.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.184 0.516 . . . . 73.530000000000001 111.667 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.4 ptmt -65.07 -20.2 66.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.983 0.734 . . . . 73.510000000000005 112.983 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -76.55 -10.25 59.25 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.314 0.487 . . . . 74.019999999999996 112.314 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -90.96 -17.73 25.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.875 0.694 . . . . 73.430000000000007 112.875 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 44' ' ' LYS . 8.9 p -75.0 117.79 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.481 0.658 . . . . 60.039999999999999 112.618 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -83.51 -61.72 1.77 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.303 0.573 . . . . 51.240000000000002 110.656 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.9 p -147.06 150.46 35.1 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.669 -0.696 . . . . 63.219999999999999 111.369 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.4 t -126.58 118.25 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.236 -0.438 . . . . 65.109999999999999 110.812 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.19 136.62 49.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.358 0.503 . . . . 71.219999999999999 112.358 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -68.03 128.18 35.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.332 -0.395 . . . . 74.25 110.523 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 4' ' ' PRO . 84.8 mt -59.16 -17.52 27.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.906 0.384 . . . . 75.340000000000003 111.779 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.77 85.09 7.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.16 0.505 . . . . 54.43 110.336 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 118.571 -0.728 . . . . 71.120000000000005 111.975 -178.279 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.182 0.515 . . . . 73.439999999999998 110.999 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.81 146.06 17.54 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.804 -0.635 . . . . 71.409999999999997 110.981 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -156.51 142.08 12.66 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 116.536 -0.302 . . . . 71.420000000000002 110.689 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.591 ' HB2' HD12 ' A' ' 53' ' ' LEU . 35.7 Cg_endo -63.42 116.76 3.82 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.565 2.176 . . . . 71.430000000000007 113.107 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -131.89 134.23 45.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.438 -0.346 . . . . 74.140000000000001 111.295 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.77 125.72 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.494 0.664 . . . . 63.25 111.685 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.3 mt -98.51 116.98 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.291 -0.413 . . . . 73.409999999999997 111.615 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.6 m -88.79 124.38 34.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.392 -0.367 . . . . 53.409999999999997 110.721 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.18 164.75 13.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.119 0.485 . . . . 71.040000000000006 112.282 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -54.61 -33.94 61.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.358 0.663 . . . . 73.439999999999998 111.384 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.14 -12.47 60.9 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.848 -0.615 . . . . 65.239999999999995 111.907 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.73 -24.72 30.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.436 -0.411 . . . . 61.149999999999999 112.677 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.16 135.7 57.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.846 0.355 . . . . 73.299999999999997 111.804 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.61 148.65 31.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.503 -0.317 . . . . 73.5 111.558 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.58 127.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.625 -0.261 . . . . 61.229999999999997 110.847 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -93.08 124.0 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.091 0.472 . . . . 71.299999999999997 111.995 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.06 156.8 26.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.122 -0.49 . . . . 53.130000000000003 111.55 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -88.94 -9.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.017 0.377 . . . . 63.329999999999998 112.017 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.61 166.44 24.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.102 0.477 . . . . 71.25 111.443 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.5 p -79.61 140.85 55.58 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 111.61 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 61.6 Cg_endo -71.47 148.73 54.85 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.594 2.196 . . . . 75.219999999999999 113.943 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -105.62 135.1 47.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.764 -0.653 . . . . 74.510000000000005 110.324 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -87.03 122.26 30.62 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.05 0.452 . . . . 75.120000000000005 111.739 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -98.1 108.67 21.43 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.144 -0.48 . . . . 70.010000000000005 110.951 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.63 -14.24 55.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.788 0.327 . . . . 71.430000000000007 111.61 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -63.0 -52.88 61.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 74.420000000000002 111.376 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -118.72 -26.8 6.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.033 0.383 . . . . 75.099999999999994 112.033 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.69 11.88 10.98 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.406 -0.902 . . . . 71.099999999999994 114.614 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.1 162.29 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.745 0.772 . . . . 70.230000000000004 112.708 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 43.6 m-85 -110.27 132.71 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.743 -0.662 . . . . 72.430000000000007 110.798 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 55.8 mt-10 -99.28 119.57 38.13 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.364 -0.21 . . . . 61.32 111.089 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -151.32 145.04 25.04 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.009 0.433 . . . . 72.329999999999998 111.434 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 3.5 ttmp? -98.26 112.44 24.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.538 -0.301 . . . . 65.319999999999993 111.494 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.68 162.15 8.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.943 0.401 . . . . 74.430000000000007 111.853 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 18' ' ' VAL . 84.1 mt -48.84 -39.91 27.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.722 0.638 . . . . 74.409999999999997 112.722 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.89 9.33 1.18 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.753 0.649 . . . . 64.349999999999994 112.753 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 46.66 25.11 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.918 -0.658 . . . . 72.439999999999998 112.322 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -125.01 104.71 8.71 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.656 -0.32 . . . . 71.420000000000002 111.289 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.9 tt0 -75.61 100.59 4.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.134 0.492 . . . . 73.140000000000001 110.371 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.3 t -114.21 165.72 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.07 0.462 . . . . 72.439999999999998 111.511 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.3 mtm180 -129.8 144.69 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.34 -0.391 . . . . 61.299999999999997 111.647 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 tt -139.51 149.71 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.301 -0.409 . . . . 73.430000000000007 110.901 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.51 153.93 30.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.797 0.665 . . . . 71.310000000000002 112.797 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 30' ' ' TYR . 25.4 pttm -58.88 -25.72 63.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.868 1.062 . . . . 74.209999999999994 113.868 -175.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -79.56 -11.22 59.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.236 0.458 . . . . 62.109999999999999 112.236 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -94.23 -18.32 21.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.426 0.528 . . . . 74.040000000000006 112.426 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.51 119.95 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.766 0.654 . . . . 71.439999999999998 112.766 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -82.68 -66.92 0.83 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.349 -0.387 . . . . 71.310000000000002 110.505 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -146.83 137.77 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.94 -0.573 . . . . 54.240000000000002 111.417 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.94 108.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.735 0.302 . . . . 54.210000000000001 110.74 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.87 142.66 39.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.084 0.469 . . . . 71.329999999999998 111.679 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -94.53 155.39 16.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.065 0.459 . . . . 71.340000000000003 111.22 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 4' ' ' PRO . 82.3 mt -95.99 -3.36 45.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.374 -0.375 . . . . 73.120000000000005 111.699 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.1 mt -112.86 85.11 2.1 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.846 0.355 . . . . 74.329999999999998 111.949 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 118.421 -0.799 . . . . 52.25 112.358 177.583 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.716 0.293 . . . . 73.219999999999999 111.205 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.07 95.35 2.06 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.092 0.473 . . . . 54.310000000000002 111.433 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 p -127.0 131.39 23.84 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-N 116.241 -0.436 . . . . 71.530000000000001 110.933 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.6 ' HB2' HD12 ' A' ' 53' ' ' LEU . 14.1 Cg_endo -55.17 118.95 5.74 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.98 2.454 . . . . 71.200000000000003 112.9 -177.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 m -126.24 126.95 44.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.192 -0.458 . . . . 74.109999999999999 111.378 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.511 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.5 p -105.13 125.94 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.141 0.496 . . . . 73.420000000000002 111.848 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.78 113.18 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.788 0.327 . . . . 74.299999999999997 111.324 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.9 m -83.44 134.58 34.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.18 -0.304 . . . . 53.439999999999998 110.18 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -100.76 170.18 8.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.053 0.454 . . . . 71.109999999999999 112.069 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -52.12 -45.11 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.864 -0.607 . . . . 75.129999999999995 112.606 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.67 -21.86 64.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.035 0.445 . . . . 73.450000000000003 111.577 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.59 -23.85 7.8 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.026 -0.607 . . . . 71.030000000000001 113.598 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -56.6 129.86 42.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.176 0.488 . . . . 64.019999999999996 111.899 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -103.31 130.48 50.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.883 0.373 . . . . 74.329999999999998 110.909 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.87 120.52 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.543 -0.299 . . . . 71.329999999999998 110.532 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -95.51 127.26 41.4 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.141 0.496 . . . . 73.310000000000002 112.045 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.9 154.83 26.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.093 -0.503 . . . . 72.109999999999999 111.744 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.0 m -75.14 -29.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.001 0.371 . . . . 64.409999999999997 112.001 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -129.04 174.61 9.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.897 0.379 . . . . 75.230000000000004 111.348 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -78.78 141.27 59.44 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 63.520000000000003 111.648 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.51 138.66 35.93 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.616 2.211 . . . . 65.239999999999995 113.79 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -93.41 130.22 39.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.97 -0.559 . . . . 75.099999999999994 110.455 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -90.82 114.8 27.29 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.153 -0.342 . . . . 75.030000000000001 111.269 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -97.89 104.52 16.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.889 0.376 . . . . 54.439999999999998 110.672 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.89 -30.51 70.68 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.945 0.35 . . . . 74.420000000000002 111.945 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.21 -52.42 65.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.034 0.445 . . . . 54.109999999999999 111.959 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -102.41 -11.63 18.47 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.105 0.409 . . . . 72.540000000000006 112.105 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.35 80.25 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.06 -0.59 . . . . 51.210000000000001 114.005 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.516 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 67.8 m-85 -97.95 156.38 16.65 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.282 0.563 . . . . 73.409999999999997 112.477 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 68.1 m-85 -101.21 127.22 47.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.799 -0.637 . . . . 74.519999999999996 110.01 169.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.3 mt-10 -99.6 119.37 37.96 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.768 0.318 . . . . 61.009999999999998 111.088 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -144.74 144.61 31.28 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 75.329999999999998 111.942 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 2.4 ttmp? -99.33 109.81 22.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.256 -0.429 . . . . 73.030000000000001 110.698 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.8 mt-30 -60.49 160.66 8.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.002 0.371 . . . . 52.140000000000001 112.002 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HA ' HG13 ' A' ' 18' ' ' VAL . 83.3 mt -56.29 -27.5 55.63 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.364 0.505 . . . . 74.0 112.364 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.46 -11.54 59.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.011 0.434 . . . . 65.230000000000004 111.778 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.98 -21.35 31.86 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.379 -0.439 . . . . 64.530000000000001 112.711 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -63.07 104.01 0.53 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 111.762 0.282 . . . . 75.109999999999999 111.762 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.9 tt0 -88.4 118.3 27.93 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.757 0.313 . . . . 71.319999999999993 110.606 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 t -136.07 164.59 27.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.397 0.517 . . . . 73.510000000000005 112.397 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 17.9 mtm180 -110.65 155.88 21.77 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.845 -0.616 . . . . 73.219999999999999 110.775 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -147.98 144.77 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.601 0.239 . . . . 73.439999999999998 110.935 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -70.32 150.18 46.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.258 0.551 . . . . 52.549999999999997 112.137 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -63.14 -14.86 53.68 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.759 1.022 . . . . 72.219999999999999 113.759 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -89.2 -14.95 34.85 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.767 -0.583 . . . . 71.200000000000003 111.979 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -81.67 -28.61 33.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.916 0.388 . . . . 73.420000000000002 111.406 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.14 114.34 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.682 0.753 . . . . 74.230000000000004 112.383 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -81.75 -59.4 2.61 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.475 -0.784 . . . . 65.099999999999994 110.665 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.1 p -147.32 128.41 14.63 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.556 -0.293 . . . . 74.409999999999997 111.617 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.65 117.26 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.775 0.321 . . . . 63.32 110.389 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' HG13 ' A' ' 6' ' ' VAL . 34.7 mttm -118.02 132.08 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.607 0.595 . . . . 75.109999999999999 112.607 -176.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 34.4 m-20 -83.14 133.24 35.05 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 74.019999999999996 109.685 170.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.6 HD12 ' HB2' ' A' ' 4' ' ' PRO . 60.3 mt -79.62 -3.29 46.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.703 -0.623 . . . . 63.329999999999998 111.268 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.6 mt -120.76 25.75 9.52 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.447 -0.342 . . . . 43.219999999999999 111.668 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 2.9 pp20? . . . . . 0 C--O 1.249 1.063 0 N-CA-C 112.43 0.53 . . . . 74.019999999999996 112.43 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.754 0.311 . . . . 62.140000000000001 110.966 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.99 126.45 39.57 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.843 0.354 . . . . 51.43 111.404 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -121.7 143.21 37.66 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.442 -0.345 . . . . 61.439999999999998 110.409 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HB2' HD12 ' A' ' 53' ' ' LEU . 29.1 Cg_endo -62.4 115.16 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.97 1.78 . . . . 74.150000000000006 112.023 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.3 m -122.25 130.74 53.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.906 0.384 . . . . 73.129999999999995 111.536 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.4 117.91 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.411 0.624 . . . . 73.129999999999995 111.316 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.406 HG23 HG23 ' A' ' 47' ' ' VAL . 61.7 mt -96.14 105.65 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.914 -0.585 . . . . 51.130000000000003 111.285 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.2 m -85.39 121.49 28.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.465 -0.334 . . . . 71.430000000000007 110.755 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 mt -85.56 167.34 15.49 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.665 0.269 . . . . 71.430000000000007 111.036 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -54.87 -39.24 68.46 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.587 0.588 . . . . 45.509999999999998 112.587 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.18 -24.4 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.704 0.287 . . . . 71.439999999999998 111.612 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.74 15.56 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.313 -0.403 . . . . 73.430000000000007 113.285 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -68.09 125.86 27.7 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 122.489 -0.418 . . . . 64.409999999999997 111.306 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.13 129.3 49.95 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.066 0.46 . . . . 72.239999999999995 111.287 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -121.54 113.65 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.485 -0.325 . . . . 73.129999999999995 110.654 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -95.18 129.06 42.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.176 0.512 . . . . 44.039999999999999 112.282 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -116.57 161.74 18.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.08 -0.509 . . . . 74.120000000000005 111.767 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.65 -24.59 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.853 0.358 . . . . 60.549999999999997 111.558 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -122.46 165.45 16.33 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.154 -0.475 . . . . 42.43 111.297 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.3 p -79.56 127.77 77.12 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.357 -0.383 . . . . 71.0 111.112 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -51.37 123.01 11.16 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.311 2.674 . . . . 63.240000000000002 113.734 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -86.62 129.4 34.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.688 -0.687 . . . . 74.409999999999997 110.292 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -82.2 134.05 35.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.567 0.699 . . . . 72.409999999999997 112.232 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -98.62 106.16 18.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.481 -0.781 . . . . 64.319999999999993 110.583 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.3 -20.1 59.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.944 0.402 . . . . 74.409999999999997 111.886 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -69.18 -54.79 13.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.104 0.409 . . . . 73.340000000000003 112.104 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -115.74 -6.59 12.12 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.734 0.642 . . . . 71.200000000000003 112.734 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.86 12.64 57.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.274 -0.965 . . . . 63.329999999999998 114.31 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 47.7 m-85 -90.19 171.86 9.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.397 0.599 . . . . 72.439999999999998 112.296 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 61.5 m-85 -119.54 132.18 55.69 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.027 -0.533 . . . . 73.319999999999993 110.992 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.57 119.95 38.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.775 0.322 . . . . 71.109999999999999 110.785 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -151.29 140.45 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.415 -0.357 . . . . 72.120000000000005 110.943 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 40.8 ttmt -93.14 109.28 20.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.885 0.374 . . . . 71.140000000000001 110.681 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 41.8 mt-30 -62.19 160.1 13.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.466 -0.334 . . . . 72.299999999999997 111.385 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -55.34 -29.07 57.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.473 0.545 . . . . 65.319999999999993 112.473 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.81 -12.04 60.29 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.937 0.398 . . . . 63.409999999999997 111.863 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.92 -20.67 28.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.421 -0.419 . . . . 73.230000000000004 113.567 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.48 108.2 8.13 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.243 0.46 . . . . 64.420000000000002 112.243 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 40.2 tt0 -86.02 120.77 27.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 75.510000000000005 110.494 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 165.53 25.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.343 -0.39 . . . . 70.349999999999994 111.131 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 75.1 mtm180 -111.02 139.48 46.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.978 0.418 . . . . 63.329999999999998 111.37 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.69 146.01 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.357 -0.383 . . . . 45.039999999999999 110.841 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -68.5 145.82 53.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.481 0.658 . . . . 55.439999999999998 112.291 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -63.09 -18.91 63.91 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.292 0.849 . . . . 72.409999999999997 113.292 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -81.36 -13.23 58.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.057 0.392 . . . . 61.43 112.057 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -90.86 -27.98 18.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.049 0.389 . . . . 73.219999999999999 112.049 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 7' ' ' ILE . 6.7 p -76.67 116.1 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.422 0.63 . . . . 75.019999999999996 112.095 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HG2' HG23 ' A' ' 49' ' ' THR . 78.7 ttt180 -81.96 -64.72 1.12 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.087 -0.506 . . . . 65.439999999999998 111.312 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.554 HG23 ' HG2' ' A' ' 48' ' ' ARG . 82.8 p -133.32 133.62 42.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.853 0.358 . . . . 71.340000000000003 111.904 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.22 111.07 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.417 -0.356 . . . . 74.400000000000006 110.27 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 43.4 mtmt -121.99 145.22 48.34 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 64.219999999999999 111.663 -177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -94.4 133.38 38.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.893 0.378 . . . . 64.120000000000005 110.957 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 4' ' ' PRO . 87.8 mt -66.01 -19.65 65.93 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.876 0.324 . . . . 75.239999999999995 111.876 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.93 35.49 1.4 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.993 0.425 . . . . 43.409999999999997 111.253 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? . . . . . 0 C--O 1.252 1.231 0 N-CA-C 113.523 0.935 . . . . 71.420000000000002 113.523 -179.792 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 110.162 -0.31 . . . . 64.24 110.162 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.13 115.46 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.152 1.901 . . . . 73.25 112.982 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 69.6 m -125.96 122.35 35.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.46 -0.337 . . . . 70.14 111.377 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.26 115.02 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.487 0.66 . . . . 63.11 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.63 117.79 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.224 -0.444 . . . . 73.51 111.031 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 14' ' ' GLU . 22.8 m -98.47 123.63 42.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.267 -0.424 . . . . 71.2 110.651 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.432 HD12 ' HD3' ' A' ' 13' ' ' ARG . 72.2 mt -83.7 174.43 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.278 0.561 . . . . 74.14 112.453 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -53.74 -43.97 69.53 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.572 -0.74 . . . . 74.43 112.866 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.77 -24.33 56.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.113 0.482 . . . . 74.42 111.455 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.98 -6.75 10.99 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.39 -0.433 . . . . 65.33 113.274 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.432 ' HD3' HD12 ' A' ' 9' ' ' LEU . 77.8 ttt180 -59.94 115.88 3.73 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.862 0.331 . . . . 75.32 111.11 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HG2' HG23 ' A' ' 8' ' ' THR . 44.8 mt-10 -105.1 130.22 53.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.745 0.307 . . . . 60.13 111.68 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -121.79 132.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.821 0.343 . . . . 75.3 110.554 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -98.73 125.86 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.132 0.492 . . . . 72.33 111.691 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.43 150.7 25.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.005 -0.543 . . . . 74.41 111.641 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.9 m -85.74 -17.18 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 120.991 0.424 . . . . 73.12 111.981 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.04 175.26 9.88 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 71.42 111.112 174.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -77.38 142.28 67.1 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 112.304 0.483 . . . . 61.3 112.304 -170.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 84.7 Cg_endo -76.47 157.47 36.6 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.855 2.37 . . . . 71.2 114.274 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -116.15 123.26 47.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.827 -0.624 . . . . 74.35 111.388 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -82.19 114.29 20.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.917 -0.401 . . . . 71.35 109.917 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.23 105.76 17.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.974 0.416 . . . . 74.5 111.591 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.43 -29.4 69.92 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.106 -0.497 . . . . 63.24 111.98 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -65.4 -55.11 19.89 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.208 0.447 . . . . 52.24 112.208 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -96.14 -17.93 20.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.014 0.375 . . . . 74.52 112.014 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.19 10.88 77.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.223 -0.513 . . . . 54.04 114.022 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.41 165.03 11.47 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.525 0.678 . . . . 71.13 112.226 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.65 122.71 44.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.413 -0.812 . . . . 72.25 110.022 167.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.592 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 26.3 mt-10 -98.96 119.66 38.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.273 -0.421 . . . . 73.45 110.527 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 23.1 p90 -140.03 144.58 36.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.192 0.52 . . . . 65.11 111.562 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 32.1 ttmt -95.08 110.58 22.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.773 -0.649 . . . . 72.25 111.564 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -60.36 169.07 1.8 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.4 0.519 . . . . 54.04 112.4 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.52 ' HA ' HG13 ' A' ' 18' ' ' VAL . 98.6 mt -53.15 -30.37 36.65 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.432 0.531 . . . . 70.25 112.432 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.642 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -73.16 -12.25 60.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.007 0.432 . . . . 72.44 111.602 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.36 60.99 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.239 -0.505 . . . . 74.23 112.55 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.642 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 30.1 mtmm -96.88 125.33 41.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.71 0.291 . . . . 73.12 111.319 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -78.44 128.36 33.49 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.841 0.353 . . . . 74.31 111.324 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.3 t -131.65 163.48 28.02 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.836 0.351 . . . . 64.42 111.002 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.592 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 87.3 mtm180 -136.43 131.55 34.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.508 -0.314 . . . . 64.23 111.635 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.15 150.92 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.524 0.202 . . . . 63.54 111.068 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.88 147.57 42.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.656 0.741 . . . . 61.41 112.881 -172.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -55.9 -24.13 35.6 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.134 1.161 . . . . 75.14 114.134 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -87.56 -17.12 32.73 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.221 0.452 . . . . 74.11 112.221 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -78.41 -17.68 56.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.342 0.497 . . . . 64.3 112.342 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.6 115.83 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.403 0.62 . . . . 73.54 112.178 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.461 ' NH2' HG21 ' A' ' 8' ' ' THR . 58.7 ttp180 -83.15 -62.29 1.63 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.141 0.496 . . . . 62.52 111.536 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.9 p -132.9 137.67 46.73 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.062 0.458 . . . . 73.24 111.963 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.2 106.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.126 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.4 149.46 49.66 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.33 0.586 . . . . 74.23 112.18 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.6 m-20 . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 70.23 111.007 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 110.671 -0.122 . . . . 44.33 110.671 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.03 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.65 1.567 . . . . 72.22 111.714 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 60.1 m -112.38 147.8 35.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.119 0.485 . . . . 72.45 111.998 -174.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.16 112.33 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.544 0.687 . . . . 63.01 110.494 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -90.41 105.68 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 70.4 111.089 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.6 m -83.72 107.7 16.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 74.23 110.987 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -78.08 153.58 32.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.653 0.263 . . . . 73.05 110.861 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -66.12 -14.32 61.6 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.918 0.39 . . . . 63.12 111.517 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.89 -8.78 57.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.762 0.315 . . . . 74.42 111.702 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 3.36 68.11 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.41 -0.424 . . . . 50.31 112.464 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -87.19 132.71 33.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.602 0.361 . . . . 74.54 111.06 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.79 130.15 55.65 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.997 0.427 . . . . 75.12 111.701 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.3 mt -109.85 128.51 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.26 -0.427 . . . . 65.42 110.894 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -97.97 126.71 43.5 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.074 0.464 . . . . 75.55 111.985 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -125.67 150.09 47.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.077 -0.51 . . . . 63.22 112.165 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.542 HG13 ' HA ' ' A' ' 35' ' ' LEU . 33.1 m -94.97 5.74 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.219 -0.446 . . . . 74.21 111.559 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -144.79 160.67 40.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.339 -0.391 . . . . 70.21 110.156 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.8 p -79.46 127.32 78.88 Favored Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.044 0.387 . . . . 74.13 112.044 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.33 113.57 2.31 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.437 2.092 . . . . 61.23 112.937 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -86.47 126.39 34.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.0 -0.545 . . . . 73.23 111.241 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -82.16 127.66 33.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 74.54 110.183 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -114.4 98.35 6.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.756 0.312 . . . . 73.34 110.836 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.95 -27.29 63.27 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.291 0.478 . . . . 75.11 112.291 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.38 -47.79 66.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.228 -0.442 . . . . 70.53 111.885 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.6 p -90.29 -27.6 19.33 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.498 -0.319 . . . . 63.21 111.654 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.27 69.35 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.529 -0.367 . . . . 73.41 113.185 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -114.13 166.18 11.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.359 0.599 . . . . 63.5 112.195 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 34.1 m-85 -101.78 129.4 47.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.774 -0.648 . . . . 74.13 110.9 170.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.476 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.7 mt-10 -99.34 119.2 37.55 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.258 -0.428 . . . . 65.23 110.688 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 34.2 p90 -146.56 153.74 40.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.9 0.381 . . . . 74.23 111.786 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -110.02 109.76 20.43 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.446 -0.343 . . . . 71.01 111.245 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.0 mt-30 -62.03 168.76 3.04 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.435 0.531 . . . . 73.41 112.435 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.542 ' HA ' HG13 ' A' ' 18' ' ' VAL . 82.0 mt -54.89 -32.25 60.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.309 -0.405 . . . . 75.12 111.868 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.72 -11.77 60.75 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.856 0.36 . . . . 72.4 111.916 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.64 61.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.169 -0.538 . . . . 73.42 112.871 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.5 112.0 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.715 -0.285 . . . . 70.21 111.714 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.5 tt0 -88.67 106.21 18.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.226 0.536 . . . . 74.13 110.518 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -123.98 167.34 14.29 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.166 -0.47 . . . . 64.23 111.681 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 82.8 mtm180 -121.8 136.77 54.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.954 0.407 . . . . 75.45 112.005 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.14 150.85 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.448 -0.342 . . . . 71.44 110.757 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -65.34 140.89 58.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.318 0.58 . . . . 73.21 111.724 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.26 -14.87 54.29 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.958 1.095 . . . . 72.52 113.958 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -83.26 -23.15 32.83 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.827 -0.545 . . . . 72.53 111.903 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 12.2 mm-40 -77.09 -28.23 54.46 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.368 0.507 . . . . 61.01 112.368 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.61 118.86 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 74.34 111.93 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -81.9 -64.74 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.939 -0.573 . . . . 73.54 111.014 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -128.38 136.06 50.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.388 -0.369 . . . . 52.21 111.662 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.73 97.42 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.467 -0.333 . . . . 75.02 111.027 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -134.96 156.53 48.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.482 0.549 . . . . 63.52 112.482 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 31.9 m-20 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.828 -0.624 . . . . 73.13 111.262 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.226 0.06 . . . . 71.31 110.886 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.5 115.17 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.777 1.651 . . . . 63.04 111.478 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 57.7 m -107.67 132.85 52.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.867 0.365 . . . . 63.12 111.865 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.75 127.63 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.336 0.589 . . . . 64.45 111.017 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.67 115.48 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.286 -0.415 . . . . 73.12 111.548 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.2 m -88.2 123.29 32.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.558 -0.292 . . . . 51.51 110.276 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.64 159.8 15.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.334 0.588 . . . . 74.14 112.489 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -56.0 -35.34 66.67 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.558 -0.746 . . . . 74.12 110.635 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.86 -30.94 71.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.505 -0.77 . . . . 73.24 111.745 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.1 -23.24 8.24 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.149 -0.478 . . . . 65.43 112.823 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.08 143.12 58.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.849 0.357 . . . . 75.13 111.94 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.05 129.91 56.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.775 0.321 . . . . 72.14 111.407 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.646 0.26 . . . . 52.51 110.871 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -95.26 135.75 36.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.235 0.54 . . . . 74.25 112.206 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -128.44 156.94 42.4 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.859 -0.61 . . . . 75.21 111.2 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.8 m -83.59 -16.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.046 0.387 . . . . 72.54 112.046 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -144.32 175.13 10.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.301 0.24 . . . . 71.43 111.092 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.9 p -78.33 132.29 66.58 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 111.902 0.334 . . . . 55.53 111.902 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 27.9 Cg_endo -60.32 133.24 48.22 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.202 2.601 . . . . 62.22 114.211 -174.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -87.23 116.42 25.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 71.31 110.876 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -81.31 113.62 19.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.902 -0.499 . . . . 72.55 110.654 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -97.62 95.61 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.157 0.504 . . . . 71.55 109.852 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.02 -31.62 72.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.965 -0.562 . . . . 73.5 112.199 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.01 -43.08 99.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.215 -0.448 . . . . 64.25 111.704 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.9 p -89.26 -26.98 20.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.735 0.303 . . . . 72.34 111.422 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.15 11.03 63.56 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.372 -0.442 . . . . 75.45 113.364 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.74 163.94 14.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.584 0.707 . . . . 74.24 112.385 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -100.88 122.86 44.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 73.21 109.854 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.24 119.4 37.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.496 -0.32 . . . . 73.53 110.273 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 31.3 p90 -134.95 145.28 48.01 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.953 0.406 . . . . 74.52 111.687 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -97.99 108.28 20.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.139 -0.482 . . . . 74.55 110.866 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 46.8 mt-30 -66.99 173.09 3.88 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.315 0.487 . . . . 70.53 112.315 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.475 ' HA ' HG13 ' A' ' 18' ' ' VAL . 87.0 mt -55.54 -32.73 63.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.452 0.538 . . . . 73.25 112.452 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.721 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.9 m-20 -83.95 9.46 12.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.83 0.348 . . . . 60.14 111.823 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.18 90.32 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.993 -0.623 . . . . 34.53 112.956 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.721 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.6 mtmm -71.76 97.72 1.83 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.71 -0.288 . . . . 70.02 111.688 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 27.7 tt0 -85.22 113.62 21.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.812 0.339 . . . . 75.42 110.865 176.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -136.58 168.21 19.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.961 0.41 . . . . 54.01 111.937 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -101.16 156.84 17.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.133 0.492 . . . . 74.4 111.28 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -145.53 139.59 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.25 -0.432 . . . . 42.11 110.292 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -62.72 139.52 58.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.038 0.447 . . . . 63.41 111.358 -174.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -57.64 -21.3 38.92 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.001 1.111 . . . . 73.51 114.001 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -81.39 -17.73 47.98 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.049 -0.407 . . . . 54.11 112.093 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -75.94 -26.87 57.3 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.211 0.449 . . . . 72.12 112.211 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.51 117.17 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.174 0.511 . . . . 65.05 112.344 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -82.72 -60.08 2.3 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.947 0.403 . . . . 73.3 110.403 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -145.42 158.63 43.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.056 -0.52 . . . . 62.32 111.293 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.9 t -130.83 110.78 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.515 -0.312 . . . . 74.4 111.297 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -127.97 157.24 41.15 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.168 0.508 . . . . 63.3 111.646 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 33.4 m-20 . . . . . 0 CA--C 1.536 0.424 0 CA-C-N 116.257 -0.429 . . . . 72.51 110.786 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 111.264 0.098 . . . . 61.52 111.264 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.82 116.01 2.9 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.532 2.155 . . . . 74.11 112.485 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.2 m -121.84 134.59 54.89 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.179 -0.464 . . . . 70.21 111.924 -173.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.25 131.77 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.332 0.587 . . . . 74.4 111.043 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.455 HG23 HG23 ' A' ' 47' ' ' VAL . 68.7 mt -107.55 110.4 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.202 -0.454 . . . . 73.23 111.453 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.4 ' HB ' ' OG1' ' A' ' 49' ' ' THR . 42.3 m -85.65 116.8 24.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.739 0.304 . . . . 73.42 110.585 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.8 mt -82.18 172.29 13.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.025 0.441 . . . . 63.02 111.529 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -56.79 -42.64 79.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.248 -0.433 . . . . 73.42 111.894 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.34 0.19 12.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.515 0.561 . . . . 74.44 112.515 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.38 66.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.133 -0.556 . . . . 65.42 112.997 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -67.99 131.79 46.11 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.842 -0.211 . . . . 74.33 110.829 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.96 138.91 51.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.893 0.377 . . . . 71.52 111.87 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.49 140.75 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.492 -0.322 . . . . 74.12 110.963 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -103.61 117.32 34.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.16 0.43 . . . . 73.0 112.16 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -121.68 152.68 39.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.284 0.476 . . . . 73.2 112.284 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.4 -19.02 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.106 0.41 . . . . 73.25 112.106 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.09 174.9 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.906 0.384 . . . . 74.45 111.587 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.7 p -79.45 143.02 58.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 112.603 0.594 . . . . 74.01 112.603 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 68.5 Cg_endo -73.12 142.9 34.97 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.459 2.106 . . . . 65.5 113.55 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 39.1 ttmt -99.47 131.58 45.38 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.246 -0.434 . . . . 45.22 110.969 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -94.25 124.35 38.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.97 0.414 . . . . 74.31 111.708 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -99.41 119.81 38.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.12 110.168 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.54 -26.3 67.07 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.748 0.647 . . . . 73.23 112.748 -174.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -82.59 -47.39 12.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.414 0.524 . . . . 70.23 112.414 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.3 p -89.95 -27.43 19.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.725 0.297 . . . . 23.32 111.639 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 9.15 83.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.171 -0.538 . . . . 33.14 113.664 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -96.41 151.56 19.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.359 0.599 . . . . 71.2 112.22 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.9 m-85 -101.39 126.62 48.18 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.625 -0.716 . . . . 54.43 110.863 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.7 mt-10 -99.09 119.01 37.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.511 0.196 . . . . 73.42 110.688 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.16 146.33 31.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.127 0.489 . . . . 75.32 112.015 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.3 ttmp? -93.0 115.67 28.34 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.082 -0.508 . . . . 71.21 111.181 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 45.6 mt-30 -67.97 164.33 20.18 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.153 0.427 . . . . 65.33 112.153 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.95 -23.0 61.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.619 0.723 . . . . 72.33 110.562 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.32 -13.75 61.57 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.252 -0.885 . . . . 72.41 111.798 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.8 -38.83 2.96 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.349 -0.453 . . . . 71.02 113.284 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -68.95 127.69 34.02 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.35 -0.5 . . . . 74.43 112.225 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 63.5 tt0 -86.03 116.27 24.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.957 0.408 . . . . 73.42 110.934 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -115.5 166.49 11.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.911 0.386 . . . . 64.43 111.651 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 60.5 mtm180 -129.85 137.58 50.52 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.141 -0.481 . . . . 65.13 111.564 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.7 149.65 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.521 -0.309 . . . . 73.12 110.656 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -70.54 151.03 45.51 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.529 0.681 . . . . 73.14 112.583 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -59.6 -29.28 67.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.662 0.986 . . . . 73.45 113.662 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -76.49 -11.77 59.93 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.126 0.417 . . . . 75.32 112.126 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.85 -28.04 17.57 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.361 0.504 . . . . 62.03 112.361 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 7' ' ' ILE . 5.6 p -77.0 114.29 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.51 0.672 . . . . 74.31 112.12 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -83.1 -56.8 3.58 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.992 -0.549 . . . . 62.04 111.353 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.4 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 71.0 p -137.24 150.92 48.17 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.958 0.408 . . . . 72.52 111.665 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.47 111.23 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.358 -0.383 . . . . 61.34 110.529 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.63 168.7 13.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.002 0.429 . . . . 70.11 111.885 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 120.923 0.392 . . . . 75.4 111.17 175.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 110.707 -0.109 . . . . 33.1 110.707 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.72 114.62 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.918 1.745 . . . . 62.4 112.536 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.8 m -125.08 132.76 53.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.209 -0.45 . . . . 71.3 111.407 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.0 124.68 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.306 0.574 . . . . 71.45 111.154 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.3 mt -102.87 118.8 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.219 -0.446 . . . . 73.41 111.451 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.473 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 60.7 m -90.27 122.02 32.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.317 -0.402 . . . . 53.14 110.675 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -88.93 157.03 18.55 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.977 0.418 . . . . 74.5 111.82 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -54.99 -30.77 60.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.964 -0.562 . . . . 74.21 111.022 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.66 -23.02 67.2 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.639 -0.709 . . . . 65.42 111.597 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.88 -30.89 8.5 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 112.014 -0.434 . . . . 73.43 112.014 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.589 ' NH1' HG12 ' A' ' 15' ' ' ILE . 49.5 ttt-85 -64.28 141.76 58.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.639 0.376 . . . . 75.14 111.554 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 8' ' ' THR . 44.0 mt-10 -116.26 143.54 45.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.861 0.362 . . . . 74.24 111.383 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.589 HG12 ' NH1' ' A' ' 13' ' ' ARG . 38.8 mt -124.09 132.65 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.282 -0.417 . . . . 73.31 110.787 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -95.66 133.28 39.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.51 111.479 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.31 146.26 48.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.453 0.538 . . . . 71.51 112.453 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.528 HG13 ' HA ' ' A' ' 35' ' ' LEU . 29.7 m -87.36 -13.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.14 0.495 . . . . 75.11 111.486 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.29 154.45 36.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.007 -0.542 . . . . 71.5 110.301 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.6 p -78.86 132.38 64.43 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.882 0.372 . . . . 61.01 111.193 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.422 ' HB3' HD11 ' A' ' 7' ' ' ILE . 41.5 Cg_endo -65.23 126.42 16.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.93 2.42 . . . . 72.54 113.755 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -96.48 127.78 42.79 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.053 -0.521 . . . . 63.23 110.615 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -83.48 115.04 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.822 -0.351 . . . . 71.13 110.376 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -97.31 103.28 15.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.064 0.459 . . . . 74.11 109.974 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.26 -28.55 66.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.131 -0.486 . . . . 75.45 111.571 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.33 -52.77 63.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.912 0.387 . . . . 73.41 111.071 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -88.36 -25.41 22.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.062 0.393 . . . . 71.25 112.062 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.41 61.76 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.389 -0.434 . . . . 74.02 113.673 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.98 159.65 17.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.429 0.633 . . . . 75.32 112.561 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.439 ' CE1' HG11 ' A' ' 47' ' ' VAL . 49.8 m-85 -100.97 122.33 43.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.636 -0.711 . . . . 64.33 109.852 169.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 47.4 mt-10 -104.69 121.64 43.99 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.821 0.343 . . . . 64.55 111.063 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -145.17 156.91 44.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 64.44 111.436 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 31.6 ttmt -106.3 111.46 24.07 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.294 -0.412 . . . . 63.21 111.197 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -60.73 166.82 3.06 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.231 0.456 . . . . 74.12 112.231 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.528 ' HA ' HG13 ' A' ' 18' ' ' VAL . 74.8 mt -61.07 -21.35 63.57 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 73.22 111.128 176.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.49 -11.44 60.22 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.963 -0.562 . . . . 52.42 111.679 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.34 -5.48 71.06 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.159 -0.544 . . . . 72.45 112.883 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -82.68 119.66 24.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.938 0.348 . . . . 70.14 111.938 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 33.8 tt0 -83.69 112.93 20.5 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.895 -0.409 . . . . 63.32 109.895 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -116.43 152.56 33.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.946 0.403 . . . . 75.21 111.802 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 44.6 mtp180 -116.28 126.32 53.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.378 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 tt -129.94 145.3 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 122.244 -0.285 . . . . 51.41 111.08 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -66.88 150.44 49.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.579 0.704 . . . . 73.21 112.687 -172.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -58.52 -19.71 39.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.936 1.087 . . . . 70.23 113.936 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -84.46 -22.92 30.15 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.879 -0.513 . . . . 73.14 112.014 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -82.24 -14.51 55.4 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.167 0.432 . . . . 73.53 112.167 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.439 HG11 ' CE1' ' A' ' 30' ' ' TYR . 7.3 p -87.49 115.37 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.453 0.644 . . . . 73.04 111.727 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -83.08 -63.49 1.35 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.136 0.493 . . . . 72.55 110.93 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.3 p -139.65 149.46 43.77 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.879 -0.601 . . . . 65.5 111.358 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.49 116.02 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.373 -0.376 . . . . 71.12 110.222 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.21 141.99 50.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.827 0.346 . . . . 74.1 111.384 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.802 0.334 . . . . 64.32 110.943 176.111 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 m . . . . . 0 CA--C 1.538 0.518 0 CA-C-O 120.396 0.141 . . . . 75.1 111.359 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -62.67 119.93 7.23 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.651 2.234 . . . . 75.24 112.409 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.0 m -128.8 147.8 50.82 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.423 -0.353 . . . . 74.43 111.47 -174.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.4 p -121.64 125.55 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.377 0.608 . . . . 72.55 111.283 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.6 mt -98.94 116.23 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 63.51 111.391 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 113.61 22.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.31 -0.404 . . . . 65.44 110.733 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -78.46 166.07 23.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 72.34 111.538 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 64.6 t30 -63.31 -33.21 75.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.136 -0.483 . . . . 75.1 111.287 -175.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.67 7.9 6.17 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.436 -0.347 . . . . 72.33 111.865 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.04 -12.95 64.53 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.233 -0.508 . . . . 70.35 113.886 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -70.12 121.1 16.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.266 0.533 . . . . 75.31 111.426 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -103.02 130.37 50.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.867 0.365 . . . . 74.12 111.274 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.96 131.23 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.497 -0.32 . . . . 73.33 110.984 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.46 137.18 34.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.19 0.519 . . . . 72.23 112.082 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.57 150.74 50.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.81 -0.632 . . . . 70.23 111.231 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.3 m -74.34 -25.42 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.921 0.391 . . . . 71.35 111.788 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.3 174.43 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.223 -0.444 . . . . 74.13 111.261 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.2 p -83.02 145.75 50.21 Favored Pre-proline 0 N--CA 1.47 0.536 0 CA-C-O 120.852 0.358 . . . . 50.23 111.792 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HB3' HD11 ' A' ' 7' ' ' ILE . 60.4 Cg_endo -71.29 130.79 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.427 2.085 . . . . 72.35 113.364 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -98.09 122.58 41.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.3 -0.409 . . . . 71.41 110.46 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -82.17 130.51 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.012 0.434 . . . . 71.24 111.391 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.28 109.8 21.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.404 -0.362 . . . . 73.32 110.57 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -72.92 -29.99 63.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.003 0.43 . . . . 73.11 111.47 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -70.47 -33.47 71.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.805 0.669 . . . . 71.31 112.805 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -118.85 -10.49 9.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.798 0.666 . . . . 72.4 112.798 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.66 82.53 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 114.702 0.641 . . . . 55.22 114.702 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -102.6 154.15 19.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 117.887 0.843 . . . . 73.2 112.335 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.2 m-85 -102.12 128.26 48.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.15 -0.477 . . . . 73.55 110.827 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 46.2 mt-10 -99.53 119.32 37.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.6 0.238 . . . . 63.14 111.235 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -146.19 145.04 30.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.968 0.413 . . . . 74.52 111.675 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.4 ttmp? -97.58 111.45 23.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.435 -0.348 . . . . 64.31 111.268 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -61.01 168.11 2.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.855 0.359 . . . . 64.13 111.956 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.424 ' HA ' HG13 ' A' ' 18' ' ' VAL . 92.9 mt -52.69 -43.17 65.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.834 0.679 . . . . 75.44 112.834 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -75.79 -3.14 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.268 0.47 . . . . 71.25 112.268 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.24 -2.81 50.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.072 -0.585 . . . . 33.12 114.224 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -82.7 104.19 12.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.504 0.652 . . . . 73.31 111.68 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.1 tt0 -72.98 119.54 17.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.272 -0.422 . . . . 62.24 111.109 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 t -125.91 165.37 18.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.792 0.33 . . . . 70.03 111.83 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 47.0 mtm180 -126.71 129.42 48.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.387 -0.37 . . . . 73.2 111.252 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.5 tt -122.1 150.75 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.663 -0.244 . . . . 70.15 110.794 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -67.58 153.67 43.18 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.303 0.573 . . . . 75.3 112.367 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 47' ' ' VAL . 15.1 ptmm? -65.4 -21.68 66.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.797 1.036 . . . . 65.24 113.797 -172.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -79.4 -25.23 42.15 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.216 0.45 . . . . 74.31 112.216 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.83 -22.32 53.76 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.82 0.674 . . . . 41.52 112.82 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 44' ' ' LYS . 8.0 p -72.84 114.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.736 0.779 . . . . 74.13 111.981 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 10.0 tpt180 -81.83 -63.36 1.4 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.82 -0.627 . . . . 75.41 110.466 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -146.54 146.61 30.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.013 -0.539 . . . . 74.15 110.984 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.83 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.722 0.296 . . . . 73.2 110.88 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB2' HG13 ' A' ' 6' ' ' VAL . 61.1 mttp -119.3 152.36 36.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.292 0.568 . . . . 72.32 111.919 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 . . . . . 0 CA--C 1.54 0.567 0 CA-C-N 116.102 -0.499 . . . . 73.33 111.329 178.794 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 110.252 -0.277 . . . . 75.44 110.252 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.39 116.01 4.32 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.906 1.737 . . . . 73.13 112.09 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 92.2 m -123.4 135.72 54.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.116 0.413 . . . . 62.41 112.116 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.86 118.53 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.484 0.659 . . . . 63.22 111.31 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -90.78 107.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.222 -0.445 . . . . 74.22 111.153 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.455 HG22 ' HD3' ' A' ' 48' ' ' ARG . 49.9 m -83.37 124.0 30.21 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.245 -0.28 . . . . 73.43 110.245 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.1 mt -96.54 162.09 13.62 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.978 0.418 . . . . 65.12 112.057 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -54.25 -45.41 72.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.027 -0.533 . . . . 74.45 111.838 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.12 5.53 5.25 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.798 0.666 . . . . 71.41 112.798 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.95 47.5 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.082 -0.58 . . . . 71.43 114.211 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -63.11 136.2 57.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.364 0.582 . . . . 63.04 111.71 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.47 129.5 55.76 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.731 0.3 . . . . 74.15 110.491 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -113.3 112.0 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.172 0.511 . . . . 65.31 111.187 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.76 117.9 30.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.324 -0.398 . . . . 71.25 111.307 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -111.93 159.9 17.94 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.159 0.504 . . . . 62.14 112.189 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.1 m -84.59 -15.03 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.955 -0.566 . . . . 73.34 111.663 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.11 164.34 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.006 0.431 . . . . 75.43 111.327 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.406 HG22 ' OG1' ' A' ' 5' ' ' THR . 71.3 p -79.7 118.95 75.09 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.407 -0.361 . . . . 73.13 110.869 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.63 123.28 12.54 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.346 2.697 . . . . 75.32 113.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 5.5 ttpm? -87.32 123.1 31.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.357 -0.383 . . . . 71.52 110.754 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -90.3 131.59 36.02 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.005 0.431 . . . . 74.53 112.086 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -99.75 116.41 31.76 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.908 0.385 . . . . 71.41 110.157 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.26 -32.26 73.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.348 0.499 . . . . 73.43 112.348 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -72.29 -50.0 30.39 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.954 0.353 . . . . 63.34 111.954 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.1 p -89.61 -27.75 19.98 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.32 0.489 . . . . 75.25 112.32 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.93 10.69 75.0 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.06 -0.591 . . . . 72.43 113.568 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.15 149.23 23.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.416 0.627 . . . . 73.4 112.452 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -102.02 128.74 48.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.604 -0.725 . . . . 74.31 110.771 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 45.7 mt-10 -100.11 124.66 45.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.703 0.287 . . . . 72.1 111.116 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.405 ' HE1' HG22 ' A' ' 42' ' ' ILE . 34.4 p90 -157.19 151.77 25.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.828 0.347 . . . . 72.54 111.417 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -106.5 115.28 29.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.599 -0.273 . . . . 54.41 110.885 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 49.5 mt-30 -60.65 158.86 11.74 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.87 0.322 . . . . 74.4 111.87 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.433 ' HA ' HG13 ' A' ' 18' ' ' VAL . 89.8 mt -51.98 -30.79 26.48 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.109 0.48 . . . . 72.33 111.777 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.91 4.33 4.31 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.088 -0.506 . . . . 71.14 112.238 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 23.63 70.78 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.304 -0.474 . . . . 74.4 113.069 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -117.07 112.56 21.08 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.7 -0.294 . . . . 65.14 111.297 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.4 tt0 -87.17 138.99 31.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.815 0.341 . . . . 73.24 111.58 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -147.24 165.15 30.93 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.497 -0.319 . . . . 73.32 111.719 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 86.0 mtt180 -115.4 125.89 53.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.888 0.375 . . . . 71.11 111.03 177.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.405 HG22 ' HE1' ' A' ' 32' ' ' PHE . 15.7 tt -117.04 149.93 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.621 0.248 . . . . 73.35 111.116 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.11 148.73 32.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.538 0.685 . . . . 62.3 112.218 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 ptmt -63.17 -15.02 55.5 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.656 0.984 . . . . 71.32 113.656 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -78.08 -22.55 48.86 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.822 -0.549 . . . . 74.45 111.591 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -79.4 -28.29 41.84 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.958 0.725 . . . . 64.31 112.958 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -68.25 113.78 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.727 0.775 . . . . 74.12 112.481 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HD3' HG22 ' A' ' 8' ' ' THR . 75.1 ttt180 -82.08 -60.32 2.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.525 -0.762 . . . . 74.44 110.671 175.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -149.36 129.58 13.68 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.066 -0.516 . . . . 74.51 111.24 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.848 0.356 . . . . 72.4 111.314 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -125.18 152.83 43.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 74.53 111.184 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 24.0 m-20 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 120.835 0.35 . . . . 64.44 110.998 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 110.768 -0.086 . . . . 73.33 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.6 114.02 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.696 1.597 . . . . 65.04 111.633 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.0 m -126.93 149.72 49.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.296 -0.411 . . . . 52.42 111.25 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.18 129.21 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.44 0.638 . . . . 64.44 111.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.3 110.44 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.027 -0.533 . . . . 74.52 110.862 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.752 HG21 HH21 ' A' ' 48' ' ' ARG . 26.0 m -89.07 118.31 28.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.749 0.309 . . . . 61.41 111.286 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.7 170.14 13.58 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.807 0.337 . . . . 61.31 111.576 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.07 -31.29 71.7 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.871 0.367 . . . . 74.44 111.697 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.27 -20.9 66.37 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 111.992 0.367 . . . . 70.55 111.992 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.07 -7.6 62.56 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.523 -0.631 . . . . 35.23 111.523 -170.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -70.06 125.05 25.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.96 0.504 . . . . 72.23 110.913 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.8 130.67 55.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.043 0.449 . . . . 72.21 111.718 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.8 mt -110.96 125.62 68.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.241 -0.436 . . . . 70.51 110.754 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -96.73 129.57 44.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.957 0.408 . . . . 62.0 111.915 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -119.55 162.04 19.59 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.121 -0.49 . . . . 63.22 111.488 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -97.11 -3.99 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.064 0.394 . . . . 61.33 112.064 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.01 174.95 10.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.328 0.585 . . . . 74.11 112.177 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.1 p -79.01 129.89 71.64 Favored Pre-proline 0 N--CA 1.471 0.618 0 CA-C-N 115.807 -0.633 . . . . 74.14 112.083 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.2 133.79 25.58 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.618 2.212 . . . . 72.14 113.238 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 135.71 35.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.476 -0.329 . . . . 70.32 111.207 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -95.63 115.51 27.53 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.602 0.239 . . . . 72.41 111.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -109.43 118.93 37.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.85 0.357 . . . . 72.44 110.75 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.15 -42.16 63.13 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.96 0.355 . . . . 63.51 111.96 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.85 -38.72 82.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.155 0.428 . . . . 72.33 112.155 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -94.44 -27.42 16.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.224 -0.298 . . . . 74.14 111.608 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.49 12.28 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.858 -0.687 . . . . 43.04 113.839 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.485 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 72.6 m-85 -116.27 163.52 15.88 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.173 0.511 . . . . 71.31 112.156 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.3 m-85 -101.24 128.68 47.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.91 -0.586 . . . . 74.4 110.424 171.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 39.6 mt-10 -98.97 119.25 37.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.535 0.207 . . . . 75.4 111.088 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.54 155.21 42.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.991 0.424 . . . . 63.41 111.486 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 3.8 ttmp? -108.91 109.77 20.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.414 -0.357 . . . . 63.22 111.129 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 47.3 mt-30 -61.63 164.84 5.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.224 0.453 . . . . 61.41 112.224 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.584 ' HA ' HG13 ' A' ' 18' ' ' VAL . 86.7 mt -48.8 -43.26 38.03 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.791 0.664 . . . . 73.34 112.791 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -73.15 -1.97 19.7 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.327 0.492 . . . . 64.32 112.327 -176.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.15 -2.24 63.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.446 -0.406 . . . . 41.22 112.676 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 31.4 mtmm -71.75 97.87 1.85 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.809 0.3 . . . . 71.14 111.809 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.8 tt0 -80.47 120.77 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.732 -0.213 . . . . 73.41 110.463 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -145.62 165.59 28.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.925 0.393 . . . . 64.33 111.709 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 59.5 mtm180 -117.48 148.05 42.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.13 -0.487 . . . . 75.3 111.265 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.65 152.15 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.369 -0.378 . . . . 65.42 110.813 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.17 133.89 55.1 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.113 0.482 . . . . 73.23 111.425 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.09 -16.17 29.54 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.221 1.193 . . . . 73.24 114.221 -172.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -91.85 -12.13 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.694 -0.629 . . . . 74.52 112.326 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -77.05 -28.06 54.65 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.911 0.386 . . . . 62.43 111.883 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -77.77 121.82 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.296 0.569 . . . . 70.4 112.312 -175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.752 HH21 HG21 ' A' ' 8' ' ' THR . 72.0 ttp85 -82.51 -59.82 2.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.008 0.432 . . . . 74.12 110.955 174.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 48' ' ' ARG . 66.5 p -141.96 136.08 30.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.156 -0.475 . . . . 61.52 111.606 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.38 108.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.645 -0.252 . . . . 44.44 110.718 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -123.96 156.34 36.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.028 0.442 . . . . 73.32 111.297 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 64.34 110.914 175.405 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 111.079 0.029 . . . . 64.12 111.079 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.83 116.12 3.49 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.159 1.906 . . . . 62.34 111.793 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.4 m -119.82 136.87 54.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.893 0.378 . . . . 63.33 111.974 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.36 0.6 . . . . 73.25 110.755 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.437 HG23 HG23 ' A' ' 47' ' ' VAL . 66.0 mt -96.59 110.53 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.153 -0.476 . . . . 72.51 111.085 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.426 ' HB ' ' OG1' ' A' ' 49' ' ' THR . 41.9 m -91.02 116.45 28.8 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.823 0.344 . . . . 73.14 110.803 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.28 161.82 21.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.894 0.378 . . . . 61.02 111.917 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.69 -40.39 79.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.434 0.531 . . . . 74.0 112.434 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.41 -12.56 53.49 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.303 0.483 . . . . 74.34 112.303 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.8 10.5 40.23 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.011 -0.614 . . . . 65.12 113.643 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -95.41 132.18 40.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.152 0.476 . . . . 71.25 111.565 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -102.95 130.47 50.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.927 0.394 . . . . 74.33 111.617 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.3 119.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.689 0.28 . . . . 63.14 110.412 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -92.34 130.88 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.164 0.507 . . . . 64.24 112.03 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.38 150.65 42.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.052 -0.522 . . . . 73.53 111.46 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 35' ' ' LEU . 26.9 m -82.52 -13.79 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.191 0.441 . . . . 71.12 112.191 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.21 173.88 11.21 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.949 0.404 . . . . 75.53 111.657 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.5 p -79.54 140.89 55.89 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 112.869 0.692 . . . . 74.44 112.869 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.33 105.01 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.572 2.181 . . . . 61.15 112.772 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.36 111.77 20.81 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.143 -0.481 . . . . 70.45 111.051 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.472 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 51.1 t80 -81.68 132.33 35.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.968 0.413 . . . . 73.13 112.102 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -123.38 119.3 29.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.9 -0.591 . . . . 71.33 110.825 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.84 -15.73 55.6 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.872 0.323 . . . . 73.41 111.872 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.46 -45.06 73.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 63.11 111.126 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.2 p -93.49 -27.53 16.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.867 0.365 . . . . 52.43 111.501 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.38 10.5 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.301 -0.476 . . . . 72.11 113.111 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 75.1 m-85 -113.44 164.69 13.29 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.507 0.67 . . . . 73.53 112.76 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 69.7 m-85 -102.34 132.41 48.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.641 -0.709 . . . . 64.24 110.457 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 43.3 mt-10 -98.57 119.5 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.882 0.372 . . . . 73.52 110.824 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -147.1 143.79 28.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.009 0.433 . . . . 72.23 111.278 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.7 ttmp? -97.72 110.38 22.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.454 -0.339 . . . . 70.03 111.13 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.36 164.12 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.906 0.384 . . . . 72.13 111.711 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.426 ' HA ' HG13 ' A' ' 18' ' ' VAL . 88.3 mt -53.41 -35.01 59.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.293 -0.412 . . . . 64.41 111.894 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.9 -12.26 61.18 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.036 0.384 . . . . 74.34 112.036 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.6 -7.62 50.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.496 -0.383 . . . . 51.22 112.665 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -75.16 100.42 4.27 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.086 0.469 . . . . 62.44 111.968 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.1 tt0 -84.04 104.41 14.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.024 0.44 . . . . 65.14 110.542 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 t -124.45 166.48 15.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.944 0.402 . . . . 63.13 111.532 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 64.4 mtm180 -115.66 132.14 56.72 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.33 -0.396 . . . . 74.44 111.685 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.12 151.21 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.494 -0.321 . . . . 53.25 110.693 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -71.52 145.57 49.06 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.152 0.501 . . . . 74.4 112.042 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -60.43 -16.79 39.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.776 1.028 . . . . 73.01 113.776 -173.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -83.65 -25.69 30.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.223 0.453 . . . . 64.22 112.223 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -77.12 -28.38 54.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.314 0.487 . . . . 73.44 112.314 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG23 HG23 ' A' ' 7' ' ' ILE . 7.3 p -74.2 113.75 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.484 0.659 . . . . 73.3 112.163 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 48' ' ' ARG . 22.0 ttt180 -83.63 -63.75 1.29 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.355 0.598 . . . . 73.41 110.856 177.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.426 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 77.6 p -132.99 151.17 52.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.759 -0.655 . . . . 75.52 111.733 -177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.42 117.85 46.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.255 -0.429 . . . . 72.13 111.202 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -127.64 134.02 49.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.84 0.352 . . . . 74.15 111.856 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.003 0.43 . . . . 75.41 110.929 175.043 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.469 0.488 0 N-CA-C 110.103 -0.332 . . . . 75.52 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -60.15 130.41 34.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.271 1.98 . . . . 53.13 112.926 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -132.25 135.99 46.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.28 -0.418 . . . . 74.54 111.327 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.2 p -98.94 122.94 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.473 0.654 . . . . 61.02 111.926 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 21' ' ' PRO . 64.4 mt -98.61 110.55 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.039 -0.528 . . . . 64.31 110.677 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.0 m -90.32 124.36 34.84 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.702 0.287 . . . . 75.03 110.716 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.2 157.49 17.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.938 0.347 . . . . 74.53 111.938 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -56.14 -30.82 62.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.2 0.524 . . . . 63.13 110.853 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.632 -0.713 . . . . 74.33 111.54 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.49 -23.38 8.0 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.332 -0.394 . . . . 52.24 112.23 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -65.31 141.25 58.66 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.925 0.342 . . . . 63.34 111.925 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.63 130.62 55.7 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.587 -0.279 . . . . 73.4 111.279 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -110.02 129.32 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.757 0.313 . . . . 73.54 110.788 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -99.96 113.12 25.47 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.973 0.416 . . . . 72.34 111.575 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.72 160.55 14.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.489 -0.323 . . . . 60.21 111.81 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -91.56 -18.68 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.475 0.546 . . . . 73.42 112.475 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -133.83 176.0 8.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.921 0.391 . . . . 74.02 111.541 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.7 p -77.35 127.85 81.94 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 116.592 -0.276 . . . . 75.14 111.66 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HB3' HD11 ' A' ' 7' ' ' ILE . 21.1 Cg_endo -60.33 125.42 17.4 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.793 2.329 . . . . 70.43 113.959 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -93.72 142.11 27.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.192 -0.913 . . . . 70.13 110.748 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.92 133.82 52.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.883 -0.511 . . . . 74.0 111.863 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.42 113.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.952 -0.567 . . . . 74.02 110.195 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -72.19 -34.66 68.59 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.863 0.363 . . . . 73.2 111.814 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -59.81 -50.58 73.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.912 0.386 . . . . 75.44 111.923 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.438 ' HG ' ' HD2' ' A' ' 29' ' ' PHE . 14.9 t -89.91 -23.39 21.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.341 -0.391 . . . . 65.11 111.511 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.43 10.88 79.02 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 52.12 113.705 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 97.0 m-85 -110.4 163.84 13.28 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.199 0.524 . . . . 62.31 111.877 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.0 m-85 -101.05 136.66 40.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.016 -0.538 . . . . 63.22 110.75 173.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.97 118.36 34.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.893 -0.41 . . . . 60.34 109.893 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -143.65 156.18 44.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.957 0.408 . . . . 73.43 111.256 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 4.6 ttmp? -118.17 110.89 18.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.191 -0.458 . . . . 75.13 111.655 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -60.8 160.6 9.23 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.291 -0.413 . . . . 73.2 111.36 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.79 -27.27 11.75 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.524 0.564 . . . . 73.21 112.524 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.26 4.69 6.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.017 0.377 . . . . 73.21 112.017 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.4 20.96 78.36 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.014 -0.612 . . . . 74.33 112.507 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.73 114.9 28.31 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.64 0.376 . . . . 75.34 111.532 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -92.35 125.65 37.1 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.893 0.378 . . . . 70.51 110.769 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -145.1 166.55 25.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.514 -0.312 . . . . 74.12 110.864 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 44.2 mtm180 -114.55 140.3 48.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.412 0.523 . . . . 64.24 112.412 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -128.59 145.54 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.242 -0.436 . . . . 73.23 110.658 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.85 146.89 52.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.662 0.744 . . . . 72.44 112.518 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 47' ' ' VAL . 19.0 pttm -53.49 -27.62 26.36 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.716 -1.129 . . . . 74.31 113.999 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -77.84 -21.86 50.81 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.363 0.505 . . . . 74.01 112.363 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -77.36 -25.03 50.63 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.9 0.704 . . . . 74.41 112.9 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.2 p -75.11 113.53 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.567 0.699 . . . . 63.34 112.612 -175.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.15 -60.48 2.14 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.912 -0.585 . . . . 54.53 110.98 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 p -139.35 153.15 47.64 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.316 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.5 t -127.87 108.29 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.506 -0.315 . . . . 72.14 111.207 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -123.15 145.56 48.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.115 0.483 . . . . 64.45 111.594 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.098 0.475 . . . . 65.44 111.744 -177.938 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 120.403 0.144 . . . . 74.24 111.156 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.99 131.83 45.92 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.483 2.122 . . . . 64.42 112.391 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -127.23 133.56 50.21 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.788 0.292 . . . . 72.33 111.788 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.79 124.88 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.51 0.672 . . . . 62.04 111.053 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.57 107.99 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.027 -0.533 . . . . 75.02 111.166 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -84.27 119.56 25.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.371 -0.377 . . . . 74.32 110.648 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -86.2 155.24 20.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.627 0.251 . . . . 61.33 111.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.2 -26.24 68.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.386 0.612 . . . . 73.45 110.655 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -58.25 -29.05 65.46 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.556 -0.747 . . . . 71.53 111.659 173.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.1 -11.33 26.87 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.513 -0.375 . . . . 71.31 112.939 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -81.45 130.42 35.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.857 0.361 . . . . 71.54 111.738 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.52 129.84 53.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.009 0.433 . . . . 75.2 110.836 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.421 HG21 ' HE2' ' A' ' 32' ' ' PHE . 46.4 mt -112.74 121.92 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.485 -0.325 . . . . 73.1 111.381 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -93.91 117.76 30.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.246 0.546 . . . . 44.13 111.976 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -105.67 153.27 22.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.931 -0.577 . . . . 54.04 111.328 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.402 HG13 ' HA ' ' A' ' 35' ' ' LEU . 32.9 m -78.77 -28.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.152 0.427 . . . . 72.11 112.152 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.43 175.4 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.976 0.417 . . . . 54.13 111.764 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.5 p -78.57 131.05 69.18 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.375 -0.375 . . . . 72.43 111.572 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 58.1 Cg_endo -68.71 153.95 72.25 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.687 2.258 . . . . 51.32 113.936 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -111.51 120.2 41.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.745 -0.661 . . . . 64.11 111.134 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -82.07 125.86 31.33 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.112 -0.367 . . . . 64.43 110.307 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.11 114.98 26.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.18 0.514 . . . . 71.34 110.231 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.5 -28.08 65.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.807 -0.633 . . . . 74.44 112.102 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -83.24 -44.76 14.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.443 -0.344 . . . . 55.34 111.919 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 m -82.37 -27.81 31.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.046 0.387 . . . . 54.21 112.046 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.57 9.43 84.76 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.299 -0.477 . . . . 50.23 113.777 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.24 162.42 13.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.351 -0.5 . . . . 61.22 112.015 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 58.6 m-85 -101.77 127.07 48.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 73.13 110.282 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.5 mt-10 -99.15 119.7 38.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.498 -0.319 . . . . 71.23 110.418 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 35.9 p90 -142.21 148.37 38.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.192 0.52 . . . . 74.11 112.086 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -106.09 108.99 20.78 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.965 -0.561 . . . . 60.04 110.566 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 45.2 mt-30 -66.43 171.14 5.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.323 0.49 . . . . 70.05 112.323 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.402 ' HA ' HG13 ' A' ' 18' ' ' VAL . 84.7 mt -58.91 -21.9 58.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.304 -0.407 . . . . 64.34 112.074 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.26 -11.91 57.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.095 0.406 . . . . 62.34 112.095 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.4 -4.73 51.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.288 -0.482 . . . . 60.43 114.095 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -75.68 117.3 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.191 -0.594 . . . . 64.41 111.765 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.07 88.56 7.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.369 0.604 . . . . 73.24 109.871 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 t -106.78 165.07 11.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.084 -0.507 . . . . 72.21 111.665 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 23.3 mtm180 -125.87 138.44 53.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.964 0.411 . . . . 73.15 112.021 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -133.17 147.65 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.245 -0.434 . . . . 62.31 110.702 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.74 148.22 50.67 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.229 0.537 . . . . 74.23 112.062 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.37 -15.49 63.33 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.736 1.013 . . . . 61.22 113.736 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -79.54 -11.01 59.9 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.797 -0.564 . . . . 55.13 111.615 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -90.57 -26.65 19.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.295 0.479 . . . . 65.4 112.295 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.81 117.63 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.455 0.645 . . . . 72.42 112.671 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.537 ' HG2' HG23 ' A' ' 49' ' ' THR . 50.9 ttt180 -82.61 -60.89 2.04 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.998 -0.547 . . . . 73.05 111.524 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.2 p -141.99 143.49 33.21 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.461 -0.336 . . . . 74.22 111.858 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.23 123.65 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.5 -0.318 . . . . 62.5 111.064 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -138.41 155.52 48.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.144 0.497 . . . . 72.31 111.822 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.222 0.534 . . . . 73.05 111.512 178.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 110.842 -0.058 . . . . 72.32 110.842 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 8.1 Cg_endo -49.15 116.31 2.17 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.79 2.327 . . . . 73.32 112.951 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.6 m -121.95 132.34 54.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.3 -0.409 . . . . 73.02 111.462 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 p -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.264 0.555 . . . . 75.05 111.17 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG23 HG23 ' A' ' 47' ' ' VAL . 67.2 mt -111.69 109.3 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.031 -0.531 . . . . 74.2 111.162 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.5 m -83.77 118.62 24.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.69 0.281 . . . . 64.34 110.353 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.44 155.62 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.906 0.384 . . . . 74.44 111.603 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.29 -21.64 65.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.078 0.465 . . . . 75.52 111.194 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.82 -2.5 47.48 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.146 -0.479 . . . . 74.4 112.192 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.09 -28.06 17.42 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.624 -0.322 . . . . 65.33 113.202 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -66.68 136.23 55.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.822 0.344 . . . . 73.4 111.827 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.74 129.6 56.06 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.29 -0.256 . . . . 61.41 110.704 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.4 mt -109.68 128.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.82 0.343 . . . . 73.22 111.118 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -95.89 119.36 34.24 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.31 0.576 . . . . 73.24 112.122 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . -110.95 168.28 9.61 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.749 -0.659 . . . . 65.04 111.33 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 33.2 m -102.65 -5.26 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 111.866 0.321 . . . . 64.32 111.866 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -138.42 174.16 10.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.248 0.546 . . . . 72.14 112.059 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.2 p -80.96 121.63 81.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.946 -0.57 . . . . 71.54 111.567 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -61.34 128.53 25.24 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.92 2.413 . . . . 71.44 113.837 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 28.2 ttmt -91.65 141.97 28.12 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.925 -0.579 . . . . 73.54 110.82 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -101.67 129.83 47.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.796 -0.565 . . . . 74.25 111.366 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -132.04 116.37 16.99 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.917 0.389 . . . . 74.4 111.337 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.44 -32.2 68.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.738 0.273 . . . . 74.21 111.738 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -55.05 -37.92 67.33 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.875 0.369 . . . . 60.21 111.587 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.1 p -97.32 -27.95 14.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.887 0.375 . . . . 51.15 110.857 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.38 10.94 69.99 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.349 -0.387 . . . . 71.33 113.209 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -122.18 171.55 8.92 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.527 0.679 . . . . 64.35 112.718 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.4 m-85 -102.17 132.78 47.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 64.34 110.484 169.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -98.27 120.43 38.66 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.68 0.276 . . . . 74.44 111.028 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -148.9 146.41 27.88 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 75.44 111.331 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 37.9 ttmt -100.85 114.67 28.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.501 -0.318 . . . . 74.15 111.606 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -60.15 164.13 4.35 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.139 0.422 . . . . 64.15 112.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -53.58 -32.13 49.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.952 0.406 . . . . 71.34 111.751 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -72.88 0.22 11.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.241 0.459 . . . . 64.21 112.241 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 25.35 61.36 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.896 -0.669 . . . . 61.34 112.121 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -106.45 106.77 17.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.829 0.347 . . . . 65.33 111.04 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 57.3 tt0 -81.52 110.84 17.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.323 -0.399 . . . . 73.14 111.056 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -124.3 166.84 15.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.081 0.467 . . . . 64.14 111.966 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 62.7 mtt180 -126.06 126.59 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.153 -0.476 . . . . 72.21 111.47 -176.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.612 0.244 . . . . 73.53 111.435 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.29 148.4 51.76 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.281 0.562 . . . . 75.22 112.356 -174.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HZ2' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -62.05 -32.03 72.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.335 1.235 . . . . 74.41 114.335 -172.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -84.44 -12.69 53.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.639 -0.663 . . . . 54.34 112.209 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.77 -28.16 55.57 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.297 0.48 . . . . 61.44 112.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 7' ' ' ILE . 7.5 p -76.82 113.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.267 0.556 . . . . 73.33 112.253 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -82.96 -60.14 2.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.031 0.444 . . . . 74.5 111.066 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.0 p -130.64 162.19 29.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.163 0.431 . . . . 64.33 112.163 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.0 t -137.36 106.95 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 116.022 -0.535 . . . . 63.42 110.743 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -132.78 154.09 50.59 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.303 0.573 . . . . 71.24 112.011 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.311 0.577 . . . . 50.1 111.133 178.8 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.238 0.066 . . . . 73.45 110.86 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 47.6 Cg_endo -68.3 114.62 3.5 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.591 1.527 . . . . 43.53 111.802 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.6 m -123.83 126.67 46.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.258 -0.428 . . . . 71.52 111.541 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.33 117.85 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.457 0.646 . . . . 60.01 110.891 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.412 HD11 ' HB3' ' A' ' 21' ' ' PRO . 66.6 mt -100.64 111.73 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.086 -0.507 . . . . 60.41 111.187 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 99.6 m -83.8 121.26 27.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.508 -0.315 . . . . 73.12 110.824 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 15' ' ' ILE . 75.3 mt -89.06 172.1 9.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 62.34 111.893 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -51.88 -41.24 61.75 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.87 -0.605 . . . . 61.3 112.212 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.2 -15.46 62.47 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.708 0.633 . . . . 75.4 112.708 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.79 -1.22 68.18 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.808 -0.517 . . . . 70.42 111.808 -170.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -72.11 136.36 46.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.763 0.425 . . . . 73.44 110.968 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.59 133.74 48.11 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.886 0.374 . . . . 71.32 111.592 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 9' ' ' LEU . 63.0 mt -108.55 124.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.739 0.304 . . . . 60.41 110.555 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.6 111.34 23.28 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 72.34 111.506 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.61 150.1 33.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.82 0.343 . . . . 64.25 111.826 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.557 HG13 HD23 ' A' ' 35' ' ' LEU . 29.5 m -96.68 2.32 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.949 0.404 . . . . 74.43 111.281 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 2.7 t0 -140.19 164.69 29.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.199 -0.455 . . . . 52.42 110.077 -175.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.7 p -80.01 140.14 53.66 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 112.396 0.517 . . . . 63.35 112.396 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 32' ' ' PHE . 61.7 Cg_endo -72.6 111.15 3.16 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.545 2.163 . . . . 72.4 113.244 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -86.8 110.29 19.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.754 -0.657 . . . . 71.41 111.321 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -84.68 122.22 28.78 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.881 0.326 . . . . 72.42 111.881 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.65 122.16 41.52 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.936 0.398 . . . . 72.43 110.52 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.03 -42.14 73.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.309 -0.405 . . . . 63.43 111.987 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.41 -40.37 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.389 0.514 . . . . 71.5 112.389 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.579 ' HG ' ' HD2' ' A' ' 29' ' ' PHE . 8.7 t -97.54 -27.3 14.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.895 0.379 . . . . 65.11 111.825 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 10.76 79.07 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.099 -0.572 . . . . 33.33 114.252 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' HD2' ' HG ' ' A' ' 27' ' ' SER . 95.9 m-85 -101.97 154.45 18.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.286 0.543 . . . . 71.03 111.99 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CE1' HG11 ' A' ' 47' ' ' VAL . 52.8 m-85 -101.51 121.75 42.55 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.043 -0.526 . . . . 64.43 110.042 171.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.1 119.33 38.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.424 -0.353 . . . . 75.41 110.555 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.486 ' HB3' ' HA ' ' A' ' 21' ' ' PRO . 28.6 p90 -148.0 168.32 22.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.745 0.646 . . . . 72.21 112.745 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 4.6 ttmp? -112.68 116.61 30.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.732 -0.667 . . . . 70.05 110.941 -176.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 47.9 mt-30 -76.28 173.52 11.29 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.17 0.433 . . . . 75.14 112.17 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 18' ' ' VAL . 78.0 mt -57.11 -30.82 64.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.909 0.385 . . . . 65.41 111.902 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.92 -11.9 60.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.952 0.406 . . . . 74.11 111.58 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.33 -11.97 69.54 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.399 -0.429 . . . . 55.12 112.401 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -69.51 124.86 25.02 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.914 0.388 . . . . 74.53 111.578 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -82.67 140.07 33.35 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.375 -0.375 . . . . 75.35 110.641 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 t -145.82 156.28 43.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.93 0.395 . . . . 62.54 112.051 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 42.5 mtm180 -127.14 129.34 47.7 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.22 -0.446 . . . . 53.24 110.842 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 tt -130.44 141.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.647 0.26 . . . . 72.12 110.927 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.433 HD22 ' H ' ' A' ' 45' ' ' ASP . 10.1 t30 -69.13 152.09 45.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.755 0.788 . . . . 75.14 112.685 -172.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -59.51 -14.96 14.82 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.309 1.226 . . . . 74.41 114.309 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' H ' HD22 ' A' ' 43' ' ' ASN . 37.5 p-10 -78.59 -32.07 47.46 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.984 -0.448 . . . . 61.23 112.018 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -78.72 -28.64 45.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.547 0.573 . . . . 74.15 112.547 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.482 HG11 ' CE1' ' A' ' 30' ' ' TYR . 7.4 p -73.4 114.03 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.446 0.641 . . . . 71.13 111.912 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -83.65 -58.08 2.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.363 -0.38 . . . . 74.23 111.115 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.5 p -142.58 135.26 28.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.061 0.393 . . . . 54.31 112.061 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.8 t -100.07 116.64 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 116.423 -0.353 . . . . 72.14 110.95 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -132.31 150.99 52.04 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.948 0.351 . . . . 74.44 111.948 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 120.963 0.411 . . . . 70.35 111.368 172.402 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 110.508 -0.182 . . . . 72.35 110.508 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.61 115.28 2.96 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.742 1.628 . . . . 64.24 111.479 173.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.9 m -125.09 128.36 48.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.761 0.315 . . . . 74.22 111.47 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.95 119.24 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.457 0.646 . . . . 73.12 111.555 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.6 mt -101.21 110.65 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.037 -0.528 . . . . 72.33 110.675 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.1 m -89.47 129.4 35.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.556 -0.293 . . . . 54.32 110.952 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.95 161.96 15.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.859 0.361 . . . . 74.31 110.8 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 11.5 t30 -62.7 -24.43 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.871 0.693 . . . . 74.13 112.871 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.52 -22.37 57.17 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.845 0.355 . . . . 71.21 111.691 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.65 -6.56 13.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.254 -0.498 . . . . 41.11 113.04 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -73.6 131.69 41.97 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.603 -0.351 . . . . 65.24 111.701 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -104.43 129.31 52.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.86 0.362 . . . . 72.22 111.178 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.93 119.37 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.781 0.324 . . . . 73.44 110.688 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -94.28 132.88 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.1 0.476 . . . . 75.03 111.584 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.3 157.34 33.43 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.183 -0.462 . . . . 72.04 111.978 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.83 2.39 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.124 -0.489 . . . . 54.14 111.296 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.61 160.47 38.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.977 -0.556 . . . . 71.11 110.529 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.8 p -79.69 142.16 56.79 Favored Pre-proline 0 N--CA 1.469 0.48 0 CA-C-O 120.694 0.283 . . . . 73.1 111.331 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HB3' HD11 ' A' ' 7' ' ' ILE . 76.2 Cg_endo -75.71 146.72 30.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.689 2.26 . . . . 75.44 113.996 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 32.2 ttmt -110.65 132.6 54.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.806 -0.634 . . . . 73.41 110.375 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -90.08 119.24 30.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.387 -0.525 . . . . 72.32 110.021 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -97.38 106.03 18.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.268 0.556 . . . . 72.33 110.641 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.31 -23.03 64.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.89 -0.595 . . . . 75.52 111.852 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -69.27 -39.24 78.52 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.584 0.587 . . . . 64.2 112.584 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -118.08 -27.19 6.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.492 0.552 . . . . 71.33 112.492 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.11 11.45 31.92 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.891 -0.671 . . . . 33.25 114.174 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.511 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 91.6 m-85 -102.05 156.65 17.41 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.776 0.658 . . . . 75.42 112.776 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 55.6 m-85 -101.43 124.46 47.14 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.808 -0.633 . . . . 72.14 110.855 173.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 22' ' ' LYS . 44.0 mt-10 -99.74 122.17 42.33 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.781 0.432 . . . . 64.14 111.955 -177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -154.85 162.3 41.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.045 0.45 . . . . 72.43 111.339 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -106.14 114.66 28.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.178 -0.464 . . . . 71.25 111.337 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -65.29 169.14 6.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.131 -0.486 . . . . 64.43 112.303 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.4 mt -55.37 -26.68 42.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.292 -0.413 . . . . 61.3 112.05 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.5 -4.7 32.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 111.997 0.369 . . . . 63.23 111.997 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 28.94 57.63 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.068 -0.587 . . . . 44.14 112.368 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.2 133.67 55.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.627 0.371 . . . . 62.43 111.296 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -89.07 123.64 33.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.837 0.351 . . . . 72.31 110.822 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -133.29 165.25 25.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.879 0.371 . . . . 73.01 111.623 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 29' ' ' PHE . 57.1 mtp180 -129.1 125.72 37.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.411 -0.359 . . . . 54.34 110.229 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.93 143.74 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.685 0.279 . . . . 75.35 111.573 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -64.5 147.5 52.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.447 0.641 . . . . 74.45 112.636 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.426 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.4 ptmt -64.0 -22.61 67.0 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.923 1.083 . . . . 63.22 113.923 -173.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -82.66 -10.85 58.75 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.61 -0.682 . . . . 73.23 111.89 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -82.67 -28.44 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.882 0.327 . . . . 73.45 111.882 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -75.7 122.17 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.777 0.798 . . . . 73.44 112.845 -173.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HG2' HG23 ' A' ' 49' ' ' THR . 63.9 ttt180 -82.06 -62.77 1.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.608 -0.724 . . . . 75.2 110.272 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 48' ' ' ARG . 46.0 p -144.38 149.03 35.46 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.832 -0.622 . . . . 71.21 111.592 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -116.01 118.94 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.289 -0.414 . . . . 75.13 110.504 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -131.25 127.8 38.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.759 0.651 . . . . 74.3 112.759 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.3 -0.63 . . . . 65.42 109.3 169.92 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 110.52 -0.178 . . . . 65.33 110.52 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.95 119.49 6.56 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.486 2.124 . . . . 71.55 112.899 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 87.2 m -116.76 128.15 55.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.779 0.323 . . . . 74.12 111.8 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 p -98.81 129.39 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.218 0.533 . . . . 63.05 110.59 173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.43 118.51 56.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.852 0.358 . . . . 73.11 111.805 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.7 m -84.01 125.94 32.56 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.788 -0.449 . . . . 65.55 109.788 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.9 176.19 6.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.944 0.878 . . . . 74.14 112.915 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -64.74 -42.45 95.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.989 -1.005 . . . . 60.21 111.166 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.55 -23.74 62.67 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.97 0.414 . . . . 73.51 111.789 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.99 -18.19 9.07 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.354 -0.451 . . . . 62.43 113.522 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -64.31 136.05 56.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.228 0.514 . . . . 73.03 111.743 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.92 135.04 52.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.616 0.246 . . . . 72.24 110.823 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.8 mt -116.83 122.98 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.597 0.237 . . . . 71.31 111.206 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -85.92 116.7 24.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.075 0.464 . . . . 72.52 111.596 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.26 142.82 41.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.32 -0.4 . . . . 73.41 111.44 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 35' ' ' LEU . 26.4 m -82.31 -11.14 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.883 0.373 . . . . 41.3 111.718 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -128.51 157.7 40.45 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.248 -0.433 . . . . 71.15 109.912 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -79.28 143.65 60.82 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-O 120.967 0.413 . . . . 74.44 111.923 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.77 131.51 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.689 2.259 . . . . 72.14 113.772 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -103.39 132.22 49.82 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.828 -0.624 . . . . 75.53 110.631 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.75 123.92 34.17 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.014 -0.429 . . . . 44.34 111.497 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.99 106.46 18.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.012 0.435 . . . . 72.3 110.19 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.84 -21.66 63.34 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.342 -0.39 . . . . 73.42 111.935 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -69.17 -46.37 67.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.86 0.362 . . . . 71.01 111.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 97.2 p -101.09 -27.03 13.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.153 0.427 . . . . 64.12 112.153 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.11 8.39 64.75 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.219 -0.515 . . . . 44.32 113.265 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.409 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 59.2 m-85 -95.71 155.21 16.84 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.201 0.524 . . . . 63.51 111.767 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 39.8 m-85 -101.46 131.05 47.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.148 -0.478 . . . . 72.3 111.114 172.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -98.9 118.94 36.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.078 -0.51 . . . . 75.32 110.655 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.47 142.4 31.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.302 0.572 . . . . 75.53 111.91 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -94.11 110.72 22.41 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.764 -0.653 . . . . 51.42 111.476 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.69 173.59 2.15 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.064 0.459 . . . . 61.31 112.217 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.605 ' HA ' HG13 ' A' ' 18' ' ' VAL . 89.2 mt -49.15 -45.75 44.28 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.23 0.826 . . . . 74.11 113.23 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.3 m-20 -80.2 15.07 1.65 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.56 0.578 . . . . 45.33 112.56 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.96 86.0 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.907 -0.663 . . . . 74.25 112.454 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.7 mtpp -80.96 105.07 11.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.605 0.362 . . . . 64.04 111.79 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -73.86 123.83 24.97 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.765 0.317 . . . . 72.43 110.905 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -135.1 160.19 39.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.504 -0.316 . . . . 63.01 110.77 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 76.2 mtm180 -134.07 142.01 47.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.964 0.357 . . . . 74.22 111.964 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.28 152.91 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.253 -0.43 . . . . 64.4 110.293 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.12 153.79 36.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.76 0.652 . . . . 65.21 112.76 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.36 -14.91 62.8 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.47 0.915 . . . . 73.24 113.47 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -85.28 -11.08 55.6 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.898 -0.501 . . . . 74.41 111.595 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -90.36 -27.59 19.26 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.207 0.447 . . . . 73.45 112.207 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.3 p -70.09 111.49 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.556 0.693 . . . . 63.23 111.508 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HG2' HG23 ' A' ' 49' ' ' THR . 21.7 ttm-85 -83.03 -62.77 1.51 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.883 -0.599 . . . . 74.14 111.254 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.513 HG23 ' HG2' ' A' ' 48' ' ' ARG . 61.7 p -141.04 135.64 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.178 0.514 . . . . 74.5 111.95 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.54 124.57 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.022 -0.535 . . . . 73.31 111.225 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -142.64 144.22 32.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.338 0.255 . . . . 71.1 111.577 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 35.6 m-20 . . . . . 0 CA--C 1.541 0.615 0 CA-C-O 121.029 0.442 . . . . 60.44 111.547 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 40.5 t . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 120.068 -0.015 . . . . 65.42 111.013 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 3' ' ' SER . 10.8 Cg_endo -53.29 116.31 2.87 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.303 2.002 . . . . 64.15 111.768 177.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.8 m -132.77 141.46 48.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.342 -0.39 . . . . 71.45 111.123 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.9 117.89 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.557 0.694 . . . . 70.53 111.468 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.16 104.5 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.253 0.549 . . . . 72.1 110.513 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.0 m -85.67 119.18 25.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.964 -0.562 . . . . 52.42 110.755 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.19 157.13 24.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.779 0.323 . . . . 74.3 111.217 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.545 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 26.4 t-20 -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.993 0.368 . . . . 64.4 111.993 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.37 -8.45 55.9 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.405 0.52 . . . . 63.12 112.405 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.45 -33.2 4.58 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.803 -0.713 . . . . 72.24 114.666 175.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.2 135.1 44.49 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.673 0.736 . . . . 72.01 112.427 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.35 129.98 53.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.28 -0.418 . . . . 75.24 110.485 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.25 130.48 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.824 0.345 . . . . 71.31 111.234 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -96.56 119.2 34.61 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.06 0.457 . . . . 71.14 111.999 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.7 153.15 38.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.348 -0.387 . . . . 54.12 111.5 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.31 -10.58 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.832 0.349 . . . . 62.05 111.769 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.7 166.55 24.55 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.419 . . . . 64.32 111.579 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.7 p -80.84 138.29 50.2 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 112.178 0.436 . . . . 61.24 112.178 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 69.0 Cg_endo -71.67 126.31 11.95 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.658 2.239 . . . . 65.21 113.941 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 2.2 ttmp? -86.45 141.21 29.29 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.412 -0.358 . . . . 75.14 110.311 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -99.11 129.89 45.4 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.12 0.486 . . . . 74.12 112.095 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -109.28 111.87 23.7 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.974 -0.557 . . . . 70.11 110.109 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.73 -35.33 79.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.554 0.575 . . . . 62.2 112.554 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.11 -52.72 53.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.954 0.407 . . . . 51.22 111.829 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.5 m -85.56 -26.96 25.85 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.306 -0.406 . . . . 34.54 111.754 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.79 8.91 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.404 -0.427 . . . . 63.33 113.912 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 83.6 m-85 -102.81 156.21 17.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.222 0.534 . . . . 73.42 112.116 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 67.7 m-85 -101.93 135.59 43.21 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.627 -0.715 . . . . 63.23 110.603 172.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 36.0 mt-10 -98.89 118.78 36.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.441 0.163 . . . . 71.24 110.786 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -147.74 152.22 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.156 0.503 . . . . 73.02 111.641 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 4.1 ttmp? -106.9 112.71 25.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.128 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -64.82 164.85 11.57 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.769 0.319 . . . . 75.54 111.799 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.9 mt -53.51 -29.72 37.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.386 0.884 . . . . 61.21 113.386 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -77.28 -11.54 59.84 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.91 0.386 . . . . 70.44 111.679 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.51 -6.28 49.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.527 -0.368 . . . . 53.31 112.242 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -70.4 101.57 1.98 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.928 0.491 . . . . 75.35 111.74 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.2 tt0 -82.07 107.28 14.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.756 0.312 . . . . 74.23 110.366 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.3 t -123.68 165.2 17.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.056 0.455 . . . . 74.42 111.836 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 49.4 mtm180 -124.59 132.49 53.44 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.962 -0.563 . . . . 75.23 111.715 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 tt -130.93 146.62 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.685 0.278 . . . . 71.13 111.211 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -71.75 152.28 42.87 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.571 0.582 . . . . 73.24 112.571 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 pttp -57.97 -31.52 66.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.516 0.932 . . . . 53.54 113.516 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -69.01 -11.64 60.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.415 0.524 . . . . 54.24 112.415 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -88.14 -27.79 21.66 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.585 0.587 . . . . 74.53 112.585 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 44' ' ' LYS . 10.7 p -76.91 118.64 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.806 0.812 . . . . 64.03 112.809 -173.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 57.4 ttt180 -81.9 -58.44 2.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.211 -0.904 . . . . 74.43 111.077 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.4 p -148.08 134.53 19.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.863 -0.608 . . . . 73.55 111.189 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 111.2 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 62.31 110.983 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -133.5 141.95 48.0 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.035 0.445 . . . . 71.04 111.761 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 116.254 -0.43 . . . . 72.31 110.464 174.669 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 p . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 120.445 0.164 . . . . 62.33 110.826 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.07 120.83 6.61 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.892 2.395 . . . . 61.13 112.339 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -125.71 133.04 52.26 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.437 -0.347 . . . . 71.52 111.826 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -99.97 124.5 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.173 0.511 . . . . 75.53 110.758 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.4 120.06 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.073 0.463 . . . . 71.34 110.988 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.0 m -100.01 118.49 36.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.033 -0.531 . . . . 71.15 110.826 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.467 HD12 ' HD3' ' A' ' 13' ' ' ARG . 78.3 mt -83.89 168.35 16.16 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.863 0.363 . . . . 73.34 111.521 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.58 -28.73 70.13 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.493 -0.321 . . . . 63.05 111.455 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.21 -16.21 59.44 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.036 0.446 . . . . 74.22 111.61 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.35 67.81 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.677 -0.569 . . . . 54.12 111.677 -170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HD3' HD12 ' A' ' 9' ' ' LEU . 78.0 ttt180 -77.33 136.37 38.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.308 0.643 . . . . 74.22 111.217 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.33 130.24 56.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.989 0.423 . . . . 71.34 111.767 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.0 mt -122.42 130.49 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.093 -0.503 . . . . 52.22 110.618 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -94.85 127.99 41.27 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.101 0.477 . . . . 74.11 112.037 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.82 164.3 17.72 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.083 -0.508 . . . . 72.24 111.453 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.73 -18.36 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.211 0.448 . . . . 72.24 112.211 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -126.94 172.48 10.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.275 0.56 . . . . 65.42 111.868 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -79.81 119.39 76.57 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.812 -0.631 . . . . 64.02 110.499 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.82 134.34 41.27 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.072 2.515 . . . . 63.02 113.951 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -85.63 124.64 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.606 -0.724 . . . . 73.44 110.746 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.81 108.62 20.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 75.32 110.983 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.25 110.54 23.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.971 0.415 . . . . 74.44 110.592 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.75 -39.29 93.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 71.51 111.993 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.19 -43.03 99.36 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.157 0.429 . . . . 72.4 112.157 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 m -91.75 -28.08 17.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.934 0.346 . . . . 54.4 111.934 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 11.94 72.85 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.922 -0.656 . . . . 72.23 113.824 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.96 155.12 21.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.387 0.613 . . . . 63.12 112.462 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.69 129.9 47.95 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.58 -0.736 . . . . 72.11 110.326 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.579 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.2 mt-10 -108.28 121.91 45.86 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.592 -0.276 . . . . 72.5 111.194 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.77 143.79 29.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.82 0.343 . . . . 72.22 111.627 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.6 ttmt -98.4 114.55 26.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.767 0.318 . . . . 71.55 111.241 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -60.6 165.11 4.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.412 -0.358 . . . . 74.23 111.779 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.64 -26.68 61.97 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.87 0.366 . . . . 73.52 111.623 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.88 -6.21 43.57 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.48 0.548 . . . . 70.11 112.48 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.09 23.9 46.81 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.075 -0.584 . . . . 73.41 112.747 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -112.63 112.3 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.794 0.331 . . . . 45.43 111.457 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.9 tt0 -89.69 109.81 20.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.806 0.336 . . . . 73.15 111.319 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -111.87 163.42 14.23 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.935 0.398 . . . . 61.11 111.529 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 55.4 mtt180 -123.51 131.64 53.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.928 0.394 . . . . 74.33 111.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.84 152.37 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.441 -0.345 . . . . 62.55 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -66.87 147.29 53.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.184 0.516 . . . . 73.53 111.667 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.4 ptmt -65.07 -20.2 66.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.983 0.734 . . . . 73.51 112.983 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -76.55 -10.25 59.25 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.314 0.487 . . . . 74.02 112.314 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -90.96 -17.73 25.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.875 0.694 . . . . 73.43 112.875 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 44' ' ' LYS . 8.9 p -75.0 117.79 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.481 0.658 . . . . 60.04 112.618 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -83.51 -61.72 1.77 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.303 0.573 . . . . 51.24 110.656 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.9 p -147.06 150.46 35.1 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.669 -0.696 . . . . 63.22 111.369 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.4 t -126.58 118.25 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.236 -0.438 . . . . 65.11 110.812 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.19 136.62 49.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.358 0.503 . . . . 71.22 112.358 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 . . . . . 0 CA--C 1.541 0.606 0 CA-C-N 116.332 -0.395 . . . . 74.25 110.523 172.227 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 110.689 -0.115 . . . . 71.42 110.689 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.42 116.76 3.82 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.565 2.176 . . . . 71.43 113.107 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -131.89 134.23 45.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.438 -0.346 . . . . 74.14 111.295 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.77 125.72 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.494 0.664 . . . . 63.25 111.685 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.3 mt -98.51 116.98 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.291 -0.413 . . . . 73.41 111.615 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.6 m -88.79 124.38 34.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.392 -0.367 . . . . 53.41 110.721 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.18 164.75 13.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.119 0.485 . . . . 71.04 112.282 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -54.61 -33.94 61.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.358 0.663 . . . . 73.44 111.384 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.14 -12.47 60.9 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.848 -0.615 . . . . 65.24 111.907 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.73 -24.72 30.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.436 -0.411 . . . . 61.15 112.677 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.16 135.7 57.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.846 0.355 . . . . 73.3 111.804 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.61 148.65 31.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.503 -0.317 . . . . 73.5 111.558 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.58 127.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.625 -0.261 . . . . 61.23 110.847 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -93.08 124.0 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.091 0.472 . . . . 71.3 111.995 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.06 156.8 26.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.122 -0.49 . . . . 53.13 111.55 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -88.94 -9.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.017 0.377 . . . . 63.33 112.017 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.61 166.44 24.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.102 0.477 . . . . 71.25 111.443 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.5 p -79.61 140.85 55.58 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.232 -0.44 . . . . 73.24 111.61 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 61.6 Cg_endo -71.47 148.73 54.85 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.594 2.196 . . . . 75.22 113.943 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -105.62 135.1 47.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.764 -0.653 . . . . 74.51 110.324 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -87.03 122.26 30.62 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.05 0.452 . . . . 75.12 111.739 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -98.1 108.67 21.43 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.144 -0.48 . . . . 70.01 110.951 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.63 -14.24 55.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.788 0.327 . . . . 71.43 111.61 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -63.0 -52.88 61.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 74.42 111.376 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -118.72 -26.8 6.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.033 0.383 . . . . 75.1 112.033 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.69 11.88 10.98 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.406 -0.902 . . . . 71.1 114.614 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.1 162.29 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.745 0.772 . . . . 70.23 112.708 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 43.6 m-85 -110.27 132.71 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.743 -0.662 . . . . 72.43 110.798 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 55.8 mt-10 -99.28 119.57 38.13 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.364 -0.21 . . . . 61.32 111.089 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -151.32 145.04 25.04 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.009 0.433 . . . . 72.33 111.434 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 3.5 ttmp? -98.26 112.44 24.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.538 -0.301 . . . . 65.32 111.494 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.68 162.15 8.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.943 0.401 . . . . 74.43 111.853 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 18' ' ' VAL . 84.1 mt -48.84 -39.91 27.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.722 0.638 . . . . 74.41 112.722 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.89 9.33 1.18 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.753 0.649 . . . . 64.35 112.753 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 46.66 25.11 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.918 -0.658 . . . . 72.44 112.322 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -125.01 104.71 8.71 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.656 -0.32 . . . . 71.42 111.289 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.9 tt0 -75.61 100.59 4.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.134 0.492 . . . . 73.14 110.371 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.3 t -114.21 165.72 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.07 0.462 . . . . 72.44 111.511 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.3 mtm180 -129.8 144.69 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.34 -0.391 . . . . 61.3 111.647 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 tt -139.51 149.71 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.301 -0.409 . . . . 73.43 110.901 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.51 153.93 30.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.797 0.665 . . . . 71.31 112.797 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 30' ' ' TYR . 25.4 pttm -58.88 -25.72 63.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.868 1.062 . . . . 74.21 113.868 -175.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -79.56 -11.22 59.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.236 0.458 . . . . 62.11 112.236 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -94.23 -18.32 21.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.426 0.528 . . . . 74.04 112.426 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.51 119.95 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.766 0.654 . . . . 71.44 112.766 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -82.68 -66.92 0.83 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.349 -0.387 . . . . 71.31 110.505 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -146.83 137.77 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.94 -0.573 . . . . 54.24 111.417 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.94 108.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.735 0.302 . . . . 54.21 110.74 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.87 142.66 39.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.084 0.469 . . . . 71.33 111.679 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.065 0.459 . . . . 71.34 111.22 177.19 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 p . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 120.389 0.137 . . . . 71.53 110.933 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.17 118.95 5.74 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.98 2.454 . . . . 71.2 112.9 -177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 m -126.24 126.95 44.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.192 -0.458 . . . . 74.11 111.378 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.511 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.5 p -105.13 125.94 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.141 0.496 . . . . 73.42 111.848 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.78 113.18 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.788 0.327 . . . . 74.3 111.324 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.9 m -83.44 134.58 34.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.18 -0.304 . . . . 53.44 110.18 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -100.76 170.18 8.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.053 0.454 . . . . 71.11 112.069 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -52.12 -45.11 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.864 -0.607 . . . . 75.13 112.606 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.67 -21.86 64.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.035 0.445 . . . . 73.45 111.577 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.59 -23.85 7.8 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.026 -0.607 . . . . 71.03 113.598 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -56.6 129.86 42.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.176 0.488 . . . . 64.02 111.899 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -103.31 130.48 50.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.883 0.373 . . . . 74.33 110.909 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.87 120.52 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.543 -0.299 . . . . 71.33 110.532 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.51 127.26 41.4 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.141 0.496 . . . . 73.31 112.045 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.9 154.83 26.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.093 -0.503 . . . . 72.11 111.744 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.0 m -75.14 -29.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.001 0.371 . . . . 64.41 112.001 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -129.04 174.61 9.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.897 0.379 . . . . 75.23 111.348 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -78.78 141.27 59.44 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 63.52 111.648 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.51 138.66 35.93 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.616 2.211 . . . . 65.24 113.79 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -93.41 130.22 39.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.97 -0.559 . . . . 75.1 110.455 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -90.82 114.8 27.29 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.153 -0.342 . . . . 75.03 111.269 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -97.89 104.52 16.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.889 0.376 . . . . 54.44 110.672 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.89 -30.51 70.68 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.945 0.35 . . . . 74.42 111.945 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.21 -52.42 65.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.034 0.445 . . . . 54.11 111.959 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -102.41 -11.63 18.47 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.105 0.409 . . . . 72.54 112.105 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.35 80.25 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.06 -0.59 . . . . 51.21 114.005 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.516 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 67.8 m-85 -97.95 156.38 16.65 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.282 0.563 . . . . 73.41 112.477 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 68.1 m-85 -101.21 127.22 47.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.799 -0.637 . . . . 74.52 110.01 169.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.3 mt-10 -99.6 119.37 37.96 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.768 0.318 . . . . 61.01 111.088 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -144.74 144.61 31.28 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 75.33 111.942 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 2.4 ttmp? -99.33 109.81 22.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.256 -0.429 . . . . 73.03 110.698 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.8 mt-30 -60.49 160.66 8.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.002 0.371 . . . . 52.14 112.002 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HA ' HG13 ' A' ' 18' ' ' VAL . 83.3 mt -56.29 -27.5 55.63 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.364 0.505 . . . . 74.0 112.364 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.46 -11.54 59.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.011 0.434 . . . . 65.23 111.778 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.98 -21.35 31.86 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.379 -0.439 . . . . 64.53 112.711 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -63.07 104.01 0.53 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 111.762 0.282 . . . . 75.11 111.762 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.9 tt0 -88.4 118.3 27.93 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.757 0.313 . . . . 71.32 110.606 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 t -136.07 164.59 27.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.397 0.517 . . . . 73.51 112.397 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 17.9 mtm180 -110.65 155.88 21.77 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.845 -0.616 . . . . 73.22 110.775 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -147.98 144.77 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.601 0.239 . . . . 73.44 110.935 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -70.32 150.18 46.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.258 0.551 . . . . 52.55 112.137 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -63.14 -14.86 53.68 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.759 1.022 . . . . 72.22 113.759 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -89.2 -14.95 34.85 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.767 -0.583 . . . . 71.2 111.979 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -81.67 -28.61 33.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.916 0.388 . . . . 73.42 111.406 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.14 114.34 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.682 0.753 . . . . 74.23 112.383 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -81.75 -59.4 2.61 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.475 -0.784 . . . . 65.1 110.665 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.1 p -147.32 128.41 14.63 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.556 -0.293 . . . . 74.41 111.617 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.65 117.26 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.775 0.321 . . . . 63.32 110.389 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' HG13 ' A' ' 6' ' ' VAL . 34.7 mttm -118.02 132.08 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.607 0.595 . . . . 75.11 112.607 -176.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 . . . . . 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 74.02 109.685 170.6 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 110.409 -0.219 . . . . 61.44 110.409 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.4 115.16 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.97 1.78 . . . . 74.15 112.023 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.3 m -122.25 130.74 53.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.906 0.384 . . . . 73.13 111.536 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.4 117.91 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.411 0.624 . . . . 73.13 111.316 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.406 HG23 HG23 ' A' ' 47' ' ' VAL . 61.7 mt -96.14 105.65 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.914 -0.585 . . . . 51.13 111.285 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.2 m -85.39 121.49 28.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.465 -0.334 . . . . 71.43 110.755 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 mt -85.56 167.34 15.49 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.665 0.269 . . . . 71.43 111.036 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -54.87 -39.24 68.46 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.587 0.588 . . . . 45.51 112.587 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.18 -24.4 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.704 0.287 . . . . 71.44 111.612 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.74 15.56 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.313 -0.403 . . . . 73.43 113.285 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -68.09 125.86 27.7 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 122.489 -0.418 . . . . 64.41 111.306 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.13 129.3 49.95 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.066 0.46 . . . . 72.24 111.287 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -121.54 113.65 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.485 -0.325 . . . . 73.13 110.654 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -95.18 129.06 42.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.176 0.512 . . . . 44.04 112.282 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -116.57 161.74 18.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.08 -0.509 . . . . 74.12 111.767 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.65 -24.59 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.853 0.358 . . . . 60.55 111.558 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -122.46 165.45 16.33 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.154 -0.475 . . . . 42.43 111.297 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.3 p -79.56 127.77 77.12 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.357 -0.383 . . . . 71.0 111.112 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -51.37 123.01 11.16 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.311 2.674 . . . . 63.24 113.734 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -86.62 129.4 34.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.688 -0.687 . . . . 74.41 110.292 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -82.2 134.05 35.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.567 0.699 . . . . 72.41 112.232 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -98.62 106.16 18.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.481 -0.781 . . . . 64.32 110.583 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.3 -20.1 59.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.944 0.402 . . . . 74.41 111.886 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -69.18 -54.79 13.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.104 0.409 . . . . 73.34 112.104 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -115.74 -6.59 12.12 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.734 0.642 . . . . 71.2 112.734 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.86 12.64 57.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.274 -0.965 . . . . 63.33 114.31 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 47.7 m-85 -90.19 171.86 9.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.397 0.599 . . . . 72.44 112.296 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 61.5 m-85 -119.54 132.18 55.69 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.027 -0.533 . . . . 73.32 110.992 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.57 119.95 38.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.775 0.322 . . . . 71.11 110.785 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -151.29 140.45 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.415 -0.357 . . . . 72.12 110.943 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 40.8 ttmt -93.14 109.28 20.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.885 0.374 . . . . 71.14 110.681 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 41.8 mt-30 -62.19 160.1 13.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.466 -0.334 . . . . 72.3 111.385 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -55.34 -29.07 57.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.473 0.545 . . . . 65.32 112.473 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.81 -12.04 60.29 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.937 0.398 . . . . 63.41 111.863 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.92 -20.67 28.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.421 -0.419 . . . . 73.23 113.567 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.48 108.2 8.13 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.243 0.46 . . . . 64.42 112.243 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 40.2 tt0 -86.02 120.77 27.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 75.51 110.494 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 165.53 25.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.343 -0.39 . . . . 70.35 111.131 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 75.1 mtm180 -111.02 139.48 46.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.978 0.418 . . . . 63.33 111.37 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.69 146.01 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.357 -0.383 . . . . 45.04 110.841 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -68.5 145.82 53.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.481 0.658 . . . . 55.44 112.291 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -63.09 -18.91 63.91 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.292 0.849 . . . . 72.41 113.292 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -81.36 -13.23 58.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.057 0.392 . . . . 61.43 112.057 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -90.86 -27.98 18.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.049 0.389 . . . . 73.22 112.049 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 7' ' ' ILE . 6.7 p -76.67 116.1 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.422 0.63 . . . . 75.02 112.095 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HG2' HG23 ' A' ' 49' ' ' THR . 78.7 ttt180 -81.96 -64.72 1.12 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.087 -0.506 . . . . 65.44 111.312 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.554 HG23 ' HG2' ' A' ' 48' ' ' ARG . 82.8 p -133.32 133.62 42.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.853 0.358 . . . . 71.34 111.904 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.22 111.07 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.417 -0.356 . . . . 74.4 110.27 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 43.4 mtmt -121.99 145.22 48.34 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 64.22 111.663 -177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.893 0.378 . . . . 64.12 110.957 177.106 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.3 tpp . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.756 0.312 . . . . 63.25 110.936 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.56 130.45 52.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.046 0.451 . . . . 72.11 111.589 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m -156.76 137.59 9.27 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.162 -0.472 . . . . 64.24 110.162 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.566 ' HB2' HD12 ' A' ' 53' ' ' LEU . 64.1 Cg_endo -72.13 115.46 4.32 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.152 1.901 . . . . 73.25 112.982 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 69.6 m -125.96 122.35 35.7 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.46 -0.337 . . . . 70.14 111.377 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.26 115.02 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.487 0.66 . . . . 63.11 111.46 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -94.63 117.79 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.224 -0.444 . . . . 73.51 111.031 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 14' ' ' GLU . 22.8 m -98.47 123.63 42.72 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.267 -0.424 . . . . 71.2 110.651 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.432 HD12 ' HD3' ' A' ' 13' ' ' ARG . 72.2 mt -83.7 174.43 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.278 0.561 . . . . 74.14 112.453 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -53.74 -43.97 69.53 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.572 -0.74 . . . . 74.43 112.866 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -75.77 -24.33 56.0 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.113 0.482 . . . . 74.42 111.455 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.98 -6.75 10.99 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.39 -0.433 . . . . 65.33 113.274 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.432 ' HD3' HD12 ' A' ' 9' ' ' LEU . 77.8 ttt180 -59.94 115.88 3.73 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.862 0.331 . . . . 75.32 111.11 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HG2' HG23 ' A' ' 8' ' ' THR . 44.8 mt-10 -105.1 130.22 53.33 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.745 0.307 . . . . 60.13 111.68 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.4 mt -121.79 132.28 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.821 0.343 . . . . 75.3 110.554 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.459 HE21 HD11 ' A' ' 53' ' ' LEU . 50.3 mt-30 -98.73 125.86 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.132 0.492 . . . . 72.33 111.691 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.43 150.7 25.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.005 -0.543 . . . . 74.41 111.641 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.9 m -85.74 -17.18 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 120.991 0.424 . . . . 73.12 111.981 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.04 175.26 9.88 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 71.42 111.112 174.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.3 p -77.38 142.28 67.1 Favored Pre-proline 0 N--CA 1.472 0.66 0 N-CA-C 112.304 0.483 . . . . 61.3 112.304 -170.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 84.7 Cg_endo -76.47 157.47 36.6 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.855 2.37 . . . . 71.2 114.274 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -116.15 123.26 47.37 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.827 -0.624 . . . . 74.35 111.388 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -82.19 114.29 20.6 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.917 -0.401 . . . . 71.35 109.917 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -98.23 105.76 17.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.974 0.416 . . . . 74.5 111.591 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.43 -29.4 69.92 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.106 -0.497 . . . . 63.24 111.98 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -65.4 -55.11 19.89 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.208 0.447 . . . . 52.24 112.208 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.8 m -96.14 -17.93 20.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.014 0.375 . . . . 74.52 112.014 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.19 10.88 77.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.223 -0.513 . . . . 54.04 114.022 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -101.41 165.03 11.47 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.525 0.678 . . . . 71.13 112.226 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.65 122.71 44.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.413 -0.812 . . . . 72.25 110.022 167.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.592 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 26.3 mt-10 -98.96 119.66 38.11 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.273 -0.421 . . . . 73.45 110.527 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 23.1 p90 -140.03 144.58 36.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.192 0.52 . . . . 65.11 111.562 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 32.1 ttmt -95.08 110.58 22.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.773 -0.649 . . . . 72.25 111.564 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -60.36 169.07 1.8 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.4 0.519 . . . . 54.04 112.4 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.52 ' HA ' HG13 ' A' ' 18' ' ' VAL . 98.6 mt -53.15 -30.37 36.65 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.432 0.531 . . . . 70.25 112.432 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.642 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -73.16 -12.25 60.82 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.007 0.432 . . . . 72.44 111.602 -178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.85 13.36 60.99 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.239 -0.505 . . . . 74.23 112.55 -172.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.642 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 30.1 mtmm -96.88 125.33 41.24 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.71 0.291 . . . . 73.12 111.319 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -78.44 128.36 33.49 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.841 0.353 . . . . 74.31 111.324 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.3 t -131.65 163.48 28.02 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.836 0.351 . . . . 64.42 111.002 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 87.3 mtm180 -136.43 131.55 34.25 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.508 -0.314 . . . . 64.23 111.635 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.9 tt -134.15 150.92 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.524 0.202 . . . . 63.54 111.068 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -60.88 147.57 42.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.656 0.741 . . . . 61.41 112.881 -172.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -55.9 -24.13 35.6 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.134 1.161 . . . . 75.14 114.134 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -87.56 -17.12 32.73 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.221 0.452 . . . . 74.11 112.221 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -78.41 -17.68 56.05 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.342 0.497 . . . . 64.3 112.342 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.6 115.83 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.403 0.62 . . . . 73.54 112.178 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.461 ' NH2' HG21 ' A' ' 8' ' ' THR . 58.7 ttp180 -83.15 -62.29 1.63 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.141 0.496 . . . . 62.52 111.536 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.9 p -132.9 137.67 46.73 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.062 0.458 . . . . 73.24 111.963 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.7 t -113.2 106.09 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.126 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -135.4 149.46 49.66 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.33 0.586 . . . . 74.23 112.18 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.545 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 35.6 m-20 -81.78 163.04 22.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.799 -0.637 . . . . 70.23 111.007 176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.566 HD12 ' HB2' ' A' ' 4' ' ' PRO . 78.1 mt -79.65 -3.78 48.76 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.324 0.583 . . . . 62.2 110.442 171.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.18 20.17 11.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.74 -0.664 . . . . 74.51 111.862 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 52' ' ' ASP . 21.2 mm-40 . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.79 -0.624 . . . . 74.45 112.329 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.597 0.237 . . . . 53.3 111.304 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.46 -176.86 1.64 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.048 0.452 . . . . 72.22 111.567 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.1 t -160.62 143.31 9.66 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.289 -0.414 . . . . 44.33 110.671 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.03 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.65 1.567 . . . . 72.22 111.714 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 60.1 m -112.38 147.8 35.64 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.119 0.485 . . . . 72.45 111.998 -174.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.16 112.33 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.544 0.687 . . . . 63.01 110.494 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -90.41 105.68 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.02 -0.536 . . . . 70.4 111.089 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.6 m -83.72 107.7 16.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 74.23 110.987 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -78.08 153.58 32.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.653 0.263 . . . . 73.05 110.861 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -66.12 -14.32 61.6 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.918 0.39 . . . . 63.12 111.517 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.89 -8.78 57.73 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.762 0.315 . . . . 74.42 111.702 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.96 3.36 68.11 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.41 -0.424 . . . . 50.31 112.464 -175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -87.19 132.71 33.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.602 0.361 . . . . 74.54 111.06 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.79 130.15 55.65 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.997 0.427 . . . . 75.12 111.701 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.3 mt -109.85 128.51 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.26 -0.427 . . . . 65.42 110.894 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -97.97 126.71 43.5 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.074 0.464 . . . . 75.55 111.985 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -125.67 150.09 47.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.077 -0.51 . . . . 63.22 112.165 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.542 HG13 ' HA ' ' A' ' 35' ' ' LEU . 33.1 m -94.97 5.74 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 116.219 -0.446 . . . . 74.21 111.559 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -144.79 160.67 40.88 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.339 -0.391 . . . . 70.21 110.156 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.8 p -79.46 127.32 78.88 Favored Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.044 0.387 . . . . 74.13 112.044 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.33 113.57 2.31 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.437 2.092 . . . . 61.23 112.937 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -86.47 126.39 34.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.0 -0.545 . . . . 73.23 111.241 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -82.16 127.66 33.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.917 0.389 . . . . 74.54 110.183 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -114.4 98.35 6.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.756 0.312 . . . . 73.34 110.836 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -57.95 -27.29 63.27 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.291 0.478 . . . . 75.11 112.291 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -68.38 -47.79 66.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.228 -0.442 . . . . 70.53 111.885 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 99.6 p -90.29 -27.6 19.33 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.498 -0.319 . . . . 63.21 111.654 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.04 10.27 69.35 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.529 -0.367 . . . . 73.41 113.185 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -114.13 166.18 11.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.359 0.599 . . . . 63.5 112.195 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 34.1 m-85 -101.78 129.4 47.96 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.774 -0.648 . . . . 74.13 110.9 170.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.7 mt-10 -99.34 119.2 37.55 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.258 -0.428 . . . . 65.23 110.688 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 34.2 p90 -146.56 153.74 40.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.9 0.381 . . . . 74.23 111.786 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -110.02 109.76 20.43 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.446 -0.343 . . . . 71.01 111.245 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.0 mt-30 -62.03 168.76 3.04 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.435 0.531 . . . . 73.41 112.435 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.542 ' HA ' HG13 ' A' ' 18' ' ' VAL . 82.0 mt -54.89 -32.25 60.74 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.309 -0.405 . . . . 75.12 111.868 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.72 -11.77 60.75 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 120.856 0.36 . . . . 72.4 111.916 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.64 61.03 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.169 -0.538 . . . . 73.42 112.871 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -72.5 112.0 8.18 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.715 -0.285 . . . . 70.21 111.714 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.5 tt0 -88.67 106.21 18.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.226 0.536 . . . . 74.13 110.518 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -123.98 167.34 14.29 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.166 -0.47 . . . . 64.23 111.681 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 82.8 mtm180 -121.8 136.77 54.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.954 0.407 . . . . 75.45 112.005 -175.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.14 150.85 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 116.448 -0.342 . . . . 71.44 110.757 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -65.34 140.89 58.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.318 0.58 . . . . 73.21 111.724 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -63.26 -14.87 54.29 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.958 1.095 . . . . 72.52 113.958 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -83.26 -23.15 32.83 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.827 -0.545 . . . . 72.53 111.903 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' A' ' 46' ' ' GLN . 12.2 mm-40 -77.09 -28.23 54.46 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.368 0.507 . . . . 61.01 112.368 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.61 118.86 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.434 0.635 . . . . 74.34 111.93 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -81.9 -64.74 1.12 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.939 -0.573 . . . . 73.54 111.014 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.9 p -128.38 136.06 50.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.388 -0.369 . . . . 52.21 111.662 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -102.73 97.42 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.467 -0.333 . . . . 75.02 111.027 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -134.96 156.53 48.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.482 0.549 . . . . 63.52 112.482 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.625 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 31.9 m-20 -90.49 161.54 15.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.828 -0.624 . . . . 73.13 111.262 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.99 -27.25 64.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.324 0.583 . . . . 63.24 109.731 170.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.4 mt -124.98 93.02 3.77 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.657 -0.702 . . . . 63.34 110.777 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.699 -0.667 . . . . 54.2 111.247 177.807 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.405 0.145 . . . . 65.21 111.089 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.61 61.57 1.69 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.224 0.535 . . . . 75.15 110.267 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 m -89.88 154.04 47.55 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 115.733 -0.667 . . . . 71.31 110.886 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HB2' HD12 ' A' ' 53' ' ' LEU . 32.4 Cg_endo -63.5 115.17 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 121.777 1.651 . . . . 63.04 111.478 174.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 57.7 m -107.67 132.85 52.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.867 0.365 . . . . 63.12 111.865 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.75 127.63 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.336 0.589 . . . . 64.45 111.017 176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.67 115.48 45.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.286 -0.415 . . . . 73.12 111.548 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.2 m -88.2 123.29 32.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.558 -0.292 . . . . 51.51 110.276 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.64 159.8 15.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.334 0.588 . . . . 74.14 112.489 -175.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -56.0 -35.34 66.67 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.558 -0.746 . . . . 74.12 110.635 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.86 -30.94 71.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.505 -0.77 . . . . 73.24 111.745 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.1 -23.24 8.24 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 116.149 -0.478 . . . . 65.43 112.823 -175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -64.08 143.12 58.11 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.849 0.357 . . . . 75.13 111.94 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.05 129.91 56.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.775 0.321 . . . . 72.14 111.407 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.0 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.646 0.26 . . . . 52.51 110.871 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.416 HE21 HD11 ' A' ' 53' ' ' LEU . 52.5 mt-30 -95.26 135.75 36.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.235 0.54 . . . . 74.25 112.206 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -128.44 156.94 42.4 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.859 -0.61 . . . . 75.21 111.2 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.8 m -83.59 -16.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.046 0.387 . . . . 72.54 112.046 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -144.32 175.13 10.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.301 0.24 . . . . 71.43 111.092 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.9 p -78.33 132.29 66.58 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 111.902 0.334 . . . . 55.53 111.902 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 27.9 Cg_endo -60.32 133.24 48.22 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 123.202 2.601 . . . . 62.22 114.211 -174.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -87.23 116.42 25.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.796 -0.638 . . . . 71.31 110.876 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -81.31 113.62 19.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.902 -0.499 . . . . 72.55 110.654 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -97.62 95.61 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.157 0.504 . . . . 71.55 109.852 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.02 -31.62 72.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.965 -0.562 . . . . 73.5 112.199 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.01 -43.08 99.41 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.215 -0.448 . . . . 64.25 111.704 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.9 p -89.26 -26.98 20.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.735 0.303 . . . . 72.34 111.422 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.15 11.03 63.56 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.372 -0.442 . . . . 75.45 113.364 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -114.74 163.94 14.77 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.584 0.707 . . . . 74.24 112.385 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -100.88 122.86 44.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.684 -0.689 . . . . 73.21 109.854 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.24 119.4 37.84 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.496 -0.32 . . . . 73.53 110.273 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 31.3 p90 -134.95 145.28 48.01 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.953 0.406 . . . . 74.52 111.687 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -97.99 108.28 20.96 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.139 -0.482 . . . . 74.55 110.866 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 46.8 mt-30 -66.99 173.09 3.88 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.315 0.487 . . . . 70.53 112.315 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.475 ' HA ' HG13 ' A' ' 18' ' ' VAL . 87.0 mt -55.54 -32.73 63.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.452 0.538 . . . . 73.25 112.452 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.721 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.9 m-20 -83.95 9.46 12.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.83 0.348 . . . . 60.14 111.823 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.7 3.18 90.32 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.993 -0.623 . . . . 34.53 112.956 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.721 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.6 mtmm -71.76 97.72 1.83 Allowed 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.71 -0.288 . . . . 70.02 111.688 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 32' ' ' PHE . 27.7 tt0 -85.22 113.62 21.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.812 0.339 . . . . 75.42 110.865 176.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.7 t -136.58 168.21 19.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.961 0.41 . . . . 54.01 111.937 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -101.16 156.84 17.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.133 0.492 . . . . 74.4 111.28 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -145.53 139.59 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.25 -0.432 . . . . 42.11 110.292 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -62.72 139.52 58.68 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.038 0.447 . . . . 63.41 111.358 -174.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -57.64 -21.3 38.92 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.001 1.111 . . . . 73.51 114.001 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -81.39 -17.73 47.98 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.049 -0.407 . . . . 54.11 112.093 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -75.94 -26.87 57.3 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.211 0.449 . . . . 72.12 112.211 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.51 117.17 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.174 0.511 . . . . 65.05 112.344 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -82.72 -60.08 2.3 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.947 0.403 . . . . 73.3 110.403 172.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -145.42 158.63 43.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.056 -0.52 . . . . 62.32 111.293 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 90.9 t -130.83 110.78 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 116.515 -0.312 . . . . 74.4 111.297 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -127.97 157.24 41.15 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.168 0.508 . . . . 63.3 111.646 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 33.4 m-20 -88.34 151.06 22.87 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.257 -0.429 . . . . 72.51 110.786 175.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.2 mt -71.28 -14.54 62.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.126 0.489 . . . . 43.42 111.052 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.82 86.82 2.63 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.289 -0.414 . . . . 61.3 111.387 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.691 -0.671 . . . . 61.11 110.976 174.058 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 111.996 0.369 . . . . 73.41 111.996 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.1 106.86 0.25 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.926 0.393 . . . . 71.31 111.713 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 m -86.3 109.64 24.93 Favored Pre-proline 0 N--CA 1.471 0.597 0 CA-C-N 116.342 -0.39 . . . . 61.52 111.264 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 19.3 Cg_endo -56.82 116.01 2.9 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.532 2.155 . . . . 74.11 112.485 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.2 m -121.84 134.59 54.89 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.179 -0.464 . . . . 70.21 111.924 -173.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.25 131.77 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.332 0.587 . . . . 74.4 111.043 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.455 HG23 HG23 ' A' ' 47' ' ' VAL . 68.7 mt -107.55 110.4 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.202 -0.454 . . . . 73.23 111.453 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.4 ' HB ' ' OG1' ' A' ' 49' ' ' THR . 42.3 m -85.65 116.8 24.15 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.739 0.304 . . . . 73.42 110.585 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.8 mt -82.18 172.29 13.33 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.025 0.441 . . . . 63.02 111.529 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -56.79 -42.64 79.81 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.248 -0.433 . . . . 73.42 111.894 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.34 0.19 12.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.515 0.561 . . . . 74.44 112.515 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.8 -13.38 66.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.133 -0.556 . . . . 65.42 112.997 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -67.99 131.79 46.11 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.842 -0.211 . . . . 74.33 110.829 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -116.96 138.91 51.24 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.893 0.377 . . . . 71.52 111.87 -174.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.9 mt -108.49 140.75 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.492 -0.322 . . . . 74.12 110.963 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -103.61 117.32 34.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.16 0.43 . . . . 73.0 112.16 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -121.68 152.68 39.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.284 0.476 . . . . 73.2 112.284 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.4 -19.02 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 112.106 0.41 . . . . 73.25 112.106 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.09 174.9 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.906 0.384 . . . . 74.45 111.587 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.7 p -79.45 143.02 58.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 112.603 0.594 . . . . 74.01 112.603 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 68.5 Cg_endo -73.12 142.9 34.97 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.459 2.106 . . . . 65.5 113.55 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 39.1 ttmt -99.47 131.58 45.38 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.246 -0.434 . . . . 45.22 110.969 175.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -94.25 124.35 38.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.97 0.414 . . . . 74.31 111.708 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -99.41 119.81 38.59 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.12 110.168 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.54 -26.3 67.07 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.748 0.647 . . . . 73.23 112.748 -174.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -82.59 -47.39 12.16 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.414 0.524 . . . . 70.23 112.414 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.3 p -89.95 -27.43 19.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.725 0.297 . . . . 23.32 111.639 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.53 9.15 83.81 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.171 -0.538 . . . . 33.14 113.664 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -96.41 151.56 19.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.359 0.599 . . . . 71.2 112.22 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.9 m-85 -101.39 126.62 48.18 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.625 -0.716 . . . . 54.43 110.863 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.7 mt-10 -99.09 119.01 37.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.511 0.196 . . . . 73.42 110.688 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.16 146.33 31.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.127 0.489 . . . . 75.32 112.015 -178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.3 ttmp? -93.0 115.67 28.34 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.082 -0.508 . . . . 71.21 111.181 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 45.6 mt-30 -67.97 164.33 20.18 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.153 0.427 . . . . 65.33 112.153 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -58.95 -23.0 61.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.619 0.723 . . . . 72.33 110.562 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.32 -13.75 61.57 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.252 -0.885 . . . . 72.41 111.798 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.8 -38.83 2.96 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.349 -0.453 . . . . 71.02 113.284 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 mtmm -68.95 127.69 34.02 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.35 -0.5 . . . . 74.43 112.225 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 63.5 tt0 -86.03 116.27 24.14 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.957 0.408 . . . . 73.42 110.934 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -115.5 166.49 11.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.911 0.386 . . . . 64.43 111.651 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 60.5 mtm180 -129.85 137.58 50.52 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.141 -0.481 . . . . 65.13 111.564 -176.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.7 149.65 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.521 -0.309 . . . . 73.12 110.656 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -70.54 151.03 45.51 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.529 0.681 . . . . 73.14 112.583 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -59.6 -29.28 67.86 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.662 0.986 . . . . 73.45 113.662 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -76.49 -11.77 59.93 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.126 0.417 . . . . 75.32 112.126 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -91.85 -28.04 17.57 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.361 0.504 . . . . 62.03 112.361 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 HG23 ' A' ' 7' ' ' ILE . 5.6 p -77.0 114.29 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.51 0.672 . . . . 74.31 112.12 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -83.1 -56.8 3.58 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.992 -0.549 . . . . 62.04 111.353 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.4 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 71.0 p -137.24 150.92 48.17 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.958 0.408 . . . . 72.52 111.665 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -120.47 111.23 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.358 -0.383 . . . . 61.34 110.529 175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -125.63 168.7 13.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.002 0.429 . . . . 70.11 111.885 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -90.53 144.89 25.35 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.923 0.392 . . . . 75.4 111.17 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 71.8 mt -67.08 -18.69 65.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.043 0.449 . . . . 72.15 111.386 175.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.0 mt -105.87 36.6 2.5 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.381 -0.372 . . . . 73.41 111.66 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.694 -0.669 . . . . 73.34 111.681 177.085 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.825 0.345 . . . . 70.33 111.091 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.03 86.77 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.146 0.498 . . . . 70.5 111.034 174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.9 m -104.38 150.35 38.35 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 115.989 -0.551 . . . . 33.1 110.707 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.544 ' HB2' HD12 ' A' ' 53' ' ' LEU . 34.0 Cg_endo -63.72 114.62 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.918 1.745 . . . . 62.4 112.536 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.8 m -125.08 132.76 53.1 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.209 -0.45 . . . . 71.3 111.407 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.0 124.68 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.306 0.574 . . . . 71.45 111.154 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.3 mt -102.87 118.8 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.219 -0.446 . . . . 73.41 111.451 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.473 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 60.7 m -90.27 122.02 32.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.317 -0.402 . . . . 53.14 110.675 176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -88.93 157.03 18.55 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.977 0.418 . . . . 74.5 111.82 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -54.99 -30.77 60.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.964 -0.562 . . . . 74.21 111.022 174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.66 -23.02 67.2 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.639 -0.709 . . . . 65.42 111.597 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.88 -30.89 8.5 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 112.014 -0.434 . . . . 73.43 112.014 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.589 ' NH1' HG12 ' A' ' 15' ' ' ILE . 49.5 ttt-85 -64.28 141.76 58.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.639 0.376 . . . . 75.14 111.554 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' A' ' 8' ' ' THR . 44.0 mt-10 -116.26 143.54 45.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.861 0.362 . . . . 74.24 111.383 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.589 HG12 ' NH1' ' A' ' 13' ' ' ARG . 38.8 mt -124.09 132.65 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.282 -0.417 . . . . 73.31 110.787 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -95.66 133.28 39.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.794 0.331 . . . . 74.51 111.479 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.31 146.26 48.91 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.453 0.538 . . . . 71.51 112.453 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.528 HG13 ' HA ' ' A' ' 35' ' ' LEU . 29.7 m -87.36 -13.98 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.14 0.495 . . . . 75.11 111.486 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.29 154.45 36.36 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.007 -0.542 . . . . 71.5 110.301 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.6 p -78.86 132.38 64.43 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.882 0.372 . . . . 61.01 111.193 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.422 ' HB3' HD11 ' A' ' 7' ' ' ILE . 41.5 Cg_endo -65.23 126.42 16.33 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.93 2.42 . . . . 72.54 113.755 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -96.48 127.78 42.79 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.053 -0.521 . . . . 63.23 110.615 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -83.48 115.04 21.89 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.822 -0.351 . . . . 71.13 110.376 172.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -97.31 103.28 15.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.064 0.459 . . . . 74.11 109.974 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.26 -28.55 66.41 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.131 -0.486 . . . . 75.45 111.571 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.33 -52.77 63.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.912 0.387 . . . . 73.41 111.071 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.5 m -88.36 -25.41 22.75 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.062 0.393 . . . . 71.25 112.062 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.87 11.41 61.76 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.389 -0.434 . . . . 74.02 113.673 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -110.98 159.65 17.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.429 0.633 . . . . 75.32 112.561 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.439 ' CE1' HG11 ' A' ' 47' ' ' VAL . 49.8 m-85 -100.97 122.33 43.33 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.636 -0.711 . . . . 64.33 109.852 169.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.408 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 47.4 mt-10 -104.69 121.64 43.99 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.821 0.343 . . . . 64.55 111.063 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -145.17 156.91 44.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.068 0.461 . . . . 64.44 111.436 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 31.6 ttmt -106.3 111.46 24.07 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.294 -0.412 . . . . 63.21 111.197 -177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -60.73 166.82 3.06 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.231 0.456 . . . . 74.12 112.231 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.528 ' HA ' HG13 ' A' ' 18' ' ' VAL . 74.8 mt -61.07 -21.35 63.57 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.183 0.516 . . . . 73.22 111.128 176.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -74.49 -11.44 60.22 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.963 -0.562 . . . . 52.42 111.679 177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.34 -5.48 71.06 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.159 -0.544 . . . . 72.45 112.883 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -82.68 119.66 24.59 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 111.938 0.348 . . . . 70.14 111.938 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 33.8 tt0 -83.69 112.93 20.5 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.895 -0.409 . . . . 63.32 109.895 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -116.43 152.56 33.76 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.946 0.403 . . . . 75.21 111.802 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 44.6 mtp180 -116.28 126.32 53.4 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.378 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 tt -129.94 145.3 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 122.244 -0.285 . . . . 51.41 111.08 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -66.88 150.44 49.18 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.579 0.704 . . . . 73.21 112.687 -172.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -58.52 -19.71 39.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.936 1.087 . . . . 70.23 113.936 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -84.46 -22.92 30.15 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.879 -0.513 . . . . 73.14 112.014 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -82.24 -14.51 55.4 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.167 0.432 . . . . 73.53 112.167 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.439 HG11 ' CE1' ' A' ' 30' ' ' TYR . 7.3 p -87.49 115.37 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.453 0.644 . . . . 73.04 111.727 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -83.08 -63.49 1.35 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.136 0.493 . . . . 72.55 110.93 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.3 p -139.65 149.46 43.77 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.879 -0.601 . . . . 65.5 111.358 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.8 t -119.49 116.02 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.373 -0.376 . . . . 71.12 110.222 176.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -131.21 141.99 50.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.827 0.346 . . . . 74.1 111.384 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -80.98 159.56 24.85 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.802 0.334 . . . . 64.32 110.943 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 4' ' ' PRO . 88.0 mt -82.66 -8.58 59.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.269 0.557 . . . . 62.24 110.619 173.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.5 mt -110.91 94.04 4.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.794 -0.639 . . . . 53.32 110.047 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.759 -0.639 . . . . 72.43 111.848 -177.02 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.871 0.367 . . . . 74.05 111.464 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.59 86.83 0.66 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.17 -0.468 . . . . 75.31 110.543 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 m -85.72 114.4 56.55 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.467 -0.333 . . . . 75.1 111.359 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HB2' HD12 ' A' ' 53' ' ' LEU . 34.7 Cg_endo -62.67 119.93 7.23 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.651 2.234 . . . . 75.24 112.409 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.0 m -128.8 147.8 50.82 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.423 -0.353 . . . . 74.43 111.47 -174.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.4 p -121.64 125.55 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.377 0.608 . . . . 72.55 111.283 177.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.6 mt -98.94 116.23 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 63.51 111.391 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.0 m -86.24 113.61 22.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.31 -0.404 . . . . 65.44 110.733 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -78.46 166.07 23.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.059 0.457 . . . . 72.34 111.538 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 64.6 t30 -63.31 -33.21 75.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.136 -0.483 . . . . 75.1 111.287 -175.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.67 7.9 6.17 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.436 -0.347 . . . . 72.33 111.865 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.04 -12.95 64.53 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.233 -0.508 . . . . 70.35 113.886 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -70.12 121.1 16.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.266 0.533 . . . . 75.31 111.426 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -103.02 130.37 50.11 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.867 0.365 . . . . 74.12 111.274 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.96 131.23 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.497 -0.32 . . . . 73.33 110.984 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.46 137.18 34.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.19 0.519 . . . . 72.23 112.082 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.57 150.74 50.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.81 -0.632 . . . . 70.23 111.231 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.3 m -74.34 -25.42 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.921 0.391 . . . . 71.35 111.788 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.3 174.43 8.97 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.223 -0.444 . . . . 74.13 111.261 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.2 p -83.02 145.75 50.21 Favored Pre-proline 0 N--CA 1.47 0.536 0 CA-C-O 120.852 0.358 . . . . 50.23 111.792 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HB3' HD11 ' A' ' 7' ' ' ILE . 60.4 Cg_endo -71.29 130.79 18.0 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.427 2.085 . . . . 72.35 113.364 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -98.09 122.58 41.41 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.3 -0.409 . . . . 71.41 110.46 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -82.17 130.51 35.11 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.012 0.434 . . . . 71.24 111.391 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.28 109.8 21.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.404 -0.362 . . . . 73.32 110.57 175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -72.92 -29.99 63.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.003 0.43 . . . . 73.11 111.47 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -70.47 -33.47 71.31 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.805 0.669 . . . . 71.31 112.805 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -118.85 -10.49 9.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.798 0.666 . . . . 72.4 112.798 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.66 82.53 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 114.702 0.641 . . . . 55.22 114.702 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -102.6 154.15 19.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 117.887 0.843 . . . . 73.2 112.335 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 51.2 m-85 -102.12 128.26 48.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.15 -0.477 . . . . 73.55 110.827 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 46.2 mt-10 -99.53 119.32 37.84 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.6 0.238 . . . . 63.14 111.235 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -146.19 145.04 30.3 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.968 0.413 . . . . 74.52 111.675 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.4 ttmp? -97.58 111.45 23.72 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.435 -0.348 . . . . 64.31 111.268 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -61.01 168.11 2.6 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.855 0.359 . . . . 64.13 111.956 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.424 ' HA ' HG13 ' A' ' 18' ' ' VAL . 92.9 mt -52.69 -43.17 65.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.834 0.679 . . . . 75.44 112.834 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -75.79 -3.14 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.268 0.47 . . . . 71.25 112.268 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.24 -2.81 50.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.072 -0.585 . . . . 33.12 114.224 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -82.7 104.19 12.77 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.504 0.652 . . . . 73.31 111.68 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.641 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.1 tt0 -72.98 119.54 17.38 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.272 -0.422 . . . . 62.24 111.109 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.3 t -125.91 165.37 18.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.792 0.33 . . . . 70.03 111.83 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 47.0 mtm180 -126.71 129.42 48.38 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.387 -0.37 . . . . 73.2 111.252 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.5 tt -122.1 150.75 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 116.663 -0.244 . . . . 70.15 110.794 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -67.58 153.67 43.18 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.303 0.573 . . . . 75.3 112.367 -174.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 47' ' ' VAL . 15.1 ptmm? -65.4 -21.68 66.7 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.797 1.036 . . . . 65.24 113.797 -172.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 p-10 -79.4 -25.23 42.15 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.216 0.45 . . . . 74.31 112.216 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -76.83 -22.32 53.76 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.82 0.674 . . . . 41.52 112.82 -175.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 44' ' ' LYS . 8.0 p -72.84 114.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.736 0.779 . . . . 74.13 111.981 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 10.0 tpt180 -81.83 -63.36 1.4 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.82 -0.627 . . . . 75.41 110.466 176.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.5 p -146.54 146.61 30.55 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.013 -0.539 . . . . 74.15 110.984 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.83 120.74 55.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.722 0.296 . . . . 73.2 110.88 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB2' HG13 ' A' ' 6' ' ' VAL . 61.1 mttp -119.3 152.36 36.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.292 0.568 . . . . 72.32 111.919 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -92.49 139.9 30.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.102 -0.499 . . . . 73.33 111.329 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.46 HD12 ' HB2' ' A' ' 4' ' ' PRO . 78.6 mt -78.12 -22.45 48.85 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.818 0.342 . . . . 72.33 111.356 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.9 mt -111.42 84.54 1.96 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.905 0.383 . . . . 71.0 111.083 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.699 -0.667 . . . . 52.25 111.37 177.518 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 110.592 -0.151 . . . . 72.42 110.592 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.11 150.68 30.17 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.292 0.479 . . . . 74.05 112.292 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -123.22 136.77 27.38 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.042 -0.527 . . . . 75.44 110.252 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HB2' HD12 ' A' ' 53' ' ' LEU . 57.9 Cg_endo -69.39 116.01 4.32 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.906 1.737 . . . . 73.13 112.09 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 92.2 m -123.4 135.72 54.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.116 0.413 . . . . 62.41 112.116 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.86 118.53 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.484 0.659 . . . . 63.22 111.31 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -90.78 107.03 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.222 -0.445 . . . . 74.22 111.153 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.455 HG22 ' HD3' ' A' ' 48' ' ' ARG . 49.9 m -83.37 124.0 30.21 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.245 -0.28 . . . . 73.43 110.245 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.1 mt -96.54 162.09 13.62 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.978 0.418 . . . . 65.12 112.057 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -54.25 -45.41 72.37 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.027 -0.533 . . . . 74.45 111.838 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.12 5.53 5.25 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.798 0.666 . . . . 71.41 112.798 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.55 -20.95 47.5 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.082 -0.58 . . . . 71.43 114.211 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -63.11 136.2 57.64 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.364 0.582 . . . . 63.04 111.71 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -110.47 129.5 55.76 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.731 0.3 . . . . 74.15 110.491 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.5 mt -113.3 112.0 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.172 0.511 . . . . 65.31 111.187 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.76 117.9 30.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.324 -0.398 . . . . 71.25 111.307 -176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -111.93 159.9 17.94 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.159 0.504 . . . . 62.14 112.189 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.1 m -84.59 -15.03 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.955 -0.566 . . . . 73.34 111.663 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -133.11 164.34 27.25 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.006 0.431 . . . . 75.43 111.327 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.406 HG22 ' OG1' ' A' ' 5' ' ' THR . 71.3 p -79.7 118.95 75.09 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.407 -0.361 . . . . 73.13 110.869 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -52.63 123.28 12.54 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.346 2.697 . . . . 75.32 113.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 5.5 ttpm? -87.32 123.1 31.94 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.357 -0.383 . . . . 71.52 110.754 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -90.3 131.59 36.02 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.005 0.431 . . . . 74.53 112.086 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -99.75 116.41 31.76 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.908 0.385 . . . . 71.41 110.157 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.26 -32.26 73.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.348 0.499 . . . . 73.43 112.348 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -72.29 -50.0 30.39 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.954 0.353 . . . . 63.34 111.954 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.1 p -89.61 -27.75 19.98 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.32 0.489 . . . . 75.25 112.32 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.93 10.69 75.0 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.06 -0.591 . . . . 72.43 113.568 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -100.15 149.23 23.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.416 0.627 . . . . 73.4 112.452 -178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -102.02 128.74 48.32 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.604 -0.725 . . . . 74.31 110.771 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 45.7 mt-10 -100.11 124.66 45.76 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.703 0.287 . . . . 72.1 111.116 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.405 ' HE1' HG22 ' A' ' 42' ' ' ILE . 34.4 p90 -157.19 151.77 25.39 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.828 0.347 . . . . 72.54 111.417 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.9 ttmt -106.5 115.28 29.94 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.599 -0.273 . . . . 54.41 110.885 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 49.5 mt-30 -60.65 158.86 11.74 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.87 0.322 . . . . 74.4 111.87 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.433 ' HA ' HG13 ' A' ' 18' ' ' VAL . 89.8 mt -51.98 -30.79 26.48 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.109 0.48 . . . . 72.33 111.777 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.91 4.33 4.31 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.088 -0.506 . . . . 71.14 112.238 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.2 23.63 70.78 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.304 -0.474 . . . . 74.4 113.069 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -117.07 112.56 21.08 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 122.7 -0.294 . . . . 65.14 111.297 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.4 tt0 -87.17 138.99 31.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.815 0.341 . . . . 73.24 111.58 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -147.24 165.15 30.93 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.497 -0.319 . . . . 73.32 111.719 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 86.0 mtt180 -115.4 125.89 53.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.888 0.375 . . . . 71.11 111.03 177.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.405 HG22 ' HE1' ' A' ' 32' ' ' PHE . 15.7 tt -117.04 149.93 19.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.621 0.248 . . . . 73.35 111.116 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -79.11 148.73 32.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.538 0.685 . . . . 62.3 112.218 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.47 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 ptmt -63.17 -15.02 55.5 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.656 0.984 . . . . 71.32 113.656 -175.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -78.08 -22.55 48.86 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.822 -0.549 . . . . 74.45 111.591 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -79.4 -28.29 41.84 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.958 0.725 . . . . 64.31 112.958 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -68.25 113.78 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.727 0.775 . . . . 74.12 112.481 -173.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.455 ' HD3' HG22 ' A' ' 8' ' ' THR . 75.1 ttt180 -82.08 -60.32 2.26 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.525 -0.762 . . . . 74.44 110.671 175.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.8 p -149.36 129.58 13.68 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.066 -0.516 . . . . 74.51 111.24 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.37 109.93 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.848 0.356 . . . . 72.4 111.314 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -125.18 152.83 43.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.849 0.357 . . . . 74.53 111.184 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 24.0 m-20 -89.01 149.39 23.28 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.835 0.35 . . . . 64.44 110.998 176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 4' ' ' PRO . 85.1 mt -63.68 -29.22 70.47 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.233 0.539 . . . . 53.31 110.167 172.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.1 mt -122.1 80.02 1.66 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.697 -0.683 . . . . 54.13 110.058 172.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.599 -0.715 . . . . 70.51 112.125 -178.584 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.802 0.334 . . . . 71.52 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.68 146.93 31.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.004 0.431 . . . . 73.2 111.523 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.6 p -153.84 142.67 14.57 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 116.108 -0.496 . . . . 73.33 110.768 -176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.571 ' HB2' HD12 ' A' ' 53' ' ' LEU . 38.5 Cg_endo -66.6 114.02 2.94 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.696 1.597 . . . . 65.04 111.633 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.0 m -126.93 149.72 49.69 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.296 -0.411 . . . . 52.42 111.25 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.18 129.21 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 121.44 0.638 . . . . 64.44 111.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.5 mt -108.3 110.44 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.027 -0.533 . . . . 74.52 110.862 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.752 HG21 HH21 ' A' ' 48' ' ' ARG . 26.0 m -89.07 118.31 28.7 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.749 0.309 . . . . 61.41 111.286 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.7 170.14 13.58 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.807 0.337 . . . . 61.31 111.576 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -62.07 -31.29 71.7 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 120.871 0.367 . . . . 74.44 111.697 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.27 -20.9 66.37 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 111.992 0.367 . . . . 70.55 111.992 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.07 -7.6 62.56 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.523 -0.631 . . . . 35.23 111.523 -170.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -70.06 125.05 25.63 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.96 0.504 . . . . 72.23 110.913 176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -109.8 130.67 55.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.043 0.449 . . . . 72.21 111.718 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 53.8 mt -110.96 125.62 68.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.241 -0.436 . . . . 70.51 110.754 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.427 HE21 HD11 ' A' ' 53' ' ' LEU . 45.4 mt-30 -96.73 129.57 44.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.957 0.408 . . . . 62.0 111.915 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -119.55 162.04 19.59 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.121 -0.49 . . . . 63.22 111.488 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -97.11 -3.99 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 112.064 0.394 . . . . 61.33 112.064 178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.01 174.95 10.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.328 0.585 . . . . 74.11 112.177 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 76.1 p -79.01 129.89 71.64 Favored Pre-proline 0 N--CA 1.471 0.618 0 CA-C-N 115.807 -0.633 . . . . 74.14 112.083 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.2 133.79 25.58 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.618 2.212 . . . . 72.14 113.238 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.95 135.71 35.0 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.476 -0.329 . . . . 70.32 111.207 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -95.63 115.51 27.53 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.602 0.239 . . . . 72.41 111.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -109.43 118.93 37.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.85 0.357 . . . . 72.44 110.75 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.15 -42.16 63.13 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.96 0.355 . . . . 63.51 111.96 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.85 -38.72 82.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.155 0.428 . . . . 72.33 112.155 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 65.6 m -94.44 -27.42 16.03 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.224 -0.298 . . . . 74.14 111.608 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.49 12.28 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.858 -0.687 . . . . 43.04 113.839 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.485 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 72.6 m-85 -116.27 163.52 15.88 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.173 0.511 . . . . 71.31 112.156 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.3 m-85 -101.24 128.68 47.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.91 -0.586 . . . . 74.4 110.424 171.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 39.6 mt-10 -98.97 119.25 37.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.535 0.207 . . . . 75.4 111.088 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -145.54 155.21 42.93 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.991 0.424 . . . . 63.41 111.486 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 3.8 ttmp? -108.91 109.77 20.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.414 -0.357 . . . . 63.22 111.129 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 47.3 mt-30 -61.63 164.84 5.56 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.224 0.453 . . . . 61.41 112.224 -178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.584 ' HA ' HG13 ' A' ' 18' ' ' VAL . 86.7 mt -48.8 -43.26 38.03 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.791 0.664 . . . . 73.34 112.791 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -73.15 -1.97 19.7 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.327 0.492 . . . . 64.32 112.327 -176.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.15 -2.24 63.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.446 -0.406 . . . . 41.22 112.676 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 31.4 mtmm -71.75 97.87 1.85 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.809 0.3 . . . . 71.14 111.809 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.8 tt0 -80.47 120.77 24.91 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.732 -0.213 . . . . 73.41 110.463 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.1 t -145.62 165.59 28.26 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.925 0.393 . . . . 64.33 111.709 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 59.5 mtm180 -117.48 148.05 42.18 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.13 -0.487 . . . . 75.3 111.265 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -134.65 152.15 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 116.369 -0.378 . . . . 65.42 110.813 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -63.17 133.89 55.1 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.113 0.482 . . . . 73.23 111.425 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -60.09 -16.17 29.54 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.221 1.193 . . . . 73.24 114.221 -172.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -91.85 -12.13 34.51 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.694 -0.629 . . . . 74.52 112.326 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -77.05 -28.06 54.65 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.911 0.386 . . . . 62.43 111.883 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -77.77 121.82 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.296 0.569 . . . . 70.4 112.312 -175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.752 HH21 HG21 ' A' ' 8' ' ' THR . 72.0 ttp85 -82.51 -59.82 2.4 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.008 0.432 . . . . 74.12 110.955 174.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 48' ' ' ARG . 66.5 p -141.96 136.08 30.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.156 -0.475 . . . . 61.52 111.606 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -108.38 108.83 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.645 -0.252 . . . . 44.44 110.718 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -123.96 156.34 36.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.028 0.442 . . . . 73.32 111.297 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 55' ' ' GLU . 35.9 m-20 -91.98 149.64 21.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 64.34 110.914 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 4' ' ' PRO . 66.6 mt -68.55 -35.1 76.97 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.266 -0.642 . . . . 64.13 109.266 172.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.6 mt -118.61 84.35 2.17 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.266 -0.879 . . . . 72.34 109.562 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 52' ' ' ASP . 47.8 mt-10 . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.616 -0.707 . . . . 55.2 112.589 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.73 0.3 . . . . 60.31 111.04 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 19' ' ' ASP . . . -131.37 141.32 49.87 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.88 0.371 . . . . 74.42 111.536 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 t -127.74 133.04 24.67 Favored Pre-proline 0 N--CA 1.474 0.753 0 CA-C-N 116.51 -0.314 . . . . 64.12 111.079 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.471 ' HB2' HD12 ' A' ' 53' ' ' LEU . 32.6 Cg_endo -63.83 116.12 3.49 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.159 1.906 . . . . 62.34 111.793 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.4 m -119.82 136.87 54.3 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.893 0.378 . . . . 63.33 111.974 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.25 117.19 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.36 0.6 . . . . 73.25 110.755 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.437 HG23 HG23 ' A' ' 47' ' ' VAL . 66.0 mt -96.59 110.53 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.153 -0.476 . . . . 72.51 111.085 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.426 ' HB ' ' OG1' ' A' ' 49' ' ' THR . 41.9 m -91.02 116.45 28.8 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.823 0.344 . . . . 73.14 110.803 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.7 mt -83.28 161.82 21.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.894 0.378 . . . . 61.02 111.917 -177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -57.69 -40.39 79.35 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.434 0.531 . . . . 74.0 112.434 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.41 -12.56 53.49 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.303 0.483 . . . . 74.34 112.303 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.8 10.5 40.23 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.011 -0.614 . . . . 65.12 113.643 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -95.41 132.18 40.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.152 0.476 . . . . 71.25 111.565 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -102.95 130.47 50.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.927 0.394 . . . . 74.33 111.617 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.4 mt -115.3 119.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.689 0.28 . . . . 63.14 110.412 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -92.34 130.88 37.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.164 0.507 . . . . 64.24 112.03 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.38 150.65 42.13 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.052 -0.522 . . . . 73.53 111.46 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 35' ' ' LEU . 26.9 m -82.52 -13.79 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.191 0.441 . . . . 71.12 112.191 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 0.5 OUTLIER -137.21 173.88 11.21 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.949 0.404 . . . . 75.53 111.657 175.099 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.5 p -79.54 140.89 55.89 Favored Pre-proline 0 N--CA 1.474 0.736 0 N-CA-C 112.869 0.692 . . . . 74.44 112.869 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.33 105.01 0.55 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.572 2.181 . . . . 61.15 112.772 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.36 111.77 20.81 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.143 -0.481 . . . . 70.45 111.051 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.472 ' HB2' ' CE2' ' A' ' 30' ' ' TYR . 51.1 t80 -81.68 132.33 35.29 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.968 0.413 . . . . 73.13 112.102 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -123.38 119.3 29.65 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.9 -0.591 . . . . 71.33 110.825 175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -80.84 -15.73 55.6 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.872 0.323 . . . . 73.41 111.872 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -68.46 -45.06 73.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.825 0.345 . . . . 63.11 111.126 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.2 p -93.49 -27.53 16.62 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.867 0.365 . . . . 52.43 111.501 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.38 10.5 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.301 -0.476 . . . . 72.11 113.111 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 75.1 m-85 -113.44 164.69 13.29 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.507 0.67 . . . . 73.53 112.76 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 69.7 m-85 -102.34 132.41 48.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.641 -0.709 . . . . 64.24 110.457 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 43.3 mt-10 -98.57 119.5 37.39 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.882 0.372 . . . . 73.52 110.824 178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -147.1 143.79 28.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.009 0.433 . . . . 72.23 111.278 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 4.7 ttmp? -97.72 110.38 22.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.454 -0.339 . . . . 70.03 111.13 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.36 164.12 4.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.906 0.384 . . . . 72.13 111.711 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.426 ' HA ' HG13 ' A' ' 18' ' ' VAL . 88.3 mt -53.41 -35.01 59.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.293 -0.412 . . . . 64.41 111.894 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.9 -12.26 61.18 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.036 0.384 . . . . 74.34 112.036 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.6 -7.62 50.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.496 -0.383 . . . . 51.22 112.665 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -75.16 100.42 4.27 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.086 0.469 . . . . 62.44 111.968 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.1 tt0 -84.04 104.41 14.08 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.024 0.44 . . . . 65.14 110.542 175.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 t -124.45 166.48 15.93 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.944 0.402 . . . . 63.13 111.532 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 64.4 mtm180 -115.66 132.14 56.72 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.33 -0.396 . . . . 74.44 111.685 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -118.12 151.21 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.494 -0.321 . . . . 53.25 110.693 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -71.52 145.57 49.06 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.152 0.501 . . . . 74.4 112.042 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -60.43 -16.79 39.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.776 1.028 . . . . 73.01 113.776 -173.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -83.65 -25.69 30.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.223 0.453 . . . . 64.22 112.223 -176.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -77.12 -28.38 54.34 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.314 0.487 . . . . 73.44 112.314 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG23 HG23 ' A' ' 7' ' ' ILE . 7.3 p -74.2 113.75 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.484 0.659 . . . . 73.3 112.163 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 48' ' ' ARG . 22.0 ttt180 -83.63 -63.75 1.29 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.355 0.598 . . . . 73.41 110.856 177.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.426 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 77.6 p -132.99 151.17 52.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.759 -0.655 . . . . 75.52 111.733 -177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.42 117.85 46.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.255 -0.429 . . . . 72.13 111.202 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -127.64 134.02 49.65 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.84 0.352 . . . . 74.15 111.856 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -84.04 127.2 33.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.003 0.43 . . . . 75.41 110.929 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 4' ' ' PRO . 87.9 mt -64.15 -21.56 66.6 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.344 0.498 . . . . 72.53 112.344 -175.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 99.2 mt -67.64 -21.42 65.38 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.5 0.556 . . . . 75.13 112.5 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.678 -0.677 . . . . 54.51 111.751 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.8 mmm . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.886 0.374 . . . . 72.13 111.081 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.19 123.42 47.81 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.036 0.446 . . . . 74.55 112.006 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.3 m -143.77 133.55 11.78 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.103 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.55 ' HB2' HD12 ' A' ' 53' ' ' LEU . 22.9 Cg_endo -60.15 130.41 34.18 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.271 1.98 . . . . 53.13 112.926 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.1 m -132.25 135.99 46.65 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.28 -0.418 . . . . 74.54 111.327 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.492 ' HB ' HD21 ' A' ' 53' ' ' LEU . 8.2 p -98.94 122.94 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.473 0.654 . . . . 61.02 111.926 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' A' ' 21' ' ' PRO . 64.4 mt -98.61 110.55 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.039 -0.528 . . . . 64.31 110.677 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.0 m -90.32 124.36 34.84 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.702 0.287 . . . . 75.03 110.716 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.2 157.49 17.68 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.938 0.347 . . . . 74.53 111.938 -175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -56.14 -30.82 62.67 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.2 0.524 . . . . 63.13 110.853 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.5 -37.3 75.27 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.632 -0.713 . . . . 74.33 111.54 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.49 -23.38 8.0 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.332 -0.394 . . . . 52.24 112.23 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -65.31 141.25 58.66 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 111.925 0.342 . . . . 63.34 111.925 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.63 130.62 55.7 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.587 -0.279 . . . . 73.4 111.279 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -110.02 129.32 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.757 0.313 . . . . 73.54 110.788 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -99.96 113.12 25.47 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.973 0.416 . . . . 72.34 111.575 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.72 160.55 14.88 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.489 -0.323 . . . . 60.21 111.81 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -91.56 -18.68 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 112.475 0.546 . . . . 73.42 112.475 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -133.83 176.0 8.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.921 0.391 . . . . 74.02 111.541 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.7 p -77.35 127.85 81.94 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 116.592 -0.276 . . . . 75.14 111.66 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HB3' HD11 ' A' ' 7' ' ' ILE . 21.1 Cg_endo -60.33 125.42 17.4 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.793 2.329 . . . . 70.43 113.959 -174.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -93.72 142.11 27.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.192 -0.913 . . . . 70.13 110.748 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.92 133.82 52.76 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.883 -0.511 . . . . 74.0 111.863 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.42 113.91 26.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.952 -0.567 . . . . 74.02 110.195 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -72.19 -34.66 68.59 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.863 0.363 . . . . 73.2 111.814 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -59.81 -50.58 73.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.912 0.386 . . . . 75.44 111.923 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.438 ' HG ' ' HD2' ' A' ' 29' ' ' PHE . 14.9 t -89.91 -23.39 21.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.341 -0.391 . . . . 65.11 111.511 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.43 10.88 79.02 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.136 -0.554 . . . . 52.12 113.705 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 97.0 m-85 -110.4 163.84 13.28 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.199 0.524 . . . . 62.31 111.877 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 60.0 m-85 -101.05 136.66 40.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.016 -0.538 . . . . 63.22 110.75 173.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -97.97 118.36 34.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.893 -0.41 . . . . 60.34 109.893 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -143.65 156.18 44.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.957 0.408 . . . . 73.43 111.256 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 4.6 ttmp? -118.17 110.89 18.13 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.191 -0.458 . . . . 75.13 111.655 -177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -60.8 160.6 9.23 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.291 -0.413 . . . . 73.2 111.36 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -51.79 -27.27 11.75 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.524 0.564 . . . . 73.21 112.524 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.26 4.69 6.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.017 0.377 . . . . 73.21 112.017 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.4 20.96 78.36 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.014 -0.612 . . . . 74.33 112.507 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -99.73 114.9 28.31 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.64 0.376 . . . . 75.34 111.532 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -92.35 125.65 37.1 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.893 0.378 . . . . 70.51 110.769 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -145.1 166.55 25.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.514 -0.312 . . . . 74.12 110.864 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 44.2 mtm180 -114.55 140.3 48.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.412 0.523 . . . . 64.24 112.412 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.8 tt -128.59 145.54 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.242 -0.436 . . . . 73.23 110.658 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.85 146.89 52.46 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.662 0.744 . . . . 72.44 112.518 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 47' ' ' VAL . 19.0 pttm -53.49 -27.62 26.36 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.716 -1.129 . . . . 74.31 113.999 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -77.84 -21.86 50.81 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.363 0.505 . . . . 74.01 112.363 -175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -77.36 -25.03 50.63 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.9 0.704 . . . . 74.41 112.9 -176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.2 p -75.11 113.53 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 121.567 0.699 . . . . 63.34 112.612 -175.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.15 -60.48 2.14 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.912 -0.585 . . . . 54.53 110.98 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.5 p -139.35 153.15 47.64 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.146 -0.479 . . . . 72.44 111.316 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 99.5 t -127.87 108.29 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.506 -0.315 . . . . 72.14 111.207 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -123.15 145.56 48.5 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.115 0.483 . . . . 64.45 111.594 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -83.07 137.7 34.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.098 0.475 . . . . 65.44 111.744 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.1 mt -75.62 -23.57 56.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.325 -0.398 . . . . 64.35 111.065 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.7 mt -119.25 87.73 2.79 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.041 0.448 . . . . 61.31 110.919 173.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.253 1.257 0 CA-C-O 118.912 -0.566 . . . . 75.05 111.159 177.793 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 111.87 0.322 . . . . 73.45 111.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.77 85.67 1.22 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.982 0.42 . . . . 74.15 111.344 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.5 m -81.38 113.61 43.04 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 116.204 -0.453 . . . . 74.24 111.156 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.586 ' HB2' HD12 ' A' ' 53' ' ' LEU . 18.4 Cg_endo -57.99 131.83 45.92 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.483 2.122 . . . . 64.42 112.391 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.6 m -127.23 133.56 50.21 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.788 0.292 . . . . 72.33 111.788 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.79 124.88 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.51 0.672 . . . . 62.04 111.053 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.57 107.99 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.027 -0.533 . . . . 75.02 111.166 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.4 m -84.27 119.56 25.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.371 -0.377 . . . . 74.32 110.648 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -86.2 155.24 20.81 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.627 0.251 . . . . 61.33 111.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -62.2 -26.24 68.24 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.386 0.612 . . . . 73.45 110.655 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -58.25 -29.05 65.46 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.556 -0.747 . . . . 71.53 111.659 173.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.1 -11.33 26.87 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.513 -0.375 . . . . 71.31 112.939 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -81.45 130.42 35.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.857 0.361 . . . . 71.54 111.738 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -105.52 129.84 53.71 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.009 0.433 . . . . 75.2 110.836 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.421 HG21 ' HE2' ' A' ' 32' ' ' PHE . 46.4 mt -112.74 121.92 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.485 -0.325 . . . . 73.1 111.381 -178.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -93.91 117.76 30.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.246 0.546 . . . . 44.13 111.976 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -105.67 153.27 22.05 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.931 -0.577 . . . . 54.04 111.328 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.402 HG13 ' HA ' ' A' ' 35' ' ' LEU . 32.9 m -78.77 -28.28 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.152 0.427 . . . . 72.11 112.152 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -128.43 175.4 8.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.976 0.417 . . . . 54.13 111.764 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 78.5 p -78.57 131.05 69.18 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.375 -0.375 . . . . 72.43 111.572 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HB3' ' HB3' ' A' ' 32' ' ' PHE . 58.1 Cg_endo -68.71 153.95 72.25 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.687 2.258 . . . . 51.32 113.936 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -111.51 120.2 41.33 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.745 -0.661 . . . . 64.11 111.134 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -82.07 125.86 31.33 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.112 -0.367 . . . . 64.43 110.307 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.11 114.98 26.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.18 0.514 . . . . 71.34 110.231 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.5 -28.08 65.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.807 -0.633 . . . . 74.44 112.102 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -83.24 -44.76 14.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.443 -0.344 . . . . 55.34 111.919 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 m -82.37 -27.81 31.9 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.046 0.387 . . . . 54.21 112.046 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.57 9.43 84.76 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.299 -0.477 . . . . 50.23 113.777 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -106.24 162.42 13.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.351 -0.5 . . . . 61.22 112.015 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 58.6 m-85 -101.77 127.07 48.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.999 -0.546 . . . . 73.13 110.282 170.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 30.5 mt-10 -99.15 119.7 38.29 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.498 -0.319 . . . . 71.23 110.418 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 21' ' ' PRO . 35.9 p90 -142.21 148.37 38.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.192 0.52 . . . . 74.11 112.086 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -106.09 108.99 20.78 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.965 -0.561 . . . . 60.04 110.566 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 45.2 mt-30 -66.43 171.14 5.21 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.323 0.49 . . . . 70.05 112.323 -176.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.402 ' HA ' HG13 ' A' ' 18' ' ' VAL . 84.7 mt -58.91 -21.9 58.55 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.304 -0.407 . . . . 64.34 112.074 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.26 -11.91 57.28 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.095 0.406 . . . . 62.34 112.095 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.4 -4.73 51.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.288 -0.482 . . . . 60.43 114.095 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -75.68 117.3 17.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.191 -0.594 . . . . 64.41 111.765 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -86.07 88.56 7.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.369 0.604 . . . . 73.24 109.871 171.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 t -106.78 165.07 11.58 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.084 -0.507 . . . . 72.21 111.665 -175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.541 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 23.3 mtm180 -125.87 138.44 53.8 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.964 0.411 . . . . 73.15 112.021 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 tt -133.17 147.65 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.245 -0.434 . . . . 62.31 110.702 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -68.74 148.22 50.67 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.229 0.537 . . . . 74.23 112.062 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.37 -15.49 63.33 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.736 1.013 . . . . 61.22 113.736 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -79.54 -11.01 59.9 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.797 -0.564 . . . . 55.13 111.615 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -90.57 -26.65 19.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.295 0.479 . . . . 65.4 112.295 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.81 117.63 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.455 0.645 . . . . 72.42 112.671 -174.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.537 ' HG2' HG23 ' A' ' 49' ' ' THR . 50.9 ttt180 -82.61 -60.89 2.04 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.998 -0.547 . . . . 73.05 111.524 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.537 HG23 ' HG2' ' A' ' 48' ' ' ARG . 75.2 p -141.99 143.49 33.21 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.461 -0.336 . . . . 74.22 111.858 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -114.23 123.65 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.5 -0.318 . . . . 62.5 111.064 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -138.41 155.52 48.42 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.144 0.497 . . . . 72.31 111.822 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -88.66 149.18 23.64 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.222 0.534 . . . . 73.05 111.512 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.0 mt -85.64 -3.96 59.03 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.232 -0.44 . . . . 74.12 111.111 174.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.3 mt -120.2 71.28 0.9 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.217 -0.447 . . . . 75.23 110.843 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 C--O 1.256 1.435 0 CA-C-O 118.745 -0.645 . . . . 74.42 111.389 179.234 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptp . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.796 0.331 . . . . 74.42 111.225 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.16 105.8 17.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.946 0.403 . . . . 72.35 111.455 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m -115.5 129.24 25.29 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.423 -0.353 . . . . 72.32 110.842 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 8.1 Cg_endo -49.15 116.31 2.17 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.79 2.327 . . . . 73.32 112.951 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 92.6 m -121.95 132.34 54.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.3 -0.409 . . . . 73.02 111.462 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.531 ' HB ' HD21 ' A' ' 53' ' ' LEU . 14.4 p -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 121.264 0.555 . . . . 75.05 111.17 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG23 HG23 ' A' ' 47' ' ' VAL . 67.2 mt -111.69 109.3 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.031 -0.531 . . . . 74.2 111.162 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.5 m -83.77 118.62 24.04 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.69 0.281 . . . . 64.34 110.353 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.44 155.62 20.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.906 0.384 . . . . 74.44 111.603 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.29 -21.64 65.38 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.078 0.465 . . . . 75.52 111.194 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.82 -2.5 47.48 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.146 -0.479 . . . . 74.4 112.192 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.09 -28.06 17.42 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.624 -0.322 . . . . 65.33 113.202 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -66.68 136.23 55.23 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.822 0.344 . . . . 73.4 111.827 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.74 129.6 56.06 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.29 -0.256 . . . . 61.41 110.704 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 52.4 mt -109.68 128.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.82 0.343 . . . . 73.22 111.118 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -95.89 119.36 34.24 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.31 0.576 . . . . 73.24 112.122 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 4' ' ' PRO . . . -110.95 168.28 9.61 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.749 -0.659 . . . . 65.04 111.33 176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 4' ' ' PRO . 33.2 m -102.65 -5.26 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 111.866 0.321 . . . . 64.32 111.866 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -138.42 174.16 10.84 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.248 0.546 . . . . 72.14 112.059 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 74.2 p -80.96 121.63 81.02 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.946 -0.57 . . . . 71.54 111.567 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -61.34 128.53 25.24 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.92 2.413 . . . . 71.44 113.837 -175.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 28.2 ttmt -91.65 141.97 28.12 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.925 -0.579 . . . . 73.54 110.82 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -101.67 129.83 47.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.796 -0.565 . . . . 74.25 111.366 173.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -132.04 116.37 16.99 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.917 0.389 . . . . 74.4 111.337 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.44 -32.2 68.07 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.738 0.273 . . . . 74.21 111.738 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -55.05 -37.92 67.33 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.875 0.369 . . . . 60.21 111.587 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.1 p -97.32 -27.95 14.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.887 0.375 . . . . 51.15 110.857 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.38 10.94 69.99 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.349 -0.387 . . . . 71.33 113.209 -179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -122.18 171.55 8.92 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.527 0.679 . . . . 64.35 112.718 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 44.4 m-85 -102.17 132.78 47.87 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 64.34 110.484 169.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -98.27 120.43 38.66 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.68 0.276 . . . . 74.44 111.028 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -148.9 146.41 27.88 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.947 0.403 . . . . 75.44 111.331 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 37.9 ttmt -100.85 114.67 28.71 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.501 -0.318 . . . . 74.15 111.606 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -60.15 164.13 4.35 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.139 0.422 . . . . 64.15 112.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.8 mt -53.58 -32.13 49.65 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.952 0.406 . . . . 71.34 111.751 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -72.88 0.22 11.7 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.241 0.459 . . . . 64.21 112.241 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 25.35 61.36 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.896 -0.669 . . . . 61.34 112.121 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -106.45 106.77 17.45 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.829 0.347 . . . . 65.33 111.04 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 57.3 tt0 -81.52 110.84 17.29 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.323 -0.399 . . . . 73.14 111.056 -177.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.6 t -124.3 166.84 15.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.081 0.467 . . . . 64.14 111.966 -176.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 62.7 mtt180 -126.06 126.59 44.48 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.153 -0.476 . . . . 72.21 111.47 -176.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.612 0.244 . . . . 73.53 111.435 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -65.29 148.4 51.76 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.281 0.562 . . . . 75.22 112.356 -174.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HZ2' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -62.05 -32.03 72.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.335 1.235 . . . . 74.41 114.335 -172.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -84.44 -12.69 53.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.639 -0.663 . . . . 54.34 112.209 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.77 -28.16 55.57 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.297 0.48 . . . . 61.44 112.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 7' ' ' ILE . 7.5 p -76.82 113.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.267 0.556 . . . . 73.33 112.253 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -82.96 -60.14 2.26 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.031 0.444 . . . . 74.5 111.066 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.0 p -130.64 162.19 29.94 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.163 0.431 . . . . 64.33 112.163 -175.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 95.0 t -137.36 106.95 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 116.022 -0.535 . . . . 63.42 110.743 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -132.78 154.09 50.59 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.303 0.573 . . . . 71.24 112.011 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -78.29 160.17 28.03 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.311 0.577 . . . . 50.1 111.133 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 6' ' ' VAL . 93.1 mt -93.86 -4.21 50.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.185 -0.461 . . . . 71.45 110.753 173.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -105.23 8.4 33.94 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.15 0.426 . . . . 72.01 112.15 -178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 119.356 -0.354 . . . . 71.23 111.881 178.24 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 mtm . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.706 0.289 . . . . 52.54 111.266 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.29 150.16 21.26 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.017 0.437 . . . . 70.21 111.084 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.6 t -145.86 133.63 10.45 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 116.331 -0.395 . . . . 73.45 110.86 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HB2' HD12 ' A' ' 53' ' ' LEU . 47.6 Cg_endo -68.3 114.62 3.5 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.591 1.527 . . . . 43.53 111.802 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.6 m -123.83 126.67 46.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.258 -0.428 . . . . 71.52 111.541 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.33 117.85 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.457 0.646 . . . . 60.01 110.891 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.412 HD11 ' HB3' ' A' ' 21' ' ' PRO . 66.6 mt -100.64 111.73 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.086 -0.507 . . . . 60.41 111.187 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 99.6 m -83.8 121.26 27.07 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.508 -0.315 . . . . 73.12 110.824 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 15' ' ' ILE . 75.3 mt -89.06 172.1 9.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.062 0.458 . . . . 62.34 111.893 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -51.88 -41.24 61.75 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.87 -0.605 . . . . 61.3 112.212 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.2 -15.46 62.47 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.708 0.633 . . . . 75.4 112.708 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.79 -1.22 68.18 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.808 -0.517 . . . . 70.42 111.808 -170.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -72.11 136.36 46.53 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.763 0.425 . . . . 73.44 110.968 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.59 133.74 48.11 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.886 0.374 . . . . 71.32 111.592 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.573 HD11 HD11 ' A' ' 9' ' ' LEU . 63.0 mt -108.55 124.82 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.739 0.304 . . . . 60.41 110.555 175.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.6 111.34 23.28 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.988 0.423 . . . . 72.34 111.506 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.61 150.1 33.59 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.82 0.343 . . . . 64.25 111.826 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.557 HG13 HD23 ' A' ' 35' ' ' LEU . 29.5 m -96.68 2.32 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.949 0.404 . . . . 74.43 111.281 175.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . 2.7 t0 -140.19 164.69 29.4 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.199 -0.455 . . . . 52.42 110.077 -175.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.7 p -80.01 140.14 53.66 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 112.396 0.517 . . . . 63.35 112.396 -174.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' A' ' 32' ' ' PHE . 61.7 Cg_endo -72.6 111.15 3.16 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.545 2.163 . . . . 72.4 113.244 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -86.8 110.29 19.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.754 -0.657 . . . . 71.41 111.321 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -84.68 122.22 28.78 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.881 0.326 . . . . 72.42 111.881 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -98.65 122.16 41.52 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.936 0.398 . . . . 72.43 110.52 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.03 -42.14 73.32 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.309 -0.405 . . . . 63.43 111.987 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.41 -40.37 85.57 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.389 0.514 . . . . 71.5 112.389 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.579 ' HG ' ' HD2' ' A' ' 29' ' ' PHE . 8.7 t -97.54 -27.3 14.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.895 0.379 . . . . 65.11 111.825 -177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.51 10.76 79.07 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.099 -0.572 . . . . 33.33 114.252 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' HD2' ' HG ' ' A' ' 27' ' ' SER . 95.9 m-85 -101.97 154.45 18.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.286 0.543 . . . . 71.03 111.99 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CE1' HG11 ' A' ' 47' ' ' VAL . 52.8 m-85 -101.51 121.75 42.55 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.043 -0.526 . . . . 64.43 110.042 171.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -100.1 119.33 38.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.424 -0.353 . . . . 75.41 110.555 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.486 ' HB3' ' HA ' ' A' ' 21' ' ' PRO . 28.6 p90 -148.0 168.32 22.64 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.745 0.646 . . . . 72.21 112.745 -178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 4.6 ttmp? -112.68 116.61 30.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.732 -0.667 . . . . 70.05 110.941 -176.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 47.9 mt-30 -76.28 173.52 11.29 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.17 0.433 . . . . 75.14 112.17 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 18' ' ' VAL . 78.0 mt -57.11 -30.82 64.7 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 120.909 0.385 . . . . 65.41 111.902 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.92 -11.9 60.75 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.952 0.406 . . . . 74.11 111.58 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.33 -11.97 69.54 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.399 -0.429 . . . . 55.12 112.401 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -69.51 124.86 25.02 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.914 0.388 . . . . 74.53 111.578 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -82.67 140.07 33.35 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.375 -0.375 . . . . 75.35 110.641 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 t -145.82 156.28 43.47 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.93 0.395 . . . . 62.54 112.051 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 42.5 mtm180 -127.14 129.34 47.7 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.22 -0.446 . . . . 53.24 110.842 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.4 tt -130.44 141.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 120.647 0.26 . . . . 72.12 110.927 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.433 HD22 ' H ' ' A' ' 45' ' ' ASP . 10.1 t30 -69.13 152.09 45.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.755 0.788 . . . . 75.14 112.685 -172.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -59.51 -14.96 14.82 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.309 1.226 . . . . 74.41 114.309 -174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' H ' HD22 ' A' ' 43' ' ' ASN . 37.5 p-10 -78.59 -32.07 47.46 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.984 -0.448 . . . . 61.23 112.018 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -78.72 -28.64 45.04 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.547 0.573 . . . . 74.15 112.547 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.482 HG11 ' CE1' ' A' ' 30' ' ' TYR . 7.4 p -73.4 114.03 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.446 0.641 . . . . 71.13 111.912 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -83.65 -58.08 2.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.363 -0.38 . . . . 74.23 111.115 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.5 p -142.58 135.26 28.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.061 0.393 . . . . 54.31 112.061 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.8 t -100.07 116.64 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 116.423 -0.353 . . . . 72.14 110.95 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -132.31 150.99 52.04 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.948 0.351 . . . . 74.44 111.948 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -88.67 150.32 23.07 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.963 0.411 . . . . 70.35 111.368 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' A' ' 4' ' ' PRO . 93.1 mt -78.16 -18.15 55.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.214 -0.448 . . . . 75.13 111.42 176.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.416 ' HG ' ' HG2' ' A' ' 4' ' ' PRO . 76.8 mt -96.27 86.99 4.36 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.056 0.455 . . . . 74.41 111.101 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.648 -0.692 . . . . 70.24 111.409 178.05 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.71 0.291 . . . . 71.24 111.249 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.9 135.11 52.56 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.144 0.497 . . . . 75.03 111.523 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -125.22 149.88 65.34 Favored Pre-proline 0 N--CA 1.469 0.493 0 CA-C-N 116.161 -0.472 . . . . 72.35 110.508 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.56 ' HB2' HD12 ' A' ' 53' ' ' LEU . 30.7 Cg_endo -63.61 115.28 2.96 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 121.742 1.628 . . . . 64.24 111.479 173.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.9 m -125.09 128.36 48.34 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.761 0.315 . . . . 74.22 111.47 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.95 119.24 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.457 0.646 . . . . 73.12 111.555 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 21' ' ' PRO . 63.6 mt -101.21 110.65 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.037 -0.528 . . . . 72.33 110.675 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.1 m -89.47 129.4 35.97 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.556 -0.293 . . . . 54.32 110.952 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.0 mt -89.95 161.96 15.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.859 0.361 . . . . 74.31 110.8 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 11.5 t30 -62.7 -24.43 67.65 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.871 0.693 . . . . 74.13 112.871 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.52 -22.37 57.17 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.845 0.355 . . . . 71.21 111.691 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.65 -6.56 13.96 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.254 -0.498 . . . . 41.11 113.04 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -73.6 131.69 41.97 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.603 -0.351 . . . . 65.24 111.701 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -104.43 129.31 52.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.86 0.362 . . . . 72.22 111.178 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.1 mt -113.93 119.37 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 120.781 0.324 . . . . 73.44 110.688 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -94.28 132.88 38.41 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.1 0.476 . . . . 75.03 111.584 -177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -123.3 157.34 33.43 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.183 -0.462 . . . . 72.04 111.978 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.83 2.39 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.124 -0.489 . . . . 54.14 111.296 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.61 160.47 38.0 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.977 -0.556 . . . . 71.11 110.529 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 50.8 p -79.69 142.16 56.79 Favored Pre-proline 0 N--CA 1.469 0.48 0 CA-C-O 120.694 0.283 . . . . 73.1 111.331 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HB3' HD11 ' A' ' 7' ' ' ILE . 76.2 Cg_endo -75.71 146.72 30.52 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.689 2.26 . . . . 75.44 113.996 -175.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 32.2 ttmt -110.65 132.6 54.05 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.806 -0.634 . . . . 73.41 110.375 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -90.08 119.24 30.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.387 -0.525 . . . . 72.32 110.021 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -97.38 106.03 18.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.268 0.556 . . . . 72.33 110.641 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.31 -23.03 64.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.89 -0.595 . . . . 75.52 111.852 -177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -69.27 -39.24 78.52 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.584 0.587 . . . . 64.2 112.584 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -118.08 -27.19 6.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.492 0.552 . . . . 71.33 112.492 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.11 11.45 31.92 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.891 -0.671 . . . . 33.25 114.174 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.511 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 91.6 m-85 -102.05 156.65 17.41 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.776 0.658 . . . . 75.42 112.776 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 55.6 m-85 -101.43 124.46 47.14 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.808 -0.633 . . . . 72.14 110.855 173.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 22' ' ' LYS . 44.0 mt-10 -99.74 122.17 42.33 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.781 0.432 . . . . 64.14 111.955 -177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -154.85 162.3 41.16 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.045 0.45 . . . . 72.43 111.339 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -106.14 114.66 28.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.178 -0.464 . . . . 71.25 111.337 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -65.29 169.14 6.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.131 -0.486 . . . . 64.43 112.303 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.4 mt -55.37 -26.68 42.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.292 -0.413 . . . . 61.3 112.05 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.5 -4.7 32.03 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 111.997 0.369 . . . . 63.23 111.997 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 28.94 57.63 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.068 -0.587 . . . . 44.14 112.368 -175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -117.2 133.67 55.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.627 0.371 . . . . 62.43 111.296 -176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -89.07 123.64 33.55 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.837 0.351 . . . . 72.31 110.822 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.0 t -133.29 165.25 25.25 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.879 0.371 . . . . 73.01 111.623 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 29' ' ' PHE . 57.1 mtp180 -129.1 125.72 37.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.411 -0.359 . . . . 54.34 110.229 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -119.93 143.74 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.685 0.279 . . . . 75.35 111.573 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -64.5 147.5 52.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.447 0.641 . . . . 74.45 112.636 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.426 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.4 ptmt -64.0 -22.61 67.0 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.923 1.083 . . . . 63.22 113.923 -173.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -82.66 -10.85 58.75 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.61 -0.682 . . . . 73.23 111.89 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -82.67 -28.44 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.882 0.327 . . . . 73.45 111.882 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 44' ' ' LYS . 7.1 p -75.7 122.17 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.777 0.798 . . . . 73.44 112.845 -173.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HG2' HG23 ' A' ' 49' ' ' THR . 63.9 ttt180 -82.06 -62.77 1.54 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.608 -0.724 . . . . 75.2 110.272 172.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 48' ' ' ARG . 46.0 p -144.38 149.03 35.46 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.832 -0.622 . . . . 71.21 111.592 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.6 t -116.01 118.94 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.289 -0.414 . . . . 75.13 110.504 175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -131.25 127.8 38.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.759 0.651 . . . . 74.3 112.759 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.33 131.09 38.98 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.3 -0.63 . . . . 65.42 109.3 169.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 4' ' ' PRO . 89.3 mt -66.74 -24.94 66.28 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.953 0.406 . . . . 74.42 110.861 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.8 mt -93.84 83.56 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.126 -0.488 . . . . 61.32 110.029 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.497 -0.763 . . . . 62.25 112.644 -175.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ttt . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.389 0.138 . . . . 73.54 111.001 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.93 121.39 12.26 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.782 0.325 . . . . 74.33 111.53 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -88.15 120.45 70.61 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-N 116.691 -0.231 . . . . 65.33 110.52 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.501 ' HB2' HD12 ' A' ' 53' ' ' LEU . 36.2 Cg_endo -63.95 119.49 6.56 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.486 2.124 . . . . 71.55 112.899 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' ASP . 87.2 m -116.76 128.15 55.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.779 0.323 . . . . 74.12 111.8 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.409 ' HB ' HD21 ' A' ' 53' ' ' LEU . 14.0 p -98.81 129.39 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.218 0.533 . . . . 63.05 110.59 173.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -109.43 118.51 56.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.852 0.358 . . . . 73.11 111.805 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.7 m -84.01 125.94 32.56 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.788 -0.449 . . . . 65.55 109.788 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.9 176.19 6.61 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.944 0.878 . . . . 74.14 112.915 -176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -64.74 -42.45 95.19 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.989 -1.005 . . . . 60.21 111.166 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.55 -23.74 62.67 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.97 0.414 . . . . 73.51 111.789 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.99 -18.19 9.07 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.354 -0.451 . . . . 62.43 113.522 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -64.31 136.05 56.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.228 0.514 . . . . 73.03 111.743 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.92 135.04 52.04 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.616 0.246 . . . . 72.24 110.823 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.8 mt -116.83 122.98 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.597 0.237 . . . . 71.31 111.206 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -85.92 116.7 24.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.075 0.464 . . . . 72.52 111.596 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.26 142.82 41.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.32 -0.4 . . . . 73.41 111.44 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.605 HG13 ' HA ' ' A' ' 35' ' ' LEU . 26.4 m -82.31 -11.14 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.883 0.373 . . . . 41.3 111.718 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -128.51 157.7 40.45 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.248 -0.433 . . . . 71.15 109.912 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -79.28 143.65 60.82 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-O 120.967 0.413 . . . . 74.44 111.923 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.77 131.51 19.95 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.689 2.259 . . . . 72.14 113.772 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -103.39 132.22 49.82 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.828 -0.624 . . . . 75.53 110.631 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -89.75 123.92 34.17 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 122.014 -0.429 . . . . 44.34 111.497 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.99 106.46 18.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.012 0.435 . . . . 72.3 110.19 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.84 -21.66 63.34 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.342 -0.39 . . . . 73.42 111.935 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -69.17 -46.37 67.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.86 0.362 . . . . 71.01 111.744 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 97.2 p -101.09 -27.03 13.48 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.153 0.427 . . . . 64.12 112.153 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.11 8.39 64.75 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.219 -0.515 . . . . 44.32 113.265 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.409 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 59.2 m-85 -95.71 155.21 16.84 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.201 0.524 . . . . 63.51 111.767 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 39.8 m-85 -101.46 131.05 47.78 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.148 -0.478 . . . . 72.3 111.114 172.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -98.9 118.94 36.81 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.078 -0.51 . . . . 75.32 110.655 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -143.47 142.4 31.16 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.302 0.572 . . . . 75.53 111.91 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -94.11 110.72 22.41 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.764 -0.653 . . . . 51.42 111.476 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -64.69 173.59 2.15 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.064 0.459 . . . . 61.31 112.217 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.605 ' HA ' HG13 ' A' ' 18' ' ' VAL . 89.2 mt -49.15 -45.75 44.28 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.23 0.826 . . . . 74.11 113.23 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' HB2' ' HG3' ' A' ' 38' ' ' LYS . 3.3 m-20 -80.2 15.07 1.65 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.56 0.578 . . . . 45.33 112.56 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.04 10.96 86.0 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.907 -0.663 . . . . 74.25 112.454 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' HG3' ' HB2' ' A' ' 36' ' ' ASP . 26.7 mtpp -80.96 105.07 11.91 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.605 0.362 . . . . 64.04 111.79 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -73.86 123.83 24.97 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.765 0.317 . . . . 72.43 110.905 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.4 t -135.1 160.19 39.13 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.504 -0.316 . . . . 63.01 110.77 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 76.2 mtm180 -134.07 142.01 47.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.964 0.357 . . . . 74.22 111.964 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.2 tt -141.28 152.91 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.253 -0.43 . . . . 64.4 110.293 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -64.12 153.79 36.58 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.76 0.652 . . . . 65.21 112.76 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -66.36 -14.91 62.8 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.47 0.915 . . . . 73.24 113.47 -174.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -85.28 -11.08 55.6 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.898 -0.501 . . . . 74.41 111.595 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -90.36 -27.59 19.26 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.207 0.447 . . . . 73.45 112.207 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.3 p -70.09 111.49 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.556 0.693 . . . . 63.23 111.508 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HG2' HG23 ' A' ' 49' ' ' THR . 21.7 ttm-85 -83.03 -62.77 1.51 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.883 -0.599 . . . . 74.14 111.254 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.513 HG23 ' HG2' ' A' ' 48' ' ' ARG . 61.7 p -141.04 135.64 31.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.178 0.514 . . . . 74.5 111.95 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.54 124.57 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.022 -0.535 . . . . 73.31 111.225 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -142.64 144.22 32.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.338 0.255 . . . . 71.1 111.577 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.578 ' HB2' ' HG2' ' A' ' 55' ' ' GLU . 35.6 m-20 -86.28 142.9 28.2 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.029 0.442 . . . . 60.44 111.547 175.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 4' ' ' PRO . 95.4 mt -67.62 -19.83 65.27 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.082 0.468 . . . . 74.33 111.568 177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.2 mt -80.63 -2.79 47.98 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.347 -0.388 . . . . 52.0 111.815 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.578 ' HG2' ' HB2' ' A' ' 52' ' ' ASP . 13.3 mm-40 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.818 -0.61 . . . . 75.54 111.643 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.537 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.733 0.302 . . . . 64.15 111.207 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.64 160.29 25.1 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.017 0.437 . . . . 75.11 111.4 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 40.5 t -161.79 118.27 1.33 Allowed Pre-proline 0 N--CA 1.469 0.509 0 CA-C-N 116.424 -0.353 . . . . 65.42 111.013 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 3' ' ' SER . 10.8 Cg_endo -53.29 116.31 2.87 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.303 2.002 . . . . 64.15 111.768 177.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.8 m -132.77 141.46 48.52 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.342 -0.39 . . . . 71.45 111.123 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HB ' HD21 ' A' ' 53' ' ' LEU . 7.2 p -105.9 117.89 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.557 0.694 . . . . 70.53 111.468 178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.16 104.5 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.253 0.549 . . . . 72.1 110.513 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.0 m -85.67 119.18 25.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.964 -0.562 . . . . 52.42 110.755 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.5 mt -82.19 157.13 24.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.779 0.323 . . . . 74.3 111.217 177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.545 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 26.4 t-20 -60.44 -36.36 78.03 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.993 0.368 . . . . 64.4 111.993 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.37 -8.45 55.9 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.405 0.52 . . . . 63.12 112.405 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.45 -33.2 4.58 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.803 -0.713 . . . . 72.24 114.666 175.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.2 135.1 44.49 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 117.673 0.736 . . . . 72.01 112.427 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.35 129.98 53.56 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.28 -0.418 . . . . 75.24 110.485 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt -111.25 130.48 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 120.824 0.345 . . . . 71.31 111.234 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -96.56 119.2 34.61 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.06 0.457 . . . . 71.14 111.999 -178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.7 153.15 38.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.348 -0.387 . . . . 54.12 111.5 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.31 -10.58 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.832 0.349 . . . . 62.05 111.769 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -143.7 166.55 24.55 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.981 0.419 . . . . 64.32 111.579 176.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.7 p -80.84 138.29 50.2 Favored Pre-proline 0 N--CA 1.47 0.552 0 N-CA-C 112.178 0.436 . . . . 61.24 112.178 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 69.0 Cg_endo -71.67 126.31 11.95 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.658 2.239 . . . . 65.21 113.941 -175.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 2.2 ttmp? -86.45 141.21 29.29 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.412 -0.358 . . . . 75.14 110.311 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -99.11 129.89 45.4 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.12 0.486 . . . . 74.12 112.095 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -109.28 111.87 23.7 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.974 -0.557 . . . . 70.11 110.109 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.73 -35.33 79.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.554 0.575 . . . . 62.2 112.554 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.11 -52.72 53.72 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.954 0.407 . . . . 51.22 111.829 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.5 m -85.56 -26.96 25.85 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.306 -0.406 . . . . 34.54 111.754 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.79 8.91 85.27 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.404 -0.427 . . . . 63.33 113.912 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 83.6 m-85 -102.81 156.21 17.81 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.222 0.534 . . . . 73.42 112.116 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 21' ' ' PRO . 67.7 m-85 -101.93 135.59 43.21 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.627 -0.715 . . . . 63.23 110.603 172.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 36.0 mt-10 -98.89 118.78 36.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.441 0.163 . . . . 71.24 110.786 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -147.74 152.22 37.38 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.156 0.503 . . . . 73.02 111.641 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' NZ ' ' HB2' ' A' ' 33' ' ' LYS . 4.1 ttmp? -106.9 112.71 25.8 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.128 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -64.82 164.85 11.57 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.769 0.319 . . . . 75.54 111.799 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.9 mt -53.51 -29.72 37.79 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.386 0.884 . . . . 61.21 113.386 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -77.28 -11.54 59.84 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.91 0.386 . . . . 70.44 111.679 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.51 -6.28 49.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.527 -0.368 . . . . 53.31 112.242 -174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -70.4 101.57 1.98 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.928 0.491 . . . . 75.35 111.74 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 61.2 tt0 -82.07 107.28 14.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.756 0.312 . . . . 74.23 110.366 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.3 t -123.68 165.2 17.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.056 0.455 . . . . 74.42 111.836 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 49.4 mtm180 -124.59 132.49 53.44 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.962 -0.563 . . . . 75.23 111.715 -176.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.6 tt -130.93 146.62 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.685 0.278 . . . . 71.13 111.211 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -71.75 152.28 42.87 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.571 0.582 . . . . 73.24 112.571 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.2 pttp -57.97 -31.52 66.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.516 0.932 . . . . 53.54 113.516 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -69.01 -11.64 60.97 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.415 0.524 . . . . 54.24 112.415 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -88.14 -27.79 21.66 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.585 0.587 . . . . 74.53 112.585 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 44' ' ' LYS . 10.7 p -76.91 118.64 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.806 0.812 . . . . 64.03 112.809 -173.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HB2' ' HA ' ' A' ' 10' ' ' ASN . 57.4 ttt180 -81.9 -58.44 2.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.211 -0.904 . . . . 74.43 111.077 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 45.4 p -148.08 134.53 19.66 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.863 -0.608 . . . . 73.55 111.189 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 111.2 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.832 0.348 . . . . 62.31 110.983 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -133.5 141.95 48.0 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.035 0.445 . . . . 71.04 111.761 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 24.2 m-20 -72.13 156.98 38.59 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.254 -0.43 . . . . 72.31 110.464 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.488 HD21 ' HB ' ' A' ' 6' ' ' VAL . 95.1 mt -85.74 -6.4 59.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.253 0.549 . . . . 61.22 110.73 173.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.5 mt -106.5 42.06 1.34 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.937 -0.574 . . . . 65.25 111.415 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 52' ' ' ASP . 49.4 mt-10 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.457 -0.782 . . . . 64.41 111.5 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.431 0.158 . . . . 75.12 110.799 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.93 102.07 1.21 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.97 0.414 . . . . 45.3 111.392 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 p -105.95 119.69 51.46 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.178 -0.465 . . . . 62.33 110.826 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HB2' HD12 ' A' ' 53' ' ' LEU . 9.6 Cg_endo -50.07 120.83 6.61 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.892 2.395 . . . . 61.13 112.339 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -125.71 133.04 52.26 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.437 -0.347 . . . . 71.52 111.826 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' HD21 ' A' ' 53' ' ' LEU . 14.2 p -99.97 124.5 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.173 0.511 . . . . 75.53 110.758 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.4 120.06 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.073 0.463 . . . . 71.34 110.988 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.0 m -100.01 118.49 36.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.033 -0.531 . . . . 71.15 110.826 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.467 HD12 ' HD3' ' A' ' 13' ' ' ARG . 78.3 mt -83.89 168.35 16.16 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.863 0.363 . . . . 73.34 111.521 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -63.58 -28.73 70.13 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.493 -0.321 . . . . 63.05 111.455 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -63.21 -16.21 59.44 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.036 0.446 . . . . 74.22 111.61 175.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 5.35 67.81 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.677 -0.569 . . . . 54.12 111.677 -170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' HD3' HD12 ' A' ' 9' ' ' LEU . 78.0 ttt180 -77.33 136.37 38.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.308 0.643 . . . . 74.22 111.217 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.33 130.24 56.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.989 0.423 . . . . 71.34 111.767 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.0 mt -122.42 130.49 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.093 -0.503 . . . . 52.22 110.618 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -94.85 127.99 41.27 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.101 0.477 . . . . 74.11 112.037 -177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.82 164.3 17.72 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.083 -0.508 . . . . 72.24 111.453 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.73 -18.36 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.211 0.448 . . . . 72.24 112.211 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -126.94 172.48 10.41 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.275 0.56 . . . . 65.42 111.868 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -79.81 119.39 76.57 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.812 -0.631 . . . . 64.02 110.499 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.82 134.34 41.27 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.072 2.515 . . . . 63.02 113.951 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -85.63 124.64 32.39 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.606 -0.724 . . . . 73.44 110.746 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.81 108.62 20.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.948 0.404 . . . . 75.32 110.983 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -98.25 110.54 23.11 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.971 0.415 . . . . 74.44 110.592 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -64.75 -39.29 93.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 71.51 111.993 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.19 -43.03 99.36 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.157 0.429 . . . . 72.4 112.157 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.4 m -91.75 -28.08 17.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.934 0.346 . . . . 54.4 111.934 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 11.94 72.85 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 120.922 -0.656 . . . . 72.23 113.824 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -108.96 155.12 21.23 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.387 0.613 . . . . 63.12 112.462 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.69 129.9 47.95 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.58 -0.736 . . . . 72.11 110.326 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.2 mt-10 -108.28 121.91 45.86 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.592 -0.276 . . . . 72.5 111.194 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.77 143.79 29.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.82 0.343 . . . . 72.22 111.627 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 39.6 ttmt -98.4 114.55 26.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.767 0.318 . . . . 71.55 111.241 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -60.6 165.11 4.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.412 -0.358 . . . . 74.23 111.779 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.1 mt -57.64 -26.68 61.97 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.87 0.366 . . . . 73.52 111.623 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.88 -6.21 43.57 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.48 0.548 . . . . 70.11 112.48 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.09 23.9 46.81 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.075 -0.584 . . . . 73.41 112.747 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -112.63 112.3 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.794 0.331 . . . . 45.43 111.457 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 53.9 tt0 -89.69 109.81 20.75 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.806 0.336 . . . . 73.15 111.319 -178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -111.87 163.42 14.23 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.935 0.398 . . . . 61.11 111.529 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 55.4 mtt180 -123.51 131.64 53.69 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.928 0.394 . . . . 74.33 111.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -134.84 152.37 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 116.441 -0.345 . . . . 62.55 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -66.87 147.29 53.43 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.184 0.516 . . . . 73.53 111.667 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' O ' HG12 ' A' ' 47' ' ' VAL . 21.4 ptmt -65.07 -20.2 66.36 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.983 0.734 . . . . 73.51 112.983 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -76.55 -10.25 59.25 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.314 0.487 . . . . 74.02 112.314 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -90.96 -17.73 25.86 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.875 0.694 . . . . 73.43 112.875 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 44' ' ' LYS . 8.9 p -75.0 117.79 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 121.481 0.658 . . . . 60.04 112.618 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -83.51 -61.72 1.77 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.303 0.573 . . . . 51.24 110.656 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.9 p -147.06 150.46 35.1 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.669 -0.696 . . . . 63.22 111.369 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 86.4 t -126.58 118.25 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.236 -0.438 . . . . 65.11 110.812 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -130.19 136.62 49.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.358 0.503 . . . . 71.22 112.358 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -68.03 128.18 35.6 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.332 -0.395 . . . . 74.25 110.523 172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 4' ' ' PRO . 84.8 mt -59.16 -17.52 27.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.906 0.384 . . . . 75.34 111.779 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.77 85.09 7.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.16 0.505 . . . . 54.43 110.336 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 118.571 -0.728 . . . . 71.12 111.975 -178.279 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.182 0.515 . . . . 73.44 110.999 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.81 146.06 17.54 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.804 -0.635 . . . . 71.41 110.981 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -156.51 142.08 12.66 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 116.536 -0.302 . . . . 71.42 110.689 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.591 ' HB2' HD12 ' A' ' 53' ' ' LEU . 35.7 Cg_endo -63.42 116.76 3.82 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.565 2.176 . . . . 71.43 113.107 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.0 m -131.89 134.23 45.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.438 -0.346 . . . . 74.14 111.295 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.77 125.72 66.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.494 0.664 . . . . 63.25 111.685 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.3 mt -98.51 116.98 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.291 -0.413 . . . . 73.41 111.615 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.6 m -88.79 124.38 34.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.392 -0.367 . . . . 53.41 110.721 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 mt -92.18 164.75 13.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.119 0.485 . . . . 71.04 112.282 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -54.61 -33.94 61.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.358 0.663 . . . . 73.44 111.384 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.14 -12.47 60.9 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.848 -0.615 . . . . 65.24 111.907 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.73 -24.72 30.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.436 -0.411 . . . . 61.15 112.677 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -63.16 135.7 57.32 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.846 0.355 . . . . 73.3 111.804 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -110.61 148.65 31.77 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.503 -0.317 . . . . 73.5 111.558 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.58 127.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.625 -0.261 . . . . 61.23 110.847 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -93.08 124.0 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.091 0.472 . . . . 71.3 111.995 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.06 156.8 26.94 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.122 -0.49 . . . . 53.13 111.55 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -88.94 -9.5 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 112.017 0.377 . . . . 63.33 112.017 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.61 166.44 24.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.102 0.477 . . . . 71.25 111.443 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.5 p -79.61 140.85 55.58 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 116.232 -0.44 . . . . 73.24 111.61 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 61.6 Cg_endo -71.47 148.73 54.85 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.594 2.196 . . . . 75.22 113.943 -174.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -105.62 135.1 47.63 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.764 -0.653 . . . . 74.51 110.324 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -87.03 122.26 30.62 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.05 0.452 . . . . 75.12 111.739 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -98.1 108.67 21.43 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.144 -0.48 . . . . 70.01 110.951 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.63 -14.24 55.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.788 0.327 . . . . 71.43 111.61 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -63.0 -52.88 61.29 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 74.42 111.376 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -118.72 -26.8 6.01 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.033 0.383 . . . . 75.1 112.033 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.69 11.88 10.98 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.406 -0.902 . . . . 71.1 114.614 177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -91.1 162.29 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.745 0.772 . . . . 70.23 112.708 -176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 43.6 m-85 -110.27 132.71 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.743 -0.662 . . . . 72.43 110.798 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 55.8 mt-10 -99.28 119.57 38.13 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 122.364 -0.21 . . . . 61.32 111.089 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -151.32 145.04 25.04 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.009 0.433 . . . . 72.33 111.434 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 3.5 ttmp? -98.26 112.44 24.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.538 -0.301 . . . . 65.32 111.494 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.68 162.15 8.95 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.943 0.401 . . . . 74.43 111.853 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 18' ' ' VAL . 84.1 mt -48.84 -39.91 27.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.722 0.638 . . . . 74.41 112.722 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.89 9.33 1.18 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.753 0.649 . . . . 64.35 112.753 -177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 46.66 25.11 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.918 -0.658 . . . . 72.44 112.322 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -125.01 104.71 8.71 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.656 -0.32 . . . . 71.42 111.289 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 60.9 tt0 -75.61 100.59 4.65 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.134 0.492 . . . . 73.14 110.371 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.3 t -114.21 165.72 12.38 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.07 0.462 . . . . 72.44 111.511 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.3 mtm180 -129.8 144.69 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.34 -0.391 . . . . 61.3 111.647 -176.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 tt -139.51 149.71 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.301 -0.409 . . . . 73.43 110.901 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -78.51 153.93 30.91 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.797 0.665 . . . . 71.31 112.797 -171.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 30' ' ' TYR . 25.4 pttm -58.88 -25.72 63.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.868 1.062 . . . . 74.21 113.868 -175.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 p30 -79.56 -11.22 59.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.236 0.458 . . . . 62.11 112.236 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -94.23 -18.32 21.81 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.426 0.528 . . . . 74.04 112.426 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.51 119.95 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.766 0.654 . . . . 71.44 112.766 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -82.68 -66.92 0.83 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.349 -0.387 . . . . 71.31 110.505 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -146.83 137.77 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.94 -0.573 . . . . 54.24 111.417 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -95.94 108.78 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.735 0.302 . . . . 54.21 110.74 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.87 142.66 39.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.084 0.469 . . . . 71.33 111.679 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -94.53 155.39 16.94 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.065 0.459 . . . . 71.34 111.22 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 4' ' ' PRO . 82.3 mt -95.99 -3.36 45.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.374 -0.375 . . . . 73.12 111.699 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.1 mt -112.86 85.11 2.1 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.846 0.355 . . . . 74.33 111.949 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 118.421 -0.799 . . . . 52.25 112.358 177.583 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.716 0.293 . . . . 73.22 111.205 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.07 95.35 2.06 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.092 0.473 . . . . 54.31 111.433 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 p -127.0 131.39 23.84 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-N 116.241 -0.436 . . . . 71.53 110.933 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.6 ' HB2' HD12 ' A' ' 53' ' ' LEU . 14.1 Cg_endo -55.17 118.95 5.74 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.98 2.454 . . . . 71.2 112.9 -177.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 m -126.24 126.95 44.87 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.192 -0.458 . . . . 74.11 111.378 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.511 HG13 ' HB2' ' A' ' 51' ' ' LYS . 7.5 p -105.13 125.94 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.141 0.496 . . . . 73.42 111.848 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.78 113.18 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.788 0.327 . . . . 74.3 111.324 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.9 m -83.44 134.58 34.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.18 -0.304 . . . . 53.44 110.18 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.8 mt -100.76 170.18 8.51 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.053 0.454 . . . . 71.11 112.069 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -52.12 -45.11 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.864 -0.607 . . . . 75.13 112.606 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.67 -21.86 64.42 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.035 0.445 . . . . 73.45 111.577 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.59 -23.85 7.8 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.026 -0.607 . . . . 71.03 113.598 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -56.6 129.86 42.77 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 117.176 0.488 . . . . 64.02 111.899 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -103.31 130.48 50.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.883 0.373 . . . . 74.33 110.909 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.87 120.52 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.543 -0.299 . . . . 71.33 110.532 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -95.51 127.26 41.4 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.141 0.496 . . . . 73.31 112.045 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -113.9 154.83 26.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.093 -0.503 . . . . 72.11 111.744 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 35' ' ' LEU . 35.0 m -75.14 -29.19 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.001 0.371 . . . . 64.41 112.001 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -129.04 174.61 9.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.897 0.379 . . . . 75.23 111.348 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.2 p -78.78 141.27 59.44 Favored Pre-proline 0 N--CA 1.469 0.514 0 CA-C-N 116.342 -0.39 . . . . 63.52 111.648 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.51 138.66 35.93 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.616 2.211 . . . . 65.24 113.79 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -93.41 130.22 39.29 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.97 -0.559 . . . . 75.1 110.455 175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -90.82 114.8 27.29 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.153 -0.342 . . . . 75.03 111.269 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -97.89 104.52 16.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.889 0.376 . . . . 54.44 110.672 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -66.89 -30.51 70.68 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 111.945 0.35 . . . . 74.42 111.945 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -58.21 -52.42 65.63 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.034 0.445 . . . . 54.11 111.959 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.5 m -102.41 -11.63 18.47 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.105 0.409 . . . . 72.54 112.105 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.52 11.35 80.25 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.06 -0.59 . . . . 51.21 114.005 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.516 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 67.8 m-85 -97.95 156.38 16.65 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.282 0.563 . . . . 73.41 112.477 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 68.1 m-85 -101.21 127.22 47.89 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.799 -0.637 . . . . 74.52 110.01 169.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HG2' ' HG2' ' A' ' 41' ' ' ARG . 36.3 mt-10 -99.6 119.37 37.96 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.768 0.318 . . . . 61.01 111.088 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -144.74 144.61 31.28 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.074 0.464 . . . . 75.33 111.942 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 2.4 ttmp? -99.33 109.81 22.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.256 -0.429 . . . . 73.03 110.698 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 48.8 mt-30 -60.49 160.66 8.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.002 0.371 . . . . 52.14 112.002 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HA ' HG13 ' A' ' 18' ' ' VAL . 83.3 mt -56.29 -27.5 55.63 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 112.364 0.505 . . . . 74.0 112.364 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -78.46 -11.54 59.96 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.011 0.434 . . . . 65.23 111.778 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.98 -21.35 31.86 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.379 -0.439 . . . . 64.53 112.711 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -63.07 104.01 0.53 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 111.762 0.282 . . . . 75.11 111.762 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 58.9 tt0 -88.4 118.3 27.93 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.757 0.313 . . . . 71.32 110.606 177.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.1 t -136.07 164.59 27.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.397 0.517 . . . . 73.51 112.397 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HG2' ' HG2' ' A' ' 31' ' ' GLU . 17.9 mtm180 -110.65 155.88 21.77 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.845 -0.616 . . . . 73.22 110.775 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -147.98 144.77 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.601 0.239 . . . . 73.44 110.935 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -70.32 150.18 46.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.258 0.551 . . . . 52.55 112.137 -172.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -63.14 -14.86 53.68 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.759 1.022 . . . . 72.22 113.759 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -89.2 -14.95 34.85 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.767 -0.583 . . . . 71.2 111.979 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -81.67 -28.61 33.47 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.916 0.388 . . . . 73.42 111.406 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.14 114.34 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.682 0.753 . . . . 74.23 112.383 -174.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -81.75 -59.4 2.61 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.475 -0.784 . . . . 65.1 110.665 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.1 p -147.32 128.41 14.63 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.556 -0.293 . . . . 74.41 111.617 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.65 117.26 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.775 0.321 . . . . 63.32 110.389 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' HG13 ' A' ' 6' ' ' VAL . 34.7 mttm -118.02 132.08 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.607 0.595 . . . . 75.11 112.607 -176.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 34.4 m-20 -83.14 133.24 35.05 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.002 -0.545 . . . . 74.02 109.685 170.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.6 HD12 ' HB2' ' A' ' 4' ' ' PRO . 60.3 mt -79.62 -3.29 46.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.703 -0.623 . . . . 63.33 111.268 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.6 mt -120.76 25.75 9.52 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.447 -0.342 . . . . 43.22 111.668 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 52' ' ' ASP . 2.9 pp20? . . . . . 0 C--O 1.249 1.063 0 N-CA-C 112.43 0.53 . . . . 74.02 112.43 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.754 0.311 . . . . 62.14 110.966 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.99 126.45 39.57 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.843 0.354 . . . . 51.43 111.404 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 m -121.7 143.21 37.66 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.442 -0.345 . . . . 61.44 110.409 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HB2' HD12 ' A' ' 53' ' ' LEU . 29.1 Cg_endo -62.4 115.16 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 121.97 1.78 . . . . 74.15 112.023 177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.3 m -122.25 130.74 53.46 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.906 0.384 . . . . 73.13 111.536 -174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.4 117.91 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.411 0.624 . . . . 73.13 111.316 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.406 HG23 HG23 ' A' ' 47' ' ' VAL . 61.7 mt -96.14 105.65 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.914 -0.585 . . . . 51.13 111.285 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.2 m -85.39 121.49 28.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.465 -0.334 . . . . 71.43 110.755 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 mt -85.56 167.34 15.49 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.665 0.269 . . . . 71.43 111.036 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -54.87 -39.24 68.46 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.587 0.588 . . . . 45.51 112.587 -176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -71.18 -24.4 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.704 0.287 . . . . 71.44 111.612 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.74 15.56 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.313 -0.403 . . . . 73.43 113.285 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -68.09 125.86 27.7 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 122.489 -0.418 . . . . 64.41 111.306 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -103.13 129.3 49.95 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.066 0.46 . . . . 72.24 111.287 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 57.5 mt -121.54 113.65 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.485 -0.325 . . . . 73.13 110.654 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -95.18 129.06 42.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.176 0.512 . . . . 44.04 112.282 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 34' ' ' GLN . . . -116.57 161.74 18.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.08 -0.509 . . . . 74.12 111.767 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.65 -24.59 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.853 0.358 . . . . 60.55 111.558 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -122.46 165.45 16.33 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.154 -0.475 . . . . 42.43 111.297 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.3 p -79.56 127.77 77.12 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 116.357 -0.383 . . . . 71.0 111.112 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -51.37 123.01 11.16 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.311 2.674 . . . . 63.24 113.734 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -86.62 129.4 34.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.688 -0.687 . . . . 74.41 110.292 176.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -82.2 134.05 35.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.567 0.699 . . . . 72.41 112.232 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -98.62 106.16 18.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.481 -0.781 . . . . 64.32 110.583 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -75.3 -20.1 59.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.944 0.402 . . . . 74.41 111.886 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -69.18 -54.79 13.01 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.104 0.409 . . . . 73.34 112.104 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.4 t -115.74 -6.59 12.12 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.734 0.642 . . . . 71.2 112.734 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.86 12.64 57.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.274 -0.965 . . . . 63.33 114.31 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 47.7 m-85 -90.19 171.86 9.21 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.397 0.599 . . . . 72.44 112.296 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 61.5 m-85 -119.54 132.18 55.69 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.027 -0.533 . . . . 73.32 110.992 171.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.57 119.95 38.89 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.775 0.322 . . . . 71.11 110.785 176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -151.29 140.45 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.415 -0.357 . . . . 72.12 110.943 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 39' ' ' GLN . 40.8 ttmt -93.14 109.28 20.77 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.885 0.374 . . . . 71.14 110.681 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . 41.8 mt-30 -62.19 160.1 13.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.466 -0.334 . . . . 72.3 111.385 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -55.34 -29.07 57.65 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.473 0.545 . . . . 65.32 112.473 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.81 -12.04 60.29 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.937 0.398 . . . . 63.41 111.863 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.92 -20.67 28.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.421 -0.419 . . . . 73.23 113.567 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.48 108.2 8.13 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.243 0.46 . . . . 64.42 112.243 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 40.2 tt0 -86.02 120.77 27.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 75.51 110.494 172.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 165.53 25.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.343 -0.39 . . . . 70.35 111.131 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 75.1 mtm180 -111.02 139.48 46.34 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.978 0.418 . . . . 63.33 111.37 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.69 146.01 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.357 -0.383 . . . . 45.04 110.841 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -68.5 145.82 53.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.481 0.658 . . . . 55.44 112.291 -175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -63.09 -18.91 63.91 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.292 0.849 . . . . 72.41 113.292 -176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -81.36 -13.23 58.57 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.057 0.392 . . . . 61.43 112.057 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -90.86 -27.98 18.45 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.049 0.389 . . . . 73.22 112.049 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG23 HG23 ' A' ' 7' ' ' ILE . 6.7 p -76.67 116.1 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.422 0.63 . . . . 75.02 112.095 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HG2' HG23 ' A' ' 49' ' ' THR . 78.7 ttt180 -81.96 -64.72 1.12 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.087 -0.506 . . . . 65.44 111.312 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.554 HG23 ' HG2' ' A' ' 48' ' ' ARG . 82.8 p -133.32 133.62 42.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 120.853 0.358 . . . . 71.34 111.904 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.0 t -103.22 111.07 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.417 -0.356 . . . . 74.4 110.27 174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 43.4 mtmt -121.99 145.22 48.34 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.836 0.351 . . . . 64.22 111.663 -177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -94.4 133.38 38.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.893 0.378 . . . . 64.12 110.957 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 4' ' ' PRO . 87.8 mt -66.01 -19.65 65.93 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.876 0.324 . . . . 75.24 111.876 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.93 35.49 1.4 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.993 0.425 . . . . 43.41 111.253 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? . . . . . 0 C--O 1.252 1.231 0 N-CA-C 113.523 0.935 . . . . 71.42 113.523 -179.792 . . . . . . . . 0 0 . 1 stop_ save_